[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"\"}":3,"_public_publisher_byId_591637e0-fd04-43ea-8c76-34d492ca99e7":656,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"totalCitation\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:591637e0-fd04-43ea-8c76-34d492ca99e7,\"}":799},{"meta":4,"data":6},{"total":5},"117",[7,60,176,207,299,413,445,480,543,572],{"id":8,"createTime":9,"updateTime":10,"relativeEntities":11,"slug":12,"properties":13,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":29,"subjectFields":30,"manageAffiliations":31,"indexDatabases":32,"url":33,"thumbnailPath":34,"statistic":35,"gsStatistic":26,"type":26,"analyzePriority":26},"5a09599f-54d1-44c3-8f16-3847ac552024","2023-08-17T04:28:50.832+00:00","2025-10-13T23:58:52.517+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Truy%E1%BB%81n-nhi%E1%BB%85m-Vi%E1%BB%87t-Nam",{"country":14,"issn":16,"introduce":18,"title":21},{"VOID":15},"VN",{"VOID":17},"08667829",{"EN":19,"VI":20},"{\"ops\":[{\"insert\":\"Vietnam Journal of Infectious Diseases is a social - professional forum of the Vietnam Society for Infectious Diseases, whose responsibility is to introduce the researches, the scientific advances in Vietnam and from the world; to contribute to the improvement of knowledges for health care staffs about clinic, treatment, guideline, prevention, epidemiology for infectious diseases, HIV\u002FAIDS and community health care; to provide, exchange and publish scientific information to the public accurately and promptly.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Vietnam Journal of Infectious Diseases publishes in the whole country; serves the professional work for researchers, clinical staffs, administrators, undergraduate and postgraduate students who are working and studying in the infections, tropical diseases and HIV\u002FAIDS from central to local levels, also organizations and individuals in the world who are interested in infectious and tropical diseases and prevention for HIV\u002FAIDS.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Editor in Chief:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Kinh. - Chairman of Editorial Board\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Mui.\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Headquarter:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Address:\"},{\"insert\":\" Level 6, National Hospital for Tropical Diseases, No. 78 Giai Phong Street, Dong Da District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tel:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913552672\"},\"insert\":\"0913552672\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Bank account:\"},{\"insert\":\" 0021000275119, Vietcombank Hanoi Branch. Transaction office No. 7, 402 Tran Khat Chan, Hai Ba Trung District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Tạp chí Truyền nhiễm Việt Nam là cơ quan ngôn luận của Hội Truyền nhiễm Việt Nam, chịu sự lãnh đạo, chỉ đạo trực tiếp của Thường vụ Ban Chấp hành Hội Truyền nhiễm Việt Nam; sự kiểm tra, giám sát về nghiệp vụ báo chí của các cơ quan chức năng quản lý báo chí thuộc Bộ Thông tin và Truyền thông và Ban Tuyên giáo Trung ương Đảng.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí có trách nhiệm giới thiệu các công trình nghiên cứu khoa học, những tiến bộ khoa học trên thế giới và trong nước, góp phần nâng cao kiến thức khoa học cho cán bộ y tế về lâm sàng, điều trị, hướng dẫn, dự phòng, dịch tễ học các bệnh truyền nhiễm, HIV\u002FAIDS và chăm sóc sức khỏe cộng đồng; cung cấp, trao đổi, phổ biến các thông tin khoa học tới công chúng chính xác và kịp thời.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí xuất bản 03 tháng\u002F01 kỳ và được phát hành qua Bưu điện và tự phát hành trong phạm vi toàn quốc.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Lãnh đạo Tạp chí: \"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Tổng Biên tập: ThS.BSCKII Nguyễn Trung Cấp\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Phó Tổng Biên tập:\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"            TS.BSCKII Phạm Ngọc Thạch\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Trụ sở tòa soạn:\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Địa chỉ: Tầng 6, Bệnh viện Bệnh Nhiệt đới Trung ương, 78 đường Giải Phóng, phường Phương Mai, quận Đống Đa, thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Điện thoại:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\" - \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tài khoản:\"},{\"insert\":\" Số 0021000275119 Ngân hàng Ngoại thương Việt Nam, chi nhánh Hà Nội (Vietcombank Hà Nội). Phòng giao dịch số 7, 402 Trần Khát Chân, quận Hai Bà Trưng, Thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":22,"VI":23},"Vietnam Journal of Infectious Diseases","Tạp chí Truyền nhiễm Việt Nam","PUBLISHER","VERIFIED",null,"Admin update database","PENDING",51,[],[],[],"https:\u002F\u002Ftruyennhiemvietnam.vn\u002Findex.php\u002Fvjid","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F5a09599f-54d1-44c3-8f16-3847ac552024\u002Fadb0e52bf25e0de580fd4289519cb8bf.jpg",{"impactFactor":36,"impactFactorByYear":37,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":41,"totalPublicationByYear":42,"totalCitation":48,"totalCitationByYear":49,"totalCitationPerPublication":54,"totalCitationPerPublicationByYear":55,"hindexLast5Year":59,"hindex":59},0,{"2022":38,"2023":39,"2024":40},0.01,0.03,0.13,315,{"2020":43,"2021":44,"2022":45,"2023":46,"2024":47},63,58,57,65,72,43,{"2020":50,"2021":51,"2022":52,"2023":53},8,15,9,11,0.14,{"2020":40,"2021":56,"2022":57,"2023":58},0.26,0.16,0.17,3,{"id":61,"createTime":62,"updateTime":63,"relativeEntities":64,"slug":65,"properties":66,"entityType":24,"verifyStatus":25,"verifyTime":78,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":79,"subjectFields":80,"manageAffiliations":81,"indexDatabases":136,"url":137,"thumbnailPath":26,"statistic":138,"gsStatistic":155,"type":175,"analyzePriority":26},"25b6bd10-676c-40c0-8dc3-356d1679a284","2023-05-19T02:22:33.430+00:00","2026-06-18T23:33:57.141+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Y-D%C6%B0%E1%BB%A3c-h%E1%BB%8Dc-C%E1%BA%A7n-Th%C6%A1",{"country":67,"issn":68,"introduce":70,"title":73,"gsId":76},{"VOID":15},{"VOID":69},"23541210",{"EN":71,"VI":72},"\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">04\u002F10\u002F2015 Ministry of Information and Communications allowed Can Tho journal of medicine and pharmacy to operate (102 \u002FGP-BTTTT)\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">07\u002F16\u002F2015 Can Tho journal of medicine and pharmacy is internationally recognized: ISSN 2354-1210\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">In 2016, The journal has been included in the list of medical science journals by The State Council for professorship which is awarded a work score of 0-0.5 points for a published article.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Can Tho Journal of Medicine and Pharmacy welcome original works that haven’t been submitted or published in other medical journals. Posts must contain content related to one of the journal’s categories.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The content published\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The journal is divided into 3 categories:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Scientific research article: are valuable scientific works, which have been researched and accepted.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Overview of medicine, biology and pharmacy: serving the objective of continuing training in the fields of medicine, biology and pharmacy; to systematize classical and modern knowledge.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Update information on new knowledge about medicine, biology, pharmacy in the country and in the world.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Scope\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Publication and introduction of scientific research in the fields:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Medicine (internal medicine, surgery, pediatrics, obstetrics and gynecology, odonto-stomatology, laboratory, oncology, traditional medicine, nursing).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Biology (genetics, biotechnology).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Pharmacology (pharmaceutics, drug quality analysis-control, synthetic pharmaceutical chemistry, biochemistry, pharmacognosy, botany, clinical pharmacy).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- To enhance the quality of undergraduate, postgraduate education, scientifically researching and meet the necessary treatment in hospital.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Introducing the updated domestic and oversea information about science technology to promote scientific research and exchanging technology in local, other universities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Exchanging pharmaceutical and medical information for social health developing in the Mekong Delta and Vietnam.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The object\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Postgraduate students, student of Can Tho University of Medicine and Pharmacy, scientists from schools, research institutes, hospitals, health centers, pharmaceutical companies of the Mekong Delta; other provinces and regions in Vietnam and other country.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Address\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Headquarters of Can Tho Journal of Medicine and Pharmacy, located Scientific Research and International Cooperation Office: 179 Nguyen Van Cu Street, An Khanh Ward, Ninh Kieu District, Can Tho City, Vietnam.\u003C\u002Fspan>\u003C\u002Fp>","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Ngày 16\u002F7\u002F2015, Tạp chí Y Dược học Cần Thơ được cấp chỉ số quốc tế: ISSN 2354-1210.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 4\u002F2016, Tạp chí đã được Hội đồng Giáo sư ngành Y đưa vào danh sách các tạp chí khoa học Y học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Năm 2020 Tạp chí Y Dược học Cần Thơ đã được phê duyệt vào danh mục của các Hội đồng Giáo sư ngành Dược học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ ra 12 số\u002Fnăm, 180-200 trang\u002Fsố.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 12\u002F2022 Tạp chí Y Dược học Cần Thơ là thành viên của hệ thống Crossref và từ tháng 01\u002F2023 tạp chí thực hiện bình duyệt online kín 2 chiều nhằm tăng tính minh bạch, tin cậy của các công trình nghiên cứu khoa học và đảm bảo tốt nhất chất lượng khoa học của bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ, mục đích và phạm vi của tạp chí\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ và mục đích hoạt động của tạp chí: xuất bản nhằm mục đích phổ biến kết quả từ các đề tài nghiên cứu khoa học; giao lưu trao đổi khoa học, chia sẻ kinh nghiệm, học tập, đồng thời cập nhật thông tin khoa học mới trong các lĩnh vực y, sinh, dược học trong và ngoài nước.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phạm vi của tạp chí: Tạp chí xuất bản được chia thành 3 chuyên mục: (i) Bài báo nghiên cứu khoa học là kết quả công trình nghiên cứu khoa học có giá trị đã được triển khai nghiên cứu, (ii) Bài tổng quan y, sinh, dược học: phục vụ mục tiêu đào tạo liên tục trong lĩnh vực y, sinh, dược học; nhằm hệ thống hóa những kiến thức kinh điển và hiện đại; (iii) Thông tin cập nhật kiến thức mới về y, sinh, dược học trong nước và trên thế giới.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Chính sách truy cập mở\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ áp dụng chính sách truy cập mở đối với các bài báo đã xuất bản đến với độc giả, nhằm mở rộng cơ hội tiếp cận các kết quả nghiên cứu chất lượng cao và tăng cường trao đổi kiến thức. Tạp chí đăng tải trực tuyến (miễn phí) toàn văn các bài báo được công bố trên website của Tạp chí (https:\u002F\u002Ftapchi.ctump.edu.vn).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đạo đức xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ cam kết tuân thủ đạo đức xuất bản phù hợp với các hướng dẫn và tiêu chuẩn của the Committee on Publication Ethics (COPE), tuân thủ các nguyên tắc của COPE’s Core Practices, Best Practices Guidelines for Journal Editors và Guidelines on Good Publication Practices.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Bản thảo bài báo chỉ được chấp nhận khi được tác giả chịu trách nhiệm chính cam kết các nội dung sau: Các nội dung của bản thảo chưa được đăng tải toàn bộ hoặc một phần ở các tạp chí khác; Tất cả các tác giả đều có đóng góp một cách đáng kể vào quá trình nghiên cứu hoặc chuẩn bị bản thảo và cùng chịu trách nhiệm về các nội dung của bản thảo; Tuân thủ các biện pháp đảm bảo đạo đức nghiên cứu (ví dụ thỏa thuận đồng ý tham gia nghiên cứu).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Cam kết bảo mật\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí cam kết thực hiện và tuân thủ các quy định của luật và các văn bản hướng dẫn liên quan đến bảo mật thông tin cá nhân trên không gian mạng. Các thông tin mà người dùng (tác giả, độc giả, biên tập viên, người phản biện) nhập vào các biểu mẫu trên Hệ thống Quản lý xuất bản trực tuyến của tạp chí chỉ được sử dụng vào các mục đích đã được tuyên bố rõ ràng và sẽ không được cung cấp cho bất kỳ bên thứ ba nào khác, hay dùng vào bất kỳ mục đích nào khác.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phí gửi bài\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng bài: 1.000.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng nhanh: 1.500.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với tác giả là cán bộ viên chức thuộc Trường Đại học Y Dược Cần Thơ thì được hỗ trợ 50% lệ phí gửi đăng bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với sinh viên thực hiện đề tài nghiên cứu khoa học cấp trường được hỗ trợ 100% lệ phí đăng bài ( Tác giả gửi đính kèm “ Quyết định về việc giao tổ chức thực hiện đề tài nghiên cứu khoa học cấp Trường của sinh viên”).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Hình thức nộp lệ phí:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Tiền mặt:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Nộp trực tiếp tại Phòng Tài chính - Kế toán, Trường Đại học Y Dược Cần Thơ, số 179 Nguyễn Văn Cừ, P. An Khánh, Q. Ninh Kiều, thành phố Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Chuyển khoản:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tên Tài khoản: Trường ĐHYD Cần Thơ, Số TK: 0111000115668, tại ngân hàng Vietcombank chi nhánh Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Thời gian: Áp dụng từ ngày 01\u002F02\u002F2023.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">* Phí gửi bài không được hoàn trả khi bài viết bị từ chối hoặc tác giả xin rút bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Quy trình phản biện bài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ thực hiện quy trình phản biện kín hai chiều nghiêm ngặt. Danh tính của những người phản biện không được tiết lộ cho các tác giả và ngược lại. Quy trình thẩm định bài báo đăng gồm các bước sau:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tiếp nhận bản thảo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tác giả liên hệ gửi bản thảo đến Tạp chí qua hệ thống trực tuyến tại website: https:\u002F\u002Ftapchi.ctump.edu.vn. Hướng dẫn về cách đăng ký, gửi bài và chuẩn bị bản thảo được cung cấp trên website của Tạp chí.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sàng lọc sơ bộ\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sau khi Tòa soạn nhận được bài báo của tác giả, Ban Thư ký sẽ tiến hành kiểm tra sơ bộ bài báo (các yêu cầu về nội dung và hình thức). Những bài báo không đúng quy cách hoặc có nội dung không phù hợp hoặc vi phạm bản quyền sẽ bị từ chối (Ban Thư ký thông báo phản hồi đến tác giả trong vòng 1 tuần). Những bài báo đủ điều kiện, được Ban Thư ký tòa soạn chuyển đến Ban Biên tập có cùng chuyên môn với nội dung bài báo để đề xuất người phản biện. Thời gian kể từ khi Ban Biên tập nhận bài báo đến khi đề xuất người phản biện bài báo chậm nhất là 5 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Vòng phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký gửi bài và yêu cầu phản biện đến 02 phản biện độc lập.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Các phản biện gởi nhận xét cho Ban Thư ký. Thời gian từ khi gửi bài cho phản biện đến khi nhận ý kiến của phản biện tối đa là 20 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xử ký kết quả phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Nếu ý kiến đồng ý cho đăng và không cần chỉnh sửa, Ban Thư ký tiếp tục đăng bài theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Nếu ý kiến đồng ý đăng và cần chỉnh sửa, Ban Thư ký sẽ thông tin đến tác giả chỉnh sửa theo yêu cầu của người phản biện. Thời gian chỉnh sửa và gửi lại kéo dài không quá 2 tuần, từ khi tác giả bài báo nhận được thông tin (Quá trình này có thể lặp lại tối đa 2 lần\u002F1 bài báo). Khi có sự thống nhất, đồng ý của người phản biện; bài báo được tiếp tục đăng theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Những bài báo có chất lượng không đạt yêu cầu, cả 2 phản biện không đồng ý cho đăng sẽ bị Tòa soạn từ chối đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký tổng hợp các bản thảo đã được tác giả hoàn thiện sau thẩm định trình Ban Biên tập xem xét, Tổng Biên tập phê duyệt, quyết định bài đăng theo các tiêu chí: sự phù hợp nội dung với tôn chỉ và mục đích, thể loại bài viết (ưu tiên các bài có bài có nghiên cứu chuyên sâu, hàm lượng khoa học cao), đóng góp mới bài báo, bài báo được ưu tiên đăng trong số gần nhất của Tạp chí theo thứ tự: tính thời sự, chất lượng bài báo và thời gian gửi bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Ban Biên tập và Ban Thư ký biên tập bản thảo, chế bản, đọc rà soát lỗi. Thời gian hoàn thành từ 10-15 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Ban Thư ký có trách nhiệm thông báo cho tác giả bài báo (bằng e-mail) về tình hình phê duyệt bài báo, thời gian, số kỳ, tập xuất bản bài báo theo qui định.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">4. Danh sách bài báo theo số Tạp chí được in ấn và phát hành trong năm định kỳ được công bố chính thức trên website: https:\u002F\u002Ftapchi.ctump.edu.vn\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>",{"EN":74,"VI":75},"Cantho Journal of Medicine and Pharmacy","Tạp chí Y Dược học Cần Thơ",{"VOID":77},"wcQ1uqwAAAAJ","2023-05-30T08:17:21.868+00:00",32,[],[82],{"id":83,"createTime":84,"updateTime":85,"relativeEntities":86,"slug":87,"properties":88,"entityType":98,"verifyStatus":25,"verifyTime":99,"verifyNote":26,"syncStatus":28,"languages":100,"translateLanguages":26,"viewCount":103,"url":104,"parentIds":105,"statistic":106},"6413896b-eca9-442b-a73f-182a58a0ce40","2023-06-12T14:59:13.446+00:00","2026-06-19T02:29:32.871+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Y-D%C6%B0%E1%BB%A3c-C%E1%BA%A7n-Th%C6%A1",{"country":89,"title":90,"address":93,"abbreviation":96},{"VOID":15},{"EN":91,"VI":92},"Can Tho University of Medicine and Pharmacy","Trường Đại học Y Dược Cần Thơ",{"VI":94,"EN":95},"Số 179, đường Nguyễn Văn Cừ, phường An Khánh, quận Ninh Kiều, thành phố Cần Thơ, Việt Nam","No 179, Nguyen Van Cu street, An Khanh ward, Ninh Kieu district, Can Tho city, Vietnam",{"VOID":97},"ctump","AFFILIATION","2023-08-01T14:07:27.977+00:00",[101,102],"VI","EN",12,"http:\u002F\u002Fwww.ctump.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":107,"i10Index":111,"i10IndexLast5Year":59,"totalPublication":112,"totalPublicationByYear":113,"totalCitation":122,"totalCitationByYear":123,"totalCitationPerPublication":128,"totalCitationPerPublicationByYear":129,"hindexLast5Year":135,"hindex":135},{"2022":108,"2023":109,"2024":110,"2025":38},0.1,0.05,0.07,4,1489,{"2013":114,"2014":115,"2015":115,"2016":111,"2017":115,"2018":59,"2019":114,"2020":116,"2021":117,"2022":118,"2023":119,"2024":120,"2025":121,"2026":111},2,1,10,84,281,680,260,156,313,{"2013":59,"2014":114,"2018":124,"2021":125,"2022":126,"2023":127},17,36,123,132,0.21,{"2013":130,"2014":114,"2018":131,"2021":132,"2022":133,"2023":134},1.5,5.67,0.43,0.44,0.19,6,[],"https:\u002F\u002Ftapchi.ctump.edu.vn\u002Findex.php\u002Fctump",{"impactFactor":36,"impactFactorByYear":139,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":140,"totalPublicationByYear":141,"totalCitation":147,"totalCitationByYear":148,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":152,"hindexLast5Year":135,"hindex":135},{"2022":38,"2023":36,"2024":39,"2025":38},1956,{"0":114,"2019":114,"2020":50,"2021":142,"2022":143,"2023":144,"2024":145,"2025":146},76,403,789,305,371,524,{"0":114,"2019":135,"2021":124,"2022":149,"2023":150,"2024":111,"2025":114},287,206,0.27,{"0":115,"2019":59,"2021":153,"2022":154,"2023":56,"2024":38,"2025":38},0.22,0.71,{"impactFactor":26,"impactFactorByYear":26,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":156,"totalPublicationByYear":157,"totalCitation":163,"totalCitationByYear":164,"totalCitationPerPublication":169,"totalCitationPerPublicationByYear":170,"hindexLast5Year":135,"hindex":135},461,{"0":158,"2019":114,"2021":159,"2022":160,"2023":161,"2024":158,"2025":162},7,37,296,107,5,419,{"2021":59,"2022":59,"2023":165,"2024":166,"2025":167,"2026":168},71,126,171,41,0.91,{"2021":171,"2022":38,"2023":172,"2024":173,"2025":174},0.08,0.66,18,34.2,"JOURNAL",{"id":177,"createTime":178,"updateTime":179,"relativeEntities":180,"slug":181,"properties":182,"entityType":24,"verifyStatus":25,"verifyTime":193,"verifyNote":26,"syncStatus":28,"languages":194,"translateLanguages":26,"viewCount":36,"subjectFields":195,"manageAffiliations":196,"indexDatabases":197,"url":198,"thumbnailPath":26,"statistic":26,"gsStatistic":199,"type":175,"analyzePriority":26},"f8d0bf97-8d89-482e-b58c-2fc481a0b79b","2025-10-27T06:27:08.591+00:00","2026-06-18T23:33:41.667+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87-nhi%E1%BB%87t-%C4%91%E1%BB%9Bi",{"country":183,"introduce":184,"gsId":186,"title":188,"issn":191},{"VOID":15},{"EN":185},"\u003Cp style=\"text-align:justify;\">     Journal of Tropical Science and Engineering (JTSE) is a multidisciplinary scientific journal, licensed to operate as a print journal in 2012 and an electronic journal in 2024 (License No.1479\u002FGP-BTTTT dated August 20, 2012 and No.91\u002FGP-BTTTT dated April 9, 2024 issued by the Ministry of Information and Communications of Vietnam). The JTSE is headquartered in Hanoi.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">        The JTSE is published every 3 months (4 issues\u002Fyear), publishing research results and overview articles in 3 groups of fields: Tropical Ecology and Environment; Chemistry and Material Sciences; Biomedicine and Pharmacy. In 2022, the JTSE registered the international identifier Digital Object Identifier (DOI): 10.58334\u002Fvrtc.jtst and assigned DOI codes to all articles of the journal. The members of the Editorial Board of the JTSE are prestigious scientists and leading scientists from Vietnam and many countries in the world. The JTSE has been recognized by the Vietnam State Council for Professorship to score scientific articles in Chemistry, Medicine and Biology with scores ranging from 0-0.75 points.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">      Currently, the JTSE is building and perfecting a set of criteria and making efforts to join the List of prestigious  international journals with a roadmap to enter Scopus and SCIE in the coming time.\u003C\u002Fp>",{"VOID":187},"MS2_GJQAAAAJ",{"VI":189,"EN":190},"Tạp chí Khoa học và Công nghệ nhiệt đới","Journal of Tropical Science and Engineering",{"VOID":192},"08667535","2025-10-27T06:27:25.058+00:00",[101,102],[],[],[],"https:\u002F\u002Ftapchikhcnnd.com.vn",{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":200,"totalPublicationByYear":201,"totalCitation":161,"totalCitationByYear":203,"totalCitationPerPublication":153,"totalCitationPerPublicationByYear":205,"hindexLast5Year":114,"hindex":114},481,{"0":115,"2020":115,"2021":115,"2022":114,"2024":115,"2025":202,"2026":115},474,{"2017":114,"2018":115,"2019":111,"2020":162,"2021":162,"2022":116,"2023":50,"2024":162,"2025":204,"2026":52},52,{"2020":162,"2021":162,"2022":162,"2024":162,"2025":206,"2026":52},0.11,{"id":208,"createTime":209,"updateTime":210,"relativeEntities":211,"slug":212,"properties":213,"entityType":24,"verifyStatus":25,"verifyTime":221,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"subjectFields":223,"manageAffiliations":224,"indexDatabases":225,"url":226,"thumbnailPath":26,"statistic":227,"gsStatistic":276,"type":175,"analyzePriority":26},"a3d1e82a-57e2-40f9-940e-f5fa8b9ef64a","2023-06-01T07:11:26.039+00:00","2026-06-18T23:33:28.573+00:00",[],"VNU-Journal-of-Science-Earth-and-Environmental-Sciences",{"issn":214,"title":216,"country":218,"gsId":219},{"VOID":215},"26159279",{"EN":217},"VNU Journal of Science: Earth and Environmental Sciences",{"VOID":15},{"VOID":220},"UmXD8vEAAAAJ","2023-06-01T07:17:59.210+00:00",27,[],[],[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FEES",{"impactFactor":36,"impactFactorByYear":228,"i10Index":234,"i10IndexLast5Year":36,"totalPublication":235,"totalPublicationByYear":236,"totalCitation":246,"totalCitationByYear":247,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":262,"hindexLast5Year":103,"hindex":103},{"2010":229,"2012":40,"2013":230,"2014":230,"2015":231,"2016":54,"2017":171,"2018":109,"2019":110,"2020":57,"2021":232,"2022":233,"2023":151,"2024":58},0.02,0.04,0.09,0.31,0.4,19,656,{"2008":237,"2009":238,"2010":239,"2011":238,"2012":240,"2013":241,"2014":239,"2015":242,"2016":243,"2017":244,"2018":245,"2019":165,"2020":125,"2021":168,"2022":125,"2023":222,"2024":111},23,24,22,28,25,20,146,29,78,1038,{"2008":248,"2009":249,"2010":250,"2011":251,"2012":252,"2013":253,"2014":254,"2015":255,"2016":256,"2017":257,"2018":161,"2019":258,"2020":259,"2021":29,"2022":260},119,64,66,86,38,73,59,31,129,39,97,53,26,1.58,{"2008":263,"2009":264,"2010":59,"2011":265,"2012":266,"2013":267,"2014":268,"2015":269,"2016":270,"2017":271,"2018":272,"2019":272,"2020":273,"2021":274,"2022":275},5.17,2.67,3.58,1.36,2.92,2.68,1.55,0.88,1.34,1.37,1.47,1.24,0.72,{"impactFactor":26,"impactFactorByYear":26,"i10Index":173,"i10IndexLast5Year":135,"totalPublication":277,"totalPublicationByYear":278,"totalCitation":279,"totalCitationByYear":280,"totalCitationPerPublication":288,"totalCitationPerPublicationByYear":289,"hindexLast5Year":158,"hindex":298},113,{"2007":114,"2008":103,"2009":173,"2010":116,"2011":51,"2012":239,"2013":103,"2014":162,"2015":53,"2016":135},616,{"2009":162,"2010":114,"2011":52,"2012":124,"2013":222,"2014":255,"2015":48,"2016":44,"2017":281,"2018":282,"2019":259,"2020":283,"2021":284,"2022":285,"2023":286,"2024":257,"2025":287,"2026":59},54,60,49,47,34,44,33,5.45,{"2009":290,"2010":291,"2011":292,"2012":293,"2013":294,"2014":295,"2015":296,"2016":297},0.28,0.2,0.6,0.77,2.25,6.2,3.91,9.67,14,{"id":300,"createTime":301,"updateTime":302,"relativeEntities":303,"slug":304,"properties":305,"entityType":24,"verifyStatus":25,"verifyTime":316,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":234,"subjectFields":317,"manageAffiliations":318,"indexDatabases":388,"url":389,"thumbnailPath":390,"statistic":391,"gsStatistic":409,"type":175,"analyzePriority":26},"a7166325-6c9e-4db3-8a59-7c879701a372","2023-07-31T04:28:49.231+00:00","2026-06-18T23:33:22.428+00:00",[],"VNU-Journal-of-Science-Policy-and-Management-Studies",{"country":306,"issn":307,"eissn":309,"title":311,"gsId":314},{"VOID":15},{"VOID":308},"26159295",{"VOID":310},"25881116",{"EN":312,"VI":313},"VNU Journal of Science: Policy and Management Studies","Tạp chí Nghiên cứu Chính sách và Quản lý",{"VOID":315},"xKW2E_cAAAAJ","2023-08-01T03:23:46.688+00:00",[],[319],{"id":320,"createTime":321,"updateTime":322,"relativeEntities":323,"slug":324,"properties":325,"entityType":98,"verifyStatus":25,"verifyTime":335,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":336,"url":337,"parentIds":338,"statistic":339},"12466116-8f60-4b01-8faf-2411483a0977","2023-05-30T09:37:38.472+00:00","2026-06-19T02:14:28.352+00:00",[],"Vietnam-National-University",{"country":326,"title":327,"abbreviation":330,"address":332},{"VOID":15},{"EN":328,"VI":329},"Vietnam National University, Hanoi","Đại học Quốc gia Hà Nội",{"VOID":331},"VNU",{"VI":333,"EN":334},"Số 144 Xuân Thủy, Phường Dịch Vọng Hậu, Quận Cầu Giấy, Hà Nội, Việt Nam","No. 144 Xuan Thuy Street, Dich Vong Hau Ward, Cau Giay District, Hanoi, Vietnam","2023-08-02T13:58:17.029+00:00",16,"http:\u002F\u002Fwww.vnu.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":340,"i10Index":285,"i10IndexLast5Year":162,"totalPublication":344,"totalPublicationByYear":345,"totalCitation":354,"totalCitationByYear":355,"totalCitationPerPublication":368,"totalCitationPerPublicationByYear":369,"hindexLast5Year":336,"hindex":336},{"2014":109,"2015":231,"2016":231,"2017":206,"2018":341,"2019":110,"2020":342,"2021":343,"2022":171,"2023":231,"2024":110,"2025":39},0.06,0.18,0.35,1247,{"2003":115,"2004":115,"2005":114,"2006":59,"2007":111,"2008":162,"2009":59,"2010":50,"2011":124,"2012":336,"2013":260,"2014":244,"2015":250,"2016":281,"2017":346,"2018":347,"2019":348,"2020":349,"2021":350,"2022":351,"2023":352,"2024":353,"2025":255,"2026":50},94,88,83,67,176,185,187,93,1644,{"2004":111,"2005":115,"2006":52,"2007":298,"2008":356,"2009":298,"2010":286,"2011":357,"2012":244,"2013":358,"2014":359,"2015":360,"2016":361,"2017":362,"2018":363,"2019":364,"2020":365,"2021":366,"2022":367,"2023":367,"2024":162},13,81,48,70,151,115,109,259,174,181,121,101,1.32,{"2004":111,"2005":370,"2006":59,"2007":371,"2008":372,"2009":373,"2010":374,"2011":375,"2012":376,"2013":377,"2014":378,"2015":379,"2016":380,"2017":381,"2018":382,"2019":383,"2020":384,"2021":385,"2022":386,"2023":387,"2024":109},0.5,3.5,2.6,4.67,5.5,4.76,1.81,1.85,2.41,2.29,2.13,1.16,2.94,2.1,2.7,0.69,0.55,0.54,[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FPaM","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002Fa7166325-6c9e-4db3-8a59-7c879701a372\u002Fecfe83f4bcc60c7023ae04d8900fe0ac.jpg",{"impactFactor":36,"impactFactorByYear":392,"i10Index":111,"i10IndexLast5Year":36,"totalPublication":394,"totalPublicationByYear":395,"totalCitation":399,"totalCitationByYear":400,"totalCitationPerPublication":293,"totalCitationPerPublicationByYear":403,"hindexLast5Year":158,"hindex":158},{"2018":109,"2019":171,"2020":393,"2021":108,"2022":54,"2023":206,"2024":54},0.23,320,{"2015":50,"2016":239,"2017":286,"2018":396,"2019":397,"2020":159,"2021":398,"2022":168,"2023":79,"2024":255},30,35,40,247,{"2015":115,"2016":242,"2017":401,"2018":222,"2019":402,"2020":79,"2021":239,"2022":50,"2023":116},77,50,{"2015":404,"2016":169,"2017":405,"2018":406,"2019":407,"2020":408,"2021":386,"2022":291,"2023":232},0.12,1.75,0.9,1.43,0.86,{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":103,"totalPublicationByYear":410,"totalCitation":234,"totalCitationByYear":411,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":412,"hindexLast5Year":114,"hindex":59},{"2015":114,"2016":116},{"2016":115,"2017":114,"2018":114,"2019":59,"2020":114,"2021":59,"2022":114,"2023":114,"2024":115,"2026":115},{"2016":108},{"id":414,"createTime":415,"updateTime":416,"relativeEntities":417,"slug":418,"properties":419,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":238,"subjectFields":428,"manageAffiliations":429,"indexDatabases":430,"url":431,"thumbnailPath":26,"statistic":432,"gsStatistic":438,"type":175,"analyzePriority":26},"16e65a3f-d274-47dd-8691-56d76eb58c3d","2023-05-30T09:10:06.062+00:00","2026-06-18T23:33:17.679+00:00",[],"Vietnam-Journal-of-Otorhinolaryngology-Head-and-Neck-Surgery",{"country":420,"issn":421,"title":423,"gsId":426},{"VOID":15},{"VOID":422},"18593704",{"EN":424,"VI":425},"Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery","Tạp chí Tai Mũi Họng Việt Nam",{"VOID":427},"L78B_eIAAAAJ",[],[],[],"https:\u002F\u002Ftapchitaimuihong.vn\u002Findex.php\u002Ftmh",{"impactFactor":36,"impactFactorByYear":433,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":434,"totalPublicationByYear":435,"totalCitation":111,"totalCitationByYear":436,"totalCitationPerPublication":230,"totalCitationPerPublicationByYear":437,"hindexLast5Year":115,"hindex":115},{"2024":229},95,{"2022":52,"2023":286,"2024":255,"2025":53},{"2023":111},{"2023":231},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":240,"totalPublicationByYear":439,"totalCitation":234,"totalCitationByYear":440,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":442,"hindexLast5Year":114,"hindex":114},{"2023":53,"2024":116,"2025":135,"2026":115},{"2024":59,"2025":298,"2026":114},0.68,{"2024":443,"2025":444,"2026":114},0.3,2.33,{"id":446,"createTime":447,"updateTime":448,"relativeEntities":449,"slug":450,"properties":451,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":396,"subjectFields":460,"manageAffiliations":461,"indexDatabases":462,"url":463,"thumbnailPath":464,"statistic":465,"gsStatistic":472,"type":175,"analyzePriority":26},"25988add-c322-4eda-afda-63b1559bb824","2023-04-07T03:49:55.817+00:00","2026-06-18T23:32:23.776+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Y%20-%20D%C6%B0%E1%BB%A3c%20h%E1%BB%8Dc%20qu%C3%A2n%20s%E1%BB%B1",{"country":452,"issn":453,"title":455,"gsId":458},{"VOID":15},{"VOID":454},"18590748",{"EN":456,"VI":457},"Journal of Military Pharmaco-medicine","Tạp chí Y - Dược học quân sự",{"VOID":459},"_pmQ8IEAAAAJ",[],[],[],"https:\u002F\u002Fjmpm.vn\u002Findex.php\u002Fjmpm","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F25988add-c322-4eda-afda-63b1559bb824\u002F09c6bc42157cf5ece95edc971ccddb52.jpg",{"impactFactor":36,"impactFactorByYear":466,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":467,"totalPublicationByYear":468,"totalCitation":135,"totalCitationByYear":470,"totalCitationPerPublication":38,"totalCitationPerPublicationByYear":471,"hindexLast5Year":115,"hindex":115},{"2023":229,"2024":38},475,{"2022":168,"2023":365,"2024":469,"2025":124},236,{"2022":114,"2023":111},{"2022":109,"2023":229},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":277,"totalPublicationByYear":473,"totalCitation":401,"totalCitationByYear":474,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":475,"hindexLast5Year":59,"hindex":59},{"2015":115,"2018":114,"2019":115,"2020":115,"2021":59,"2022":103,"2023":159,"2024":287,"2025":237},{"2020":115,"2021":115,"2022":115,"2023":52,"2024":237,"2025":79,"2026":116},{"2020":115,"2021":476,"2022":171,"2023":477,"2024":478,"2025":479},0.33,0.24,0.7,1.39,{"id":481,"createTime":482,"updateTime":483,"relativeEntities":484,"slug":485,"properties":486,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":496,"translateLanguages":26,"viewCount":45,"subjectFields":497,"manageAffiliations":498,"indexDatabases":525,"url":526,"thumbnailPath":527,"statistic":528,"gsStatistic":26,"type":26,"analyzePriority":26},"2b8d7b12-2d20-4777-be98-077f44f03c69","2023-09-07T07:40:58.286+00:00","2025-07-13T21:21:00.542+00:00",[],"VNU-Journal-of-Social-Sciences-and-Humanities",{"country":487,"issn":488,"introduce":490,"title":493},{"VOID":15},{"VOID":489},"23541172",{"EN":491,"VI":492},"{\"ops\":[{\"insert\":\"VNU Journal of Social Sciences and Humanities (ISSN 2354-1172) is a double-blind peer-reviewed journal published by University of Social Sciences and Humanities, Vietnam National University, Hanoi, Vietnam, under the publication permit no. 155\u002FGP-BTTTT, issued on 11\"},{\"attributes\":{\"script\":\"super\"},\"insert\":\"th \"},{\"insert\":\"May, 2015 by Ministry of Information and Communications. The journal publishes four Vietnamese issues and two English issues per year.\\nCurrently, there are 35 reputable professors in the editorial board. The main objectives of the journal include: providing an intellectual platform for Vietnamese and international scholars; promoting interdisciplinary studies in social sciences and humanities; becoming the leading journal in social sciences and humanities in Vietnam; being indexed by worldwide databases and having academic recognition internationally in the near future.\\nThe journal is currently indexed by Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services and Vietnam National University’s digital archive.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Journal of Social Sciences and Humanities-Vietnam\"},{\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"ISSN 2354-1172, email: tapchikhxhnv@gmail.com, tckhxhnv@vnu.edu.vn\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Được thành lập ngày 31\u002F8\u002F2015 (giấy phép hoạt động số 155\u002FGP-BVHTT ngày 11 tháng 5 năm 2015 của Bộ Thông tin và Truyền thông, mã số tiêu chuẩn quốc tế ISSN 2354-1172), Tạp chí Khoa học Xã hội và Nhân văn (Journal of Social Sciences and Humanities) là ấn phẩm khoa học chính thức, duy nhất của Trường Đại học Khoa học Xã hội và Nhân văn, ĐHQG Hà Nội, phát triển và kế thừa Chuyên san Khoa học Xã hội và Nhân văn, Tạp chí Khoa học, ĐHQG Hà Nội.\\nTạp chí xuất bản định kỳ (04 số tiếng Việt\u002Fnăm và 02 số tiếng Anh\u002Fnăm), có nhiệm vụ \"},{\"attributes\":{\"italic\":true},\"insert\":\"công bố, giới thiệu các công trình nghiên cứu khoa học khoa học xã hội và nhân văn của các tác giả là các nhà khoa học trong và ngoài nước, phục vụ giảng dạy, học tập và nghiên cứu khoa học\"},{\"insert\":\". Hội đồng biên tập của Tạp chí hiện bao gồm 33 nhà khoa học có uy tín trong nước và quốc tế. Tạp chí tập trung và ưu tiên đăng tải những bài báo theo định hướng của tinh thần cởi mở, sáng tạo, nhanh chóng vươn lên để tiếp cận và sánh ngang với các tạp chí có uy tín hàng đầu của khu vực và trên thế giới. Nội dung chính của Tạp chí bao gồm các Bài nghiên cứu (khoảng 6000 đến 15000 từ), các bài điểm sách, thông tin khoa học (khoảng 300 đến 1500 từ) được trình bày theo đúng cấu trúc và chuẩn mực của một tạp chí khoa học.\\nCác bài viết của Tạp chí hiện đang được trích dẫn bởi Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services.\\nMọi thông tin xin liên hệ: \"},{\"attributes\":{\"italic\":true},\"insert\":\"Phòng Tạp chí, 701 - E, Trường Đại học Khoa học Xã hội và Nhân văn, 336 Nguyễn Trãi, Thanh Xuân, Hà Nội. ĐT: 024.35581984; email: tckhxhnv@vnu.edu.vn \"},{\"insert\":\"hoặc \"},{\"attributes\":{\"italic\":true},\"insert\":\"tapchikhxhnv@gmail.com \"},{\"insert\":\"\\n\"}]}",{"EN":494,"VI":495},"VNU Journal of Social Sciences and Humanities","Tạp chí Khoa học Xã hội và Nhân văn",[101,102],[],[499],{"id":500,"createTime":501,"updateTime":502,"relativeEntities":503,"slug":504,"properties":505,"entityType":98,"verifyStatus":25,"verifyTime":509,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"url":26,"parentIds":510,"statistic":511},"8b6e349b-0daf-4895-9c3f-85f30f1bfd42","2023-07-31T12:55:58.430+00:00","2026-06-19T02:30:07.899+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Khoa-h%E1%BB%8Dc-X%C3%A3-h%E1%BB%99i-v%C3%A0-Nh%C3%A2n-v%C4%83n-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-H%C3%A0-N%E1%BB%99i",{"title":506},{"EN":507,"VI":508},"VNU University of Social Sciences and Humanities","Trường Đại học Khoa học Xã hội và Nhân văn, Đại học Quốc gia Hà Nội","2023-08-02T15:28:49.057+00:00",[],{"impactFactor":36,"impactFactorByYear":512,"i10Index":59,"i10IndexLast5Year":115,"totalPublication":514,"totalPublicationByYear":515,"totalCitation":518,"totalCitationByYear":519,"totalCitationPerPublication":520,"totalCitationPerPublicationByYear":521,"hindexLast5Year":162,"hindex":162},{"2016":229,"2017":230,"2018":229,"2021":230,"2022":58,"2023":513,"2024":38},0.15,365,{"2013":115,"2014":158,"2015":125,"2016":252,"2017":44,"2018":516,"2019":286,"2020":396,"2021":259,"2022":517,"2023":396,"2024":115,"2025":59,"2026":115},21,42,169,{"2015":283,"2016":135,"2017":52,"2018":50,"2019":298,"2020":53,"2021":359,"2022":115,"2023":115},0.46,{"2015":266,"2016":57,"2017":57,"2018":522,"2019":523,"2020":524,"2021":368,"2022":229,"2023":39},0.38,0.32,0.37,[],"http:\u002F\u002Fjournal.ussh.vnu.edu.vn\u002Findex.php\u002Fvjossh","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F2b8d7b12-2d20-4777-be98-077f44f03c69\u002F0bd0751202944a4b4165b482e6e623e4.png",{"impactFactor":36,"impactFactorByYear":529,"i10Index":162,"i10IndexLast5Year":115,"totalPublication":530,"totalPublicationByYear":531,"totalCitation":537,"totalCitationByYear":538,"totalCitationPerPublication":343,"totalCitationPerPublicationByYear":540,"hindexLast5Year":135,"hindex":135},{"2016":341,"2017":39,"2018":229,"2019":38,"2020":110,"2021":231,"2022":231,"2023":341,"2024":39},764,{"2015":255,"2016":245,"2017":532,"2018":259,"2019":533,"2020":534,"2021":535,"2022":536,"2023":534,"2024":254,"2025":50},111,106,68,92,89,265,{"2015":539,"2016":241,"2017":168,"2018":51,"2019":349,"2020":260,"2021":244,"2022":298,"2023":114},46,{"2015":541,"2016":523,"2017":524,"2018":290,"2019":542,"2020":522,"2021":523,"2022":57,"2023":39},1.48,0.63,{"id":544,"createTime":545,"updateTime":546,"relativeEntities":547,"slug":548,"properties":549,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":558,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":50,"subjectFields":559,"manageAffiliations":560,"indexDatabases":561,"url":562,"thumbnailPath":563,"statistic":564,"gsStatistic":26,"type":26,"analyzePriority":26},"6ec01bd0-15c0-469a-86ac-41339076ae0a","2023-08-10T07:08:33.153+00:00","2026-01-31T21:19:06.362+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Da-li%E1%BB%85u-h%E1%BB%8Dc-Vi%E1%BB%87t-Nam",{"country":550,"issn":551,"introduce":553,"title":555},{"VOID":15},{"VOID":552},"18594824",{"VI":554},"{\"ops\":[{\"insert\":\"Tạp chí “Da liễu học Việt Nam” (Tiếng Anh: Vietnamese Journal of Dermatology and Venereology) thuộc Hội Da liễu Việt Nam, xuất bản 4 số mỗi năm bằng tiếng Việt hoặc tiếng Anh.\\nTạp chí Da liễu học Việt Nam hoạt động với mục đích, tôn chỉ là phổ biến, trao đổi thông tin trong lĩnh vực chuyên ngành da liễu; đăng tải các công trình nghiên cứu khoa học; chuyển giao công nghệ - kinh tế và khoa học kỹ thuật liên quan đến lĩnh vực da liễu.\\nPhạm vi của tạp chí là tất cả các bài báo khoa học, bài tổng quan, giới thiệu ca lâm sàng, … có liên quan tới chuyên ngành da liễu trong và ngoài nước. Tạp chí công bố các công trình nghiên cứu liên quan đến mô hình bệnh tật, các phương pháp chẩn đoán, điều trị, dự phòng và phục hồi chức năng các bệnh thuộc chuyên ngành da liễu. Ngoài ra, tạp chí còn đăng tải các bài tổng quan, cập nhật thông tin, kiến thức, hướng dẫn chẩn đoán, điều trị trong chuyên ngành da liễu trong nước và quốc tế; đăng tải các bài ca lâm sàng đặc biệt trong chuyên ngành da liễu.\\nTạp chí Da liễu học Việt Nam được biết tới là một tạp chí chuyên ngành có uy tín trong lĩnh vực da liễu. Các bài báo về nghiên cứu khoa học đăng trong Tạp chí được bình duyệt một cách nghiêm ngặt bởi ít nhất 2 chuyên gia. Hội đồng biên tập tạp chí bao gồm các nhà khoa học có uy tín (Giáo sư, Phó Giáo sư, Tiến sĩ, Bác sĩ…) trong chuyên ngành da liễu nhằm đảm bảo chất lượng và tính khách quan, khoa học cho các bài viết đăng trên Tạp chí.\\n\"}]}",{"EN":556,"VI":557},"Vietnamese Journal of Dermatology and Venereology","Tạp chí Da liễu học Việt Nam","Admin Import",[],[],[],"https:\u002F\u002Fvjdv.vn\u002Findex.php\u002Fvjdv","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F6ec01bd0-15c0-469a-86ac-41339076ae0a\u002F3cbc81720e58429dc7b1c4d7ab1935ca.jpg",{"impactFactor":36,"impactFactorByYear":565,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":566,"totalPublicationByYear":567,"totalCitation":116,"totalCitationByYear":570,"totalCitationPerPublication":109,"totalCitationPerPublicationByYear":571,"hindexLast5Year":115,"hindex":115},{"2023":38,"2024":230},182,{"2022":568,"2023":45,"2024":569},69,56,{"2022":52,"2023":115},{"2022":40,"2023":229},{"id":573,"createTime":574,"updateTime":575,"relativeEntities":576,"slug":577,"properties":578,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":587,"translateLanguages":26,"viewCount":283,"subjectFields":588,"manageAffiliations":589,"indexDatabases":647,"url":648,"thumbnailPath":649,"statistic":650,"gsStatistic":26,"type":26,"analyzePriority":26},"19221551-7519-47ff-a892-331d1139c64b","2023-09-12T07:03:05.744+00:00","2026-01-24T20:54:40.144+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-S%E1%BB%A9c-kho%E1%BA%BB-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":579,"issn":580,"introduce":582,"title":584},{"VOID":15},{"VOID":581},"27349446",{"EN":583},"{\"ops\":[{\"attributes\":{\"bold\":true},\"insert\":\"1. History\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Science and Technology Development Journal\"},{\"insert\":\" (STDJ) (ISSN 2734-9446), Vietnam National University - Ho Chi Minh City (VNU-HCM) was established in 1997. And the first issue was published in January 1998 with ISSN 1859-0128. Since then, STDJ has become the most important scientific forum of scientists from VNU-HCM as well as other universities. The magazine has undergone 20 years of development and has become a bridge for scientific exchanges, as well as enriching reference materials for the faculty, doctoral students, students of VNU-HCM in particular and other universities, institutes...\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Science and Technology Development Journal - Health Sciences (STDJ-HS) is a subjournal of Science and Technology Development Journal since 2020.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\" \"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"2. Focus and Scope\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Publishing articles with contents on healthcare, research projects in the field of health, advanced directions in health education and management. Therefore, STDJ-HS will accept articles from doctors, administrators, teachers, researchers, graduate students and fellows. The authors will be responsible for the accuracy of the data, opinions, opinions and material cited in the article.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Facilitating the exchange of scientific and technological information and act as a bridge between theory and practice in the community of educators, scientists, managers, policy makers and enterprises in and out of the country.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":585,"VI":586},"VNUHCM JOURNAL OF HEALTH SCIENCES","Tạp chí Khoa học Sức khoẻ Đại học Quốc gia Thành phố Hồ Chí Minh",[101,102],[],[590],{"id":591,"createTime":592,"updateTime":593,"relativeEntities":594,"slug":595,"properties":596,"entityType":98,"verifyStatus":25,"verifyTime":606,"verifyNote":26,"syncStatus":28,"languages":607,"translateLanguages":26,"viewCount":608,"url":609,"parentIds":610,"statistic":611},"fc4c2560-868c-4677-acb1-8686bef88727","2023-06-26T04:48:23.774+00:00","2026-06-19T01:46:17.248+00:00",[],"%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":597,"title":598,"abbreviation":601,"address":603},{"VOID":15},{"EN":599,"VI":600},"Vietnam National University Ho Chi Minh City","Đại học Quốc gia Thành phố Hồ Chí Minh",{"VOID":602},"VNUHCM",{"VI":604,"EN":605},"khu phố 6, Phường Linh Trung, Thành phố Thủ Đức, Thành phố Hồ Chí Minh, Việt Nam","Quarter 6, Linh Trung Ward, Thu Duc City, Ho Chi Minh City, Vietnam","2023-08-16T14:13:07.134+00:00",[101,102],45,"https:\u002F\u002Fvnuhcm.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":612,"i10Index":285,"i10IndexLast5Year":51,"totalPublication":613,"totalPublicationByYear":614,"totalCitation":624,"totalCitationByYear":625,"totalCitationPerPublication":634,"totalCitationPerPublicationByYear":635,"hindexLast5Year":124,"hindex":124},{"2014":36,"2015":38,"2016":109,"2017":39,"2018":229,"2019":38,"2020":110,"2021":171,"2022":110,"2023":110,"2024":171,"2025":229},3708,{"2005":115,"2006":115,"2007":115,"2008":135,"2009":111,"2010":53,"2011":52,"2012":568,"2013":615,"2014":351,"2015":616,"2016":469,"2017":617,"2018":127,"2019":618,"2020":619,"2021":620,"2022":621,"2023":622,"2024":623,"2025":159,"2026":50},164,266,177,226,603,931,314,246,74,2399,{"2006":115,"2008":50,"2010":162,"2011":242,"2012":222,"2013":43,"2014":626,"2015":627,"2016":628,"2017":629,"2018":258,"2019":630,"2020":631,"2021":632,"2022":633,"2023":353,"2024":115},250,124,157,162,152,385,559,128,0.65,{"2006":115,"2008":636,"2010":637,"2011":638,"2012":639,"2013":522,"2014":640,"2015":641,"2016":642,"2017":643,"2018":644,"2019":642,"2020":645,"2021":292,"2022":646,"2023":522,"2024":38},1.33,0.45,2.22,0.39,1.35,0.47,0.67,0.92,0.73,0.64,0.41,[],"http:\u002F\u002Fstdjhs.scienceandtechnology.com.vn\u002Findex.php\u002Fstdjhs","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F19221551-7519-47ff-a892-331d1139c64b\u002F2e10768b7d1e380c36a25ed0c714dd7e.png",{"impactFactor":36,"impactFactorByYear":651,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":652,"totalPublicationByYear":653,"totalCitation":516,"totalCitationByYear":654,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":655,"hindexLast5Year":59,"hindex":59},{"2022":57,"2023":108,"2024":39},79,{"2020":116,"2021":240,"2022":239,"2023":52,"2024":162,"2025":162},{"2020":59,"2021":51,"2022":59},{"2020":443,"2021":387,"2022":54},{"code":657,"data":658,"meta":26},"SUCCESS",{"id":659,"createTime":660,"updateTime":661,"relativeEntities":662,"slug":663,"properties":664,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":675,"manageAffiliations":692,"indexDatabases":713,"url":753,"thumbnailPath":26,"statistic":754,"gsStatistic":26,"type":26,"analyzePriority":26},"591637e0-fd04-43ea-8c76-34d492ca99e7","2023-05-29T11:07:44.472+00:00","2025-11-21T10:02:14.823+00:00",[],"Nature-Reviews-Gastroenterology-and-Hepatology",{"country":665,"issn":667,"introduce":669,"eissn":671,"title":673},{"VOID":666},"GB",{"VOID":668},"17595045",{"EN":670},"The basic, translational and clinical content in Nature Reviews Gastroenterology & Hepatology is written by internationally renowned basic and clinical academics and researchers and targeted towards readers in the biological and medical sciences, from postgraduate level upwards. While intended to be read by practising doctors, researchers and academics within a specialty, we aim to make all our articles accessible to readers working in any biological or medical discipline. In-depth Reviews present authoritative, up-to-date information on a topic, placing it in the context of a field's history and development. Consensus Statements provide evidence-based or eminence-based recommendations and present a balanced review put together by a task force of experts. Topical discussion and opinions are proffered in Perspectives, Comment and News & Views articles, and in the Research Highlights section we filter primary research from a range of specialty and general medical and scientific journals. Subjects Covered: -Cancer -Diagnosis and screening -Endoscopy (including imaging) -Epidemiology -Gall bladder and biliary tract -Gastro-oesophageal reflux disease -Gastrointestinal bleeding -Genetics -Geriatric medicine -Gut microbiota -Hepatitis -Infection (including bacterial, viral, parasitic) -Inflammatory bowel disease -Large intestine (including anus) -Liver (including cirrhosis and fibrosis) -Motility (including irritable bowel syndrome) -Nutrition (including digestion, intolerance, allergies, therapy, obesity) -Pancreas -Paediatrics -Small intestine -Stomach -Surgery (including transplantation) -Therapy (including pharmacotherapy, radiotherapy, nutrition, alternative) -Translational medicine -Ulcers -Upper gastrointestinal tract (including mouth, oesophagus, ingestion)",{"VOID":672},"17595053",{"EN":674},"Nature Reviews Gastroenterology and Hepatology",[676,684],{"id":677,"createTime":678,"updateTime":679,"relativeEntities":680,"label":681,"description":683,"parentId":26,"standard":26,"scholarHubFieldId":26},"a520f91c-9c10-4000-96b1-c80ea7776e25","2023-05-29T10:24:12.053+00:00","2023-11-21T07:53:13.948+00:00",[],{"EN":682},"Gastroenterology",{},{"id":685,"createTime":686,"updateTime":687,"relativeEntities":688,"label":689,"description":691,"parentId":26,"standard":26,"scholarHubFieldId":26},"01203b2d-e9ba-432d-a4b0-d0f3ced5dfa6","2023-05-29T10:24:07.274+00:00","2023-11-21T07:04:43.214+00:00",[],{"EN":690},"Hepatology",{},[693,703],{"id":694,"createTime":695,"updateTime":696,"relativeEntities":697,"slug":698,"properties":699,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"url":26,"parentIds":702,"statistic":26},"b134a19f-d595-49fa-bd59-70d90fa3a3b3","2023-05-29T12:35:12.827+00:00","2024-02-20T05:01:33.021+00:00",[],"NATURE-PORTFOLIO",{"title":700},{"EN":701},"NATURE PORTFOLIO",[],{"id":704,"createTime":705,"updateTime":706,"relativeEntities":707,"slug":708,"properties":709,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":135,"url":26,"parentIds":712,"statistic":26},"ae54b068-a7dd-4746-b752-b7b24439de47","2023-05-29T10:24:12.391+00:00","2025-11-21T09:53:50.486+00:00",[],"Nature-Publishing-Group",{"title":710},{"EN":711},"Nature Publishing Group",[],[714,734],{"id":715,"indexDatabase":716,"url":728,"indexYears":729,"academicFieldIds":730,"indexDatabaseRanking":733},"f7653d24-c751-4d20-a7b9-913862d89fe4",{"id":717,"createTime":718,"updateTime":719,"relativeEntities":720,"label":721,"description":723,"key":725,"publicationTags":726,"standard":26},"3c7051d4-eb7d-4c57-a56b-36fc74c5d1e9","2023-05-22T09:57:18.509+00:00","2025-11-21T10:07:52.274+00:00",[],{"EN":722,"VI":722},"Scopus - Elsevier",{"EN":722,"VI":724},"Cơ sở dữ liệu Scopus thuộc Elsevier","scopus",[727],"SCOPUS","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F17700156208","2009-2025",[731,732],"34ca0c58-3b99-4064-9bf3-a754a6e2e9a7","d39aa686-8d5d-45f0-81c4-13c21a0f2f39","SCOPUS__Q1",{"id":735,"indexDatabase":736,"url":750,"indexYears":26,"academicFieldIds":751,"indexDatabaseRanking":26},"427a9c31-7c72-4c70-a6f4-a9b95a7df13a",{"id":737,"createTime":738,"updateTime":739,"relativeEntities":740,"label":741,"description":743,"key":746,"publicationTags":747,"standard":26},"a4921856-b128-4d9f-8f1f-e80813d3bbd4","2023-05-22T09:59:31.026+00:00","2025-11-21T10:07:52.153+00:00",[],{"EN":742,"VI":742},"ISI\u002FSCIE - Science Citation Index Expanded",{"VI":744,"EN":745},"Cơ sở dữ liệu SCIE","SCIE database","scie",[748,749],"SCIE","ISI","https:\u002F\u002Fmjl.clarivate.com\u002Fsearch-results?issn=1759-5045",[752],"4b2c1694-c69d-4b20-b2eb-9687848dfb30","http:\u002F\u002Fwww.nature.com\u002Fnrgastro\u002Findex.html",{"impactFactor":36,"impactFactorByYear":755,"i10Index":259,"i10IndexLast5Year":356,"totalPublication":259,"totalPublicationByYear":768,"totalCitation":769,"totalCitationByYear":770,"totalCitationPerPublication":783,"totalCitationPerPublicationByYear":784,"hindexLast5Year":283,"hindex":283},{"2012":756,"2013":757,"2014":758,"2015":759,"2016":760,"2017":761,"2018":762,"2019":763,"2020":764,"2021":765,"2022":766,"2023":767},29.75,23.71,23.67,48.86,56.88,41.22,50.09,109.45,178,169.17,129.86,178.57,{"2009":59,"2010":59,"2011":162,"2012":114,"2013":111,"2014":59,"2015":162,"2016":111,"2017":158,"2018":111,"2019":111,"2020":114,"2021":162,"2022":114},40142,{"2009":144,"2010":771,"2011":772,"2012":146,"2013":773,"2014":774,"2015":775,"2016":776,"2017":777,"2018":778,"2019":779,"2020":780,"2021":781,"2022":782},1769,2446,1975,7104,2913,1563,6437,6132,4865,469,2852,457,757.4,{"2009":785,"2010":786,"2011":787,"2012":788,"2013":789,"2014":790,"2015":791,"2016":792,"2017":793,"2018":794,"2019":795,"2020":796,"2021":797,"2022":798},263,589.67,489.2,185.5,493.75,2368,582.6,390.75,919.57,1533,1216.25,234.5,570.4,228.5,{"meta":800,"data":802},{"total":801},"69",[803,1447,2139,3055,4061,4362,5262,5776,6767,7542],{"id":804,"createTime":805,"updateTime":805,"relativeEntities":806,"slug":807,"properties":808,"entityType":821,"verifyStatus":25,"verifyTime":805,"verifyNote":822,"syncStatus":28,"languages":823,"translateLanguages":26,"viewCount":36,"primaryUrl":824,"fullTextUrl":26,"authors":825,"publicationType":1081,"publisherRelationship":1082,"citationCount":1120,"citationInfo":1121,"publishDate":1133,"publishYear":1134,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":1135,"isForceReanalyzing":1446},"64cbd50b-a665-4e88-a1b3-c4e551e1f839","2024-09-01T12:43:13.202+00:00",[],"The-International-Scientific-Association-for-Probiotics-and-Prebiotics-consensus-statement-on-the-scope-and-appropriate-use-of-the-term-probiotic",{"mag":809,"keywords":811,"openalex":812,"abstract":814,"title":815,"pm":817,"doi":819},{"VOID":810},"2149074973",{},{"VOID":813},"W2149074973",{},{"EN":816},"The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic",{"VOID":818},"24912386",{"VOID":820},"10.1038\u002Fnrgastro.2014.66","PUBLICATION","Auto Verify",[102],"https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fnrgastro.2014.66",[826,848,869,891,912,933,955,976,997,1018,1039,1060],{"id":827,"sortIndex":59,"researcher":26,"roles":828,"affiliations":829,"properties":841},"3b8cba25-f1fc-4c39-acbd-bad88b9f84f6",[],[830],{"id":831,"sortIndex":36,"affiliation":832,"properties":26},"6dc42af1-bedc-492a-92e0-25382e76cf95",{"id":833,"createTime":834,"updateTime":835,"relativeEntities":836,"slug":837,"properties":838,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"b4b750f9-3d03-4f8f-a195-0fc7ce17720b","2024-01-24T16:23:56.861+00:00","2024-10-09T07:19:02.271+00:00",[],"Department-of-Food-and-Nutritional-Sciences-The-University-of-Reading-Whiteknights-PO-Box-226-Reading-RG6-6AP-UK",{"title":839},{"VI":840},"Department of Food and Nutritional Sciences, The University of Reading, Whiteknights, PO Box 226, Reading RG6 6AP, UK",{"openalex":842,"orcid":844,"title":846},{"VOID":843},"A5030229220",{"VOID":845},"https:\u002F\u002Forcid.org\u002F0000-0002-0566-0476",{"EN":847},"Glenn R. Gibson",{"id":849,"sortIndex":158,"researcher":26,"roles":850,"affiliations":851,"properties":862},"2cee7948-8b1d-4b39-8da2-f52c28474fdb",[],[852],{"id":853,"sortIndex":36,"affiliation":854,"properties":26},"f536bfc6-094e-4293-9c37-1bbeabc1e0ca",{"id":855,"createTime":856,"updateTime":856,"relativeEntities":857,"slug":858,"properties":859,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"e9928bb3-0a08-4639-988b-eb5ec36c700d","2024-09-01T12:43:13.679+00:00",[],"Department-of-Translational-Medical-Science-and-European-Laboratory-for-the-Investigation-of-Food-Induced-Diseases-University-of-Naples-Federico-II-Naples-Italy-80131",{"title":860},{"EN":861},"Department of Translational Medical Science and European Laboratory for the Investigation of Food Induced Diseases, University of Naples Federico II, Naples, Italy, 80131",{"openalex":863,"orcid":865,"title":867},{"VOID":864},"A5025023582",{"VOID":866},"https:\u002F\u002Forcid.org\u002F0000-0002-5169-9574",{"EN":868},"Roberto Berni Canani",{"id":870,"sortIndex":36,"researcher":26,"roles":871,"affiliations":872,"properties":884},"1169605f-ef6a-4e53-bf41-a7922a3272a6",[],[873],{"id":874,"sortIndex":36,"affiliation":875,"properties":26},"44f7793d-8a90-4023-9777-a867a95efd27",{"id":876,"createTime":877,"updateTime":878,"relativeEntities":879,"slug":880,"properties":881,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"604e333c-d9cb-4769-85b4-66b5b5109f24","2023-12-26T09:47:07.984+00:00","2025-01-06T03:11:09.962+00:00",[],"Alimentary-Pharmabiotic-Centre-University-College-Cork-Cork-Ireland",{"title":882},{"VI":883},"Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland",{"openalex":885,"orcid":887,"title":889},{"VOID":886},"A5047441756",{"VOID":888},"https:\u002F\u002Forcid.org\u002F0000-0002-8527-1445",{"EN":890},"Colin Hill",{"id":892,"sortIndex":50,"researcher":26,"roles":893,"affiliations":894,"properties":905},"29b60fb4-5c8b-4dc5-b68d-233960f2279b",[],[895],{"id":896,"sortIndex":36,"affiliation":897,"properties":26},"fe78ce30-b6a3-4a7f-a61e-a9b3592b3b00",{"id":898,"createTime":899,"updateTime":899,"relativeEntities":900,"slug":901,"properties":902,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"501d3819-c3de-4b6d-80a0-bb121980d12c","2024-09-01T12:43:13.764+00:00",[],"Microbiology-Group-Rowett-Institute-of-Nutrition-and-Health-University-of-Aberdeen-Greenburn-Road-Aberdeen-AB21-9SB-Bucksburn-UK",{"title":903},{"EN":904},"Microbiology Group, Rowett Institute of Nutrition and Health, University of Aberdeen, Greenburn Road, Aberdeen, AB21 9SB, Bucksburn, UK",{"openalex":906,"orcid":908,"title":910},{"VOID":907},"A5027275191",{"VOID":909},"https:\u002F\u002Forcid.org\u002F0000-0003-2116-0188",{"EN":911},"Harry J. Flint",{"id":913,"sortIndex":135,"researcher":26,"roles":914,"affiliations":915,"properties":926},"51ff6ec6-8a72-4d8a-b0f1-a0cf4cad315f",[],[916],{"id":917,"sortIndex":36,"affiliation":918,"properties":26},"011f9a5c-62fb-4fad-b0ef-3f5090929f6d",{"id":919,"createTime":920,"updateTime":920,"relativeEntities":921,"slug":922,"properties":923,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"40958776-366a-46e9-822d-23d8d2b22cd9","2024-09-01T12:43:13.596+00:00",[],"Universit%C3%A0-Cattolica-del-Sacro-Cuore-Via-Emilia-Parmense-84-Piacenza-Italy-29122",{"title":924},{"EN":925},"Università Cattolica del Sacro Cuore, Via Emilia Parmense 84, Piacenza, Italy, 29122",{"openalex":927,"orcid":929,"title":931},{"VOID":928},"A5102852041",{"VOID":930},"https:\u002F\u002Forcid.org\u002F0000-0003-0475-2712",{"EN":932},"Lorenzo Morelli",{"id":934,"sortIndex":116,"researcher":26,"roles":935,"affiliations":936,"properties":948},"67c752ed-4ebc-4197-bf1f-c69e3ed3b4bb",[],[937],{"id":938,"sortIndex":36,"affiliation":939,"properties":26},"3ac60460-3d81-450e-be56-b1be99865011",{"id":940,"createTime":941,"updateTime":942,"relativeEntities":943,"slug":944,"properties":945,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"37daaf7c-6486-4970-b9cc-53500f37933e","2024-01-05T00:23:12.002+00:00","2024-09-17T12:03:02.653+00:00",[],"Human-Development-and-Health-Academic-Unit-Faculty-of-Medicine-University-of-Southampton-Southampton-SO16-6YD-UK",{"title":946},{"VI":947},"Human Development and Health Academic Unit, Faculty of Medicine, University of Southampton, Southampton, SO16 6YD, UK",{"openalex":949,"orcid":951,"title":953},{"VOID":950},"A5074645101",{"VOID":952},"https:\u002F\u002Forcid.org\u002F0000-0002-6038-710X",{"EN":954},"Philip C. Calder",{"id":956,"sortIndex":53,"researcher":26,"roles":957,"affiliations":958,"properties":969},"a4bab417-3bf2-4dc6-91ac-71d1dab1f9db",[],[959],{"id":960,"sortIndex":36,"affiliation":961,"properties":26},"01863a97-1e07-4c7d-b81d-8defce6e56f1",{"id":962,"createTime":963,"updateTime":963,"relativeEntities":964,"slug":965,"properties":966,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"9ff00899-23bd-496f-93c0-00b573b2e4f5","2024-09-01T12:43:13.534+00:00",[],"International-Scientific-Association-for-Probiotics-and-Prebiotics-7119-S-Glencoe-Court-Centennial-80122-CO-USA",{"title":967},{"EN":968},"International Scientific Association for Probiotics and Prebiotics, 7119 S. Glencoe Court, Centennial, 80122, CO, USA",{"openalex":970,"orcid":972,"title":974},{"VOID":971},"A5008835562",{"VOID":973},"https:\u002F\u002Forcid.org\u002F0000-0001-6321-3423",{"EN":975},"Mary Ellen Sanders",{"id":977,"sortIndex":111,"researcher":26,"roles":978,"affiliations":979,"properties":990},"2751c52f-0a31-482a-bb7d-008a3601e777",[],[980],{"id":981,"sortIndex":36,"affiliation":982,"properties":26},"0b9fc816-96b7-458d-affc-d09c0d0847d2",{"id":983,"createTime":984,"updateTime":984,"relativeEntities":985,"slug":986,"properties":987,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"474dd193-4756-48c2-a130-5522d2af43d5","2024-09-01T12:43:13.416+00:00",[],"Department-of-Family-Medicine-Georgetown-University-Medical-Center-Building-D-240-4000-Reservoir-Road-NW-Washington-USA-20007-DC",{"title":988},{"EN":989},"Department of Family Medicine, Georgetown University Medical Center, Building D 240, 4000 Reservoir Road NW, Washington, USA, 20007, DC",{"openalex":991,"orcid":993,"title":995},{"VOID":992},"A5044317355",{"VOID":994},"https:\u002F\u002Forcid.org\u002F0000-0002-8808-6907",{"EN":996},"Daniel Merenstein",{"id":998,"sortIndex":162,"researcher":26,"roles":999,"affiliations":1000,"properties":1011},"e97560de-8095-4d01-9d56-6f0ac0dfb84a",[],[1001],{"id":1002,"sortIndex":36,"affiliation":1003,"properties":26},"ae337331-c1c0-4582-b6ba-1db361da7a4f",{"id":1004,"createTime":1005,"updateTime":1005,"relativeEntities":1006,"slug":1007,"properties":1008,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"1e46bb9b-0a49-4d91-8573-dfdf2c8e5fe0","2024-09-01T12:43:13.473+00:00",[],"Center-for-Infection-and-Immunity-Institut-Pasteur-de-Lille-1-Rue-Prof-Calmette-Lille-59019-France",{"title":1009},{"EN":1010},"Center for Infection and Immunity, Institut Pasteur de Lille, 1 Rue Prof Calmette, Lille, 59019, France",{"openalex":1012,"orcid":1014,"title":1016},{"VOID":1013},"A5086665853",{"VOID":1015},"https:\u002F\u002Forcid.org\u002F0000-0001-5995-6929",{"EN":1017},"Bruno Pot",{"id":1019,"sortIndex":114,"researcher":26,"roles":1020,"affiliations":1021,"properties":1032},"e65b44c5-4c23-4d42-8346-bb8c62a357d3",[],[1022],{"id":1023,"sortIndex":36,"affiliation":1024,"properties":26},"a92f4e81-0331-454f-bfa6-ad6eed8fded2",{"id":1025,"createTime":1026,"updateTime":1026,"relativeEntities":1027,"slug":1028,"properties":1029,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"eb5d1d5e-0e66-415e-965d-971e0636a2c4","2024-09-01T12:43:13.224+00:00",[],"Lawson-Health-Research-Institute-and-Departments-of-Microbiology-Immunology-and-Surgery-University-of-Western-Ontario-268-Grosvenor-Street-London-ON-N6A-4V2-Canada",{"title":1030},{"EN":1031},"Lawson Health Research Institute and Departments of Microbiology & Immunology, and Surgery, University of Western Ontario, 268 Grosvenor Street, London, ON N6A 4V2, Canada",{"openalex":1033,"orcid":1035,"title":1037},{"VOID":1034},"A5043064717",{"VOID":1036},"https:\u002F\u002Forcid.org\u002F0000-0001-9658-5696",{"EN":1038},"Gregor Reid",{"id":1040,"sortIndex":115,"researcher":26,"roles":1041,"affiliations":1042,"properties":1053},"71fc3080-0595-4d0a-a940-1fe5d1e37d04",[],[1043],{"id":1044,"sortIndex":36,"affiliation":1045,"properties":26},"51227b8e-4a84-427a-8794-8813422e04a6",{"id":1046,"createTime":1047,"updateTime":1047,"relativeEntities":1048,"slug":1049,"properties":1050,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"e0aaf479-cf4c-48e1-9174-e4f861f7e26d","2024-09-01T12:43:13.309+00:00",[],"University-Hospital-Vall-d-Hebron-Ciberehd-Barcelona-08035-Spain",{"title":1051},{"EN":1052},"University Hospital Vall d'Hebron, Ciberehd, Barcelona, 08035, Spain",{"openalex":1054,"orcid":1056,"title":1058},{"VOID":1055},"A5020045811",{"VOID":1057},"https:\u002F\u002Forcid.org\u002F0000-0002-4051-0836",{"EN":1059},"Francisco Guarner",{"id":1061,"sortIndex":52,"researcher":26,"roles":1062,"affiliations":1063,"properties":1074},"13088651-b412-41ee-8a85-29cb678a450d",[],[1064],{"id":1065,"sortIndex":36,"affiliation":1066,"properties":26},"cffe8953-c132-423b-959a-a97a6058697d",{"id":1067,"createTime":1068,"updateTime":1068,"relativeEntities":1069,"slug":1070,"properties":1071,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d3eb6083-43c5-4fa3-baf3-216bf0851b2c","2024-09-01T12:43:13.858+00:00",[],"Functional-Foods-Forum-University-of-Turku-Turku-20014-Finland",{"title":1072},{"EN":1073},"Functional Foods Forum, University of Turku, Turku, 20014, Finland",{"openalex":1075,"orcid":1077,"title":1079},{"VOID":1076},"A5072093984",{"VOID":1078},"https:\u002F\u002Forcid.org\u002F0000-0002-9737-7642",{"EN":1080},"Seppo Salminen","ARTICLE",{"url":26,"publisher":1083,"properties":1113},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":1084,"slug":663,"properties":1085,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1091,"manageAffiliations":1092,"indexDatabases":1093,"url":753,"thumbnailPath":26,"statistic":1108,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"country":1086,"issn":1087,"introduce":1088,"eissn":1089,"title":1090},{"VOID":666},{"VOID":668},{"EN":670},{"VOID":672},{"EN":674},[],[],[1094,1101],{"id":735,"indexDatabase":1095,"url":750,"indexYears":26,"academicFieldIds":1100,"indexDatabaseRanking":26},{"id":737,"createTime":738,"updateTime":739,"relativeEntities":1096,"label":1097,"description":1098,"key":746,"publicationTags":1099,"standard":26},[],{"EN":742,"VI":742},{"VI":744,"EN":745},[748,749],[752],{"id":715,"indexDatabase":1102,"url":728,"indexYears":729,"academicFieldIds":1107,"indexDatabaseRanking":733},{"id":717,"createTime":718,"updateTime":719,"relativeEntities":1103,"label":1104,"description":1105,"key":725,"publicationTags":1106,"standard":26},[],{"EN":722,"VI":722},{"EN":722,"VI":724},[727],[731,732],{"impactFactor":36,"impactFactorByYear":1109,"i10Index":259,"i10IndexLast5Year":356,"totalPublication":259,"totalPublicationByYear":1110,"totalCitation":769,"totalCitationByYear":1111,"totalCitationPerPublication":783,"totalCitationPerPublicationByYear":1112,"hindexLast5Year":283,"hindex":283},{"2012":756,"2013":757,"2014":758,"2015":759,"2016":760,"2017":761,"2018":762,"2019":763,"2020":764,"2021":765,"2022":766,"2023":767},{"2009":59,"2010":59,"2011":162,"2012":114,"2013":111,"2014":59,"2015":162,"2016":111,"2017":158,"2018":111,"2019":111,"2020":114,"2021":162,"2022":114},{"2009":144,"2010":771,"2011":772,"2012":146,"2013":773,"2014":774,"2015":775,"2016":776,"2017":777,"2018":778,"2019":779,"2020":780,"2021":781,"2022":782},{"2009":785,"2010":786,"2011":787,"2012":788,"2013":789,"2014":790,"2015":791,"2016":792,"2017":793,"2018":794,"2019":795,"2020":796,"2021":797,"2022":798},{"volume":1114,"pages":1116,"issue":1118},{"VOID":1115},"11",{"VOID":1117},"506-514",{"VOID":1119},"8",6471,{"total":1120,"publishYear":26,"statisticByYear":1122},{"2014":356,"2015":1123,"2016":1124,"2017":1125,"2018":1126,"2019":1127,"2020":1128,"2021":1129,"2022":1130,"2023":1131,"2024":1132},149,215,272,411,558,726,928,1192,1144,677,"2014-08-01",2014,[1136,1139,1142,1145,1149,1152,1155,1158,1162,1165,1169,1173,1177,1181,1185,1189,1193,1197,1201,1205,1209,1213,1217,1221,1225,1229,1233,1237,1241,1245,1249,1253,1257,1261,1265,1269,1273,1277,1281,1285,1289,1293,1297,1301,1305,1309,1313,1317,1321,1325,1329,1333,1336,1340,1344,1348,1351,1355,1359,1363,1367,1371,1375,1379,1383,1387,1391,1395,1399,1403,1407,1410,1414,1418,1422,1426,1429,1432,1436,1439,1442],{"id":26,"text":1137,"url":26,"identifiers":1138},"Food and Agricultural Organization of the United Nations and World Health Organization. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. World Health Organization \n                    [online]\n                    \n                  , (2001).",{},{"id":26,"text":1140,"url":26,"identifiers":1141},"Food and Agricultural Organization of the United Nations and World Health Organization. Joint FAO\u002FWHO working group report on drafting guidelines for the evaluation of probiotics in food. Food and Agricultural Organization of the United Nations \n                    [online]\n                    \n                  , (2002).",{},{"id":26,"text":1143,"url":26,"identifiers":1144},"Health Canada. Accepted Claims about the Nature of Probiotic Microorganisms in Food. Health Canada \n                    [online]\n                    \n                  , (2009).",{},{"id":26,"text":1146,"url":26,"identifiers":1147},"Guarner, F.  et al. World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J. Clin. Gastroenterol. 46, 468–481 (2012).",{"doi":1148},"10.1097\u002FMCG.0b013e3182549092",{"id":26,"text":1150,"url":26,"identifiers":1151},"Ohr, L. M. Health benefits of probiotics and prebiotics. Institute of Food Technologists \n                    [online]\n                    \n                  , (2010).",{},{"id":26,"text":1153,"url":26,"identifiers":1154},"Sanders, M. E. How do we know when something called “probiotic” is really a probiotic? A guideline for consumers and health care professionals. Functional Food Rev. 1, 3–12 (2009).",{},{"id":26,"text":1156,"url":26,"identifiers":1157},"Food Safety Authority of Ireland. Probiotic Health Claims. Food Safety Authority of Ireland \n                    [online]\n                    \n                  , (2013).",{},{"id":26,"text":1159,"url":26,"identifiers":1160},"Smug, L. N., Salminen, S., Sanders, M. E. & Ebner, S. Yoghurt and probiotic bacteria in dietary guidelines of the member states of the European Union. Benef. Microbes 5, 61–66 (2014).",{"doi":1161},"10.3920\u002FBM2013.0050",{"id":26,"text":1163,"url":26,"identifiers":1164},"Ministero della Salute, Commissione unica per la nutrizione e la dietetica. Guidelines on probiotics and prebiotics. Ministero della Salute \n                    [online]\n                    \n                  , (2013).",{},{"id":26,"text":1166,"url":26,"identifiers":1167},"Backhed, F.  et al. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 12, 611–622 (2012).",{"doi":1168},"10.1016\u002Fj.chom.2012.10.012",{"id":26,"text":1170,"url":26,"identifiers":1171},"Ritchie, M. L. & Romanuk, T. N. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS ONE 7, e34938 (2012).",{"doi":1172},"10.1371\u002Fjournal.pone.0034938",{"id":26,"text":1174,"url":26,"identifiers":1175},"Bernaola Aponte, G., Bada Mancilla, C. A., Carreazo, N. Y. & Rojas Galarza, R. A. Probiotics for treating persistent diarrhoea in children. Cochrane Database of Systematic Reviews, Issue 8. Art. No.: CD007401 \n                    http:\u002F\u002Fdx.doi.org\u002F10.1002\u002F14651858.CD007401.pub3\n                    \n                  .",{"doi":1176},"10.1002\u002F14651858.CD007401.pub3",{"id":26,"text":1178,"url":26,"identifiers":1179},"Goldenberg, J. Z.  et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database of Systematic Reviews, Issue 5. Art. No.: CD006095 \n                    http:\u002F\u002Fdx.doi.org\u002F10.1002\u002F14651858.CD006095.pub3\n                    \n                  .",{"doi":1180},"10.1002\u002F14651858.CD006095.pub3",{"id":26,"text":1182,"url":26,"identifiers":1183},"Alfaleh, K., Anabrees, J., Bassler, D. & Al-Kharfi, T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database of Systematic Reviews, Issue 3. Art. No.: CD005496 \n                    http:\u002F\u002Fdx.doi.org\u002F10.1002\u002F14651858.CD005496.pub3\n                    \n                  .",{"doi":1184},"10.1002\u002F14651858.CD005496.pub3",{"id":26,"text":1186,"url":26,"identifiers":1187},"Allen, S. J., Martinez, E. G., Gregorio, G. V. & Dans, L. F. Probiotics for treating acute infectious diarrhoea. Cochrane Database of Systematic Reviews Issue 11. Art. No.: CD003048 \n                    http:\u002F\u002Fdx.doi.org\u002F10.1002\u002F14651858.CD003048.pub3\n                    \n                  .",{"doi":1188},"10.1002\u002F14651858.CD003048.pub3",{"id":26,"text":1190,"url":26,"identifiers":1191},"Lomax, A. R. & Calder, P. C. Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans. Curr. Pharm. Des. 15, 1428–1518 (2009).",{"doi":1192},"10.2174\u002F138161209788168155",{"id":26,"text":1194,"url":26,"identifiers":1195},"Maidens, C., Childs, C., Przemska, A., Dayel, I. B. & Yaqoob, P. Modulation of vaccine response by concomitant probiotic administration. Br. J. Clin. Pharmacol. 75, 663–670 (2013).",{"doi":1196},"10.1111\u002Fj.1365-2125.2012.04404.x",{"id":26,"text":1198,"url":26,"identifiers":1199},"Kumar, M.  et al. Probiotic metabolites as epigenetic targets in the prevention of colon cancer. Nutr. Rev. 71, 23–34 (2013).",{"doi":1200},"10.1111\u002Fj.1753-4887.2012.00542.x",{"id":26,"text":1202,"url":26,"identifiers":1203},"Reid, G.  et al. Microbiota restoration: natural and supplemented recovery of human microbial communities. Nature Rev. Microbiol 9, 27–38 (2011).",{"doi":1204},"10.1038\u002Fnrmicro2473",{"id":26,"text":1206,"url":26,"identifiers":1207},"van Baarlen, P.  et al. Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc. Natl Acad. Sci. USA 108 (Suppl. 1), 4562–4569 (2011).",{"doi":1208},"10.1073\u002Fpnas.1000079107",{"id":26,"text":1210,"url":26,"identifiers":1211},"Heuvelin, E.  et al. Mechanisms involved in alleviation of intestinal inflammation by Bifidobacterium breve soluble factors. PLoS ONE 4, e5184 (2009).",{"doi":1212},"10.1371\u002Fjournal.pone.0005184",{"id":26,"text":1214,"url":26,"identifiers":1215},"Macho Fernandez, E.  et al. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut 60, 1050–1059 (2011).",{"doi":1216},"10.1136\u002Fgut.2010.232918",{"id":26,"text":1218,"url":26,"identifiers":1219},"EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific Opinion on the substantiation of health claims related to live yoghurt cultures and improved lactose digestion (ID 1143, 2976) pursuant to Article 13(1) of Regulation (EC) No 1924\u002F2006. EFSA Journal 8, 1763 (2010).",{"doi":1220},"10.2903\u002Fj.efsa.2010.1763",{"id":26,"text":1222,"url":26,"identifiers":1223},"Tong, X., Dong, J. Y., Wu, Z. W., Li, W. & Qin, L. Q. Dairy consumption and risk of type 2 diabetes mellitus: a meta-analysis of cohort studies. Eur. J. Clin. Nutr. 65, 1027–1031 (2011).",{"doi":1224},"10.1038\u002Fejcn.2011.62",{"id":26,"text":1226,"url":26,"identifiers":1227},"Struijk, E. A.  et al. Dairy product intake in relation to glucose regulation indices and risk of type 2 diabetes. Nutr. Metab. Cardiovasc. Dis. 23, 822–828 (2013).",{"doi":1228},"10.1016\u002Fj.numecd.2012.05.011",{"id":26,"text":1230,"url":26,"identifiers":1231},"Sluijs, I.  et al. The amount and type of dairy product intake and incident type 2 diabetes: results from the EPIC-InterAct Study. Am. J. Clin. Nutr. 96, 382–390 (2012).",{"doi":1232},"10.3945\u002Fajcn.111.021907",{"id":26,"text":1234,"url":26,"identifiers":1235},"Mozaffarian, D., Hao, T., Rimm, E. B., Willett, W. C. & Hu, F. B. Changes in diet and lifestyle and long-term weight gain in women and men. N. Engl. J. Med. 364, 2392–2404 (2011).",{"doi":1236},"10.1056\u002FNEJMoa1014296",{"id":26,"text":1238,"url":26,"identifiers":1239},"Soedamah-Muthu, S. S., Masset, G., Verberne, L., Geleijnse, J. M. & Brunner, E. J. Consumption of dairy products and associations with incident diabetes, CHD and mortality in the Whitehall II study. Br. J. Nutr. 109, 718–726 (2013).",{"doi":1240},"10.1017\u002FS0007114512001845",{"id":26,"text":1242,"url":26,"identifiers":1243},"Wang, H., Livingston, K. A., Fox, C. S., Meigs, J. B. & Jacques, P. F. Yogurt consumption is associated with better diet quality and metabolic profile in American men and women. Nutr. Res. 33, 18–26 (2013).",{"doi":1244},"10.1016\u002Fj.nutres.2012.11.009",{"id":26,"text":1246,"url":26,"identifiers":1247},"Qin, J.  et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65 (2010).",{"doi":1248},"10.1038\u002Fnature08821",{"id":26,"text":1250,"url":26,"identifiers":1251},"Lepage, P.  et al. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 141, 227–236 (2011).",{"doi":1252},"10.1053\u002Fj.gastro.2011.04.011",{"id":26,"text":1254,"url":26,"identifiers":1255},"Manichanh, C., Borruel, N., Casellas, F. & Guarner, F. The gut microbiota in IBD. Nat. Rev. Gastroenterol. Hepatol. 9, 599–608 (2012).",{"doi":1256},"10.1038\u002Fnrgastro.2012.152",{"id":26,"text":1258,"url":26,"identifiers":1259},"Qin, J.  et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55–60 (2012).",{"doi":1260},"10.1038\u002Fnature11450",{"id":26,"text":1262,"url":26,"identifiers":1263},"Le Chatelier, E.  et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541–546 (2013).",{"doi":1264},"10.1038\u002Fnature12506",{"id":26,"text":1266,"url":26,"identifiers":1267},"Jeffery, I. B.  et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 61, 997–1006 (2012).",{"doi":1268},"10.1136\u002Fgutjnl-2011-301501",{"id":26,"text":1270,"url":26,"identifiers":1271},"Rajilic-Stojanovic, M.  et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141, 1792–1801 (2011).",{"doi":1272},"10.1053\u002Fj.gastro.2011.07.043",{"id":26,"text":1274,"url":26,"identifiers":1275},"Hviid, A., Svanstrom, H. & Frisch, M. Antibiotic use and inflammatory bowel diseases in childhood. Gut 60, 49–54 (2011).",{"doi":1276},"10.1136\u002Fgut.2010.219683",{"id":26,"text":1278,"url":26,"identifiers":1279},"Trasande, L.  et al. Infant antibiotic exposures and early-life body mass. Int. J. Obes. (Lond.) 37, 16–23 (2013).",{"doi":1280},"10.1038\u002Fijo.2012.132",{"id":26,"text":1282,"url":26,"identifiers":1283},"Guarner, F.  et al. Mechanisms of disease: the hygiene hypothesis revisited. Nat. Clin. Pract. Gastroenterol. Hepatol. 3, 275–284 (2006).",{"doi":1284},"10.1038\u002Fncpgasthep0471",{"id":26,"text":1286,"url":26,"identifiers":1287},"Blaser, M. J. & Falkow, S. What are the consequences of the disappearing human microbiota? Nat. Rev. Microbiol. 7, 887–894 (2009).",{"doi":1288},"10.1038\u002Fnrmicro2245",{"id":26,"text":1290,"url":26,"identifiers":1291},"Sokol, H.  et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl Acad. Sci. USA 105, 16731–16736 (2008).",{"doi":1292},"10.1073\u002Fpnas.0804812105",{"id":26,"text":1294,"url":26,"identifiers":1295},"Atarashi, K.  et al. Treg induction by a rationally selected mixture of clostridia strains from the human microbiota. Nature 500, 232–236 (2013).",{"doi":1296},"10.1038\u002Fnature12331",{"id":26,"text":1298,"url":26,"identifiers":1299},"Everard, A.  et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl Acad. Sci. USA 110, 9066–9071 (2013).",{"doi":1300},"10.1073\u002Fpnas.1219451110",{"id":26,"text":1302,"url":26,"identifiers":1303},"Joyce, S. A. & Gahan, C. G. The gut microbiota and the metabolic health of the host. Curr. Opin. Gastroenterol. 30, 120–127 (2014).",{"doi":1304},"10.1097\u002FMOG.0000000000000039",{"id":26,"text":1306,"url":26,"identifiers":1307},"Miquel, S.  et al. Faecalibacterium prausnitzii and human intestinal health. Curr. Opin. Microbiol. 16, 255–261 (2013).",{"doi":1308},"10.1016\u002Fj.mib.2013.06.003",{"id":26,"text":1310,"url":26,"identifiers":1311},"Louis, P., Scott, K. P., Duncan, S. H. & Flint, H. J. Understanding the effects of diet on bacterial metabolism in the large intestine. J. Appl. Microbiol. 102, 1197–1208 (2007).",{"doi":1312},"10.1111\u002Fj.1365-2672.2007.03322.x",{"id":26,"text":1314,"url":26,"identifiers":1315},"Vrieze, A.  et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143, 913–916 (2012).",{"doi":1316},"10.1053\u002Fj.gastro.2012.06.031",{"id":26,"text":1318,"url":26,"identifiers":1319},"Smits, L. P., Bouter, K. E., de Vos, W. M., Borody, T. J. & Nieuwdorp, M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology 145, 946–953 (2013).",{"doi":1320},"10.1053\u002Fj.gastro.2013.08.058",{"id":26,"text":1322,"url":26,"identifiers":1323},"van Nood, E.  et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368, 407–415 (2013).",{"doi":1324},"10.1056\u002FNEJMoa1205037",{"id":26,"text":1326,"url":26,"identifiers":1327},"Allen-Vercoe, E.  et al. A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics. Can. J. Gastroenterol. 26, 457–462 (2012).",{"doi":1328},"10.1155\u002F2012\u002F213828",{"id":26,"text":1330,"url":26,"identifiers":1331},"Caporaso, J. G.  et al. Moving pictures of the human microbiome. Genome Biol. 12, R50 (2011).",{"doi":1332},"10.1186\u002Fgb-2011-12-5-r50",{"id":26,"text":1334,"url":26,"identifiers":1335},"US Department of Health & Human Services. Guidance for industry: enforcement policy regarding investigational new drug requirements for use of fecal microbiota for transplantation to treat Clostridium difficile infection not responsive to standard therapies. US Food and Drug Administration \n                    [online]\n                    \n                  , (2013).",{},{"id":26,"text":1337,"url":26,"identifiers":1338},"Petrof, E. O.  et al. Stool substitute transplant therapy for the eradication of C. difficile infection: 'RePOOPulating the gut'. Microbiome 1, 3 (2013).",{"doi":1339},"10.1186\u002F2049-2618-1-3",{"id":26,"text":1341,"url":26,"identifiers":1342},"Petrof, E. O., Claud, E. C., Gloor, G. B. & Allen-Vercoe, E. Microbial ecosystems therapeutics: a new paradigm in medicine? Benef. Microbes 4, 53–65 (2013).",{"doi":1343},"10.3920\u002FBM2012.0039",{"id":26,"text":1345,"url":26,"identifiers":1346},"Schunemann, H., Hill, S., Guyatt, G., Akl, E. A. & Ahmed, F. The GRADE approach and Bradford §Hill's criteria for causation. J. Epidemiol. Community Health 65, 392–395 (2011).",{"doi":1347},"10.1136\u002Fjech.2010.119933",{"id":26,"text":1349,"url":26,"identifiers":1350},"Gordis, L. Epidemiology (W. B. Saunder Company, 2000).",{},{"id":26,"text":1352,"url":26,"identifiers":1353},"European Food Safety Authority. Scientific opinion on the substantiation of health claims related to vitamin C and reduction of tiredness and fatigue (ID 139, 2622), contribution to normal psychological functions (ID 140), regeneration of the reduced form of vitamin E (ID 202), contribution to normal energy-yielding metabolism (ID 2334, 3196), maintenance of the normal function of the immune system (ID 4321) and protection of DNA, proteins and lipids from oxidative damage (ID 3331) pursuant to Article 13(1) of Regulation (EC) No 1924\u002F2006. EFSA Journal 8, 1815 (2010).",{"doi":1354},"10.2903\u002Fj.efsa.2010.1815",{"id":26,"text":1356,"url":26,"identifiers":1357},"Hemila, H. Vitamin C and the common cold. Br. J. Nutr. 67, 3–16 (1992).",{"doi":1358},"10.1079\u002FBJN19920004",{"id":26,"text":1360,"url":26,"identifiers":1361},"Hemila, H. Vitamin C and common cold incidence: a review of studies with subjects under heavy physical stress. Int. J. Sports Med. 17, 379–383 (1996).",{"doi":1362},"10.1055\u002Fs-2007-972864",{"id":26,"text":1364,"url":26,"identifiers":1365},"Hemila, H. & Chalker, E. Vitamin C for preventing and treating the common cold. Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD000980 \n                    http:\u002Fdx.doi.org\u002F10.1002\u002F14651858.CD000980.pub4\n                    \n                  .",{"doi":1366},"10.1002\u002F14651858.CD000980.pub4",{"id":26,"text":1368,"url":26,"identifiers":1369},"Douglas, R. M., Hemila, H., Chalker, E. & Treacy, B. Vitamin C for preventing and treating the common cold. Cochrane Database of Systematic Reviews, Issue 3. Art. No.: CD000980 \n                    http:\u002F\u002Fdx.doi.org\u002F10.1002\u002F14651858.CD000980.pub3\n                    \n                  .",{"doi":1370},"10.1002\u002F14651858.CD000980.pub3",{"id":26,"text":1372,"url":26,"identifiers":1373},"Winzenberg, T. M., Powell, S., Shaw, K. A. & Jones, G. Vitamin D supplementation for improving bone mineral density in children. Cochrane Database of Systematic Reviews, Issue 10. Art No.: CD006944 \n                    http:\u002F\u002Fdx.doi.org\u002F10.1002\u002F14651858.CD006944.pub2\n                    \n                  .",{"doi":1374},"10.1002\u002F14651858.CD006944.pub2",{"id":26,"text":1376,"url":26,"identifiers":1377},"Hao, Q., Lu, Z., Dong, B. R., Huang, C. Q. & Wu, T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database of Systematic Reviews, Issue 9. Art. No.: CD006895 \n                    http:\u002F\u002Fdx.doi.org\u002F10.1002\u002F14651858.CD006895.pub2\n                    \n                  .",{"doi":1378},"10.1002\u002F14651858.CD006895.pub2",{"id":26,"text":1380,"url":26,"identifiers":1381},"Johnston, B. C.  et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann. Intern. Med. 157, 878–888 (2012).",{"doi":1382},"10.7326\u002F0003-4819-157-12-201212180-00563",{"id":26,"text":1384,"url":26,"identifiers":1385},"Hempel, S.  et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 307, 1959–1969 (2012).",{"doi":1386},"10.1001\u002Fjama.2012.3507",{"id":26,"text":1388,"url":26,"identifiers":1389},"Hoveyda, N.  et al. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol. 9, 15 (2009).",{"doi":1390},"10.1186\u002F1471-230X-9-15",{"id":26,"text":1392,"url":26,"identifiers":1393},"Reid, G. Microbiology: Categorize probiotics to speed research. Nature 485, 446 (2012).",{"doi":1394},"10.1038\u002F485446a",{"id":26,"text":1396,"url":26,"identifiers":1397},"Sanders, M. E.  et al.Probiotics and prebiotics: prospects for public health and nutritional recommendations. Ann. N.Y. Acad. Sci. 1309, 19–29 (2014).",{"doi":1398},"10.1111\u002Fnyas.12377",{"id":26,"text":1400,"url":26,"identifiers":1401},"Hill, C. & Sanders, M. E. Rethinking “probiotics”. Gut Microbes 4, 269–270 (2013).",{"doi":1402},"10.4161\u002Fgmic.25143",{"id":26,"text":1404,"url":26,"identifiers":1405},"Hoffmann, D. E.  et al. Science and regulation. Probiotics: finding the right regulatory balance. Science 342, 314–315 (2013).",{"doi":1406},"10.1126\u002Fscience.1244656",{"id":26,"text":1408,"url":26,"identifiers":1409},"US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research & Center for Food Safety and Applied Nutrition. Guidance for clinical investigators, sponsors, and IRBs. Investigational new drug applications (INDs)—determining whether human research studies can be conducted without an IND. US Food and Drug Administration \n                    [online]\n                    \n                  , (2013).",{},{"id":26,"text":1411,"url":26,"identifiers":1412},"Hungin, A. P.  et al. Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice—an evidence-based international guide. Aliment. Pharmacol. Ther. 38, 864–886 (2013).",{"doi":1413},"10.1111\u002Fapt.12460",{"id":26,"text":1415,"url":26,"identifiers":1416},"Bertazzoni, E., Donelli, G., Midtvedt, T., Nicoli, J. & Sanz, Y. Probiotics and clinical effects: is the number what counts? J. Chemother. 25, 193–212 (2013).",{"doi":1417},"10.1179\u002F1973947813Y.0000000078",{"id":26,"text":1419,"url":26,"identifiers":1420},"de Vrese, M.  et al. Probiotics—compensation for lactase insufficiency. Am. J. Clin. Nutr. 73, 421S–429S (2001).",{"doi":1421},"10.1093\u002Fajcn\u002F73.2.421s",{"id":26,"text":1423,"url":26,"identifiers":1424},"Guarner, F.  et al. Should yoghurt cultures be considered probiotic? Br. J. Nutr. 93, 783–786 (2005).",{"doi":1425},"10.1079\u002FBJN20051428",{"id":26,"text":1427,"url":26,"identifiers":1428},"European Food Safety Authority. Introduction of a Qualified Presumption of Safety (QPS) approach for assessment of selected microorganisms referred to EFSA—Opinion of the Scientific Committee \n                    [online]\n                    \n                  , (2007).",{},{"id":26,"text":1430,"url":26,"identifiers":1431},"US Department of Health & Human Services. Generally Recognized as Safe (GRAS). US Food and Drug Administration \n                    [online]\n                    \n                  , (2013).",{},{"id":26,"text":1433,"url":26,"identifiers":1434},"Higgins, J. & Green, S. Cochrane Handbook for Systematic Reviews of Interventions (John Wiley & Sons Ltd, 2008).",{"doi":1435},"10.1002\u002F9780470712184",{"id":26,"text":1437,"url":26,"identifiers":1438},"International Life Sciences Institute—Europe. PASSCLAIM. A European Commission Concerted Action Programme. International Life Sciences Institute \n                    [online]\n                    \n                  , (2005).",{},{"id":26,"text":1440,"url":26,"identifiers":1441},"GRADE Working Group. Grading the quality of evidence and the strength of recommendations. GRADE \n                    [online]\n                    \n                  , (2013).",{},{"id":26,"text":1443,"url":26,"identifiers":1444},"van Loveren, H., Sanz, Y. & Salminen, S. Health claims in Europe: probiotics and prebiotics as case examples. Annu. Rev. Food Sci. Technol. 3, 247–261 (2012).",{"doi":1445},"10.1146\u002Fannurev-food-022811-101206",false,{"id":1448,"createTime":1449,"updateTime":1449,"relativeEntities":1450,"slug":1451,"properties":1452,"entityType":821,"verifyStatus":25,"verifyTime":1465,"verifyNote":822,"syncStatus":28,"languages":1466,"translateLanguages":26,"viewCount":36,"primaryUrl":1467,"fullTextUrl":26,"authors":1468,"publicationType":1081,"publisherRelationship":1625,"citationCount":1663,"citationInfo":1664,"publishDate":1673,"publishYear":1674,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":1675,"isForceReanalyzing":1446},"478f924c-f8b9-4894-bb31-9443d575abab","2024-08-30T12:57:48.533+00:00",[],"Global-burden-of-NAFLD-and-NASH-trends-predictions-risk-factors-and-prevention",{"mag":1453,"keywords":1455,"openalex":1456,"abstract":1458,"title":1459,"pm":1461,"doi":1463},{"VOID":1454},"2759997926",{},{"VOID":1457},"W2759997926",{},{"EN":1460},"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention",{"VOID":1462},"28930295",{"VOID":1464},"10.1038\u002Fnrgastro.2017.109","2024-08-30T12:57:48.532+00:00",[102],"https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fnrgastro.2017.109",[1469,1490,1511,1532,1549,1570,1587,1608],{"id":1470,"sortIndex":59,"researcher":26,"roles":1471,"affiliations":1472,"properties":1483},"5a8e0730-5cf7-48ac-a24e-c7fca31b26c4",[],[1473],{"id":1474,"sortIndex":36,"affiliation":1475,"properties":26},"7cc01dfb-9dda-40ca-8cab-c6383320081d",{"id":1476,"createTime":1477,"updateTime":1477,"relativeEntities":1478,"slug":1479,"properties":1480,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"68a068ac-5789-4141-9e7e-ea96ca5b02b9","2024-08-30T12:57:48.569+00:00",[],"Institute-of-Cellular-Medicine-Faculty-of-Medical-Sciences-Newcastle-University-4-th-Floor-William-Leech-Building-Framlington-Place-NE2-4HH-Newcastle-upon-Tyne-UK",{"title":1481},{"EN":1482},"Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle University, 4 th Floor, William Leech Building, Framlington Place, NE2 4HH, Newcastle upon Tyne, UK",{"openalex":1484,"orcid":1486,"title":1488},{"VOID":1485},"A5075207072",{"VOID":1487},"https:\u002F\u002Forcid.org\u002F0000-0001-9777-9134",{"EN":1489},"Timothy Hardy",{"id":1491,"sortIndex":114,"researcher":26,"roles":1492,"affiliations":1493,"properties":1504},"27df46ee-3149-4c50-b431-a84343408e87",[],[1494],{"id":1495,"sortIndex":36,"affiliation":1496,"properties":26},"5af11c86-74c0-4cf3-b87e-8e844fa15306",{"id":1497,"createTime":1498,"updateTime":1498,"relativeEntities":1499,"slug":1500,"properties":1501,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"b9901382-6827-4958-9650-fecbc749eded","2024-08-30T12:57:48.592+00:00",[],"Division-of-Gastroenterology-Department-of-Medical-Sciences-University-of-Torino-AOU-Citt%C3%A0-della-Salute-e-della-Scienza-Corso-Dogliotti-14-Torino-10126-Italy",{"title":1502},{"EN":1503},"Division of Gastroenterology, Department of Medical Sciences, University of Torino, AOU Città della Salute e della Scienza, Corso Dogliotti 14, Torino, 10126, Italy",{"openalex":1505,"orcid":1507,"title":1509},{"VOID":1506},"A5028775498",{"VOID":1508},"https:\u002F\u002Forcid.org\u002F0000-0003-3974-1538",{"EN":1510},"M. Marietti",{"id":1512,"sortIndex":111,"researcher":26,"roles":1513,"affiliations":1514,"properties":1525},"7e792980-cb2c-4be7-bf09-c791c4d70e06",[],[1515],{"id":1516,"sortIndex":36,"affiliation":1517,"properties":26},"9b9229cb-4d4d-41f3-bc70-b7afdb927fdc",{"id":1518,"createTime":1519,"updateTime":1519,"relativeEntities":1520,"slug":1521,"properties":1522,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"e92e893b-c808-40f1-b02c-5ae22d44f15b","2024-08-30T12:57:48.627+00:00",[],"Center-for-Outcomes-Research-in-Liver-Disease-2411-I-Street-NW-20037-Washington-DC-USA",{"title":1523},{"EN":1524},"Center for Outcomes Research in Liver Disease, 2411 I Street NW, 20037, Washington DC, USA",{"openalex":1526,"orcid":1528,"title":1530},{"VOID":1527},"A5071309777",{"VOID":1529},"https:\u002F\u002Forcid.org\u002F0000-0002-7833-6124",{"EN":1531},"Linda Henry",{"id":1533,"sortIndex":115,"researcher":26,"roles":1534,"affiliations":1535,"properties":1542},"a1b2a9d0-7d13-4252-a44b-4e2134fe3b29",[],[1536],{"id":1537,"sortIndex":36,"affiliation":1538,"properties":26},"274b0d52-89b6-4699-845d-131a0a79a4ca",{"id":1476,"createTime":1477,"updateTime":1477,"relativeEntities":1539,"slug":1479,"properties":1540,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1541},{"EN":1482},{"openalex":1543,"orcid":1545,"title":1547},{"VOID":1544},"A5059068278",{"VOID":1546},"https:\u002F\u002Forcid.org\u002F0000-0002-9518-0088",{"EN":1548},"Quentin M. Anstee",{"id":1550,"sortIndex":36,"researcher":26,"roles":1551,"affiliations":1552,"properties":1563},"982130e5-ef53-4ad7-8191-1697c38fd1ac",[],[1553],{"id":1554,"sortIndex":36,"affiliation":1555,"properties":26},"aa8c3afc-ad82-44f0-a0f4-4d4c3c84e5e2",{"id":1556,"createTime":1557,"updateTime":1557,"relativeEntities":1558,"slug":1559,"properties":1560,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"9ed5b0ef-a21d-4071-b373-cfade4101e6e","2024-08-30T12:57:48.548+00:00",[],"Department-of-Medicine-Center-for-Liver-Diseases-Inova-Fairfax-Hospital-3300-Gallows-Road-Falls-Church-22042-Virginia-USA",{"title":1561},{"EN":1562},"Department of Medicine, Center for Liver Diseases, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, 22042, Virginia, USA",{"openalex":1564,"orcid":1566,"title":1568},{"VOID":1565},"A5080386622",{"VOID":1567},"https:\u002F\u002Forcid.org\u002F0000-0001-9313-577X",{"EN":1569},"Zobair M. Younossi",{"id":1571,"sortIndex":158,"researcher":26,"roles":1572,"affiliations":1573,"properties":1580},"fa23787e-7a45-401c-85e9-f3ca51abff67",[],[1574],{"id":1575,"sortIndex":36,"affiliation":1576,"properties":26},"556aa4df-bd8a-4056-b8df-09cee6473975",{"id":1497,"createTime":1498,"updateTime":1498,"relativeEntities":1577,"slug":1500,"properties":1578,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1579},{"EN":1503},{"openalex":1581,"orcid":1583,"title":1585},{"VOID":1582},"A5039389628",{"VOID":1584},"https:\u002F\u002Forcid.org\u002F0000-0002-0502-4381",{"EN":1586},"Elisabetta Bugianesi",{"id":1588,"sortIndex":135,"researcher":26,"roles":1589,"affiliations":1590,"properties":1601},"3efceace-eb75-41b7-af47-b11163bf931e",[],[1591],{"id":1592,"sortIndex":36,"affiliation":1593,"properties":26},"bc801f51-aaa7-413a-8547-aa2be4b2313e",{"id":1594,"createTime":1595,"updateTime":1595,"relativeEntities":1596,"slug":1597,"properties":1598,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"e8f125f4-cc20-4e37-b26d-dc79a6685835","2024-08-30T12:57:48.647+00:00",[],"Storr-Liver-Centre-Westmead-Institute-for-Medical-Research-Westmead-Hospital-and-University-of-Sydney-176-Hawkesbury-Rd-Westmead-NSW-2145-Sydney-New-South-Wales-Australia",{"title":1599},{"EN":1600},"Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, 176 Hawkesbury Rd, Westmead NSW 2145, Sydney, New South Wales, Australia",{"openalex":1602,"orcid":1604,"title":1606},{"VOID":1603},"A5101478389",{"VOID":1605},"https:\u002F\u002Forcid.org\u002F0000-0002-6592-3215",{"EN":1607},"Jacob George",{"id":1609,"sortIndex":162,"researcher":26,"roles":1610,"affiliations":1611,"properties":1618},"b0193b19-0e70-420c-8337-c924aa4c4967",[],[1612],{"id":1613,"sortIndex":36,"affiliation":1614,"properties":26},"e0933960-5f25-4136-b6fc-8a8da2918dae",{"id":1594,"createTime":1595,"updateTime":1595,"relativeEntities":1615,"slug":1597,"properties":1616,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1617},{"EN":1600},{"openalex":1619,"orcid":1621,"title":1623},{"VOID":1620},"A5071565406",{"VOID":1622},"https:\u002F\u002Forcid.org\u002F0000-0002-4315-4144",{"EN":1624},"Mohammed Eslam",{"url":26,"publisher":1626,"properties":1656},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":1627,"slug":663,"properties":1628,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1634,"manageAffiliations":1635,"indexDatabases":1636,"url":753,"thumbnailPath":26,"statistic":1651,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"country":1629,"issn":1630,"introduce":1631,"eissn":1632,"title":1633},{"VOID":666},{"VOID":668},{"EN":670},{"VOID":672},{"EN":674},[],[],[1637,1644],{"id":735,"indexDatabase":1638,"url":750,"indexYears":26,"academicFieldIds":1643,"indexDatabaseRanking":26},{"id":737,"createTime":738,"updateTime":739,"relativeEntities":1639,"label":1640,"description":1641,"key":746,"publicationTags":1642,"standard":26},[],{"EN":742,"VI":742},{"VI":744,"EN":745},[748,749],[752],{"id":715,"indexDatabase":1645,"url":728,"indexYears":729,"academicFieldIds":1650,"indexDatabaseRanking":733},{"id":717,"createTime":718,"updateTime":719,"relativeEntities":1646,"label":1647,"description":1648,"key":725,"publicationTags":1649,"standard":26},[],{"EN":722,"VI":722},{"EN":722,"VI":724},[727],[731,732],{"impactFactor":36,"impactFactorByYear":1652,"i10Index":259,"i10IndexLast5Year":356,"totalPublication":259,"totalPublicationByYear":1653,"totalCitation":769,"totalCitationByYear":1654,"totalCitationPerPublication":783,"totalCitationPerPublicationByYear":1655,"hindexLast5Year":283,"hindex":283},{"2012":756,"2013":757,"2014":758,"2015":759,"2016":760,"2017":761,"2018":762,"2019":763,"2020":764,"2021":765,"2022":766,"2023":767},{"2009":59,"2010":59,"2011":162,"2012":114,"2013":111,"2014":59,"2015":162,"2016":111,"2017":158,"2018":111,"2019":111,"2020":114,"2021":162,"2022":114},{"2009":144,"2010":771,"2011":772,"2012":146,"2013":773,"2014":774,"2015":775,"2016":776,"2017":777,"2018":778,"2019":779,"2020":780,"2021":781,"2022":782},{"2009":785,"2010":786,"2011":787,"2012":788,"2013":789,"2014":790,"2015":791,"2016":792,"2017":793,"2018":794,"2019":795,"2020":796,"2021":797,"2022":798},{"volume":1657,"pages":1659,"issue":1661},{"VOID":1658},"15",{"VOID":1660},"11-20",{"VOID":1662},"1",3959,{"total":1663,"publishYear":26,"statisticByYear":1665},{"2017":59,"2018":1666,"2019":1667,"2020":1668,"2021":1669,"2022":1670,"2023":1671,"2024":1672},142,369,582,727,821,806,448,"2018-01-01",2018,[1676,1680,1684,1688,1692,1696,1700,1704,1708,1712,1716,1720,1724,1728,1732,1735,1739,1743,1747,1751,1755,1759,1763,1767,1771,1775,1779,1783,1787,1791,1795,1798,1802,1806,1810,1814,1818,1822,1826,1830,1834,1838,1842,1846,1850,1854,1858,1861,1865,1869,1873,1877,1881,1885,1889,1893,1897,1900,1904,1908,1912,1916,1919,1923,1927,1931,1935,1939,1943,1947,1951,1955,1959,1963,1966,1969,1973,1977,1980,1984,1988,1992,1996,2000,2004,2008,2012,2016,2020,2024,2028,2032,2036,2040,2044,2048,2052,2056,2060,2064,2068,2072,2076,2080,2084,2088,2092,2096,2100,2104,2108,2112,2116,2120,2124,2128,2132,2136],{"id":26,"text":1677,"url":26,"identifiers":1678},"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease — meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73–84 (2016).",{"doi":1679},"10.1002\u002Fhep.28431",{"id":26,"text":1681,"url":26,"identifiers":1682},"Anstee, Q. M., Targher, G. & Day, C. P. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat. Rev. Gastroenterol. Hepatol. 10, 330–344 (2013).",{"doi":1683},"10.1038\u002Fnrgastro.2013.41",{"id":26,"text":1685,"url":26,"identifiers":1686},"Lazo, M. et al. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988–1994. Am. J. Epidemiol. 178, 38–45 (2013).",{"doi":1687},"10.1093\u002Faje\u002Fkws448",{"id":26,"text":1689,"url":26,"identifiers":1690},"Pan, J. J. & Fallon, M. B. Gender and racial differences in nonalcoholic fatty liver disease. World J. Hepatol. 6, 274–283 (2014).",{"doi":1691},"10.4254\u002Fwjh.v6.i5.274",{"id":26,"text":1693,"url":26,"identifiers":1694},"Browning, J. D. et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40, 1387–1395 (2004).",{"doi":1695},"10.1002\u002Fhep.20466",{"id":26,"text":1697,"url":26,"identifiers":1698},"Schneider, A. L., Lazo, M., Selvin, E. & Clark, J. M. Racial differences in nonalcoholic fatty liver disease in the U. S. population. Obesity (Silver Spring) 22, 292–299 (2014).",{"doi":1699},"10.1002\u002Foby.20426",{"id":26,"text":1701,"url":26,"identifiers":1702},"Sherif, Z. A. et al. Global epidemiology of nonalcoholic fatty liver disease and perspectives on US minority populations. Dig. Dis. Sci. 61, 1214–1225 (2016).",{"doi":1703},"10.1007\u002Fs10620-016-4143-0",{"id":26,"text":1705,"url":26,"identifiers":1706},"Saab, S., Manne, V., Nieto, J., Schwimmer, J. B. & Chalasani, N. P. Nonalcoholic fatty liver disease in Latinos. Clin. Gastroenterol. Hepatol. 14, 5–12 (2016).",{"doi":1707},"10.1016\u002Fj.cgh.2015.05.001",{"id":26,"text":1709,"url":26,"identifiers":1710},"Balakrishnan, M., Kanwal, F., El-Serag, H. B. & Thrift, A. P. Acculturation and nonalcoholic fatty liver disease risk among hispanics of mexican origin: findings from the National Health and Nutrition Examination Survey. Clin. Gastroenterol. Hepatol. 15, 310–312 (2017).",{"doi":1711},"10.1016\u002Fj.cgh.2016.09.149",{"id":26,"text":1713,"url":26,"identifiers":1714},"Kanwal, F. et al. Trends in the burden of nonalcoholic fatty liver disease in a United States cohort of veterans. Clin. Gastroenterol. Hepatol. 14, 301–308.e2 (2016).",{"doi":1715},"10.1016\u002Fj.cgh.2015.08.010",{"id":26,"text":1717,"url":26,"identifiers":1718},"Carroll, J. F. et al. Impact of race\u002Fethnicity on the relationship between visceral fat and inflammatory biomarkers. Obesity (Silver Spring) 17, 1420–1427 (2009).",{"doi":1719},"10.1038\u002Foby.2008.657",{"id":26,"text":1721,"url":26,"identifiers":1722},"Smits, M. M., Ioannou, G. N., Boyko, E. J. & Utzschneider, K. M. Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groups. J. Gastroenterol. Hepatol. 28, 664–670 (2013).",{"doi":1723},"10.1111\u002Fjgh.12106",{"id":26,"text":1725,"url":26,"identifiers":1726},"Bambha, K. et al. Ethnicity and nonalcoholic fatty liver disease. Hepatology 55, 769–780 (2012).",{"doi":1727},"10.1002\u002Fhep.24726",{"id":26,"text":1729,"url":26,"identifiers":1730},"Fleischman, M. W., Budoff, M., Zeb, I., Li, D. & Foster, T. NAFLD prevalence differs among hispanic subgroups: the Multi-Ethnic Study of Atherosclerosis. World J. Gastroenterol. 20, 4987–4993 (2014).",{"doi":1731},"10.3748\u002Fwjg.v20.i17.4987",{"id":26,"text":1733,"url":26,"identifiers":1734},"Karnikowski, M., Cordova, C., Oliveira, R. J., Karnikowski, M. G. & Nobrega Ode, T. Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults. Sao Paulo Med. J. 125, 333–337 (2007).",{},{"id":26,"text":1736,"url":26,"identifiers":1737},"Kallwitz, E. R. et al. Prevalence of suspected nonalcoholic fatty liver disease in Hispanic\u002FLatino individuals differs by heritage. Clin. Gastroenterol. Hepatol. 13, 569–576 (2015).",{"doi":1738},"10.1016\u002Fj.cgh.2014.08.037",{"id":26,"text":1740,"url":26,"identifiers":1741},"Oni, E. T. et al. Relation of physical activity to prevalence of nonalcoholic Fatty liver disease independent of cardiometabolic risk. Am. J. Cardiol. 115, 34–39 (2015).",{"doi":1742},"10.1016\u002Fj.amjcard.2014.09.044",{"id":26,"text":1744,"url":26,"identifiers":1745},"Riquelme, A. et al. Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics. Liver Int. 29, 82–88 (2009).",{"doi":1746},"10.1111\u002Fj.1478-3231.2008.01823.x",{"id":26,"text":1748,"url":26,"identifiers":1749},"Lopez-Velazquez, J. A. et al. The prevalence of nonalcoholic fatty liver disease in the Americas. Ann. Hepatol. 13, 166–178 (2014).",{"doi":1750},"10.1016\u002FS1665-2681(19)30879-8",{"id":26,"text":1752,"url":26,"identifiers":1753},"Feijo, S. G. et al. The spectrum of non alcoholic fatty liver disease in morbidly obese patients: prevalence and associate risk factors. Acta Cir. Bras. 28, 788–793 (2013).",{"doi":1754},"10.1590\u002FS0102-86502013001100008",{"id":26,"text":1756,"url":26,"identifiers":1757},"Hernaez, R. et al. Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey. Clin. Gastroenterol. Hepatol. 11, 1183–1190.e2 (2013).",{"doi":1758},"10.1016\u002Fj.cgh.2013.02.011",{"id":26,"text":1760,"url":26,"identifiers":1761},"Ballestri, S., Nascimbeni, F., Romagnoli, D. & Lonardo, A. The independent predictors of non-alcoholic steatohepatitis and its individual histological features: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment. Hepatol. Res. 46, 1074–1087 (2016).",{"doi":1762},"10.1111\u002Fhepr.12656",{"id":26,"text":1764,"url":26,"identifiers":1765},"Stepanova, M. et al. Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD). Dig. Dis. Sci. 58, 3017–3023 (2013).",{"doi":1766},"10.1007\u002Fs10620-013-2743-5",{"id":26,"text":1768,"url":26,"identifiers":1769},"Motamed, N. et al. Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases. Clin. Res. Hepatol. Gastroenterol. 41, 31–38 (2017).",{"doi":1770},"10.1016\u002Fj.clinre.2016.07.005",{"id":26,"text":1772,"url":26,"identifiers":1773},"Kotronen, A., Westerbacka, J., Bergholm, R., Pietilainen, K. H. & Yki-Jarvinen, H. Liver fat in the metabolic syndrome. J. Clin. Endocrinol. Metabolism 92, 3490–3497 (2007).",{"doi":1774},"10.1210\u002Fjc.2007-0482",{"id":26,"text":1776,"url":26,"identifiers":1777},"Haring, R. et al. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum γ-glutamyl transpeptidase levels. Hepatology 50, 1403–1411 (2009).",{"doi":1778},"10.1002\u002Fhep.23135",{"id":26,"text":1780,"url":26,"identifiers":1781},"Armstrong, M. J. et al. Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort. J. Hepatol. 56, 234–240 (2012).",{"doi":1782},"10.1016\u002Fj.jhep.2011.03.020",{"id":26,"text":1784,"url":26,"identifiers":1785},"de Ledinghen, V. et al. Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study. J. Hepatol. 45, 592–599 (2006).",{"doi":1786},"10.1016\u002Fj.jhep.2006.05.008",{"id":26,"text":1788,"url":26,"identifiers":1789},"Bedogni, G. et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42, 44–52 (2005).",{"doi":1790},"10.1002\u002Fhep.20734",{"id":26,"text":1792,"url":26,"identifiers":1793},"Caballeria, L. et al. Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain. Eur. J. Gastroenterol. Hepatol. 22, 24–32 (2010).",{"doi":1794},"10.1097\u002FMEG.0b013e32832fcdf0",{"id":26,"text":1796,"url":26,"identifiers":1797},"Radu, C. et al. Prevalence and associated risk factors of non-alcoholic fatty liver disease in hospitalized patients. J. Gastrointestin. Liver Dis. 17, 255–260 (2008).",{},{"id":26,"text":1799,"url":26,"identifiers":1800},"Tarnoki, A. D. et al. Heritability of non-alcoholic fatty liver disease and association with abnormal vascular parameters: a twin study. Liver Int. 32, 1287–1293 (2012).",{"doi":1801},"10.1111\u002Fj.1478-3231.2012.02823.x",{"id":26,"text":1803,"url":26,"identifiers":1804},"Soresi, M. et al. Nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society. Acta Diabetol. 50, 241–249 (2013).",{"doi":1805},"10.1007\u002Fs00592-012-0406-1",{"id":26,"text":1807,"url":26,"identifiers":1808},"Targher, G. et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30, 1212–1218 (2007).",{"doi":1809},"10.2337\u002Fdc06-2247",{"id":26,"text":1811,"url":26,"identifiers":1812},"Williamson, R. M. et al. Prevalence of and risk factors for hepatic steatosis and nonalcoholic ffatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 34, 1139–1144 (2011).",{"doi":1813},"10.2337\u002Fdc10-2229",{"id":26,"text":1815,"url":26,"identifiers":1816},"Bedogni, G. et al. Incidence and natural course of fatty liver in the general population: the Dionysos study. Hepatology 46, 1387–1391 (2007).",{"doi":1817},"10.1002\u002Fhep.21827",{"id":26,"text":1819,"url":26,"identifiers":1820},"Koehler, E. M. et al. Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam Study. Hepatology 63, 138–147 (2016).",{"doi":1821},"10.1002\u002Fhep.27981",{"id":26,"text":1823,"url":26,"identifiers":1824},"McPherson, S. et al. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management. J. Hepatol. 62, 1148–1155 (2015).",{"doi":1825},"10.1016\u002Fj.jhep.2014.11.034",{"id":26,"text":1827,"url":26,"identifiers":1828},"Zois, C. D. et al. Steatosis and steatohepatitis in postmortem material from Northwestern Greece. World J. Gastroenterol. 16, 3944–3949 (2010).",{"doi":1829},"10.3748\u002Fwjg.v16.i31.3944",{"id":26,"text":1831,"url":26,"identifiers":1832},"Garcia-Monzon, C. et al. Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones. Liver Int. 35, 1983–1991 (2015).",{"doi":1833},"10.1111\u002Fliv.12813",{"id":26,"text":1835,"url":26,"identifiers":1836},"Minervini, M. I. et al. Liver biopsy findings from healthy potential living liver donors: reasons for disqualification, silent diseases and correlation with liver injury tests. J. Hepatol. 50, 501–510 (2009).",{"doi":1837},"10.1016\u002Fj.jhep.2008.10.030",{"id":26,"text":1839,"url":26,"identifiers":1840},"Ekstedt, M. et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 61, 1547–1554 (2015).",{"doi":1841},"10.1002\u002Fhep.27368",{"id":26,"text":1843,"url":26,"identifiers":1844},"Dyson, J. et al. Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team. J. Hepatol. 60, 110–117 (2014).",{"doi":1845},"10.1016\u002Fj.jhep.2013.08.011",{"id":26,"text":1847,"url":26,"identifiers":1848},"Williams, R. et al. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet 384, 1953–1997 (2014).",{"doi":1849},"10.1016\u002FS0140-6736(14)61838-9",{"id":26,"text":1851,"url":26,"identifiers":1852},"Fan, J. G. et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J. Hepatol. 43, 508–514 (2005).",{"doi":1853},"10.1016\u002Fj.jhep.2005.02.042",{"id":26,"text":1855,"url":26,"identifiers":1856},"Zhou, Y. J. et al. Prevalence of fatty liver disease and its risk factors in the population of South China. World J. Gastroenterol. 13, 6419–6424 (2007).",{"doi":1857},"10.3748\u002Fwjg.v13.i47.6419",{"id":26,"text":1859,"url":26,"identifiers":1860},"Li, H. et al. Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China. Hepatobiliary Pancreat. Dis. Int. 8, 377–382 (2009).",{},{"id":26,"text":1862,"url":26,"identifiers":1863},"Hu, X. et al. Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units. BMC Gastroenterol. 12, 123 (2012).",{"doi":1864},"10.1186\u002F1471-230X-12-123",{"id":26,"text":1866,"url":26,"identifiers":1867},"Wei, J. L. et al. Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients: a population study using proton-magnetic resonance spectroscopy. Am. J. Gastroenterol. 110, 1306–1314 (2015).",{"doi":1868},"10.1038\u002Fajg.2015.235",{"id":26,"text":1870,"url":26,"identifiers":1871},"Chen, C. H. et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J. Clin. Gastroenterol. 40, 745–752 (2006).",{"doi":1872},"10.1097\u002F00004836-200609000-00016",{"id":26,"text":1874,"url":26,"identifiers":1875},"Hung, S.-C., Lai, S.-W., Chen, M.-C., Li, P.-C. & Lin, K.-C. Prevalence and related factors of non-alcoholic fatty liver disease among the elderly in Taiwan. Eur. Geriatr. Med. 4, 78–81 (2013).",{"doi":1876},"10.1016\u002Fj.eurger.2012.11.004",{"id":26,"text":1878,"url":26,"identifiers":1879},"Tung, T. H. et al. Clinical correlation of nonalcoholic fatty liver disease in a Chinese taxi drivers population in Taiwan: Experience at a teaching hospital. BMC Res. Notes 4, 315 (2011).",{"doi":1880},"10.1186\u002F1756-0500-4-315",{"id":26,"text":1882,"url":26,"identifiers":1883},"Kojima, S., Watanabe, N., Numata, M., Ogawa, T. & Matsuzaki, S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J. Gastroenterol. 38, 954–961 (2003).",{"doi":1884},"10.1007\u002Fs00535-003-1178-8",{"id":26,"text":1886,"url":26,"identifiers":1887},"Hamaguchi, M. et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann. Intern. Med. 143, 722–728 (2005).",{"doi":1888},"10.7326\u002F0003-4819-143-10-200511150-00009",{"id":26,"text":1890,"url":26,"identifiers":1891},"Jeong, E. H. et al. Regional prevalence of non-alcoholic fatty liver disease in Seoul and Gyeonggi-do, Korea. Clin. Mol. Hepatol. 19, 266–272 (2013).",{"doi":1892},"10.3350\u002Fcmh.2013.19.3.266",{"id":26,"text":1894,"url":26,"identifiers":1895},"Das, K. et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology 51, 1593–1602 (2010).",{"doi":1896},"10.1002\u002Fhep.23567",{"id":26,"text":1898,"url":26,"identifiers":1899},"Singh, S. P. et al. Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey. Trop. Gastroenterol. 25, 76–79 (2004).",{},{"id":26,"text":1901,"url":26,"identifiers":1902},"Amarapurkar, D. et al. Prevalence of non-alcoholic fatty liver disease: population based study. Ann. Hepatol. 6, 161–163 (2007).",{"doi":1903},"10.1016\u002FS1665-2681(19)31922-2",{"id":26,"text":1905,"url":26,"identifiers":1906},"Dassanayake, A. S. et al. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population. J. Gastroenterol. Hepatol. 24, 1284–1288 (2009).",{"doi":1907},"10.1111\u002Fj.1440-1746.2009.05831.x",{"id":26,"text":1909,"url":26,"identifiers":1910},"Mohan, V., Farooq, S., Deepa, M., Ravikumar, R. & Pitchumoni, C. S. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res. Clin. Pract. 84, 84–91 (2009).",{"doi":1911},"10.1016\u002Fj.diabres.2008.11.039",{"id":26,"text":1913,"url":26,"identifiers":1914},"Goh, S. C., Ho, E. L. & Goh, K. L. Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia. Hepatol. Int. 7, 548–554 (2013).",{"doi":1915},"10.1007\u002Fs12072-012-9359-2",{"id":26,"text":1917,"url":26,"identifiers":1918},"Chow, W. C. et al. Significant non-alcoholic fatty liver disease is found in non-diabetic, pre-obese Chinese in Singapore. Singapore Med. J. 48, 752–757 (2007).",{},{"id":26,"text":1920,"url":26,"identifiers":1921},"Onyekwere, C. A., Ogbera, A. O. & Balogun, B. O. Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community. Ann. Hepatol. 10, 119–124 (2011).",{"doi":1922},"10.1016\u002FS1665-2681(19)31559-5",{"id":26,"text":1924,"url":26,"identifiers":1925},"Olusanya, T. O., Lesi, O. A., Adeyomoye, A. A. & Fasanmade, O. A. Non alcoholic fatty liver disease in a Nigerian population with type II diabetes mellitus. Pan Afr. Med. J. 24, 20 (2016).",{"doi":1926},"10.11604\u002Fpamj.2016.24.20.8181",{"id":26,"text":1928,"url":26,"identifiers":1929},"Kruger, F. C. et al. Non-alcoholic fatty liver disease (NAFLD) in the Western Cape: a descriptive analysis. S. Afr. Med. J. 100, 168–171 (2010).",{"doi":1930},"10.7196\u002FSAMJ.1422",{"id":26,"text":1932,"url":26,"identifiers":1933},"Almobarak, A. O. et al. Non alcoholic fatty liver disease (NAFLD) in a Sudanese population: What is the prevalence and risk factors? Arab J. Gastroenterol. 15, 12–15 (2014).",{"doi":1934},"10.1016\u002Fj.ajg.2014.01.008",{"id":26,"text":1936,"url":26,"identifiers":1937},"Younossi, Z. M. et al. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore) 91, 319–327 (2012).",{"doi":1938},"10.1097\u002FMD.0b013e3182779d49",{"id":26,"text":1940,"url":26,"identifiers":1941},"Bhat, G., Baba, C. S., Pandey, A., Kumari, N. & Choudhuri, G. Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease. Trop. Gastroenterol. 34, 18–24 (2013).",{"doi":1942},"10.7869\u002Ftg.2012.86",{"id":26,"text":1944,"url":26,"identifiers":1945},"Feng, R. N. et al. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population. World J. Gastroenterol. 20, 17932–17940 (2014).",{"doi":1946},"10.3748\u002Fwjg.v20.i47.17932",{"id":26,"text":1948,"url":26,"identifiers":1949},"Nishioji, K. et al. Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011–2012. J. Gastroenterol. 50, 95–108 (2015).",{"doi":1950},"10.1007\u002Fs00535-014-0948-9",{"id":26,"text":1952,"url":26,"identifiers":1953},"Kim, N. H. et al. Clinical and metabolic factors associated with development and regression of nonalcoholic fatty liver disease in nonobese subjects. Liver Int. 34, 604–611 (2014).",{"doi":1954},"10.1111\u002Fliv.12454",{"id":26,"text":1956,"url":26,"identifiers":1957},"Omagari, K. et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J. Gastroenterol. Hepatol. 17, 1098–1105 (2002).",{"doi":1958},"10.1046\u002Fj.1440-1746.2002.02846.x",{"id":26,"text":1960,"url":26,"identifiers":1961},"Kwon, Y. M. et al. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults. Am. J. Gastroenterol. 107, 1852–1858 (2012).",{"doi":1962},"10.1038\u002Fajg.2012.314",{"id":26,"text":1964,"url":26,"identifiers":1965},"Vos, B. et al. Lean non-alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease. Acta Gastroenterol. Belg. 74, 389–394 (2011).",{},{"id":26,"text":1967,"url":26,"identifiers":1968},"Margariti, E., Deutsch, M., Manolakopoulos, S. & Papatheodoridis, G. V. Non-alcoholic fatty liver disease may develop in individuals with normal body mass index. Ann. Gastroenterol. 25, 45–51 (2012).",{},{"id":26,"text":1970,"url":26,"identifiers":1971},"Cho, H. C. Prevalence and factors associated with nonalcoholic fatty liver disease in a nonobese Korean population. Gut Liver 10, 117–125 (2016).",{"doi":1972},"10.5009\u002Fgnl14444",{"id":26,"text":1974,"url":26,"identifiers":1975},"Kim, H. J. et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch. Intern. Med. 164, 2169–2175 (2004).",{"doi":1976},"10.1001\u002Farchinte.164.19.2169",{"id":26,"text":1978,"url":26,"identifiers":1979},"Ortiz, P. et al. Incidence of non-alcoholic fatty liver disease in non-obese and non-diabetic individuals during normal aging. Presented at the AASLD Industry Colloquium: Novel Targets and Therapies in Liver Disease 2015.",{},{"id":26,"text":1981,"url":26,"identifiers":1982},"Conus, F., Rabasa-Lhoret, R. & Peronnet, F. Characteristics of metabolically obese normal-weight (MONW) subjects. Appl. Physiol. Nutr. Metab. 32, 4–12 (2007).",{"doi":1983},"10.1139\u002Fh06-092",{"id":26,"text":1985,"url":26,"identifiers":1986},"Younossi, Z. M., Otgonsuren, M., Venkatesan, C. & Mishra, A. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. Metabolism 62, 352–360 (2013).",{"doi":1987},"10.1016\u002Fj.metabol.2012.08.005",{"id":26,"text":1989,"url":26,"identifiers":1990},"Bugianesi, E. et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 48, 634–642 (2005).",{"doi":1991},"10.1007\u002Fs00125-005-1682-x",{"id":26,"text":1993,"url":26,"identifiers":1994},"Fracanzani, A. L. et al. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity. J. Hepatol. 54, 1244–1249 (2011).",{"doi":1995},"10.1016\u002Fj.jhep.2010.09.037",{"id":26,"text":1997,"url":26,"identifiers":1998},"Leung, J. C. et al. Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients. Hepatology 65, 54–64 (2017).",{"doi":1999},"10.1002\u002Fhep.28697",{"id":26,"text":2001,"url":26,"identifiers":2002},"Kumar, R. et al. Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease? Indian J. Endocrinol. Metab. 17, 665–671 (2013).",{"doi":2003},"10.4103\u002F2230-8210.113758",{"id":26,"text":2005,"url":26,"identifiers":2006},"Dela Cruz, A. C. et al. 379 characteristics and long-term prognosis of lean patients with nonalcoholic fatty liver disease. Gastroenterology 146, S909 (2014).",{"doi":2007},"10.1016\u002FS0016-5085(14)63307-2",{"id":26,"text":2009,"url":26,"identifiers":2010},"Ogden, C. L., Carroll, M. D., Kit, B. K. & Flegal, K. M. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999–2010. JAMA 307, 483–490 (2012).",{"doi":2011},"10.1001\u002Fjama.2012.40",{"id":26,"text":2013,"url":26,"identifiers":2014},"Zimmermann, E. et al. Body mass index in school-aged children and the risk of routinely diagnosed non-alcoholic fatty liver disease in adulthood: a prospective study based on the Copenhagen School Health Records Register. BMJ Open 5, e006998 (2015).",{"doi":2015},"10.1136\u002Fbmjopen-2014-006998",{"id":26,"text":2017,"url":26,"identifiers":2018},"Hagstrom, H., Stal, P., Hultcrantz, R., Hemmingsson, T. & Andreasson, A. Overweight in late adolescence predicts development of severe liver disease later in life: A 39years follow-up study. J. Hepatol. 65, 363–368 (2016).",{"doi":2019},"10.1016\u002Fj.jhep.2016.03.019",{"id":26,"text":2021,"url":26,"identifiers":2022},"Berentzen, T. L., Gamborg, M., Holst, C., Sorensen, T. I. & Baker, J. L. Body mass index in childhood and adult risk of primary liver cancer. J. Hepatol. 60, 325–330 (2014).",{"doi":2023},"10.1016\u002Fj.jhep.2013.09.015",{"id":26,"text":2025,"url":26,"identifiers":2026},"Suomela, E. et al. Childhood predictors of adult fatty liver. The Cardiovascular Risk Young Finns Study. J. Hepatol. 65, 784–790 (2016).",{"doi":2027},"10.1016\u002Fj.jhep.2016.05.020",{"id":26,"text":2029,"url":26,"identifiers":2030},"Singh, S. et al. Fibrosis progression in nonalcoholic fatty liver versus nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin. Gastroenterol. Hepatol. 13, 643–654.e9 (2015).",{"doi":2031},"10.1016\u002Fj.cgh.2014.04.014",{"id":26,"text":2033,"url":26,"identifiers":2034},"Angulo, P. et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 149, 389–397.e10 (2015).",{"doi":2035},"10.1053\u002Fj.gastro.2015.04.043",{"id":26,"text":2037,"url":26,"identifiers":2038},"Loomba, R. et al. Heritability of hepatic fibrosis and steatosis based on a prospective twin study. Gastroenterology 149, 1784–1793 (2015).",{"doi":2039},"10.1053\u002Fj.gastro.2015.08.011",{"id":26,"text":2041,"url":26,"identifiers":2042},"Schwimmer, J. B. et al. Heritability of nonalcoholic fatty liver disease. Gastroenterology 136, 1585–1592 (2009).",{"doi":2043},"10.1053\u002Fj.gastro.2009.01.050",{"id":26,"text":2045,"url":26,"identifiers":2046},"Cui, J. et al. Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study. Hepatology 64, 1547–1558 (2016).",{"doi":2047},"10.1002\u002Fhep.28674",{"id":26,"text":2049,"url":26,"identifiers":2050},"Anstee, Q. M. & Day, C. P. The genetics of NAFLD. Nat. Rev. Gastroenterol. Hepatol. 10, 645–655 (2013).",{"doi":2051},"10.1038\u002Fnrgastro.2013.182",{"id":26,"text":2053,"url":26,"identifiers":2054},"Foster, T., Anania, F. A., Li, D., Katz, R. & Budoff, M. The prevalence and clinical correlates of nonalcoholic fatty liver disease (NAFLD) in African Americans: the multiethnic study of atherosclerosis (MESA). Dig. Dis. Sci. 58, 2392–2398 (2013).",{"doi":2055},"10.1007\u002Fs10620-013-2652-7",{"id":26,"text":2057,"url":26,"identifiers":2058},"Anstee, Q. M. & Day, C. P. The genetics of nonalcoholic fatty liver disease: spotlight on PNPLA3 and TM6SF2. Semin. Liver Dis. 35, 270–290 (2015).",{"doi":2059},"10.1055\u002Fs-0035-1562947",{"id":26,"text":2061,"url":26,"identifiers":2062},"Liu, Y. L. et al. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nat. Commun. 5, 4309 (2014).",{"doi":2063},"10.1038\u002Fncomms5309",{"id":26,"text":2065,"url":26,"identifiers":2066},"Valenti, L. et al. Homozygosity for the patatin-like phospholipase-3\u002Fadiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 51, 1209–1217 (2010).",{"doi":2067},"10.1002\u002Fhep.23622",{"id":26,"text":2069,"url":26,"identifiers":2070},"Mancina, R. M. et al. The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent. Gastroenterology 150, 1219–1230.e6 (2016).",{"doi":2071},"10.1053\u002Fj.gastro.2016.01.032",{"id":26,"text":2073,"url":26,"identifiers":2074},"Anstee, Q. M., Seth, D. & Day, C. P. Genetic factors that affect risk of alcoholic and nonalcoholic fatty liver disease. Gastroenterology 150, 1728–1744.e7 (2016).",{"doi":2075},"10.1053\u002Fj.gastro.2016.01.037",{"id":26,"text":2077,"url":26,"identifiers":2078},"Zarrinpar, A., Gupta, S., Maurya, M. R., Subramaniam, S. & Loomba, R. Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study. Gut 65, 1546–1554 (2016).",{"doi":2079},"10.1136\u002Fgutjnl-2015-309456",{"id":26,"text":2081,"url":26,"identifiers":2082},"Zeybel, M. et al. Multigenerational epigenetic adaptation of the hepatic wound-healing response. Nat. Med. 18, 1369–1377 (2012).",{"doi":2083},"10.1038\u002Fnm.2893",{"id":26,"text":2085,"url":26,"identifiers":2086},"Hardy, T. et al. Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease. Gut 66, 1321–1328 (2016).",{"doi":2087},"10.1136\u002Fgutjnl-2016-311526",{"id":26,"text":2089,"url":26,"identifiers":2090},"Leslie, T. et al. Survey of health status, nutrition and geography of food selection of chronic liver disease patients. Ann. Hepatol. 13, 533–540 (2014).",{"doi":2091},"10.1016\u002FS1665-2681(19)31253-0",{"id":26,"text":2093,"url":26,"identifiers":2094},"Kim, C. H. et al. Nutritional assessments of patients with non-alcoholic fatty liver disease. Obes. Surg. 20, 154–160 (2010).",{"doi":2095},"10.1007\u002Fs11695-008-9549-0",{"id":26,"text":2097,"url":26,"identifiers":2098},"McCarthy, E. M. & Rinella, M. E. The role of diet and nutrient composition in nonalcoholic Fatty liver disease. J. Acad. Nutr. Diet 112, 401–409 (2012).",{"doi":2099},"10.1016\u002Fj.jada.2011.10.007",{"id":26,"text":2101,"url":26,"identifiers":2102},"Gerber, L. et al. Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study. Aliment. Pharmacol. Ther. 36, 772–781 (2012).",{"doi":2103},"10.1111\u002Fapt.12038",{"id":26,"text":2105,"url":26,"identifiers":2106},"Hallsworth, K. et al. Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls. Frontline Gastroenterol. 6, 44–51 (2015).",{"doi":2107},"10.1136\u002Fflgastro-2014-100432",{"id":26,"text":2109,"url":26,"identifiers":2110},"Keating, S. E., George, J. & Johnson, N. A. The benefits of exercise for patients with non-alcoholic fatty liver disease. Expert Rev. Gastroenterol. Hepatol. 9, 1247–1250 (2015).",{"doi":2111},"10.1586\u002F17474124.2015.1075392",{"id":26,"text":2113,"url":26,"identifiers":2114},"Volzke, H. Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin? World J. Gastroenterol. 18, 3492–3501 (2012).",{"doi":2115},"10.3748\u002Fwjg.v18.i27.3492",{"id":26,"text":2117,"url":26,"identifiers":2118},"Hart, C. L., Morrison, D. S., Batty, G. D., Mitchell, R. J. & Davey Smith, G. Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ 340, c1240 (2010).",{"doi":2119},"10.1136\u002Fbmj.c1240",{"id":26,"text":2121,"url":26,"identifiers":2122},"Loomba, R. et al. Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study. Am. J. Epidemiol. 177, 333–342 (2013).",{"doi":2123},"10.1093\u002Faje\u002Fkws252",{"id":26,"text":2125,"url":26,"identifiers":2126},"Younossi, Z. M. et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology 64, 1577–1586 (2016).",{"doi":2127},"10.1002\u002Fhep.28785",{"id":26,"text":2129,"url":26,"identifiers":2130},"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) & European Association for the Study of Obesity (EASO). EASL-EASD-EASO clinical-practice guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol. 64, 1388–1402 (2016).",{"doi":2131},"10.1016\u002Fj.jhep.2015.11.004",{"id":26,"text":2133,"url":26,"identifiers":2134},"Younossi, Z. M. et al. Trends in outpatient resource utilizations and outcomes for Medicare beneficiaries with nonalcoholic fatty liver disease. J. Clin. Gastroenterol. 49, 222–227 (2015).",{"doi":2135},"10.1097\u002FMCG.0000000000000071",{"id":26,"text":2137,"url":26,"identifiers":2138},"National Institute for Health and Care Excellence. Non-alcoholic fatty lver disease (NAFLD): assessment and management. NICE https:\u002F\u002Fwww.nice.org.uk\u002Fguidance\u002Fng49 (2016).",{},{"id":2140,"createTime":2141,"updateTime":2141,"relativeEntities":2142,"slug":2143,"properties":2144,"entityType":821,"verifyStatus":25,"verifyTime":2141,"verifyNote":822,"syncStatus":28,"languages":2157,"translateLanguages":26,"viewCount":36,"primaryUrl":2158,"fullTextUrl":26,"authors":2159,"publicationType":1081,"publisherRelationship":2398,"citationCount":2435,"citationInfo":2436,"publishDate":2443,"publishYear":2444,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":2445,"isForceReanalyzing":1446},"490e2584-a0f9-4031-97db-3225019fed8a","2024-10-09T07:19:02.257+00:00",[],"Expert-consensus-document-The-International-Scientific-Association-for-Probiotics-and-Prebiotics-ISAPP-consensus-statement-on-the-definition-and-scope-of-prebiotics",{"mag":2145,"keywords":2147,"openalex":2148,"abstract":2150,"title":2151,"pm":2153,"doi":2155},{"VOID":2146},"2627092521",{},{"VOID":2149},"W2627092521",{},{"EN":2152},"Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics",{"VOID":2154},"28611480",{"VOID":2156},"10.1038\u002Fnrgastro.2017.75",[102],"https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fnrgastro.2017.75",[2160,2181,2199,2220,2238,2260,2281,2295,2317,2335,2356,2377],{"id":2161,"sortIndex":59,"researcher":26,"roles":2162,"affiliations":2163,"properties":2174},"6beb7219-7a3d-4c32-b818-a7c5c48c454c",[],[2164],{"id":2165,"sortIndex":36,"affiliation":2166,"properties":26},"54930fd9-c8ca-481e-8671-e439855a3286",{"id":2167,"createTime":2168,"updateTime":2168,"relativeEntities":2169,"slug":2170,"properties":2171,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"8fd76cae-72cc-4ba8-8a8f-95f8f1279f69","2024-10-09T07:19:02.302+00:00",[],"School-of-Paediatrics-and-Child-Health-The-University-of-Western-Australia-35-Stirling-Highway-Perth-6009-WA-Australia",{"title":2172},{"EN":2173},"School of Paediatrics and Child Health, The University of Western Australia, 35 Stirling Highway, Perth, 6009, WA, Australia",{"openalex":2175,"orcid":2177,"title":2179},{"VOID":2176},"A5077492180",{"VOID":2178},"https:\u002F\u002Forcid.org\u002F0000-0003-4845-8590",{"EN":2180},"Susan L. Prescott",{"id":2182,"sortIndex":162,"researcher":26,"roles":2183,"affiliations":2184,"properties":2195},"e3ac4cbb-4867-4c5f-9c94-9458b33c6a95",[],[2185],{"id":2186,"sortIndex":36,"affiliation":2187,"properties":26},"534c6414-5f26-4ae4-b9f6-b8523daba637",{"id":2188,"createTime":2189,"updateTime":2189,"relativeEntities":2190,"slug":2191,"properties":2192,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"2ffb894f-195c-482a-8cf6-be260ff62ff7","2024-10-09T07:19:02.318+00:00",[],"Functional-Foods-Forum-Faculty-of-Medicine-It%C3%A4inen-Pitk%C3%A4katu-4A-FI-20014-University-of-Turku-Turku-20014-Finland",{"title":2193},{"EN":2194},"Functional Foods Forum, Faculty of Medicine, Itäinen Pitkäkatu 4A, FI-20014, University of Turku, Turku, 20014, Finland",{"openalex":2196,"orcid":2197,"title":2198},{"VOID":1076},{"VOID":1078},{"EN":1080},{"id":2200,"sortIndex":158,"researcher":26,"roles":2201,"affiliations":2202,"properties":2213},"a33e0e9a-bb4f-4f76-88c3-47a1c5c0cb34",[],[2203],{"id":2204,"sortIndex":36,"affiliation":2205,"properties":26},"8280dfe4-0b29-4549-b748-f288ae455bf7",{"id":2206,"createTime":2207,"updateTime":2207,"relativeEntities":2208,"slug":2209,"properties":2210,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"896769b2-1fd1-41d7-989a-873dd19d4c80","2024-10-09T07:19:02.332+00:00",[],"Teagasc-Moorepark-Food-Research-Centre-Fermoy-P61-C996-Cork-Ireland",{"title":2211},{"EN":2212},"Teagasc Moorepark Food Research Centre, Fermoy, P61 C996, Cork, Ireland",{"openalex":2214,"orcid":2216,"title":2218},{"VOID":2215},"A5074717784",{"VOID":2217},"https:\u002F\u002Forcid.org\u002F0000-0002-6724-7011",{"EN":2219},"Catherine Stanton",{"id":2221,"sortIndex":114,"researcher":26,"roles":2222,"affiliations":2223,"properties":2234},"96c661af-6956-441e-ba67-c3aa595aa6ff",[],[2224],{"id":2225,"sortIndex":36,"affiliation":2226,"properties":26},"1520cc26-b07c-4bc3-94b9-3d75f467d1e4",{"id":2227,"createTime":2228,"updateTime":2228,"relativeEntities":2229,"slug":2230,"properties":2231,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"103cab26-8a7c-4339-b4d6-a908eaead73c","2024-10-09T07:19:02.295+00:00",[],"International-Scientific-Association-for-Probiotics-and-Prebiotics-7119-S-Glencoe-Court-Centennial-80122-Colorado-USA",{"title":2232},{"EN":2233},"International Scientific Association for Probiotics and Prebiotics, 7119 S. Glencoe Court, Centennial, 80122, Colorado, USA",{"openalex":2235,"orcid":2236,"title":2237},{"VOID":971},{"VOID":973},{"EN":975},{"id":2239,"sortIndex":116,"researcher":26,"roles":2240,"affiliations":2241,"properties":2253},"18c9f1d2-f471-4fa0-9d70-ce7e88a73222",[],[2242],{"id":2243,"sortIndex":36,"affiliation":2244,"properties":26},"6cfaaa8b-f6d6-4977-8b05-4521cf5eb217",{"id":2245,"createTime":2246,"updateTime":2247,"relativeEntities":2248,"slug":2249,"properties":2250,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"02bc93d2-de18-4059-88e1-573159265381","2024-10-09T07:19:02.357+00:00","2025-06-11T16:07:31.041+00:00",[],"Translational-Research-in-Gastrointestinal-Disorders-KU-Leuven-Targid-Herestraat-49-Leuven-Belgium-and-Leuven-Food-Science-and-Nutrition-Research-Centre-Leuven-BE-3001-Belgium",{"title":2251},{"EN":2252},"Translational Research in Gastrointestinal Disorders, KU Leuven, Targid - Herestraat 49, Leuven, Belgium and Leuven Food Science and Nutrition Research Centre, Leuven, BE 3001, Belgium",{"openalex":2254,"orcid":2256,"title":2258},{"VOID":2255},"A5042026584",{"VOID":2257},"https:\u002F\u002Forcid.org\u002F0000-0002-5352-7565",{"EN":2259},"Kristin Verbeke",{"id":2261,"sortIndex":115,"researcher":26,"roles":2262,"affiliations":2263,"properties":2274},"2de5a36a-778c-4dd7-b227-1b1124bcf676",[],[2264],{"id":2265,"sortIndex":36,"affiliation":2266,"properties":26},"78735bc9-df5c-4440-ba63-3b25e9fa562d",{"id":2267,"createTime":2268,"updateTime":2268,"relativeEntities":2269,"slug":2270,"properties":2271,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"9a64cf79-9c01-4bc9-bbc5-ec1fcc21668a","2024-10-09T07:19:02.279+00:00",[],"Department-of-Food-Science-and-Technology-258-Food-Innovation-Center-University-of-Nebraska-Lincoln-Lincoln-68588-6205-Nebraska-USA",{"title":2272},{"EN":2273},"Department of Food Science and Technology, 258 Food Innovation Center, University of Nebraska - Lincoln, Lincoln, 68588–6205, Nebraska, USA",{"openalex":2275,"orcid":2277,"title":2279},{"VOID":2276},"A5016959484",{"VOID":2278},"https:\u002F\u002Forcid.org\u002F0000-0003-1206-5947",{"EN":2280},"Robert W. Hutkins",{"id":2282,"sortIndex":36,"researcher":26,"roles":2283,"affiliations":2284,"properties":2291},"e79da32f-b237-48f2-9282-881866d07b2e",[],[2285],{"id":2286,"sortIndex":36,"affiliation":2287,"properties":26},"e8b61b25-5d0a-4e0c-b71c-70a018bba065",{"id":833,"createTime":834,"updateTime":835,"relativeEntities":2288,"slug":837,"properties":2289,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2290},{"VI":840},{"openalex":2292,"orcid":2293,"title":2294},{"VOID":843},{"VOID":845},{"EN":847},{"id":2296,"sortIndex":135,"researcher":26,"roles":2297,"affiliations":2298,"properties":2310},"ba7b8318-fefd-44e9-92c0-ca7aabaddb40",[],[2299],{"id":2300,"sortIndex":36,"affiliation":2301,"properties":26},"fabf4ab7-bfad-439e-8f64-9293b385f157",{"id":2302,"createTime":2303,"updateTime":2304,"relativeEntities":2305,"slug":2306,"properties":2307,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"97c56a6a-c5d5-44af-b968-f47d05d5f03f","2024-02-07T08:23:38.336+00:00","2024-10-09T07:19:02.325+00:00",[],"Rowett-Institute-of-Nutrition-and-Health-University-of-Aberdeen-Aberdeen-AB21-9SB-UK",{"title":2308},{"VI":2309},"Rowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen AB21 9SB, UK",{"openalex":2311,"orcid":2313,"title":2315},{"VOID":2312},"A5048845992",{"VOID":2314},"https:\u002F\u002Forcid.org\u002F0000-0002-4608-0013",{"EN":2316},"Karen P. Scott",{"id":2318,"sortIndex":53,"researcher":26,"roles":2319,"affiliations":2320,"properties":2331},"27e512ab-831a-4510-a26a-1ec38a198ce8",[],[2321],{"id":2322,"sortIndex":36,"affiliation":2323,"properties":26},"5a2b0de3-c072-4115-9f12-6f4b096bf13a",{"id":2324,"createTime":2325,"updateTime":2325,"relativeEntities":2326,"slug":2327,"properties":2328,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"c19465ce-3070-4b75-905c-9a20f392e932","2024-10-09T07:19:02.287+00:00",[],"Lawson-Health-Research-Institute-University-of-Western-Ontario-268-Grosvenor-Street-London-N6A-4V2-Ontario-Canada",{"title":2329},{"EN":2330},"Lawson Health Research Institute, University of Western Ontario, 268 Grosvenor Street, London, N6A 4V2, Ontario, Canada",{"openalex":2332,"orcid":2333,"title":2334},{"VOID":1034},{"VOID":1036},{"EN":1038},{"id":2336,"sortIndex":50,"researcher":26,"roles":2337,"affiliations":2338,"properties":2349},"1ea87cb7-78e1-4f8f-81a5-6d6c0a7c7227",[],[2339],{"id":2340,"sortIndex":36,"affiliation":2341,"properties":26},"1738b367-e369-482d-876e-21d1ff2f2a23",{"id":2342,"createTime":2343,"updateTime":2343,"relativeEntities":2344,"slug":2345,"properties":2346,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"1f2ca26d-6cd1-422e-aef6-fefc7fd7e4c1","2024-10-09T07:19:02.339+00:00",[],"Department-of-Animal-Sciences-University-of-Illinois-at-Urbana-Champaign-1207-W-Gregory-Drive-Urbana-61801-Illinois-USA",{"title":2347},{"EN":2348},"Department of Animal Sciences, University of Illinois at Urbana-Champaign, 1207 W Gregory Drive, Urbana, 61801, Illinois, USA",{"openalex":2350,"orcid":2352,"title":2354},{"VOID":2351},"A5053823114",{"VOID":2353},"https:\u002F\u002Forcid.org\u002F0000-0001-5518-3076",{"EN":2355},"Kelly S. Swanson",{"id":2357,"sortIndex":52,"researcher":26,"roles":2358,"affiliations":2359,"properties":2370},"ff08cfce-6e8f-4ad9-8adb-12c5fb61f53b",[],[2360],{"id":2361,"sortIndex":36,"affiliation":2362,"properties":26},"af8c5800-044f-4e8e-8a42-4fa895525153",{"id":2363,"createTime":2364,"updateTime":2364,"relativeEntities":2365,"slug":2366,"properties":2367,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d68decb5-97e1-494f-b54d-8ba5a3199813","2024-10-09T07:19:02.349+00:00",[],"Universit%C3%A9-catholique-de-Louvain-Louvain-Drug-Research-Institute-73-Avenue-E-Mounier-WELBIO-Walloon-Excellence-in-Life-Sciences-and-Biotechnology-Metabolism-and-Nutrition-Research-Group-Brussels-1200-Belgium",{"title":2368},{"EN":2369},"Université catholique de Louvain, Louvain Drug Research Institute, 73 Avenue E Mounier, WELBIO (Walloon Excellence in Life Sciences and Biotechnology), Metabolism and Nutrition Research Group, Brussels, 1200, Belgium",{"openalex":2371,"orcid":2373,"title":2375},{"VOID":2372},"A5070336660",{"VOID":2374},"https:\u002F\u002Forcid.org\u002F0000-0003-2040-2448",{"EN":2376},"Patrice D. Cani",{"id":2378,"sortIndex":111,"researcher":26,"roles":2379,"affiliations":2380,"properties":2391},"f4452262-ff46-4a0f-a275-eaa1a681edfe",[],[2381],{"id":2382,"sortIndex":36,"affiliation":2383,"properties":26},"5b2357a6-8580-47ff-957a-56729cf5f7e3",{"id":2384,"createTime":2385,"updateTime":2385,"relativeEntities":2386,"slug":2387,"properties":2388,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"5ef8a4cb-fe43-47c9-820f-721ab07b78b1","2024-10-09T07:19:02.310+00:00",[],"Faculty-of-Kinesiology-and-Department-of-Biochemistry-and-Molecular-Biology-2500-University-Drive-Cumming-School-of-Medicine-University-of-Calgary-Calgary-Alberta-Canada",{"title":2389},{"EN":2390},"Faculty of Kinesiology and Department of Biochemistry and Molecular Biology, 2500 University Drive, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada",{"openalex":2392,"orcid":2394,"title":2396},{"VOID":2393},"A5006636972",{"VOID":2395},"https:\u002F\u002Forcid.org\u002F0000-0001-5088-7947",{"EN":2397},"Raylene A. Reimer",{"url":26,"publisher":2399,"properties":2429},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":2400,"slug":663,"properties":2401,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":2407,"manageAffiliations":2408,"indexDatabases":2409,"url":753,"thumbnailPath":26,"statistic":2424,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"country":2402,"issn":2403,"introduce":2404,"eissn":2405,"title":2406},{"VOID":666},{"VOID":668},{"EN":670},{"VOID":672},{"EN":674},[],[],[2410,2417],{"id":735,"indexDatabase":2411,"url":750,"indexYears":26,"academicFieldIds":2416,"indexDatabaseRanking":26},{"id":737,"createTime":738,"updateTime":739,"relativeEntities":2412,"label":2413,"description":2414,"key":746,"publicationTags":2415,"standard":26},[],{"EN":742,"VI":742},{"VI":744,"EN":745},[748,749],[752],{"id":715,"indexDatabase":2418,"url":728,"indexYears":729,"academicFieldIds":2423,"indexDatabaseRanking":733},{"id":717,"createTime":718,"updateTime":719,"relativeEntities":2419,"label":2420,"description":2421,"key":725,"publicationTags":2422,"standard":26},[],{"EN":722,"VI":722},{"EN":722,"VI":724},[727],[731,732],{"impactFactor":36,"impactFactorByYear":2425,"i10Index":259,"i10IndexLast5Year":356,"totalPublication":259,"totalPublicationByYear":2426,"totalCitation":769,"totalCitationByYear":2427,"totalCitationPerPublication":783,"totalCitationPerPublicationByYear":2428,"hindexLast5Year":283,"hindex":283},{"2012":756,"2013":757,"2014":758,"2015":759,"2016":760,"2017":761,"2018":762,"2019":763,"2020":764,"2021":765,"2022":766,"2023":767},{"2009":59,"2010":59,"2011":162,"2012":114,"2013":111,"2014":59,"2015":162,"2016":111,"2017":158,"2018":111,"2019":111,"2020":114,"2021":162,"2022":114},{"2009":144,"2010":771,"2011":772,"2012":146,"2013":773,"2014":774,"2015":775,"2016":776,"2017":777,"2018":778,"2019":779,"2020":780,"2021":781,"2022":782},{"2009":785,"2010":786,"2011":787,"2012":788,"2013":789,"2014":790,"2015":791,"2016":792,"2017":793,"2018":794,"2019":795,"2020":796,"2021":797,"2022":798},{"volume":2430,"pages":2432,"issue":2434},{"VOID":2431},"14",{"VOID":2433},"491-502",{"VOID":1119},3825,{"total":2435,"publishYear":26,"statisticByYear":2437},{"2016":115,"2017":286,"2018":2438,"2019":514,"2020":147,"2021":2439,"2022":2440,"2023":2441,"2024":2442},220,735,718,681,552,"2017-08-01",2017,[2446,2450,2454,2458,2462,2466,2470,2474,2477,2481,2485,2488,2491,2495,2499,2503,2507,2511,2515,2519,2523,2527,2531,2535,2539,2543,2547,2551,2555,2559,2563,2567,2570,2574,2578,2582,2586,2590,2594,2598,2602,2606,2610,2614,2618,2622,2626,2630,2634,2638,2642,2646,2650,2654,2658,2662,2666,2670,2674,2677,2681,2685,2689,2693,2697,2701,2705,2709,2713,2717,2721,2725,2729,2733,2737,2741,2745,2749,2753,2756,2760,2764,2768,2772,2776,2780,2784,2788,2792,2796,2800,2804,2808,2812,2816,2819,2823,2827,2830,2834,2838,2842,2846,2849,2853,2857,2860,2864,2868,2872,2876,2880,2884,2888,2892,2895,2899,2903,2907,2910,2914,2918,2922,2926,2930,2934,2938,2942,2946,2950,2954,2958,2962,2966,2970,2974,2978,2982,2986,2990,2994,2998,3002,3006,3010,3014,3018,3022,3026,3030,3034,3038,3042,3046,3049,3052],{"id":26,"text":2447,"url":26,"identifiers":2448},"Prescott, S. L., Logan, A. C., Millstein, R. A. & Katszman, M. A. Biodiversity, the human microbiome and mental health: moving toward a new clinical ecology for the 21st Century? Int. J. Biodiversity 2016, 2718275 (2016).",{"doi":2449},"10.1155\u002F2016\u002F2718275",{"id":26,"text":2451,"url":26,"identifiers":2452},"David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559–563 (2014).",{"doi":2453},"10.1038\u002Fnature12820",{"id":26,"text":2455,"url":26,"identifiers":2456},"Cani, P. D. & Everard, A. Talking microbes: when gut bacteria interact with diet and host organs. Mol. Nutr. Food Res. 60, 58–66 (2016).",{"doi":2457},"10.1002\u002Fmnfr.201500406",{"id":26,"text":2459,"url":26,"identifiers":2460},"Gibson, G. R. & Roberfroid, M. B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 125, 1401–1412 (1995).",{"doi":2461},"10.1093\u002Fjn\u002F125.6.1401",{"id":26,"text":2463,"url":26,"identifiers":2464},"Collins, S. & Reid, G. Distant site effects of ingested prebiotics. Nutrients 8, E523 (2016).",{"doi":2465},"10.3390\u002Fnu8090523",{"id":26,"text":2467,"url":26,"identifiers":2468},"Propst, E. L. et al. A dose-response experiment evaluating the effects of oligofructose and inulin on nutrient digestibility, stool quality, and fecal protein catabolites in healthy adult dogs. J. Anim. Sci. 81, 3057–3066 (2003).",{"doi":2469},"10.2527\u002F2003.81123057x",{"id":26,"text":2471,"url":26,"identifiers":2472},"Park, S. H., Lee, S. I. & Ricke, S. C. Microbial populations in naked neck chicken ceca raised on pasture flock fed with commercial yeast cell wall prebiotics via an Illumina MiSeq platform. PLoS ONE 11, e0151944 (2016).",{"doi":2473},"10.1371\u002Fjournal.pone.0151944",{"id":26,"text":2475,"url":26,"identifiers":2476},"Rettger, L. F. & Cheplin, H. A. A. Treatise on the Transformation of the Intestinal Flora: with Special Reference to the Implantation of Bacillus acidophilus Vol. 13 (Yale Univ. Press, 1921).",{},{"id":26,"text":2478,"url":26,"identifiers":2479},"Dubos, R. et al. Indigenous, normal, and autochthonous flora of the gastrointestinal tract. J. Exp. Med. 122, 67–76 (1965).",{"doi":2480},"10.1084\u002Fjem.122.1.67",{"id":26,"text":2482,"url":26,"identifiers":2483},"Savage, D. C. Microbial ecology of the gastrointestinal tract. Ann. Rev. Microbiol. 31, 107–133 (1977).",{"doi":2484},"10.1146\u002Fannurev.mi.31.100177.000543",{"id":26,"text":2486,"url":26,"identifiers":2487},"Food and Agricultural Organization of the United Nations & World Health Organization. Probiotics in food: Health and nutrition properties and guidelines for evaluation. FAO http:\u002F\u002Fwww.fao.org\u002F3\u002Fa-a0512e.pdf (2006).",{},{"id":26,"text":2489,"url":26,"identifiers":2490},"Hill, C. et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11, 506–514 (2014).",{"doi":820},{"id":26,"text":2492,"url":26,"identifiers":2493},"Simpson, H. L. & Campbell, B. J. Review article: dietary fibre–microbiota interactions. Aliment. Pharmacol. Ther. 42, 158–179 (2015).",{"doi":2494},"10.1111\u002Fapt.13248",{"id":26,"text":2496,"url":26,"identifiers":2497},"Depeint, F., Tzortzis, G., Vulevic, J., l'Anson, K. & Gibson, G. R. Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study. Am. J. Clin. Nutr. 87, 785–791 (2008).",{"doi":2498},"10.1093\u002Fajcn\u002F87.3.785",{"id":26,"text":2500,"url":26,"identifiers":2501},"Costabile, A. et al. A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects. Br. J. Nutr. 104, 1007–1011 (2010).",{"doi":2502},"10.1017\u002FS0007114510001571",{"id":26,"text":2504,"url":26,"identifiers":2505},"Roberfroid, M. et al. Prebiotic effects: metabolic and health benefits. Br. J. Nutr. 104 (Suppl. 2), S1–S63 (2010).",{"doi":2506},"10.1017\u002FS0007114510003363",{"id":26,"text":2508,"url":26,"identifiers":2509},"Schrezenmeir, J. & de Vrese, M. Probiotics, prebiotics, and synbiotics — approaching a definition. Am. J. Clin. Nutr. 73, 361S–364S (2001).",{"doi":2510},"10.1093\u002Fajcn\u002F73.2.361s",{"id":26,"text":2512,"url":26,"identifiers":2513},"Gibson, G. R., Probert, H. M., Loo, J. V., Rastall, R. A. & Roberfroid, M. B. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr. Res. Rev. 17, 259–275 (2004).",{"doi":2514},"10.1079\u002FNRR200479",{"id":26,"text":2516,"url":26,"identifiers":2517},"Pineiro, M. et al. FAO technical meeting on prebiotics. J. Clin. Gastroenterol. 42, S156–S159 (2008).",{"doi":2518},"10.1097\u002FMCG.0b013e31817f184e",{"id":26,"text":2520,"url":26,"identifiers":2521},"Gibson, G. R. et al. Dietary prebiotics: current status and new definition. Food Sci. Tech. Bull. Funct. Food 7, 1–19 (2010).",{"doi":2522},"10.1616\u002F1476-2137.15880",{"id":26,"text":2524,"url":26,"identifiers":2525},"Bindels, L. B., Delzenne, N. M., Cani, P. D. & Walter, J. Towards a more comprehensive concept for prebiotics. Nat. Rev. Gastroenterol. Hepatol. 12, 303–310 (2015).",{"doi":2526},"10.1038\u002Fnrgastro.2015.47",{"id":26,"text":2528,"url":26,"identifiers":2529},"Dewulf, E. M. et al. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62, 1112–1121 (2013).",{"doi":2530},"10.1136\u002Fgutjnl-2012-303304",{"id":26,"text":2532,"url":26,"identifiers":2533},"Hutkins, R. W. et al. Prebiotics: why definitions matter. Curr. Opin. Biotechnol. 37, 1–7 (2016).",{"doi":2534},"10.1016\u002Fj.copbio.2015.09.001",{"id":26,"text":2536,"url":26,"identifiers":2537},"Louis, P., Flint, H. J. & Michel, C. How to manipulate the microbiota: prebiotics. Adv. Exp. Med. Biol. 902, 119–142 (2016).",{"doi":2538},"10.1007\u002F978-3-319-31248-4_9",{"id":26,"text":2540,"url":26,"identifiers":2541},"Shannahan, F. Fibre man meets microbe man. Am. J. Clin. Nutr. 10, 1–2 (2015).",{"doi":2542},"10.3945\u002Fajcn.114.101550",{"id":26,"text":2544,"url":26,"identifiers":2545},"Verspreet, J. et al. A critical look at prebiotics within the dietary fiber concept. Ann. Rev. Food Sci. Technol. 7, 167–190 (2016).",{"doi":2546},"10.1146\u002Fannurev-food-081315-032749",{"id":26,"text":2548,"url":26,"identifiers":2549},"Vandeputte, D. et al. Prebiotic inulin-type fructans induce specific changes in the human gut microbiota. Gut http:\u002F\u002Fdx.doi.org\u002F10.1136\u002Fgutjnl-2016-313271 (2017).",{"doi":2550},"10.1136\u002Fgutjnl-2016-313271",{"id":26,"text":2552,"url":26,"identifiers":2553},"Canfora, E. E., Jocken, J. W. & Blaak, E. E. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat. Rev. Endocrinol. 11, 577–591 (2015).",{"doi":2554},"10.1038\u002Fnrendo.2015.128",{"id":26,"text":2556,"url":26,"identifiers":2557},"Koh, A., De Vadder, F., Kovatcheva-Datchary, P. & Backhed, F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165, 1332–1345 (2016).",{"doi":2558},"10.1016\u002Fj.cell.2016.05.041",{"id":26,"text":2560,"url":26,"identifiers":2561},"Rastall, R. A. & Gibson, G. R. Recent developments in prebiotics to selectively impact beneficial microbes and promote intestinal health. Curr. Opin. Biotechnol. 32, 42–46 (2015).",{"doi":2562},"10.1016\u002Fj.copbio.2014.11.002",{"id":26,"text":2564,"url":26,"identifiers":2565},"Rastall, R. A. Functional oligosaccharides: application and manufacture. Ann. Rev. Food Sci. Technol. 1, 305–339 (2010).",{"doi":2566},"10.1146\u002Fannurev.food.080708.100746",{"id":26,"text":2568,"url":26,"identifiers":2569},"Sarbini, S. & Rastall, R. A. Prebiotics: metabolism, structure, and function. Func. Food Rev. 3, 93–106 (2011).",{},{"id":26,"text":2571,"url":26,"identifiers":2572},"Goh, Y. J. & Klaenhammer, T. R. Genetic mechanisms of prebiotic oligosaccharide metabolism in probiotic microbes. Ann. Rev. Food Sci. Technol. 6, 137–156 (2015).",{"doi":2573},"10.1146\u002Fannurev-food-022814-015706",{"id":26,"text":2575,"url":26,"identifiers":2576},"Delcour, J. A., Aman, P., Courtin, C. M., Hamaker, B. R. & Verbeke, K. Prebiotics, fermentable dietary fiber, and health claims. Adv. Nutr. 7, 1–4 (2016).",{"doi":2577},"10.3945\u002Fan.115.010546",{"id":26,"text":2579,"url":26,"identifiers":2580},"Ben David, Y. et al. Ruminococcal cellulosome systems from rumen to human. Environ. Microbiol. 17, 3407–3426 (2015).",{"doi":2581},"10.1111\u002F1462-2920.12868",{"id":26,"text":2583,"url":26,"identifiers":2584},"Garrido, D. et al. Comparative transcriptomics reveals key differences in the response to milk oligosaccharides of infant gut-associated bifidobacteria. Sci. Rep. 5, 13517 (2015).",{"doi":2585},"10.1038\u002Fsrep13517",{"id":26,"text":2587,"url":26,"identifiers":2588},"Oozeer, R. et al. Intestinal microbiology in early life: specific prebiotics can have similar functionalities as human-milk oligosaccharides. Am. J. Clin. Nutr. 98, 561S–571S (2013).",{"doi":2589},"10.3945\u002Fajcn.112.038893",{"id":26,"text":2591,"url":26,"identifiers":2592},"De Leoz, M. L. A. et al. Human milk glycomics and gut microbial genomics in infant feces show a correlation between human milk oligosaccharides and gut microbiota: a proof-of-concept study. J. Proteome Res. 14, 491–502 (2015).",{"doi":2593},"10.1021\u002Fpr500759e",{"id":26,"text":2595,"url":26,"identifiers":2596},"Rockova, S. et al. Inter-species differences in the growth of bifidobacteria cultured on human milk oligosaccharides. Folia Microbiol. 57, 321–324 (2012).",{"doi":2597},"10.1007\u002Fs12223-012-0134-5",{"id":26,"text":2599,"url":26,"identifiers":2600},"He, Y., Lawlor, N. T. & Newburg, D. S. Human milk components modulate Toll-like receptor-mediated inflammation. Adv. Nutr. 7, 102–111 (2016).",{"doi":2601},"10.3945\u002Fan.115.010090",{"id":26,"text":2603,"url":26,"identifiers":2604},"Kulinich, A. & Liu, L. Human milk oligosaccharides: the role in the fine-tuning of innate immune responses. Carbohydr. Res. 432, 62–70 (2016).",{"doi":2605},"10.1016\u002Fj.carres.2016.07.009",{"id":26,"text":2607,"url":26,"identifiers":2608},"Morrow, A. L., Ruiz-Palacios, G. M., Jiang, X. & Newburg, D. S. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J. Nutr. 135, 1304–1307 (2005).",{"doi":2609},"10.1093\u002Fjn\u002F135.5.1304",{"id":26,"text":2611,"url":26,"identifiers":2612},"Charbonneau, M. R. et al. Sialylated milk oligosaccharides promote microbiota-dependent growth in models of infant undernutrition. Cell 164, 859–871 (2016).",{"doi":2613},"10.1016\u002Fj.cell.2016.01.024",{"id":26,"text":2615,"url":26,"identifiers":2616},"Marriage, B. J., Buck, R. H., Goehring, K. C., Oliver, J. S. & Williams, J. A. Infants fed a lower calorie formula with 2′FL show growth and 2′FL uptake like breast-fed infants. J. Pediatr. Gastroenterol. Nutr. 61, 649–658 (2015).",{"doi":2617},"10.1097\u002FMPG.0000000000000889",{"id":26,"text":2619,"url":26,"identifiers":2620},"Goehring, K. C. et al. Similar to those who are breastfed, infants fed a formula containing 2′-fucosyllactose have lower inflammatory cytokines in a randomized controlled trial. J. Nutr. 146, 2559–2566 (2016).",{"doi":2621},"10.3945\u002Fjn.116.236919",{"id":26,"text":2623,"url":26,"identifiers":2624},"Elison, E. et al. Oral supplementation of healthy adults with 2′-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota. Br. J. Nutr. 116, 1356–1368 (2016).",{"doi":2625},"10.1017\u002FS0007114516003354",{"id":26,"text":2627,"url":26,"identifiers":2628},"Underwood, M. A., German, J. B., Lebrilla, C. B. & Mills, D. A. Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut. Pediatr. Res. 77, 229–235 (2015).",{"doi":2629},"10.1038\u002Fpr.2014.156",{"id":26,"text":2631,"url":26,"identifiers":2632},"Charbonneau, M. R. et al. A microbial perspective of human developmental biology. Nature 535, 48–55 (2016).",{"doi":2633},"10.1038\u002Fnature18845",{"id":26,"text":2635,"url":26,"identifiers":2636},"Clifford, M. N. Diet-derived phenols in plasma and tissues and their implications for health. Planta Med. 70, 1103–1114 (2004).",{"doi":2637},"10.1055\u002Fs-2004-835835",{"id":26,"text":2639,"url":26,"identifiers":2640},"Duenas, M. et al. A survey of modulation of gut microbiota by dietary polyphenols. Biomed. Res. Int. 2015, 850902 (2015).",{"doi":2641},"10.1155\u002F2015\u002F850902",{"id":26,"text":2643,"url":26,"identifiers":2644},"O'Keefe, S. J. Diet, microorganisms and their metabolites, and colon cancer. Nat. Rev. Gastroenterol. Hepatol. 13, 691–706 (2016).",{"doi":2645},"10.1038\u002Fnrgastro.2016.165",{"id":26,"text":2647,"url":26,"identifiers":2648},"Pluznick, J. L. Gut microbiota in renal physiology: focus on short-chain fatty acids and their receptors. Kidney Int. 90, 1191–1198 (2016).",{"doi":2649},"10.1016\u002Fj.kint.2016.06.033",{"id":26,"text":2651,"url":26,"identifiers":2652},"Boets, E. et al. Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study. J. Physiol. 595, 541–555 (2017).",{"doi":2653},"10.1113\u002FJP272613",{"id":26,"text":2655,"url":26,"identifiers":2656},"Canani, R. B. et al. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J. Gastroenterol. 17, 1519–1528 (2011).",{"doi":2657},"10.3748\u002Fwjg.v17.i12.1519",{"id":26,"text":2659,"url":26,"identifiers":2660},"McMillan, A. et al. A multi-platform metabolomics approach identifies highly specific biomarkers of bacterial diversity in the vagina of pregnant and non-pregnant women. Sci. Rep. 5, 14174 (2015).",{"doi":2661},"10.1038\u002Fsrep14174",{"id":26,"text":2663,"url":26,"identifiers":2664},"Vulevic, J. et al. Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly persons. Br. J. Nutr. 114, 586–595 (2015).",{"doi":2665},"10.1017\u002FS0007114515001889",{"id":26,"text":2667,"url":26,"identifiers":2668},"de Preter, V. et al. Baseline microbiota activity and initial bifidobacteria counts influence responses to prebiotic dosing in healthy subjects. Aliment. Pharmacol. Ther. 27, 504–513 (2008).",{"doi":2669},"10.1111\u002Fj.1365-2036.2007.03588.x",{"id":26,"text":2671,"url":26,"identifiers":2672},"Albert, A. Y. et al. A study of the vaginal microbiome in healthy Canadian women utilizing cpn60-based molecular profiling reveals distinct Gardnerella subgroup community state types. PLoS ONE 10, e0135620 (2015).",{"doi":2673},"10.1371\u002Fjournal.pone.0135620",{"id":26,"text":2675,"url":26,"identifiers":2676},"Korshonov, V. M. et al. Study of vaginal bifidoflora of women of reproductive age [Russian]. Zh. Microbiol. Epidemiol. Immunobiol. 4, 74–78 (1999).",{},{"id":26,"text":2678,"url":26,"identifiers":2679},"Antonio, M. A., Rabe, L. K. & Hillier, S. L. Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J. Infect. Dis. 3, 394–398 (2005).",{"doi":2680},"10.1086\u002F430926",{"id":26,"text":2682,"url":26,"identifiers":2683},"Joyce, S. A. & Gahan, C. G. Bile acid modifications at the microbe-host interface: potential for nutraceutical and pharmaceutical interventions in host health. Ann. Rev. Food Sci. Technol. 7, 313–333 (2016).",{"doi":2684},"10.1146\u002Fannurev-food-041715-033159",{"id":26,"text":2686,"url":26,"identifiers":2687},"Kuo, S. M., Merhige, P. M. & Hagey, L. R. The effect of dietary prebiotics and probiotics on body weight, large intestine indices, and fecal bile acid profile in wild type and IL10−\u002F− mice. PLoS ONE 8, e60270 (2013).",{"doi":2688},"10.1371\u002Fjournal.pone.0060270",{"id":26,"text":2690,"url":26,"identifiers":2691},"Savignac, H. M. et al. Prebiotic administration normalizes lipopolysaccharide (LPS)-induced anxiety and cortical 5-HT2A receptor and IL1-β levels in male mice. Brain Behav. Immunol. 52, 120–131 (2016).",{"doi":2692},"10.1016\u002Fj.bbi.2015.10.007",{"id":26,"text":2694,"url":26,"identifiers":2695},"de Cossío, L. F. et al. Impact of prebiotics on metabolic and behavioral alterations in a mouse model of metabolic syndrome. Brain Behav. Immunol. http:\u002F\u002Fdx.doi.org\u002F10.1016\u002Fj.bbi.2016.12.022 (2016).",{"doi":2696},"10.1016\u002Fj.bbi.2016.12.022",{"id":26,"text":2698,"url":26,"identifiers":2699},"Malaguarnera, M. et al. Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy. Eur. J. Gastroenterol. Hepatol. 22, 199–206 (2010).",{"doi":2700},"10.1097\u002FMEG.0b013e328330a8d3",{"id":26,"text":2702,"url":26,"identifiers":2703},"Madhok, V., Futamura, M., Thomas, K. S. & Barbarot, S. What's new in atopic eczema? An analysis of systematic reviews published in 2012 and 2013. Part 2. Treatment and prevention. Clin. Exp. Dermatol. 40, 349–354 (2015).",{"doi":2704},"10.1111\u002Fced.12591",{"id":26,"text":2706,"url":26,"identifiers":2707},"Moro, G. et al. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch. Dis. Child. 91, 814–819 (2006).",{"doi":2708},"10.1136\u002Fadc.2006.098251",{"id":26,"text":2710,"url":26,"identifiers":2711},"Hong, K. B. et al. Photoprotective effects of galacto-oligosaccharide and\u002For Bifidobacterium longum supplementation against skin damage induced by ultraviolet irradiation in hairless mice. Int. J. Food Sci. Nutr. 66, 923–930 (2015).",{"doi":2712},"10.3109\u002F09637486.2015.1088823",{"id":26,"text":2714,"url":26,"identifiers":2715},"Gao, Z., Tseng, C. H., Strober, B. E., Pei, Z. & Blaser, M. J. Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS ONE 3, e2719 (2008).",{"doi":2716},"10.1371\u002Fjournal.pone.0002719",{"id":26,"text":2718,"url":26,"identifiers":2719},"Paulino, L. C., Tseng, C. H., Strober, B. E. & Blaser, M. J. Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions. J. Clin. Microbiol. 44, 2933–2941 (2006).",{"doi":2720},"10.1128\u002FJCM.00785-06",{"id":26,"text":2722,"url":26,"identifiers":2723},"Campananti, A. et al. A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor. Ann. Oncol. 23, 1081–1082 (2012).",{"doi":2724},"10.1093\u002Fannonc\u002Fmds026",{"id":26,"text":2726,"url":26,"identifiers":2727},"Everard, A. et al. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J. 8, 2116–2130 (2014).",{"doi":2728},"10.1038\u002Fismej.2014.45",{"id":26,"text":2730,"url":26,"identifiers":2731},"Paul, H. A., Bomhof, M. R., Vogel, H. J. & Reimer, R. A. Diet-induced changes in maternal gut microbiota and metabolomic profiles influence programming of offspring obesity risk in rats. Sci. Rep. 6, 20683 (2016).",{"doi":2732},"10.1038\u002Fsrep20683",{"id":26,"text":2734,"url":26,"identifiers":2735},"Delzenne, N. M., Cani, P. D., Daubioul, C. & Neyrinck, A. M. Impact of inulin and oligofructose on gastrointestinal peptides. Br. J. Nutr. 93, S157–S161 (2005).",{"doi":2736},"10.1079\u002FBJN20041342",{"id":26,"text":2738,"url":26,"identifiers":2739},"Cani, P. D. et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am. J. Clin. Nutr. 90, 1236–1243 (2009).",{"doi":2740},"10.3945\u002Fajcn.2009.28095",{"id":26,"text":2742,"url":26,"identifiers":2743},"Parnell, J. A. & Reimer, R. A. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am. J. Clin. Nutr. 89, 1751–1759 (2009).",{"doi":2744},"10.3945\u002Fajcn.2009.27465",{"id":26,"text":2746,"url":26,"identifiers":2747},"Devine, D. A. & Marsh, P. D. Prospects for the development of probiotics and prebiotics for oral applications. J. Oral Microbiol. http:\u002F\u002Fdx.doi.org\u002F10.3402\u002Fjom.v1i0.1949 (2009).",{"doi":2748},"10.3402\u002Fjom.v1i0.1949",{"id":26,"text":2750,"url":26,"identifiers":2751},"van de Pol, M. A., Lutter, R., Smids, B. S., Weersink, E. J. & van der Zee, J. S. Synbiotics reduce allergen-induced T-helper 2 response and improve peak expiratory flow in allergic asthmatics. Allergy 66, 39–47 (2011).",{"doi":2752},"10.1111\u002Fj.1398-9995.2010.02454.x",{"id":26,"text":2754,"url":26,"identifiers":2755},"Depner, M. et al. Bacterial microbiota of the upper respiratory tract and childhood asthma. J. Allergy Clin. Immunol. 6749, 30710–30712 (2016).",{},{"id":26,"text":2757,"url":26,"identifiers":2758},"Bomar, L., Brugger, S. D., Yost, B. H., Davies, S. S. & Lemon, K. P. Corynebacterium accolens releases antipneumococcal free fatty acids from human nostril and skin surface triacylglycerols. mBio 7, e01725-15 (2016).",{"doi":2759},"10.1128\u002FmBio.01725-15",{"id":26,"text":2761,"url":26,"identifiers":2762},"Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K. & Knight, R. Diversity, stability and resilience of the human gut microbiota. Nature 489, 220–230 (2012).",{"doi":2763},"10.1038\u002Fnature11550",{"id":26,"text":2765,"url":26,"identifiers":2766},"Reid, G. et al. The case in favour of probiotics before, during and after pregnancy: insights from the first 1,500 days. Benef. Microbes 7, 353–362 (2016).",{"doi":2767},"10.3920\u002FBM2015.0140",{"id":26,"text":2769,"url":26,"identifiers":2770},"Kellow, N. J., Coughlan, M. T. & Reid, C. M. Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials. Br. J. Nutr. 111, 1147–1161 (2014).",{"doi":2771},"10.1017\u002FS0007114513003607",{"id":26,"text":2773,"url":26,"identifiers":2774},"Beserra, B. T. S. et al. A systematic review and meta-analysis of the prebiotics and synbiotics effects on glycemia, insulin concentrations and lipid parameters in adult patients with overweight or obesity. Clin. Nutr. 34, 845–858 (2015).",{"doi":2775},"10.1016\u002Fj.clnu.2014.10.004",{"id":26,"text":2777,"url":26,"identifiers":2778},"Fernandes, R., do Rosario, V. A., Mocellin, M. C., Kuntz, M. G. F. & Trindale, E. B. S. M. Effects of inulin-type fructans, galacto-oligosaccharides and related synbiotics on inflammatory markers in adult patients with overweight or obesity: a systematic review. Clin. Nutr. http:\u002F\u002Fdx.doi.org\u002F10.1016\u002Fj.clnu.2016.10.003 (2016).",{"doi":2779},"10.1016\u002Fj.clnu.2016.10.003",{"id":26,"text":2781,"url":26,"identifiers":2782},"Nicolucci, A. C. & Reimer, R. A. Prebiotics as a modulator of gut microbiota in paediatric obesity. Ped. Obes. http:\u002F\u002Fdx.doi.org\u002F10.1111\u002Fijpo.12140 (2016).",{"doi":2783},"10.1111\u002Fijpo.12140",{"id":26,"text":2785,"url":26,"identifiers":2786},"Barengolts, E. Gut microbiota, prebiotics, probiotics, and synbiotics in management of obesity and prediabetes: review of randomized controlled trials. Endocr. Pract. 22, 1224–1234 (2016).",{"doi":2787},"10.4158\u002FEP151157.RA",{"id":26,"text":2789,"url":26,"identifiers":2790},"Parnell, J. A., Raman, M., Rioux, K. P. & Reimer, R. A. The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and metabolic syndrome. Liver Int. 32, 701–711 (2012).",{"doi":2791},"10.1111\u002Fj.1478-3231.2011.02730.x",{"id":26,"text":2793,"url":26,"identifiers":2794},"Vulevic, J., Juric, A., Tzortzis, G. & Gibson, G. R. A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J. Nutr. 143, 324–331 (2013).",{"doi":2795},"10.3945\u002Fjn.112.166132",{"id":26,"text":2797,"url":26,"identifiers":2798},"Cani, P. D. et al. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 55, 1484–1490 (2006).",{"doi":2799},"10.2337\u002Fdb05-1360",{"id":26,"text":2801,"url":26,"identifiers":2802},"Verhoef, S. P., Meyer, D. & Westerterp, K. R. Effects of oligofructose on appetite profile, glucagon-like peptide 1 and peptide YY3-36 concentrations and energy intake. Br. J. Nutr. 106, 1757–1762 (2011).",{"doi":2803},"10.1017\u002FS0007114511002194",{"id":26,"text":2805,"url":26,"identifiers":2806},"Hume, M. P., Nicolucci, A. C. & Reimer, R. A. Prebiotic supplementation improves appetite in children with overweight and obesity: a randomized controlled trial. Am. J. Clin. Nutr. http:\u002F\u002Fdx.doi.org\u002F10.3945\u002Fajcn.116.140947 (2017).",{"doi":2807},"10.3945\u002Fajcn.116.140947",{"id":26,"text":2809,"url":26,"identifiers":2810},"Schmidt, K. et al. Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology (Berl.) 232, 1793–1801 (2015).",{"doi":2811},"10.1007\u002Fs00213-014-3810-0",{"id":26,"text":2813,"url":26,"identifiers":2814},"Sherwin, E., Rea, K., Dinan, T. G. & Cryan, J. F. A gut (microbiome) feeling about the brain. Curr. Opin. Gastroenterol. 32, 96–102 (2016).",{"doi":2815},"10.1097\u002FMOG.0000000000000244",{"id":26,"text":2817,"url":26,"identifiers":2818},"Kim, Y. Y. et al. The effect of chicory fructan fiber on calcium absorption and bone metabolism in Korean postmenopausal women. Nutr. Sci. 7, 151–157 (2004).",{},{"id":26,"text":2820,"url":26,"identifiers":2821},"Holloway, L. et al. Effects of oligofructose-enriched inulin on intestinal absorption of calcium and magnesium and bone turnover markers in postmenopausal women. Br. J. Nutr. 97, 365–372 (2007).",{"doi":2822},"10.1017\u002FS000711450733674X",{"id":26,"text":2824,"url":26,"identifiers":2825},"McCabe, L., Britton, R. A. & Parameswaran, N. Prebiotic and probiotic regulation of bone health: role of the intestine and its microbiome. Curr. Osteoporos. Res. 13, 363–371 (2015).",{"doi":2826},"10.1007\u002Fs11914-015-0292-x",{"id":26,"text":2828,"url":26,"identifiers":2829},"Firmansyah, A. et al. Fructans in the first 1000 days of life and beyond, and for pregnancy. Asia Pac. J. Clin. Nutr. 25, 652–675 (2016).",{},{"id":26,"text":2831,"url":26,"identifiers":2832},"Abrams, S. A. et al. A combination of prebiotic short- and long-chain inulin type fructans enhances calcium absorption and bone mineralization in young adolescents. Am. J. Clin. Nutr. 82, 471–476 (2005).",{"doi":2833},"10.1093\u002Fajcn\u002F82.2.471",{"id":26,"text":2835,"url":26,"identifiers":2836},"Kano, M. et al. Consecutive intake of fermented milk containing Bifidobacterium breve strain Yakult and galacto-oligosaccharides benefits skin condition in healthy adult women. Biosci. Microbiota Food Health 32, 33–39 (2013).",{"doi":2837},"10.12938\u002Fbmfh.32.33",{"id":26,"text":2839,"url":26,"identifiers":2840},"Miyazaki, K., Masuoka, N., Kano, M. & Iizuka, R. Bifidobacterium fermented milk and galacto-oligosaccharides lead to improved skin health by decreasing phenols production by gut microbiota. Benef. Microbes 5, 121–128 (2014).",{"doi":2841},"10.3920\u002FBM2012.0066",{"id":26,"text":2843,"url":26,"identifiers":2844},"Cuello-Garcia, C. A. et al. World Allergy Organization — McMaster University guidelines for allergic disease prevention (GLAD-P): prebiotics. World Allergy Organ. J. 9, 10 (2016).",{"doi":2845},"10.1186\u002Fs40413-016-0102-7",{"id":26,"text":2847,"url":26,"identifiers":2848},"Osborn, D. A. & Sinn, J. K. Prebiotics in infants for prevention of allergy. Cochrane Database Syst. Rev. 3, CD006474 (2013).",{},{"id":26,"text":2850,"url":26,"identifiers":2851},"Dang, D. et al. Meta-analysis of probiotics and\u002For prebiotics for the prevention of eczema. J. Int. Med. Res. 41, 1426–1436 (2013).",{"doi":2852},"10.1177\u002F0300060513493692",{"id":26,"text":2854,"url":26,"identifiers":2855},"Boyle, R. J. et al. Prebiotic-supplemented partially hydrolysed cow's milk formula for the prevention of eczema in high-risk infants: a randomized controlled trial. Allergy 71, 701–710 (2016).",{"doi":2856},"10.1111\u002Fall.12848",{"id":26,"text":2858,"url":26,"identifiers":2859},"Ghouri, Y. A. et al. Systematic review of randomized controlled trials of probiotics, prebiotics and synbiotics in inflammatory bowel disease. Clin. Exp. Gastroenterol. 7, 473–487 (2014).",{},{"id":26,"text":2861,"url":26,"identifiers":2862},"Coste, I., Judlin, P., Lepargneur, J.-P. & Bou-Antoun, S. Safety and efficacy of an intravaginal prebiotic gel in the prevention of recurrent bacterial vaginosis: a randomized double-blind study. Obstet. Gynecol. Int. 2012, 147867 (2012).",{"doi":2863},"10.1155\u002F2012\u002F147867",{"id":26,"text":2865,"url":26,"identifiers":2866},"Giovannini, M. et al. Prebiotic effect of an infant formula supplemented with galacto-oligosaccharides: randomized multicenter trial. J. Am. Coll. Nutr. 33, 385–393 (2014).",{"doi":2867},"10.1080\u002F07315724.2013.878232",{"id":26,"text":2869,"url":26,"identifiers":2870},"Radke, M. et al. Starter formula enriched in prebiotics and probiotics ensures normal growth of infants and promotes gut health: a randomized clinical trial. Pediatr. Res. 81, 622–631 (2016).",{"doi":2871},"10.1038\u002Fpr.2016.270",{"id":26,"text":2873,"url":26,"identifiers":2874},"Martinez, R. C. R., Bedani, R. & Saad, S. M. I. Scientific evidence for the health effects attributed to the consumption of probiotics and prebiotics: an update for current perspectives and future challenges. Br. J. Nutr. 114, 1993–2015 (2015).",{"doi":2875},"10.1017\u002FS0007114515003864",{"id":26,"text":2877,"url":26,"identifiers":2878},"Valdez, Y., Brown, E. M. & Finlay, B. B. Influence of the microbiota on vaccine effectiveness. Trend. Immunol. 35, 526–537 (2014).",{"doi":2879},"10.1016\u002Fj.it.2014.07.003",{"id":26,"text":2881,"url":26,"identifiers":2882},"Lohner, S., Kullenberg, D., Antes, G., Decsi, T. & Meerpohl, J. J. Prebiotics in healthy infants and children for prevention of acute infectious diseases: a systematic review and meta-analysis. Nutr. Rev. 8, 523–531 (2014).",{"doi":2883},"10.1111\u002Fnure.12117",{"id":26,"text":2885,"url":26,"identifiers":2886},"Chatchatee, P. et al. Effects of growing-up milk supplemented with prebiotics and LCPUFAs on infections in young children. J. Ped. Gastroenterol. Nutr. 58, 428–437 (2014).",{"doi":2887},"10.1097\u002FMPG.0000000000000252",{"id":26,"text":2889,"url":26,"identifiers":2890},"Luoto, R. et al. Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 133, 405–413 (2014).",{"doi":2891},"10.1016\u002Fj.jaci.2013.08.020",{"id":26,"text":2893,"url":26,"identifiers":2894},"Armanian, A. M. et al. The effect of neutral oligosaccharides on reducing the incidence of necrotizing enterocolitis in preterm infants: a randomized clinical trial. Int. J. Prev. Med. 5, 1387–1395 (2014).",{},{"id":26,"text":2896,"url":26,"identifiers":2897},"Silk, D. B., Davis, A., Vulevic, J., Tzortzis, G. & Gibson, G. R. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Alim. Pharm. Ther. 29, 508–518 (2009).",{"doi":2898},"10.1111\u002Fj.1365-2036.2008.03911.x",{"id":26,"text":2900,"url":26,"identifiers":2901},"Drakoularakou, A., Tzortzis, G., Rastall, R. A. & Gibson, G. R. A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers' diarrhoea. Eur. J. Clin. Nutr. 64, 146–152 (2010).",{"doi":2902},"10.1038\u002Fejcn.2009.120",{"id":26,"text":2904,"url":26,"identifiers":2905},"Christodoulides, S. et al. Systematic review with meta-analysis: effect of fibre supplementation on chronic idiopathic constipation in adults. Aliment. Pharmacol. Ther. 44, 103–116 (2016).",{"doi":2906},"10.1111\u002Fapt.13662",{"id":26,"text":2908,"url":26,"identifiers":2909},"Closa-Monasterolo, R. et al. The use of inulin-type fructans improves stool consistency in constipated children. A randomised clinical trial: pilot study. Int. J. Food Sci. Nutr. 8, 1–11 (2016).",{},{"id":26,"text":2911,"url":26,"identifiers":2912},"Vulevic, J., Drakoularakou, A., Yaqoob, P., Tzortzis, G. & Gibson, G. R. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am. J. Clin. Nutr. 88, 1438–1446 (2008).",{"doi":2913},"10.3945\u002Fajcn.2008.26242",{"id":26,"text":2915,"url":26,"identifiers":2916},"Matsuki, T. et al. A key genetic factor for fucosyllactose utilization affects infant gut microbiota development. Nat. Commun. 7, 11939 (2016).",{"doi":2917},"10.1038\u002Fncomms11939",{"id":26,"text":2919,"url":26,"identifiers":2920},"Marques, T. M. et al. Programming infant gut microbiota: influence of dietary and environmental factors. Curr. Opin. Biotechnol. 21, 149–156 (2010).",{"doi":2921},"10.1016\u002Fj.copbio.2010.03.020",{"id":26,"text":2923,"url":26,"identifiers":2924},"Blaser, M. J. Antibiotic use and its consequences for the normal microbiome. Science 352, 544–545 (2016).",{"doi":2925},"10.1126\u002Fscience.aad9358",{"id":26,"text":2927,"url":26,"identifiers":2928},"Rogler, G., Zeitz, J. & Biedermann, L. The search for causative environmental factors in inflammatory bowel disease. Dig. Dis. 34, 48–55 (2016).",{"doi":2929},"10.1159\u002F000447283",{"id":26,"text":2931,"url":26,"identifiers":2932},"Griffin, N. W. et al. Prior dietary practices and connections to a human gut microbial metacommunity alter responses to diet interventions. Cell Host Microbe 21, 84–96 (2017).",{"doi":2933},"10.1016\u002Fj.chom.2016.12.006",{"id":26,"text":2935,"url":26,"identifiers":2936},"Stevens, C. E. & Hume, I. D. Contributions of microbes in vertebrate gastrointestinal tract to production and conservation of nutrients. Physiol. Rev. 78, 393–427 (1998).",{"doi":2937},"10.1152\u002Fphysrev.1998.78.2.393",{"id":26,"text":2939,"url":26,"identifiers":2940},"Respondek, F. et al. Short-chain fructooligosaccharides influence insulin sensitivity and gene expression of fat tissue in obese dogs. J. Nutr. 138, 1712–1718 (2008).",{"doi":2941},"10.1093\u002Fjn\u002F138.9.1712",{"id":26,"text":2943,"url":26,"identifiers":2944},"Apanavicius, C. J. et al. Fructan supplementation and infection affect food intake, fever, and epithelial sloughing from salmonella challenge in weanling puppies. J. Nutr. 137, 1923–1930 (2007).",{"doi":2945},"10.1093\u002Fjn\u002F137.8.1923",{"id":26,"text":2947,"url":26,"identifiers":2948},"Gouveia, E. M. M. F. et al. Action of phosphorylated mannanoligosaccharides on immune and hematological responses and fecal consistency of dogs experimentally infected with enteropathogenic Escherichia coli strains. Braz. J. Microbiol. 44, 499–504 (2013).",{"doi":2949},"10.1590\u002FS1517-83822013000200027",{"id":26,"text":2951,"url":26,"identifiers":2952},"Kanakupt, K., Vester Boler, B. M., Dunsford, B. R. & Fahey, G. C. Jr. Effects of short-chain fructooligosaccharides and galactooligosaccharides, individually and in combination, on nutrient digestibility, fecal fermentative metabolite concentrations, and large bowel microbial ecology of healthy adults cats. J. Anim. Sci. 89, 1376–1384 (2011).",{"doi":2953},"10.2527\u002Fjas.2010-3201",{"id":26,"text":2955,"url":26,"identifiers":2956},"Verbrugghe, A. et al. Oligofructose and inulin modulate glucose and amino acid metabolism through propionate production in normal-weight and obese cats. J. Nutr. 102, 694–702 (2009).",{"doi":2957},"10.1017\u002FS0007114509288982",{"id":26,"text":2959,"url":26,"identifiers":2960},"Correa-Matos, N. J. et al. Fermentable fiber reduces recovery time and improves intestinal function in piglets following Salmonella typhimurium infection. J. Nutr. 133, 1845–1852 (2003).",{"doi":2961},"10.1093\u002Fjn\u002F133.6.1845",{"id":26,"text":2963,"url":26,"identifiers":2964},"Liu, P. et al. Effects of chito-oligosaccharide supplementation on the growth performance, nutrient digestibility, intestinal morphology, and fecal shedding of Escherichia coli and Lactobacillus in weaning pigs. J. Anim. Sci. 86, 2609–2618 (2008).",{"doi":2965},"10.2527\u002Fjas.2007-0668",{"id":26,"text":2967,"url":26,"identifiers":2968},"Che, T. M. et al. Mannan oligosaccharide improves immune responses and growth efficiency of nursery pigs experimentally infected with porcine reproductive and respiratory syndrome virus. J. Anim. Sci. 89, 2592–2602 (2011).",{"doi":2969},"10.2527\u002Fjas.2010-3208",{"id":26,"text":2971,"url":26,"identifiers":2972},"Halas, V. & Nochta, I. Mannan oligosaccharides in nursery pig nutrition and their potential mode of action. Animals 23, 261–274 (2012).",{"doi":2973},"10.3390\u002Fani2020261",{"id":26,"text":2975,"url":26,"identifiers":2976},"Quigley, J. D. III, Drewry, J. J., Murray, L. M. & Ivey, S. J. Body weight gain, feed efficiency, and fecal scores of dairy calves in response to galactosyl-lactose or antibiotics in milk replacers. J. Dairy Sci. 80, 1751–1754 (1997).",{"doi":2977},"10.3168\u002Fjds.S0022-0302(97)76108-3",{"id":26,"text":2979,"url":26,"identifiers":2980},"Ghosh, S. & Mehla, R. K. Influence of dietary supplementation of prebiotics (mannanoligosaccharide) on the performance of crossbred calves. Trop. Anim. Health Prod. 44, 617–622 (2012).",{"doi":2981},"10.1007\u002Fs11250-011-9944-8",{"id":26,"text":2983,"url":26,"identifiers":2984},"Roodposhti, P. M. & Dabiri, N. Effects of probiotic and prebiotic on average daily gain, fecal shedding of Escherichia coli, and immune system status in newborn female calves. Asian–Australas. J. Anim. Sci. 25, 1255–1261 (2012).",{"doi":2985},"10.5713\u002Fajas.2011.11312",{"id":26,"text":2987,"url":26,"identifiers":2988},"Baines, D. & Erb, S. Characterization of Shiga toxin-producing Escherichia coli infections in beef feeder calves and the effectiveness of a prebiotic in alleviating Shiga toxin-producing Escherichia coli infections. Ir. Vet. J. 66, 17 (2013).",{"doi":2989},"10.1186\u002F2046-0481-66-17",{"id":26,"text":2991,"url":26,"identifiers":2992},"Ortiz, L. T., Rodríguez, M. L., Alzueta, C., Rebolé, A. & Treviño, J. Effect of inulin on growth performance, intestinal tract sizes, mineral retention and tibial bone mineralization in broiler chickens. Br. Poult. Sci. 50, 325–332 (2009).",{"doi":2993},"10.1080\u002F00071660902806962",{"id":26,"text":2995,"url":26,"identifiers":2996},"Sohail, M. U. et al. Effect of supplementation of prebiotic manna-oligosaccharides and probiotic mixture on growth performance of broilers subjected to chronic heat stress. Poult. Sci. 91, 2235–2240 (2012).",{"doi":2997},"10.3382\u002Fps.2012-02182",{"id":26,"text":2999,"url":26,"identifiers":3000},"Shanmugasundaram, R., Sifri, M. & Selvaraj, R. K. Effect of yeast cell product supplementation on broiler cecal microflora species and immune responses during an experimental coccidial infection. Poult. Sci. 92, 1195–1201 (2013).",{"doi":3001},"10.3382\u002Fps.2012-02991",{"id":26,"text":3003,"url":26,"identifiers":3004},"Cho, J. H. & Kim, I. H. Effects of lactulose supplementation on performance, blood profiles, excreta microbial shedding of Lactobacillus and Escherichia coli, relative organ weight and excreta noxious gas contents in broilers. J. Anim. Physiol. Anim. Nutr. 98, 424–430 (2014).",{"doi":3005},"10.1111\u002Fjpn.12086",{"id":26,"text":3007,"url":26,"identifiers":3008},"Roto, S. M., Kwon, Y. M. & Ricke, S. C. Applications of in ovo technique for the optimal development of the gastrointestinal tract and the potential influence on the establishment of its microbiome in poultry. Front. Vet. Sci. 3, 63 (2016).",{"doi":3009},"10.3389\u002Ffvets.2016.00063",{"id":26,"text":3011,"url":26,"identifiers":3012},"Pruszynska-Oszmalek, E. et al. In ovo injection of prebiotics and synbiotics affects the digestive potency of the pancreas in growing chickens. Poult. Sci. 94, 1909–1916 (2015).",{"doi":3013},"10.3382\u002Fps\u002Fpev162",{"id":26,"text":3015,"url":26,"identifiers":3016},"Bednarczyk, M. et al. Influence of different prebiotics and mode of their administration on broiler chicken performance. Animal 10, 1271–1279 (2016).",{"doi":3017},"10.1017\u002FS1751731116000173",{"id":26,"text":3019,"url":26,"identifiers":3020},"Li, P. et al. Dietary supplementation of short-chain fructooligosaccharides influences gastrointestinal microbiota composition and immunity characteristics of Pacific white shrimp. Litopenaeus vannamei, cultured in a recirculating system. J. Nutr. 137, 2763–2768 (2007).",{"doi":3021},"10.1093\u002Fjn\u002F137.12.2763",{"id":26,"text":3023,"url":26,"identifiers":3024},"Hoseinifar, S. H., Khalili, M., Rostami, H. K. & Esteban, M. Á. Dietary galactooligosaccharide affects intestinal microbiota, stress resistance, and performance of Caspian roach (Rutilus rutilus) fry. Fish Shellfish Immunol. 35, 1416–1420 (2013).",{"doi":3025},"10.1016\u002Fj.fsi.2013.08.007",{"id":26,"text":3027,"url":26,"identifiers":3028},"Hoseinifar, S. H., Soleimani, N. & Ringø, E. Effects of dietary fructo-oligosaccharide supplementation on the growth performance, haemato-immunological parameters, gut microbiota and stress resistance of common carp (Cyprinus carpio) fry. Br. J. Nutr. 112, 1296–1302 (2014).",{"doi":3029},"10.1017\u002FS0007114514002037",{"id":26,"text":3031,"url":26,"identifiers":3032},"Morgan, L. M., Coverdale, J. A., Froetschel, M. A. & Yoon, I. Effect of yeast culture supplementation on digestibility of varying forage quality in mature horses. J. Equine Vet. Sci. 27, 260–265 (2007).",{"doi":3033},"10.1016\u002Fj.jevs.2007.04.009",{"id":26,"text":3035,"url":26,"identifiers":3036},"Respondek, F., Goachet, A. G. & Julliand, V. Effects of dietary short-chain fructooligosaccharide on the intestinal microflora of horses subjected to a sudden change in diet. J. Anim. Sci. 86, 316–323 (2008).",{"doi":3037},"10.2527\u002Fjas.2006-782",{"id":26,"text":3039,"url":26,"identifiers":3040},"Respondek, F., Myers, K., Smith, T. L., Wagner, A. & Geor, R. J. Dietary supplementation with short-chain fructooligosaccharides improves insulin sensitivity in obese horses. J. Anim. Sci. 89, 77–83 (2011).",{"doi":3041},"10.2527\u002Fjas.2010-3108",{"id":26,"text":3043,"url":26,"identifiers":3044},"EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies). Scientific Opinion on the substantiation of a health claim related to “native chicory inulin” and maintenance of normal defecation by increasing stool frequency pursuant to Article 13.5 of Regulation (EC) No 1924\u002F2006. EFSA https:\u002F\u002Fwww.efsa.europa.eu\u002Fen\u002Fefsajournal\u002Fpub\u002F3951 (2015).",{"doi":3045},"10.2903\u002Fj.efsa.2015.3951",{"id":26,"text":3047,"url":26,"identifiers":3048},"EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies). Guidance on the preparation and presentation of an application for authorisation of a novel food in the context of Regulation (EU) 2015\u002F2283. EFSA J. 14, 4594–4624 (2016).",{},{"id":26,"text":3050,"url":26,"identifiers":3051},"U.S. Food and Drug Administration. Draft guidance for industry: dietary supplements: new dietary ingredient notifications and related issues. FDA http:\u002F\u002Fwww.fda.gov\u002Ffood\u002Fguidanceregulation\u002Fguidancedocumentsregulatoryinformation\u002Fdietarysupplements\u002Fucm257563.htm (2016).",{},{"id":26,"text":3053,"url":26,"identifiers":3054},"U.S. Food and Drug Administration. Changes to the nutrition factors label. FDA http:\u002F\u002Fwww.fda.gov\u002FFood\u002FGuidanceRegulation\u002FGuidanceDocumentsRegulatoryInformation\u002FLabelingNutrition\u002Fucm385663.htm (2014).",{},{"id":3056,"createTime":3057,"updateTime":3057,"relativeEntities":3058,"slug":3059,"properties":3060,"entityType":821,"verifyStatus":25,"verifyTime":3057,"verifyNote":822,"syncStatus":28,"languages":3073,"translateLanguages":26,"viewCount":36,"primaryUrl":3074,"fullTextUrl":26,"authors":3075,"publicationType":1081,"publisherRelationship":3113,"citationCount":3151,"citationInfo":3152,"publishDate":3158,"publishYear":3159,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":3160,"isForceReanalyzing":1446},"1995afd2-ca15-4b7f-a7a5-c9b9b9d0971e","2024-10-12T10:36:46.340+00:00",[],"Global-burden-of-colorectal-cancer-emerging-trends-risk-factors-and-prevention-strategies",{"mag":3061,"keywords":3063,"openalex":3064,"abstract":3066,"title":3067,"pm":3069,"doi":3071},{"VOID":3062},"2970045605",{},{"VOID":3065},"W2970045605",{},{"EN":3068},"Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies",{"VOID":3070},"31455888",{"VOID":3072},"10.1038\u002Fs41575-019-0189-8",[102],"https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fs41575-019-0189-8",[3076,3098],{"id":3077,"sortIndex":115,"researcher":26,"roles":3078,"affiliations":3079,"properties":3091},"1d241bb0-8d6c-4a89-94ca-15b1af738cf3",[],[3080],{"id":3081,"sortIndex":36,"affiliation":3082,"properties":26},"12609f80-c5e2-46f0-b989-c4dcbbb385c2",{"id":3083,"createTime":3084,"updateTime":3085,"relativeEntities":3086,"slug":3087,"properties":3088,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"7e6c1e11-e365-42a4-81a5-fcd56bb2936e","2024-08-30T07:04:44.468+00:00","2025-02-06T11:51:26.434+00:00",[],"Department-of-Nutrition-Harvard-T-H-Chan-School-of-Public-Health-Boston-MA-USA",{"title":3089},{"EN":3090},"Department of Nutrition, Harvard T H Chan School of Public Health, Boston, MA, USA",{"openalex":3092,"orcid":3094,"title":3096},{"VOID":3093},"A5038373228",{"VOID":3095},"https:\u002F\u002Forcid.org\u002F0000-0002-6123-0219",{"EN":3097},"Edward L. Giovannucci",{"id":3099,"sortIndex":36,"researcher":26,"roles":3100,"affiliations":3101,"properties":3108},"fae5dc00-ffd8-43bb-ad26-0ec9f7ffa9c3",[],[3102],{"id":3103,"sortIndex":36,"affiliation":3104,"properties":26},"93c42576-5294-4101-b43f-d379c0ab50bb",{"id":3083,"createTime":3084,"updateTime":3085,"relativeEntities":3105,"slug":3087,"properties":3106,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":3107},{"EN":3090},{"openalex":3109,"title":3111},{"VOID":3110},"A5012751911",{"EN":3112},"NaNa Keum",{"url":26,"publisher":3114,"properties":3144},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":3115,"slug":663,"properties":3116,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":3122,"manageAffiliations":3123,"indexDatabases":3124,"url":753,"thumbnailPath":26,"statistic":3139,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"country":3117,"issn":3118,"introduce":3119,"eissn":3120,"title":3121},{"VOID":666},{"VOID":668},{"EN":670},{"VOID":672},{"EN":674},[],[],[3125,3132],{"id":735,"indexDatabase":3126,"url":750,"indexYears":26,"academicFieldIds":3131,"indexDatabaseRanking":26},{"id":737,"createTime":738,"updateTime":739,"relativeEntities":3127,"label":3128,"description":3129,"key":746,"publicationTags":3130,"standard":26},[],{"EN":742,"VI":742},{"VI":744,"EN":745},[748,749],[752],{"id":715,"indexDatabase":3133,"url":728,"indexYears":729,"academicFieldIds":3138,"indexDatabaseRanking":733},{"id":717,"createTime":718,"updateTime":719,"relativeEntities":3134,"label":3135,"description":3136,"key":725,"publicationTags":3137,"standard":26},[],{"EN":722,"VI":722},{"EN":722,"VI":724},[727],[731,732],{"impactFactor":36,"impactFactorByYear":3140,"i10Index":259,"i10IndexLast5Year":356,"totalPublication":259,"totalPublicationByYear":3141,"totalCitation":769,"totalCitationByYear":3142,"totalCitationPerPublication":783,"totalCitationPerPublicationByYear":3143,"hindexLast5Year":283,"hindex":283},{"2012":756,"2013":757,"2014":758,"2015":759,"2016":760,"2017":761,"2018":762,"2019":763,"2020":764,"2021":765,"2022":766,"2023":767},{"2009":59,"2010":59,"2011":162,"2012":114,"2013":111,"2014":59,"2015":162,"2016":111,"2017":158,"2018":111,"2019":111,"2020":114,"2021":162,"2022":114},{"2009":144,"2010":771,"2011":772,"2012":146,"2013":773,"2014":774,"2015":775,"2016":776,"2017":777,"2018":778,"2019":779,"2020":780,"2021":781,"2022":782},{"2009":785,"2010":786,"2011":787,"2012":788,"2013":789,"2014":790,"2015":791,"2016":792,"2017":793,"2018":794,"2019":795,"2020":796,"2021":797,"2022":798},{"volume":3145,"pages":3147,"issue":3149},{"VOID":3146},"16",{"VOID":3148},"713-732",{"VOID":3150},"12",1762,{"total":3151,"publishYear":26,"statisticByYear":3153},{"2019":111,"2020":365,"2021":3154,"2022":3155,"2023":3156,"2024":3157},334,443,486,304,"2019-12-01",2019,[3161,3164,3168,3172,3176,3180,3183,3187,3191,3194,3198,3201,3205,3209,3212,3216,3220,3224,3227,3231,3235,3238,3242,3246,3250,3254,3258,3262,3266,3270,3274,3278,3282,3286,3290,3293,3297,3301,3305,3309,3313,3317,3321,3325,3329,3333,3337,3340,3344,3348,3352,3356,3360,3364,3368,3372,3376,3380,3383,3387,3391,3395,3399,3403,3407,3411,3415,3419,3423,3427,3431,3435,3439,3443,3447,3451,3455,3459,3463,3467,3470,3474,3478,3482,3486,3490,3493,3497,3501,3505,3509,3513,3517,3521,3525,3529,3533,3537,3541,3545,3549,3553,3557,3561,3565,3569,3573,3577,3581,3585,3589,3593,3597,3601,3605,3609,3612,3616,3620,3624,3628,3632,3636,3640,3644,3648,3652,3656,3660,3664,3668,3672,3676,3680,3684,3687,3691,3695,3699,3703,3707,3711,3715,3719,3723,3727,3731,3735,3739,3743,3747,3751,3754,3757,3761,3765,3769,3773,3777,3781,3785,3789,3793,3797,3801,3805,3809,3813,3817,3821,3825,3828,3832,3836,3840,3844,3848,3852,3856,3860,3864,3868,3872,3876,3880,3884,3888,3892,3896,3900,3904,3908,3912,3916,3920,3924,3928,3932,3936,3940,3944,3948,3952,3956,3959,3963,3967,3971,3975,3979,3983,3987,3991,3995,3999,4003,4007,4010,4014,4018,4022,4026,4030,4033,4037,4041,4045,4049,4053,4057],{"id":26,"text":3162,"url":26,"identifiers":3163},"Fleming, M., Ravula, S., Tatishchev, S. F. & Wang, H. L. Colorectal carcinoma: pathologic aspects. J. Gastrointest. Oncol. 3, 153–173 (2012).",{},{"id":26,"text":3165,"url":26,"identifiers":3166},"Jasperson, K. W., Tuohy, T. M., Neklason, D. W. & Burt, R. W. Hereditary and familial colon cancer. Gastroenterology 138, 2044–2058 (2010).",{"doi":3167},"10.1053\u002Fj.gastro.2010.01.054",{"id":26,"text":3169,"url":26,"identifiers":3170},"Graff, R. E. et al. Familial risk and heritability of colorectal cancer in the nordic twin study of cancer. Clin. Gastroenterol. Hepatol. 15, 1256–1264 (2017).",{"doi":3171},"10.1016\u002Fj.cgh.2016.12.041",{"id":26,"text":3173,"url":26,"identifiers":3174},"Lichtenstein, P. et al. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J Med. 343, 78–85 (2000).",{"doi":3175},"10.1056\u002FNEJM200007133430201",{"id":26,"text":3177,"url":26,"identifiers":3178},"Jiao, S. et al. Estimating the heritability of colorectal cancer. Hum. Mol. Genet. 23, 3898–3905 (2014).",{"doi":3179},"10.1093\u002Fhmg\u002Fddu087",{"id":26,"text":3181,"url":26,"identifiers":3182},"International Agency for Research on Cancer. Globocan 2018: Cancer Fact Sheets — Colorectal Cancer. IARC http:\u002F\u002Fgco.iarc.fr\u002Ftoday\u002Fdata\u002Ffactsheets\u002Fcancers\u002F10_8_9-Colorectum-fact-sheet.pdf (2018).",{},{"id":26,"text":3184,"url":26,"identifiers":3185},"Brenner, H., Stock, C. & Hoffmeister, M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 348, g2467 (2014).",{"doi":3186},"10.1136\u002Fbmj.g2467",{"id":26,"text":3188,"url":26,"identifiers":3189},"Schreuders, E. H. et al. Colorectal cancer screening: a global overview of existing programmes. Gut 64, 1637–1649 (2015).",{"doi":3190},"10.1136\u002Fgutjnl-2014-309086",{"id":26,"text":3192,"url":26,"identifiers":3193},"World Cancer Research Fund International\u002FAmerican Institute for Cancer Research. Continuous update project report: Diet, nutrition, physical activity, and colorectal cancer. American Institute for Cancer Research https:\u002F\u002Fwww.aicr.org\u002Fcontinuous-update-project\u002Freports\u002Fcolorectal-cancer-2017-report.pdf (2018).",{},{"id":26,"text":3195,"url":26,"identifiers":3196},"Center, M. M., Jemal, A. & Ward, E. International trends in colorectal cancer incidence rates. Cancer Epidemiol. Biomarkers Prev. 18, 1688–1694 (2009).",{"doi":3197},"10.1158\u002F1055-9965.EPI-09-0090",{"id":26,"text":3199,"url":26,"identifiers":3200},"United Nations Development Programme. 2018 Statistical Update and Human Development Index. United Nations Development Programme http:\u002F\u002Fhdr.undp.org\u002F (2018).",{},{"id":26,"text":3202,"url":26,"identifiers":3203},"Arnold, M. et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut 66, 683–691 (2017).",{"doi":3204},"10.1136\u002Fgutjnl-2015-310912",{"id":26,"text":3206,"url":26,"identifiers":3207},"Imamura, F. et al. Dietary quality among men and women in 187 countries in 1990 and 2010: a systematic assessment. Lancet Glob. Health 3, e132–e142 (2015).",{"doi":3208},"10.1016\u002FS2214-109X(14)70381-X",{"id":26,"text":3210,"url":26,"identifiers":3211},"World Health Organization. Mean Body Mass Index Trends Among Adults, Age-Standardized Estimates by Country. World Health Organization http:\u002F\u002Fapps.who.int\u002Fgho\u002Fdata\u002Fnode.main.A904?lang=en (2017).",{},{"id":26,"text":3213,"url":26,"identifiers":3214},"Mousavi, S. M., Fallah, M., Sundquist, K. & Hemminki, K. Age- and time-dependent changes in cancer incidence among immigrants to Sweden: colorectal, lung, breast and prostate cancers. Int. J. Cancer 131, E122–E128 (2012).",{"doi":3215},"10.1002\u002Fijc.27334",{"id":26,"text":3217,"url":26,"identifiers":3218},"Karastergiou, K., Smith, S. R., Greenberg, A. S. & Fried, S. K. Sex differences in human adipose tissues – the biology of pear shape. Biol. Sex Differ. 3, 13 (2012).",{"doi":3219},"10.1186\u002F2042-6410-3-13",{"id":26,"text":3221,"url":26,"identifiers":3222},"Wilsnack, R. W., Wilsnack, S. C., Kristjanson, A. F., Vogeltanz-Holm, N. D. & Gmel, G. Gender and alcohol consumption: patterns from the multinational GENACIS project. Addiction 104, 1487–1500 (2009).",{"doi":3223},"10.1111\u002Fj.1360-0443.2009.02696.x",{"id":26,"text":3225,"url":26,"identifiers":3226},"World Health Organization. WHO Global Report on Trends in Prevalence of Tobacco Smoking. 2015. World Health Organization http:\u002F\u002Fapps.who.int\u002Firis\u002Fbitstream\u002Fhandle\u002F10665\u002F156262\u002F9789241564922_eng.pdf;jsessionid=3E603A72D553D128773D0836AECE325E?sequence=1 (2015).",{},{"id":26,"text":3228,"url":26,"identifiers":3229},"Clarke, N., Sharp, L., Osborne, A. & Kearney, P. M. Comparison of uptake of colorectal cancer screening based on fecal immunochemical testing (FIT) in males and females: a systematic review and meta-analysis. Cancer Epidemiol. Biomarkers Prev. 24, 39–47 (2015).",{"doi":3230},"10.1158\u002F1055-9965.EPI-14-0774",{"id":26,"text":3232,"url":26,"identifiers":3233},"Murphy, N. et al. A prospective evaluation of endogenous sex hormone levels and colorectal cancer risk in postmenopausal women. J. Natl Cancer. Inst. 107, djv210 (2015).",{"doi":3234},"10.1093\u002Fjnci\u002Fdjv210",{"id":26,"text":3236,"url":26,"identifiers":3237},"U.S. Cancer Statistics Working Group. U.S. Cancer Statistics Data Visualizations Tool, based on November 2017 submission data (1999-2015): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Centers for Disease Control and Prevention www.cdc.gov\u002Fcancer\u002Fdataviz (2016).",{},{"id":26,"text":3239,"url":26,"identifiers":3240},"Augustus, G. J. & Ellis, N. A. Colorectal cancer disparity in african americans: risk factors and carcinogenic mechanisms. Am. J. Pathol. 188, 291–303 (2018).",{"doi":3241},"10.1016\u002Fj.ajpath.2017.07.023",{"id":26,"text":3243,"url":26,"identifiers":3244},"Ashktorab, H. et al. Identification of novel mutations by exome sequencing in African American colorectal cancer patients. Cancer 121, 34–42 (2015).",{"doi":3245},"10.1002\u002Fcncr.28922",{"id":26,"text":3247,"url":26,"identifiers":3248},"Wang, H. et al. Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans. Int. J. Cancer 140, 2728–2733 (2017).",{"doi":3249},"10.1002\u002Fijc.30687",{"id":26,"text":3251,"url":26,"identifiers":3252},"Huyghe, J. R. et al. Discovery of common and rare genetic risk variants for colorectal cancer. Nat. Genet. 51, 76–87 (2019).",{"doi":3253},"10.1038\u002Fs41588-018-0286-6",{"id":26,"text":3255,"url":26,"identifiers":3256},"Ashktorab, H. et al. A meta-analysis of MSI frequency and race in colorectal cancer. Oncotarget 7, 34546–34557 (2016).",{"doi":3257},"10.18632\u002Foncotarget.8945",{"id":26,"text":3259,"url":26,"identifiers":3260},"Pawlik, T. M., Raut, C. P. & Rodriguez-Bigas, M. A. Colorectal carcinogenesis: MSI-H versus MSI-L. Dis. Markers 20, 199–206 (2004).",{"doi":3261},"10.1155\u002F2004\u002F368680",{"id":26,"text":3263,"url":26,"identifiers":3264},"Guindalini, R. S. et al. Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome. Gastroenterology 149, 1446–1453 (2015).",{"doi":3265},"10.1053\u002Fj.gastro.2015.07.052",{"id":26,"text":3267,"url":26,"identifiers":3268},"Pitot, H. C. The molecular biology of carcinogenesis. Cancer 72, 962–970 (1993).",{"doi":3269},"10.1002\u002F1097-0142(19930801)72:3+\u003C962::AID-CNCR2820721303>3.0.CO;2-H",{"id":26,"text":3271,"url":26,"identifiers":3272},"Carethers, J. M. & Jung, B. H. Genetics and genetic biomarkers in sporadic colorectal cancer. Gastroenterology 149, 1177–1190.e3 (2015).",{"doi":3273},"10.1053\u002Fj.gastro.2015.06.047",{"id":26,"text":3275,"url":26,"identifiers":3276},"Munro, M. J., Wickremesekera, S. K., Peng, L., Tan, S. T. & Itinteang, T. Cancer stem cells in colorectal cancer: a review. J. Clin. Pathol. 71, 110–116 (2018).",{"doi":3277},"10.1136\u002Fjclinpath-2017-204739",{"id":26,"text":3279,"url":26,"identifiers":3280},"Ogino, S. & Goel, A. Molecular classification and correlates in colorectal cancer. J. Mol. Diagn. 10, 13–27 (2008).",{"doi":3281},"10.2353\u002Fjmoldx.2008.070082",{"id":26,"text":3283,"url":26,"identifiers":3284},"Grady, W. M. & Carethers, J. M. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 135, 1079–1099 (2008).",{"doi":3285},"10.1053\u002Fj.gastro.2008.07.076",{"id":26,"text":3287,"url":26,"identifiers":3288},"Bakhoum, S. F. et al. The mitotic origin of chromosomal instability. Curr. Biol. 24, R148–R149 (2014).",{"doi":3289},"10.1016\u002Fj.cub.2014.01.019",{"id":26,"text":3291,"url":26,"identifiers":3292},"Nazemalhosseini Mojarad, E., Kuppen, P. J., Aghdaei, H. A. & Zali, M. R. The CpG island methylator phenotype (CIMP) in colorectal cancer. Gastroenterol. Hepatol. Bed Bench 6, 120–128 (2013).",{},{"id":26,"text":3294,"url":26,"identifiers":3295},"Markowitz, S. D. & Bertagnolli, M. M. Molecular origins of cancer: molecular basis of colorectal cancer. N. Engl J. Med. 361, 2449–2460 (2009).",{"doi":3296},"10.1056\u002FNEJMra0804588",{"id":26,"text":3298,"url":26,"identifiers":3299},"Jia, M., Gao, X., Zhang, Y., Hoffmeister, M. & Brenner, H. Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review. Clin. Epigenetics 8, 25 (2016).",{"doi":3300},"10.1186\u002Fs13148-016-0191-8",{"id":26,"text":3302,"url":26,"identifiers":3303},"Funkhouser, W. K. Jr. et al. Relevance, pathogenesis, and testing algorithm for mismatch repair-defective colorectal carcinomas: a report of the association for molecular pathology. J. Mol. Diagn. 14, 91–103 (2012).",{"doi":3304},"10.1016\u002Fj.jmoldx.2011.11.001",{"id":26,"text":3306,"url":26,"identifiers":3307},"Weisenberger, D. J. et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat. Genet. 38, 787–793 (2006).",{"doi":3308},"10.1038\u002Fng1834",{"id":26,"text":3310,"url":26,"identifiers":3311},"Conteduca, V., Sansonno, D., Russi, S. & Dammacco, F. Precancerous colorectal lesions (Review). Int. J. Oncol. 43, 973–984 (2013).",{"doi":3312},"10.3892\u002Fijo.2013.2041",{"id":26,"text":3314,"url":26,"identifiers":3315},"Winawer, S. J. et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112, 594–642 (1997).",{"doi":3316},"10.1053\u002Fgast.1997.v112.agast970594",{"id":26,"text":3318,"url":26,"identifiers":3319},"Brenner, H. et al. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut 56, 1585–1589 (2007).",{"doi":3320},"10.1136\u002Fgut.2007.122739",{"id":26,"text":3322,"url":26,"identifiers":3323},"Strum, W. B. Colorectal adenomas. N. Engl J. Med. 374, 1065–1075 (2016).",{"doi":3324},"10.1056\u002FNEJMra1513581",{"id":26,"text":3326,"url":26,"identifiers":3327},"East, J. E. et al. British Society of Gastroenterology position statement on serrated polyps in the colon and rectum. Gut 66, 1181–1196 (2017).",{"doi":3328},"10.1136\u002Fgutjnl-2017-314005",{"id":26,"text":3330,"url":26,"identifiers":3331},"Erichsen, R. et al. Increased risk of colorectal cancer development among patients with serrated polyps. Gastroenterology 150, 895–902e5 (2016).",{"doi":3332},"10.1053\u002Fj.gastro.2015.11.046",{"id":26,"text":3334,"url":26,"identifiers":3335},"Dow, L. E. et al. Apc restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal cancer. Cell 161, 1539–1552 (2015).",{"doi":3336},"10.1016\u002Fj.cell.2015.05.033",{"id":26,"text":3338,"url":26,"identifiers":3339},"Armaghany, T., Wilson, J. D., Chu, Q. & Mills, G. Genetic alterations in colorectal cancer. Gastrointest. Cancer Res. 5, 19–27 (2012).",{},{"id":26,"text":3341,"url":26,"identifiers":3342},"Pino, M. S. & Chung, D. C. The chromosomal instability pathway in colon cancer. Gastroenterology 138, 2059–2072 (2010).",{"doi":3343},"10.1053\u002Fj.gastro.2009.12.065",{"id":26,"text":3345,"url":26,"identifiers":3346},"Leggett, B. & Whitehall, V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 138, 2088–2100 (2010).",{"doi":3347},"10.1053\u002Fj.gastro.2009.12.066",{"id":26,"text":3349,"url":26,"identifiers":3350},"Kedrin, D. & Gala, M. K. Genetics of the serrated pathway to colorectal cancer. Clin. Transl Gastroenterol. 6, e84 (2015).",{"doi":3351},"10.1038\u002Fctg.2015.12",{"id":26,"text":3353,"url":26,"identifiers":3354},"O’Brien, M. J. et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am. J. Surg. Pathol. 30, 1491–1501 (2006).",{"doi":3355},"10.1097\u002F01.pas.0000213313.36306.85",{"id":26,"text":3357,"url":26,"identifiers":3358},"Kim, K. M. et al. Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma\u002Fpolyps from Korea. Am. J. Surg. Pathol. 35, 1274–1286 (2011).",{"doi":3359},"10.1097\u002FPAS.0b013e318224cd2e",{"id":26,"text":3361,"url":26,"identifiers":3362},"Yang, S., Farraye, F. A., Mack, C., Posnik, O. & O’Brien, M. J. BRAF and KRAS mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am. J. Surg. Pathol. 28, 1452–1459 (2004).",{"doi":3363},"10.1097\u002F01.pas.0000141404.56839.6a",{"id":26,"text":3365,"url":26,"identifiers":3366},"Jess, T., Rungoe, C. & Peyrin-Biroulet, L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin. Gastroenterol. Hepatol. 10, 639–645 (2012).",{"doi":3367},"10.1016\u002Fj.cgh.2012.01.010",{"id":26,"text":3369,"url":26,"identifiers":3370},"Itzkowitz, S. H. & Yio, X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G7–G17 (2004).",{"doi":3371},"10.1152\u002Fajpgi.00079.2004",{"id":26,"text":3373,"url":26,"identifiers":3374},"Buchner, A. M. & Lichtenstein, G. R. Evaluation and detection of dysplasia in IBD: the role of chromoendoscopy and enhanced imaging techniques. Curr. Treat. Options Gastroenterol. 14, 73–82 (2016).",{"doi":3375},"10.1007\u002Fs11938-016-0078-y",{"id":26,"text":3377,"url":26,"identifiers":3378},"Robles, A. I. et al. Whole-exome sequencing analyses of inflammatory bowel disease-associated colorectal cancers. Gastroenterology 150, 931–943 (2016).",{"doi":3379},"10.1053\u002Fj.gastro.2015.12.036",{"id":26,"text":3381,"url":26,"identifiers":3382},"Triantafillidis, J. K., Nasioulas, G. & Kosmidis, P. A. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res. 29, 2727–2737 (2009).",{},{"id":26,"text":3384,"url":26,"identifiers":3385},"Li, F. Y. & Lai, M. D. Colorectal cancer, one entity or three. J. Zhejiang Univ. Sci. B 10, 219–229 (2009).",{"doi":3386},"10.1631\u002Fjzus.B0820273",{"id":26,"text":3388,"url":26,"identifiers":3389},"Murphy, N. et al. Heterogeneity of colorectal cancer risk factors by anatomical subsite in 10 European countries: a multinational cohort study. Clin. Gastroenterol. Hepatol. 17, 1323–1331.e6 (2019).",{"doi":3390},"10.1016\u002Fj.cgh.2018.07.030",{"id":26,"text":3392,"url":26,"identifiers":3393},"Wei, E. K. et al. Comparison of risk factors for colon and rectal cancer. Int. J. Cancer 108, 433–442 (2004).",{"doi":3394},"10.1002\u002Fijc.11540",{"id":26,"text":3396,"url":26,"identifiers":3397},"Drewes, J. L., Housseau, F. & Sears, C. L. Sporadic colorectal cancer: microbial contributors to disease prevention, development and therapy. Br. J. Cancer 115, 273–280 (2016).",{"doi":3398},"10.1038\u002Fbjc.2016.189",{"id":26,"text":3400,"url":26,"identifiers":3401},"Yang, L. et al. Proximal shift of colorectal cancer with increasing age in different ethnicities. Cancer Manag. Res. 10, 2663–2673 (2018).",{"doi":3402},"10.2147\u002FCMAR.S166548",{"id":26,"text":3404,"url":26,"identifiers":3405},"Murphy, G. et al. Sex disparities in colorectal cancer incidence by anatomic subsite, race and age. Int. J. Cancer 128, 1668–1675 (2011).",{"doi":3406},"10.1002\u002Fijc.25481",{"id":26,"text":3408,"url":26,"identifiers":3409},"Shin, A. et al. Increasing trend of colorectal cancer incidence in Korea, 1999-2009. Cancer Res. Treat. 44, 219–226 (2012).",{"doi":3410},"10.4143\u002Fcrt.2012.44.4.219",{"id":26,"text":3412,"url":26,"identifiers":3413},"Missiaglia, E. et al. Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features. Ann. Oncol. 25, 1995–2001 (2014).",{"doi":3414},"10.1093\u002Fannonc\u002Fmdu275",{"id":26,"text":3416,"url":26,"identifiers":3417},"Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330–337 (2012).",{"doi":3418},"10.1038\u002Fnature11252",{"id":26,"text":3420,"url":26,"identifiers":3421},"Guastadisegni, C., Colafranceschi, M., Ottini, L. & Dogliotti, E. Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data. Eur. J. Cancer 46, 2788–2798 (2010).",{"doi":3422},"10.1016\u002Fj.ejca.2010.05.009",{"id":26,"text":3424,"url":26,"identifiers":3425},"Boland, C. R. & Goel, A. Microsatellite instability in colorectal cancer. Gastroenterology 138, 2073–2087.e3 (2010).",{"doi":3426},"10.1053\u002Fj.gastro.2009.12.064",{"id":26,"text":3428,"url":26,"identifiers":3429},"Schumacher, T. N. & Schreiber, R. D. Neoantigens in cancer immunotherapy. Science 348, 69–74 (2015).",{"doi":3430},"10.1126\u002Fscience.aaa4971",{"id":26,"text":3432,"url":26,"identifiers":3433},"Westdorp, H. et al. Opportunities for immunotherapy in microsatellite instable colorectal cancer. Cancer Immunol. Immunother. 65, 1249–1259 (2016).",{"doi":3434},"10.1007\u002Fs00262-016-1832-7",{"id":26,"text":3436,"url":26,"identifiers":3437},"Giannakis, M. et al. Genomic correlates of immune-cell infiltrates in colorectal carcinoma. Cell Rep. 15, 857–865 (2016).",{"doi":3438},"10.1016\u002Fj.celrep.2016.03.075",{"id":26,"text":3440,"url":26,"identifiers":3441},"Passardi, A., Canale, M., Valgiusti, M. & Ulivi, P. Immune checkpoints as a target for colorectal cancer treatment. Int. J. Mol. Sci. 18, E1324 (2017).",{"doi":3442},"10.3390\u002Fijms18061324",{"id":26,"text":3444,"url":26,"identifiers":3445},"Jia, M. et al. No association of CpG island methylator phenotype and colorectal cancer survival: population-based study. Br. J. Cancer 115, 1359–1366 (2016).",{"doi":3446},"10.1038\u002Fbjc.2016.361",{"id":26,"text":3448,"url":26,"identifiers":3449},"Jass, J. R. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50, 113–130 (2007).",{"doi":3450},"10.1111\u002Fj.1365-2559.2006.02549.x",{"id":26,"text":3452,"url":26,"identifiers":3453},"Guinney, J. et al. The consensus molecular subtypes of colorectal cancer. Nat. Med. 21, 1350–1356 (2015).",{"doi":3454},"10.1038\u002Fnm.3967",{"id":26,"text":3456,"url":26,"identifiers":3457},"Alwers, E. et al. Associations between molecular classifications of colorectal cancer and patient survival: a systematic review. Clin. Gastroenterol. Hepatol. 17, 402–410.e2 (2019).",{"doi":3458},"10.1016\u002Fj.cgh.2017.12.038",{"id":26,"text":3460,"url":26,"identifiers":3461},"Butterworth, A. S., Higgins, J. P. & Pharoah, P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur. J. Cancer 42, 216–227 (2006).",{"doi":3462},"10.1016\u002Fj.ejca.2005.09.023",{"id":26,"text":3464,"url":26,"identifiers":3465},"Weigl, K. et al. Strongly enhanced colorectal cancer risk stratification by combining family history and genetic risk score. Clin. Epidemiol. 10, 143–152 (2018).",{"doi":3466},"10.2147\u002FCLEP.S145636",{"id":26,"text":3468,"url":26,"identifiers":3469},"Rahner, N. & Steinke, V. Hereditary cancer syndromes. Dtsch. Arztebl. Int. 105, 706–714 (2008).",{},{"id":26,"text":3471,"url":26,"identifiers":3472},"Mork, M. E. et al. High prevalence of hereditary cancer syndromes in adolescents and young adults with colorectal cancer. J. Clin. Oncol. 33, 3544–3549 (2015).",{"doi":3473},"10.1200\u002FJCO.2015.61.4503",{"id":26,"text":3475,"url":26,"identifiers":3476},"Goodenberger, M. L. et al. PMS2 monoallelic mutation carriers: the known unknown. Genet. Med. 18, 13–19 (2016).",{"doi":3477},"10.1038\u002Fgim.2015.27",{"id":26,"text":3479,"url":26,"identifiers":3480},"Win, A. K. et al. Prevalence and penetrance of major genes and polygenes for colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 26, 404–412 (2017).",{"doi":3481},"10.1158\u002F1055-9965.EPI-16-0693",{"id":26,"text":3483,"url":26,"identifiers":3484},"Lynch, H. T. & de la Chapelle, A. Hereditary colorectal cancer. N. Engl. J. Med. 348, 919–932 (2003).",{"doi":3485},"10.1056\u002FNEJMra012242",{"id":26,"text":3487,"url":26,"identifiers":3488},"Lindgren, G., Liljegren, A., Jaramillo, E., Rubio, C. & Lindblom, A. Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer. Gut 50, 228–234 (2002).",{"doi":3489},"10.1136\u002Fgut.50.2.228",{"id":26,"text":3491,"url":26,"identifiers":3492},"Jass, J. R. et al. Pathology of hereditary non-polyposis colorectal cancer. Anticancer Res. 14, 1631–1634 (1994).",{},{"id":26,"text":3494,"url":26,"identifiers":3495},"Half, E., Bercovich, D. & Rozen, P. Familial adenomatous polyposis. Orphanet J. Rare Dis. 4, 22 (2009).",{"doi":3496},"10.1186\u002F1750-1172-4-22",{"id":26,"text":3498,"url":26,"identifiers":3499},"Patel, S. G. & Ahnen, D. J. Familial colon cancer syndromes: an update of a rapidly evolving field. Curr. Gastroenterol. Rep. 14, 428–438 (2012).",{"doi":3500},"10.1007\u002Fs11894-012-0280-6",{"id":26,"text":3502,"url":26,"identifiers":3503},"Murphy, C. C. & Singal, A. G. Establishing a research agenda for early-onset colorectal cancer. PLOS Med. 15, e1002577 (2018).",{"doi":3504},"10.1371\u002Fjournal.pmed.1002577",{"id":26,"text":3506,"url":26,"identifiers":3507},"Pearlman, R. et al. Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol. 3, 464–471 (2017).",{"doi":3508},"10.1001\u002Fjamaoncol.2016.5194",{"id":26,"text":3510,"url":26,"identifiers":3511},"Crosbie, A. B. et al. Trends in colorectal cancer incidence among younger adults-disparities by age, sex, race, ethnicity, and subsite. Cancer Med. 7, 4077–4086 (2018).",{"doi":3512},"10.1002\u002Fcam4.1621",{"id":26,"text":3514,"url":26,"identifiers":3515},"Ballester, V., Rashtak, S. & Boardman, L. Clinical and molecular features of young-onset colorectal cancer. World J. Gastroenterol. 22, 1736–1744 (2016).",{"doi":3516},"10.3748\u002Fwjg.v22.i5.1736",{"id":26,"text":3518,"url":26,"identifiers":3519},"Kim, T. J., Kim, E. R., Hong, S. N., Chang, D. K. & Kim, Y. H. Long-term outcome and prognostic factors of sporadic colorectal cancer in young patients: a large institutional-based retrospective study. Medicine 95, e3641 (2016).",{"doi":3520},"10.1097\u002FMD.0000000000003641",{"id":26,"text":3522,"url":26,"identifiers":3523},"Nimptsch, K. & Wu, K. Is timing important? the role of diet and lifestyle during early life on colorectal neoplasia. Curr. Colorectal Cancer Rep. 14, 1–11 (2018).",{"doi":3524},"10.1007\u002Fs11888-018-0396-7",{"id":26,"text":3526,"url":26,"identifiers":3527},"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet 390, 2627–2642 (2017).",{"doi":3528},"10.1016\u002FS0140-6736(17)32129-3",{"id":26,"text":3530,"url":26,"identifiers":3531},"Liu, P. H. et al. Association of obesity with risk of early-onset colorectal cancer among women. JAMA Oncol. 5, 37–44 (2019).",{"doi":3532},"10.1001\u002Fjamaoncol.2018.4280",{"id":26,"text":3534,"url":26,"identifiers":3535},"Renehan, A. G., Tyson, M., Egger, M., Heller, R. F. & Zwahlen, M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371, 569–578 (2008).",{"doi":3536},"10.1016\u002FS0140-6736(08)60269-X",{"id":26,"text":3538,"url":26,"identifiers":3539},"Dong, Y. et al. Abdominal obesity and colorectal cancer risk: systematic review and meta-analysis of prospective studies. Biosci. Rep. 37, BSR20170945 (2017).",{"doi":3540},"10.1042\u002FBSR20170945",{"id":26,"text":3542,"url":26,"identifiers":3543},"Kune, G. A. The Melbourne Colorectal Cancer Study: reflections on a 30-year experience. Med. J. Aust. 193, 648–652 (2010).",{"doi":3544},"10.5694\u002Fj.1326-5377.2010.tb04093.x",{"id":26,"text":3546,"url":26,"identifiers":3547},"Mansournia, M. A. & Altman, D. G. Population attributable fraction. BMJ 360, k757 (2018).",{"doi":3548},"10.1136\u002Fbmj.k757",{"id":26,"text":3550,"url":26,"identifiers":3551},"Liang, P. S., Chen, T. Y. & Giovannucci, E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int. J. Cancer 124, 2406–2415 (2009).",{"doi":3552},"10.1002\u002Fijc.24191",{"id":26,"text":3554,"url":26,"identifiers":3555},"Song, M. et al. Long-term status and change of body fat distribution, and risk of colorectal cancer: a prospective cohort study. Int. J. Epidemiol. 45, 871–883 (2016).",{"doi":3556},"10.1093\u002Fije\u002Fdyv177",{"id":26,"text":3558,"url":26,"identifiers":3559},"Moore, L. L. et al. BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults. Int. J. Obes. Relat. Metab. Disord. 28, 559–567 (2004).",{"doi":3560},"10.1038\u002Fsj.ijo.0802606",{"id":26,"text":3562,"url":26,"identifiers":3563},"Samaras, K., Botelho, N. K., Chisholm, D. J. & Lord, R. V. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes. Obesity 18, 884–889 (2010).",{"doi":3564},"10.1038\u002Foby.2009.443",{"id":26,"text":3566,"url":26,"identifiers":3567},"Bruun, J. M., Lihn, A. S., Pedersen, S. B. & Richelsen, B. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J. Clin. Endocrinol. Metab. 90, 2282–2289 (2005).",{"doi":3568},"10.1210\u002Fjc.2004-1696",{"id":26,"text":3570,"url":26,"identifiers":3571},"Ouchi, N., Parker, J. L., Lugus, J. J. & Walsh, K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 11, 85–97 (2011).",{"doi":3572},"10.1038\u002Fnri2921",{"id":26,"text":3574,"url":26,"identifiers":3575},"Park, J., Morley, T. S., Kim, M., Clegg, D. J. & Scherer, P. E. Obesity and cancer–mechanisms underlying tumour progression and recurrence. Nat. Rev. Endocrinol. 10, 455–465 (2014).",{"doi":3576},"10.1038\u002Fnrendo.2014.94",{"id":26,"text":3578,"url":26,"identifiers":3579},"Calle, E. E. & Kaaks, R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4, 579–591 (2004).",{"doi":3580},"10.1038\u002Fnrc1408",{"id":26,"text":3582,"url":26,"identifiers":3583},"Keum, N., Lee, D. H., Kim, R., Greenwood, D. C. & Giovannucci, E. L. Visceral adiposity and colorectal adenomas: dose-response meta-analysis of observational studies. Ann. Oncol. 26, 1101–1109 (2015).",{"doi":3584},"10.1093\u002Fannonc\u002Fmdu563",{"id":26,"text":3586,"url":26,"identifiers":3587},"Lim, U. et al. Asian women have greater abdominal and visceral adiposity than Caucasian women with similar body mass index. Nutr. Diabetes 1, e6 (2011).",{"doi":3588},"10.1038\u002Fnutd.2011.2",{"id":26,"text":3590,"url":26,"identifiers":3591},"Wang, T. et al. Effects of obesity related genetic variations on visceral and subcutaneous fat distribution in a chinese population. Sci. Rep. 6, 20691 (2016).",{"doi":3592},"10.1038\u002Fsrep20691",{"id":26,"text":3594,"url":26,"identifiers":3595},"Leeners, B., Geary, N., Tobler, P. N. & Asarian, L. Ovarian hormones and obesity. Hum. Reprod. Update 23, 300–321 (2017).",{"doi":3596},"10.1093\u002Fhumupd\u002Fdmw045",{"id":26,"text":3598,"url":26,"identifiers":3599},"Ning, Y., Wang, L. & Giovannucci, E. L. A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes. Rev. 11, 19–30 (2010).",{"doi":3600},"10.1111\u002Fj.1467-789X.2009.00613.x",{"id":26,"text":3602,"url":26,"identifiers":3603},"Kim, H. & Giovannucci, E. L. Sex differences in the association of obesity and colorectal cancer risk. Cancer Causes Control 28, 1–4 (2017).",{"doi":3604},"10.1007\u002Fs10552-016-0831-5",{"id":26,"text":3606,"url":26,"identifiers":3607},"Thrift, A. P. et al. Mendelian randomization study of body mass index and colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev. 24, 1024–1031 (2015).",{"doi":3608},"10.1158\u002F1055-9965.EPI-14-1309",{"id":26,"text":3610,"url":26,"identifiers":3611},"World Cancer Research Fund\u002FAmerican Institute for Cancer Research. World Cancer Research Fund Internationl Systematic Literature Review: The Associations between Food, Nutrition and Physical Activity and the Risk of Colorectal Cancer, 2017. World Cancer Research Fund https:\u002F\u002Fwww.wcrf.org\u002Fsites\u002Fdefault\u002Ffiles\u002Fcolorectal-cancer-slr.pdf (2017).",{},{"id":26,"text":3613,"url":26,"identifiers":3614},"Hetemaki, N. et al. Estrogen metabolism in abdominal subcutaneous and visceral adipose tissue in postmenopausal women. J. Clin. Endocrinol. Metab. 102, 4588–4595 (2017).",{"doi":3615},"10.1210\u002Fjc.2017-01474",{"id":26,"text":3617,"url":26,"identifiers":3618},"Rezende, L. F. M. et al. Physical activity and cancer: an umbrella review of the literature including 22 major anatomical sites and 770 000 cancer cases. Br. J. Sports Med. 52, 826–833 (2018).",{"doi":3619},"10.1136\u002Fbjsports-2017-098391",{"id":26,"text":3621,"url":26,"identifiers":3622},"Kushi, L. H. et al. American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J. Clin. 62, 30–67 (2012).",{"doi":3623},"10.3322\u002Fcaac.20140",{"id":26,"text":3625,"url":26,"identifiers":3626},"Ainsworth, B. E. et al. 2011 Compendium of Physical Activities: a second update of codes and MET values. Med. Sci. Sports Exerc. 43, 1575–1581 (2011).",{"doi":3627},"10.1249\u002FMSS.0b013e31821ece12",{"id":26,"text":3629,"url":26,"identifiers":3630},"Ruiz-Casado, A. et al. Exercise and the hallmarks of cancer. Trends Cancer 3, 423–441 (2017).",{"doi":3631},"10.1016\u002Fj.trecan.2017.04.007",{"id":26,"text":3633,"url":26,"identifiers":3634},"Giovannucci, E. An integrative approach for deciphering the causal associations of physical activity and cancer risk: the role of adiposity. J. Natl Cancer Inst. 110, 935–941 (2018).",{"doi":3635},"10.1093\u002Fjnci\u002Fdjy091",{"id":26,"text":3637,"url":26,"identifiers":3638},"Ross, R. et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann. Intern. Med. 133, 92–103 (2000).",{"doi":3639},"10.7326\u002F0003-4819-133-2-200007180-00008",{"id":26,"text":3641,"url":26,"identifiers":3642},"Ross, R. et al. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes. Res. 12, 789–798 (2004).",{"doi":3643},"10.1038\u002Foby.2004.95",{"id":26,"text":3645,"url":26,"identifiers":3646},"Ismail, I., Keating, S. E., Baker, M. K. & Johnson, N. A. A systematic review and meta-analysis of the effect of aerobic vs. resistance exercise training on visceral fat. Obes. Rev. 13, 68–91 (2012).",{"doi":3647},"10.1111\u002Fj.1467-789X.2011.00931.x",{"id":26,"text":3649,"url":26,"identifiers":3650},"Keum, N. et al. Association of physical activity by type and intensity with digestive system cancer risk. JAMA Oncol. 2, 1146–1153 (2016).",{"doi":3651},"10.1001\u002Fjamaoncol.2016.0740",{"id":26,"text":3653,"url":26,"identifiers":3654},"Schmid, D. & Leitzmann, M. F. Television viewing and time spent sedentary in relation to cancer risk: a meta-analysis. J. Natl Cancer Inst. 106, dju098 (2014).",{"doi":3655},"10.1093\u002Fjnci\u002Fdju098",{"id":26,"text":3657,"url":26,"identifiers":3658},"Ma, P., Yao, Y., Sun, W., Dai, S. & Zhou, C. Daily sedentary time and its association with risk for colorectal cancer in adults: a dose-response meta-analysis of prospective cohort studies. Medicine 96, e7049 (2017).",{"doi":3659},"10.1097\u002FMD.0000000000007049",{"id":26,"text":3661,"url":26,"identifiers":3662},"Lynch, B. M. Sedentary behavior and cancer: a systematic review of the literature and proposed biological mechanisms. Cancer Epidemiol. Biomarkers Prev. 19, 2691–2709 (2010).",{"doi":3663},"10.1158\u002F1055-9965.EPI-10-0815",{"id":26,"text":3665,"url":26,"identifiers":3666},"Healy, G. N. et al. Breaks in sedentary time: beneficial associations with metabolic risk. Diabetes Care 31, 661–666 (2008).",{"doi":3667},"10.2337\u002Fdc07-2046",{"id":26,"text":3669,"url":26,"identifiers":3670},"Cespedes, E. M. & Hu, F. B. Dietary patterns: from nutritional epidemiologic analysis to national guidelines. Am. J. Clin. Nutr. 101, 899–900 (2015).",{"doi":3671},"10.3945\u002Fajcn.115.110213",{"id":26,"text":3673,"url":26,"identifiers":3674},"Tabung, F. K., Brown, L. S. & Fung, T. T. Dietary patterns and colorectal cancer risk: a review of 17 years of evidence (2000-2016). Curr. Colorectal Cancer Rep. 13, 440–454 (2017).",{"doi":3675},"10.1007\u002Fs11888-017-0390-5",{"id":26,"text":3677,"url":26,"identifiers":3678},"Garcia-Larsen, V. et al. Dietary patterns derived from principal component analysis (PCA) and risk of colorectal cancer: a systematic review and meta-analysis. Eur. J. Clin. Nutr. 73, 366–386 (2019).",{"doi":3679},"10.1038\u002Fs41430-018-0234-7",{"id":26,"text":3681,"url":26,"identifiers":3682},"Vieira, A. R. et al. Foods and beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR Continuous Update Project. Ann. Oncol. 28, 1788–1802 (2017).",{"doi":3683},"10.1093\u002Fannonc\u002Fmdx171",{"id":26,"text":3685,"url":26,"identifiers":3686},"Cascella, M. et al. Dissecting the mechanisms and molecules underlying the potential carcinogenicity of red and processed meat in colorectal cancer (CRC): an overview on the current state of knowledge. Infect. Agent Cancer 13, 3 (2018).",{},{"id":26,"text":3688,"url":26,"identifiers":3689},"Helmus, D. S., Thompson, C. L., Zelenskiy, S., Tucker, T. C. & Li, L. Red meat-derived heterocyclic amines increase risk of colon cancer: a population-based case-control study. Nutr. Cancer 65, 1141–1150 (2013).",{"doi":3690},"10.1080\u002F01635581.2013.834945",{"id":26,"text":3692,"url":26,"identifiers":3693},"Bastide, N. M., Pierre, F. H. & Corpet, D. E. Heme iron from meat and risk of colorectal cancer: a meta-analysis and a review of the mechanisms involved. Cancer Prev. Res. 4, 177–184 (2011).",{"doi":3694},"10.1158\u002F1940-6207.CAPR-10-0113",{"id":26,"text":3696,"url":26,"identifiers":3697},"Gamage, S. M. K., Dissabandara, L., Lam, A. K. & Gopalan, V. The role of heme iron molecules derived from red and processed meat in the pathogenesis of colorectal carcinoma. Crit. Rev. Oncol. Hematol. 126, 121–128 (2018).",{"doi":3698},"10.1016\u002Fj.critrevonc.2018.03.025",{"id":26,"text":3700,"url":26,"identifiers":3701},"Fung, T. T. et al. A dietary pattern that is associated with C-peptide and risk of colorectal cancer in women. Cancer Causes Control 23, 959–965 (2012).",{"doi":3702},"10.1007\u002Fs10552-012-9969-y",{"id":26,"text":3704,"url":26,"identifiers":3705},"Tabung, F. K. et al. Association of dietary inflammatory potential with colorectal cancer risk in men and women. JAMA Oncol. 4, 366–373 (2018).",{"doi":3706},"10.1001\u002Fjamaoncol.2017.4844",{"id":26,"text":3708,"url":26,"identifiers":3709},"Burkitt, D. P. Epidemiology of cancer of the colon and rectum. Cancer 28, 3–13 (1971).",{"doi":3710},"10.1002\u002F1097-0142(197107)28:1\u003C3::AID-CNCR2820280104>3.0.CO;2-N",{"id":26,"text":3712,"url":26,"identifiers":3713},"Holscher, H. D. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes 8, 172–184 (2017).",{"doi":3714},"10.1080\u002F19490976.2017.1290756",{"id":26,"text":3716,"url":26,"identifiers":3717},"Zeng, H., Lazarova, D. L. & Bordonaro, M. Mechanisms linking dietary fiber, gut microbiota and colon cancer prevention. World J. Gastrointest. Oncol. 6, 41–51 (2014).",{"doi":3718},"10.4251\u002Fwjgo.v6.i2.41",{"id":26,"text":3720,"url":26,"identifiers":3721},"Zeng, H., Taussig, D. P., Cheng, W. H., Johnson, L. K. & Hakkak, R. Butyrate inhibits cancerous HCT116 colon cell proliferation but to a lesser extent in noncancerous NCM460 colon cells. Nutrients 9, E25 (2017).",{"doi":3722},"10.3390\u002Fnu9010025",{"id":26,"text":3724,"url":26,"identifiers":3725},"Elce, A. et al. Butyrate modulating effects on pro-inflammatory pathways in human intestinal epithelial cells. Benef. Microbes 8, 841–847 (2017).",{"doi":3726},"10.3920\u002FBM2016.0197",{"id":26,"text":3728,"url":26,"identifiers":3729},"Shang, F. M. & Liu, H. L. Fusobacterium nucleatum and colorectal cancer: a review. World J. Gastrointest. Oncol. 10, 71–81 (2018).",{"doi":3730},"10.4251\u002Fwjgo.v10.i3.71",{"id":26,"text":3732,"url":26,"identifiers":3733},"Mehta, R. S. et al. Association of dietary patterns with risk of colorectal cancer subtypes classified by fusobacterium nucleatum in tumor tissue. JAMA Oncol. 3, 921–927 (2017).",{"doi":3734},"10.1001\u002Fjamaoncol.2016.6374",{"id":26,"text":3736,"url":26,"identifiers":3737},"Aune, D. et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 343, d6617 (2011).",{"doi":3738},"10.1136\u002Fbmj.d6617",{"id":26,"text":3740,"url":26,"identifiers":3741},"Kunzmann, A. T. et al. Dietary fiber intake and risk of colorectal cancer and incident and recurrent adenoma in the prostate, lung, colorectal, and ovarian cancer screening trial. Am. J. Clin. Nutr. 102, 881–890 (2015).",{"doi":3742},"10.3945\u002Fajcn.115.113282",{"id":26,"text":3744,"url":26,"identifiers":3745},"Song, M. et al. Fiber intake and survival after colorectal cancer diagnosis. JAMA Oncol. 4, 71–79 (2018).",{"doi":3746},"10.1001\u002Fjamaoncol.2017.3684",{"id":26,"text":3748,"url":26,"identifiers":3749},"Alberts, D. S. et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. phoenix colon cancer prevention physicians’ network. N. Engl. J. Med. 342, 1156–1162 (2000).",{"doi":3750},"10.1056\u002FNEJM200004203421602",{"id":26,"text":3752,"url":26,"identifiers":3753},"World Cancer Research Fund International\u002FAmerican Institute for Cancer Research. Continuous update project report: Food, nutrition, physical activity, and the prevention of colorectal cancer. World Cancer Research Fund https:\u002F\u002Fwww.wcrf.org\u002Fsites\u002Fdefault\u002Ffiles\u002FColorectal-Cancer-2011-Report.pdf (2011).",{},{"id":26,"text":3755,"url":26,"identifiers":3756},"International Agency for Research on Cancer. Agents Classified by the IARC Monographs, volumes 1-122. International Agency for Research on Cancer https:\u002F\u002Fmonographs.iarc.fr\u002Fagents-classified-by-the-iarc\u002F (2018).",{},{"id":26,"text":3758,"url":26,"identifiers":3759},"Choi, Y. J., Myung, S. K. & Lee, J. H. Light alcohol drinking and risk of cancer: a meta-analysis of cohort studies. Cancer Res. Treat. 50, 474–487 (2018).",{"doi":3760},"10.4143\u002Fcrt.2017.094",{"id":26,"text":3762,"url":26,"identifiers":3763},"Cho, E. et al. Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann. Intern. Med. 140, 603–613 (2004).",{"doi":3764},"10.7326\u002F0003-4819-140-8-200404200-00007",{"id":26,"text":3766,"url":26,"identifiers":3767},"Salaspuro, M. Microbial metabolism of ethanol and acetaldehyde and clinical consequences. Addict. Biol. 2, 35–46 (1997).",{"doi":3768},"10.1080\u002F13556219772840",{"id":26,"text":3770,"url":26,"identifiers":3771},"Seitz, H. K. & Stickel, F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat. Rev. Cancer 7, 599–612 (2007).",{"doi":3772},"10.1038\u002Fnrc2191",{"id":26,"text":3774,"url":26,"identifiers":3775},"Giovannucci, E. Alcohol, one-carbon metabolism, and colorectal cancer: recent insights from molecular studies. J. Nutr. 134, 2475S–2481S (2004).",{"doi":3776},"10.1093\u002Fjn\u002F134.9.2475S",{"id":26,"text":3778,"url":26,"identifiers":3779},"Chang, J. S., Hsiao, J. R. & Chen, C. H. ALDH2 polymorphism and alcohol-related cancers in Asians: a public health perspective. J. Biomed. Sci. 24, 19 (2017).",{"doi":3780},"10.1186\u002Fs12929-017-0327-y",{"id":26,"text":3782,"url":26,"identifiers":3783},"Li, H. et al. Refined geographic distribution of the oriental ALDH2*504Lys (nee 487Lys) variant. Ann. Hum. Genet. 73, 335–345 (2009).",{"doi":3784},"10.1111\u002Fj.1469-1809.2009.00517.x",{"id":26,"text":3786,"url":26,"identifiers":3787},"Mizoue, T. et al. Alcohol drinking and colorectal cancer in Japanese: a pooled analysis of results from five cohort studies. Am. J. Epidemiol. 167, 1397–1406 (2008).",{"doi":3788},"10.1093\u002Faje\u002Fkwn073",{"id":26,"text":3790,"url":26,"identifiers":3791},"Zhao, H., Liu, K. J., Lei, Z. D., Lei, S. L. & Tian, Y. Q. Meta-analysis of the aldehyde dehydrogenases-2 (ALDH2) Glu487Lys polymorphism and colorectal cancer risk. PLOS ONE 9, e88656 (2014).",{"doi":3792},"10.1371\u002Fjournal.pone.0088656",{"id":26,"text":3794,"url":26,"identifiers":3795},"Giovannucci, E. & Martinez, M. E. Tobacco, colorectal cancer, and adenomas: a review of the evidence. J. Natl Cancer Inst. 88, 1717–1730 (1996).",{"doi":3796},"10.1093\u002Fjnci\u002F88.23.1717",{"id":26,"text":3798,"url":26,"identifiers":3799},"Johnson, C. M. et al. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control 24, 1207–1222 (2013).",{"doi":3800},"10.1007\u002Fs10552-013-0201-5",{"id":26,"text":3802,"url":26,"identifiers":3803},"Limsui, D. et al. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J. Natl Cancer Inst. 102, 1012–1022 (2010).",{"doi":3804},"10.1093\u002Fjnci\u002Fdjq201",{"id":26,"text":3806,"url":26,"identifiers":3807},"Carr, P. R. et al. Lifestyle factors and risk of sporadic colorectal cancer by microsatellite instability status: a systematic review and meta-analyses. Ann. Oncol. 29, 825–834 (2018).",{"doi":3808},"10.1053\u002Fj.gastro.2018.08.044",{"id":26,"text":3810,"url":26,"identifiers":3811},"Figueiredo, J. et al. Smoking-association risks of conventional adenomas and serrated polyps in the colorectum. Cancer Causes Control 26, 377–389 (2015).",{"doi":3812},"10.1007\u002Fs10552-014-0513-0",{"id":26,"text":3814,"url":26,"identifiers":3815},"Zeilinger, S. et al. Tobacco smoking leads to extensive genome-wide changes in DNA methylation. PLOS ONE 8, e63812 (2013).",{"doi":3816},"10.1371\u002Fjournal.pone.0063812",{"id":26,"text":3818,"url":26,"identifiers":3819},"Nishihara, R. et al. A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification. Am. J. Epidemiol. 178, 84–100 (2013).",{"doi":3820},"10.1093\u002Faje\u002Fkws431",{"id":26,"text":3822,"url":26,"identifiers":3823},"Bae, J. M., Kim, J. H. & Kang, G. H. Molecular subtypes of colorectal cancer and their clinicopathologic features, with an emphasis on the serrated neoplasia pathway. Arch. Pathol. Lab. Med. 140, 406–412 (2016).",{"doi":3824},"10.5858\u002Farpa.2015-0310-RA",{"id":26,"text":3826,"url":26,"identifiers":3827},"Rogot, E. & Murray, J. L. Smoking and causes of death among U.S. veterans: 16 years of observation. Public Health Rep. 95, 213–222 (1980).",{},{"id":26,"text":3829,"url":26,"identifiers":3830},"Heineman, E. F., Zahm, S. H., McLaughlin, J. K. & Vaught, J. B. Increased risk of colorectal cancer among smokers: results of a 26-year follow-up of US veterans and a review. Int. J. Cancer 59, 728–738 (1994).",{"doi":3831},"10.1002\u002Fijc.2910590603",{"id":26,"text":3833,"url":26,"identifiers":3834},"Lin, J. H. et al. Association between sex hormones and colorectal cancer risk in men and women. Clin. Gastroenterol. Hepatol. 11, 419–424.e1 (2013).",{"doi":3835},"10.1016\u002Fj.cgh.2012.11.012",{"id":26,"text":3837,"url":26,"identifiers":3838},"Freeman, E. W., Sammel, M. D., Lin, H. & Gracia, C. R. Obesity and reproductive hormone levels in the transition to menopause. Menopause 17, 718–726 (2010).",{"doi":3839},"10.1097\u002Fgme.0b013e3181cec85d",{"id":26,"text":3841,"url":26,"identifiers":3842},"Kelly, D. M. & Jones, T. H. Testosterone and obesity. Obes. Rev. 16, 581–606 (2015).",{"doi":3843},"10.1111\u002Fobr.12282",{"id":26,"text":3845,"url":26,"identifiers":3846},"Hillman, E. T., Lu, H., Yao, T. & Nakatsu, C. H. Microbial ecology along the gastrointestinal tract. Microbes Environ. 32, 300–313 (2017).",{"doi":3847},"10.1264\u002Fjsme2.ME17017",{"id":26,"text":3849,"url":26,"identifiers":3850},"Flemer, B. et al. Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut 66, 633–643 (2017).",{"doi":3851},"10.1136\u002Fgutjnl-2015-309595",{"id":26,"text":3853,"url":26,"identifiers":3854},"Zhang, Y. et al. Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study. BMC Microbiol. 18, 92 (2018).",{"doi":3855},"10.1186\u002Fs12866-018-1232-6",{"id":26,"text":3857,"url":26,"identifiers":3858},"O’Keefe, S. J. et al. Fat, fibre and cancer risk in African Americans and rural Africans. Nat. Commun. 6, 6342 (2015).",{"doi":3859},"10.1038\u002Fncomms7342",{"id":26,"text":3861,"url":26,"identifiers":3862},"Allen, J. M. et al. Exercise alters gut microbiota composition and function in lean and obese humans. Med. Sci. Sports Exerc. 50, 747–757 (2018).",{"doi":3863},"10.1249\u002FMSS.0000000000001495",{"id":26,"text":3865,"url":26,"identifiers":3866},"Louis, S., Tappu, R. M., Damms-Machado, A., Huson, D. H. & Bischoff, S. C. Characterization of the gut microbial community of obese patients following a weight-loss intervention using whole metagenome shotgun sequencing. PLOS ONE 11, e0149564 (2016).",{"doi":3867},"10.1371\u002Fjournal.pone.0149564",{"id":26,"text":3869,"url":26,"identifiers":3870},"Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022–1023 (2006).",{"doi":3871},"10.1038\u002F4441022a",{"id":26,"text":3873,"url":26,"identifiers":3874},"Coker, O. O. et al. Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer. Gut 68, 654–662 (2019).",{"doi":3875},"10.1136\u002Fgutjnl-2018-317178",{"id":26,"text":3877,"url":26,"identifiers":3878},"Nakatsu, G. et al. Alterations in enteric virome are associated with colorectal cancer and survival outcomes. Gastroenterology 155, 529–541.e5 (2018).",{"doi":3879},"10.1053\u002Fj.gastro.2018.04.018",{"id":26,"text":3881,"url":26,"identifiers":3882},"Rothwell, P. M. et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 376, 1741–1750 (2010).",{"doi":3883},"10.1016\u002FS0140-6736(10)61543-7",{"id":26,"text":3885,"url":26,"identifiers":3886},"Cook, N. R. et al. Low-dose aspirin in the primary prevention of cancer the women’s health study: a randomized controlled trial. JAMA 294, 47–55 (2005).",{"doi":3887},"10.1001\u002Fjama.294.1.47",{"id":26,"text":3889,"url":26,"identifiers":3890},"Cook, N. R., Lee, I. M., Zhang, S. M. M., Moorthy, M. V. & Buring, J. E. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann. Int. Med. 159, 77–85 (2013).",{"doi":3891},"10.7326\u002F0003-4819-159-2-201307160-00002",{"id":26,"text":3893,"url":26,"identifiers":3894},"Giovannucci, E. et al. Aspirin and the risk of colorectal-cancer in women. N. Engl. J. Med. 333, 609–614 (1995).",{"doi":3895},"10.1056\u002FNEJM199509073331001",{"id":26,"text":3897,"url":26,"identifiers":3898},"Cole, B. F. et al. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J. Natl Cancer Inst. 101, 256–266 (2009).",{"doi":3899},"10.1093\u002Fjnci\u002Fdjn485",{"id":26,"text":3901,"url":26,"identifiers":3902},"Cao, Y. et al. Population-wide impact of long-term use of aspirin and the risk for cancer. JAMA Oncol. 2, 762–769 (2016).",{"doi":3903},"10.1001\u002Fjamaoncol.2015.6396",{"id":26,"text":3905,"url":26,"identifiers":3906},"Zelenay, S. et al. Cyclooxygenase-dependent tumor growth through evasion of immunity. Cell 162, 1257–1270 (2015).",{"doi":3907},"10.1016\u002Fj.cell.2015.08.015",{"id":26,"text":3909,"url":26,"identifiers":3910},"Chan, A. T., Ogino, S. & Fuchs, C. S. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N. Engl. J. Med. 356, 2131–2142 (2007).",{"doi":3911},"10.1056\u002FNEJMoa067208",{"id":26,"text":3913,"url":26,"identifiers":3914},"Cao, Y. et al. Regular aspirin use associates with lower risk of colorectal cancers with low numbers of tumor-infiltrating lymphocytes. Gastroenterology 151, 879–892.e4 (2016).",{"doi":3915},"10.1053\u002Fj.gastro.2016.07.030",{"id":26,"text":3917,"url":26,"identifiers":3918},"Keum, N., Aune, D., Greenwood, D. C., Ju, W. & Giovannucci, E. L. Calcium intake and colorectal cancer risk: dose-response meta-analysis of prospective observational studies. Int. J. Cancer 135, 1940–1948 (2014).",{"doi":3919},"10.1002\u002Fijc.28840",{"id":26,"text":3921,"url":26,"identifiers":3922},"Bristow, S. M. et al. Calcium supplements and cancer risk: a meta-analysis of randomised controlled trials. Br. J. Nutr. 110, 1384–1393 (2013).",{"doi":3923},"10.1017\u002FS0007114513001050",{"id":26,"text":3925,"url":26,"identifiers":3926},"Wactawski-Wende, J. et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N. Engl. J. Med. 354, 684–696 (2006).",{"doi":3927},"10.1056\u002FNEJMoa055222",{"id":26,"text":3929,"url":26,"identifiers":3930},"Lappe, J. et al. Effect of vitamin D and calcium supplementation on cancer incidence in older women: a randomized clinical trial. JAMA 317, 1234–1243 (2017).",{"doi":3931},"10.1001\u002Fjama.2017.2115",{"id":26,"text":3933,"url":26,"identifiers":3934},"Zhang, X. et al. Calcium intake and colorectal cancer risk: results from the Nurses’ Health Study and Health Professionals Follow-up Study. Int. J. Cancer 139, 2232–2242 (2016).",{"doi":3935},"10.1002\u002Fijc.30293",{"id":26,"text":3937,"url":26,"identifiers":3938},"Keum, N., Lee, D. H., Greenwood, D. C., Zhang, X. & Giovannucci, E. L. Calcium intake and colorectal adenoma risk: dose-response meta-analysis of prospective observational studies. Int. J. Cancer 136, 1680–1687 (2015).",{"doi":3939},"10.1002\u002Fijc.29164",{"id":26,"text":3941,"url":26,"identifiers":3942},"Veettil, S. K. et al. Effects of calcium on the incidence of recurrent colorectal adenomas: a systematic review with meta-analysis and trial sequential analysis of randomized controlled trials. Medicine 96, e7661 (2017).",{"doi":3943},"10.1097\u002FMD.0000000000007661",{"id":26,"text":3945,"url":26,"identifiers":3946},"Lamprecht, S. A. & Lipkin, M. Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat. Rev. Cancer 3, 601–614 (2003).",{"doi":3947},"10.1038\u002Fnrc1144",{"id":26,"text":3949,"url":26,"identifiers":3950},"Tennakoon, S., Aggarwal, A. & Kallay, E. The calcium-sensing receptor and the hallmarks of cancer. Biochim. Biophys. Acta 1863, 1398–1407 (2016).",{"doi":3951},"10.1016\u002Fj.bbamcr.2015.11.017",{"id":26,"text":3953,"url":26,"identifiers":3954},"Ahearn, T. U., Shaukat, A., Flanders, W. D., Rutherford, R. E. & Bostick, R. M. A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on the APC\u002Fβ-catenin pathway in the normal mucosa of colorectal adenoma patients. Cancer Prev. Res. 5, 1247–1256 (2012).",{"doi":3955},"10.1158\u002F1940-6207.CAPR-12-0292",{"id":26,"text":3957,"url":26,"identifiers":3958},"PDQ Screening and Prevention Editorial Board. Colorectal Cancer Screening (PDQ®): Health Professional Version. PDQ Cancer Information Summaries. NIH.gov https:\u002F\u002Fwww.ncbi.nlm.nih.gov\u002Fbooks\u002FNBK65825\u002F (2012).",{},{"id":26,"text":3960,"url":26,"identifiers":3961},"Wieten, E. et al. Incidence of faecal occult blood test interval cancers in population-based colorectal cancer screening: a systematic review and meta-analysis. Gut 68, 873-881 (2019).",{"doi":3962},"10.1136\u002Fgutjnl-2017-315340",{"id":26,"text":3964,"url":26,"identifiers":3965},"Imperiale, T. F. et al. Multitarget stool DNA testing for colorectal-cancer screening. N. Engl. J. Med. 370, 1287–1297 (2014).",{"doi":3966},"10.1056\u002FNEJMoa1311194",{"id":26,"text":3968,"url":26,"identifiers":3969},"Brenner, H. & Chen, H. Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population. Clin. Epidemiol. 9, 377–384 (2017).",{"doi":3970},"10.2147\u002FCLEP.S136565",{"id":26,"text":3972,"url":26,"identifiers":3973},"US Preventive Services Task Force, Bibbins-Domingo, K. et al. Screening for colorectal cancer: us preventive services task force recommendation statement. JAMA 315, 2564–2575 (2016).",{"doi":3974},"10.1001\u002Fjama.2016.5989",{"id":26,"text":3976,"url":26,"identifiers":3977},"Welch, H. G. & Black, W. C. Overdiagnosis in cancer. J. Natl Cancer Inst. 102, 605–613 (2010).",{"doi":3978},"10.1093\u002Fjnci\u002Fdjq099",{"id":26,"text":3980,"url":26,"identifiers":3981},"Lansdorp-Vogelaar, I., Knudsen, A. B. & Brenner, H. Cost-effectiveness of colorectal cancer screening. Epidemiol. Rev. 33, 88–100 (2011).",{"doi":3982},"10.1093\u002Fepirev\u002Fmxr004",{"id":26,"text":3984,"url":26,"identifiers":3985},"Tinmouth, J., Lansdorp-Vogelaar, I. & Allison, J. E. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Gut 64, 1327–1337 (2015).",{"doi":3986},"10.1136\u002Fgutjnl-2014-308074",{"id":26,"text":3988,"url":26,"identifiers":3989},"Wolf, A. M. D. et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J. Clin. 68, 250–281 (2018).",{"doi":3990},"10.3322\u002Fcaac.21457",{"id":26,"text":3992,"url":26,"identifiers":3993},"Inadomi, J. M. et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch. Intern. Med. 172, 575–582 (2012).",{"doi":3994},"10.1001\u002Farchinternmed.2012.332",{"id":26,"text":3996,"url":26,"identifiers":3997},"Ebell, M. H., Thai, T. N. & Royalty, K. J. Cancer screening recommendations: an international comparison of high income countries. Public Health Rev. 39, 7 (2018).",{"doi":3998},"10.1186\u002Fs40985-018-0080-0",{"id":26,"text":4000,"url":26,"identifiers":4001},"Keum, N. & Giovannucci, E. L. Folic acid fortification and colorectal cancer risk. Am. J. Prev. Med. 46, S65–S72 (2014).",{"doi":4002},"10.1016\u002Fj.amepre.2013.10.025",{"id":26,"text":4004,"url":26,"identifiers":4005},"Cokkinides, V., Bandi, P., Shah, M., Virgo, K. & Ward, E. The association between state mandates of colorectal cancer screening coverage and colorectal cancer screening utilization among US adults aged 50 to 64 years with health insurance. BMC Health Serv. Res. 11, 19 (2011).",{"doi":4006},"10.1186\u002F1472-6963-11-19",{"id":26,"text":4008,"url":26,"identifiers":4009},"James, T. M., Greiner, K. A., Ellerbeck, E. F., Feng, C. & Ahluwalia, J. S. Disparities in colorectal cancer screening: a guideline-based analysis of adherence. Ethn. Dis. 16, 228–233 (2006).",{},{"id":26,"text":4011,"url":26,"identifiers":4012},"Syngal, S. et al. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am. J. Gastroenterol. 110, 223–262; quiz 263 (2015).",{"doi":4013},"10.1038\u002Fajg.2014.435",{"id":26,"text":4015,"url":26,"identifiers":4016},"Rex, D. K. et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology 153, 307–323 (2017).",{"doi":4017},"10.1053\u002Fj.gastro.2017.05.013",{"id":26,"text":4019,"url":26,"identifiers":4020},"Veronese, N. et al. Combined associations of body weight and lifestyle factors with all cause and cause specific mortality in men and women: prospective cohort study. BMJ 355, i5855 (2016).",{"doi":4021},"10.1136\u002Fbmj.i5855",{"id":26,"text":4023,"url":26,"identifiers":4024},"Dulai, P. S. et al. Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis. BMJ 355, i6188 (2016).",{"doi":4025},"10.1136\u002Fbmj.i6188",{"id":26,"text":4027,"url":26,"identifiers":4028},"Cea Soriano, L., Lanas, A., Soriano-Gabarro, M. & Garcia Rodriguez, L. A. Incidence of upper and lower gastrointestinal bleeding in new users of low-dose aspirin. Clin. Gastroenterol. Hepatol. 17, 887-895.e6 (2019).",{"doi":4029},"10.1016\u002Fj.cgh.2018.05.061",{"id":26,"text":4031,"url":26,"identifiers":4032},"Chubak, J., Kamineni, A., Buist, D. S. M., Anderson, M. L. & Whitlock, E. P. Aspirin Use for the Prevention of Colorectal Cancer: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force (Report No.: 15-05228-EF-1), NIH.gov https:\u002F\u002Fwww.ncbi.nlm.nih.gov\u002Fbooks\u002FNBK321661\u002F (2015).",{},{"id":26,"text":4034,"url":26,"identifiers":4035},"Drew, D. A. et al. ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial. Trials 18, 50 (2017).",{"doi":4036},"10.1186\u002Fs13063-016-1744-z",{"id":26,"text":4038,"url":26,"identifiers":4039},"Han, C. et al. Dietary calcium intake and the risk of colorectal cancer: a case control study. BMC Cancer 15, 966 (2015).",{"doi":4040},"10.1186\u002Fs12885-015-1963-9",{"id":26,"text":4042,"url":26,"identifiers":4043},"Shin, A. et al. Dietary intake of calcium, fiber and other micronutrients in relation to colorectal cancer risk: results from the Shanghai Women’s Health Study. Int. J. Cancer 119, 2938–2942 (2006).",{"doi":4044},"10.1002\u002Fijc.22196",{"id":26,"text":4046,"url":26,"identifiers":4047},"Ishihara, J., Inoue, M., Iwasaki, M., Sasazuki, S. & Tsugane, S. Dietary calcium, vitamin D, and the risk of colorectal cancer. Am. J. Clin. Nutr. 88, 1576–1583 (2008).",{"doi":4048},"10.3945\u002Fajcn.2008.26195",{"id":26,"text":4050,"url":26,"identifiers":4051},"Jones, R. M., Devers, K. J., Kuzel, A. J. & Woolf, S. H. Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis. Am. J. Prev. Med. 38, 508–516 (2010).",{"doi":4052},"10.1016\u002Fj.amepre.2010.01.021",{"id":26,"text":4054,"url":26,"identifiers":4055},"Li, Y. et al. Impact of healthy lifestyle factors on life expectancies in the US population. Circulation 138, 345–355 (2018).",{"doi":4056},"10.1161\u002FCIRCULATIONAHA.117.032047",{"id":26,"text":4058,"url":26,"identifiers":4059},"Jeon, J. et al. Determining risk of colorectal cancer and starting age of screening based on lifestyle, environmental, and genetic factors. Gastroenterology 154, 2152–2164.e19 (2018).",{"doi":4060},"10.1053\u002Fj.gastro.2018.02.021",{"id":4062,"createTime":4063,"updateTime":4063,"relativeEntities":4064,"slug":4065,"properties":4066,"entityType":821,"verifyStatus":25,"verifyTime":4079,"verifyNote":822,"syncStatus":28,"languages":4080,"translateLanguages":26,"viewCount":36,"primaryUrl":4081,"fullTextUrl":26,"authors":4082,"publicationType":1081,"publisherRelationship":4126,"citationCount":4163,"citationInfo":4164,"publishDate":4170,"publishYear":4171,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":4172,"isForceReanalyzing":1446},"3ea7076e-2406-48f0-b32c-4aa038d93391","2024-10-15T22:53:33.350+00:00",[],"The-global-NAFLD-epidemic",{"mag":4067,"keywords":4069,"openalex":4070,"abstract":4072,"title":4073,"pm":4075,"doi":4077},{"VOID":4068},"2002349285",{},{"VOID":4071},"W2002349285",{},{"EN":4074},"The global NAFLD epidemic",{"VOID":4076},"24042449",{"VOID":4078},"10.1038\u002Fnrgastro.2013.171","2024-10-15T22:53:33.349+00:00",[102],"https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fnrgastro.2013.171",[4083,4104],{"id":4084,"sortIndex":36,"researcher":26,"roles":4085,"affiliations":4086,"properties":4097},"78da9887-2249-4ea6-8ed2-d42a193cf4ea",[],[4087],{"id":4088,"sortIndex":36,"affiliation":4089,"properties":26},"1834093f-b1cb-469a-b233-97ac34fdcee1",{"id":4090,"createTime":4091,"updateTime":4091,"relativeEntities":4092,"slug":4093,"properties":4094,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"e114d29b-b13a-4e7d-9d46-16a6bacf5eb0","2024-10-15T22:53:33.374+00:00",[],"Division-of-Gastroenterology-Department-of-Medicine-and-Division-of-Epidemiology-Department-of-Family-and-Preventive-Medicine-University-of-California-at-San-Diego-9500-Gilman-Drive-La-Jolla-CA-92093-0063-USA-",{"title":4095},{"EN":4096},"Division of Gastroenterology, Department of Medicine and Division of Epidemiology, Department of Family and Preventive Medicine, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0063, USA,",{"openalex":4098,"orcid":4100,"title":4102},{"VOID":4099},"A5052059601",{"VOID":4101},"https:\u002F\u002Forcid.org\u002F0000-0002-4845-9991",{"EN":4103},"Rohit Loomba",{"id":4105,"sortIndex":115,"researcher":26,"roles":4106,"affiliations":4107,"properties":4119},"e50885b9-9ebc-4538-bb00-ec30d4c9fd9e",[],[4108],{"id":4109,"sortIndex":36,"affiliation":4110,"properties":26},"ca5cae83-6c25-4ae5-9d8a-1ff430600b2d",{"id":4111,"createTime":4112,"updateTime":4113,"relativeEntities":4114,"slug":4115,"properties":4116,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"8f6f2184-96c2-4a03-94d6-9107f7da55e4","2024-01-26T18:04:36.535+00:00","2024-10-15T22:53:33.386+00:00",[],"Division-of-Gastroenterology-Hepatology-and-Nutrition-Virginia-Commonwealth-University-Richmond-USA",{"title":4117},{"VI":4118},"Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, USA",{"openalex":4120,"orcid":4122,"title":4124},{"VOID":4121},"A5070639714",{"VOID":4123},"https:\u002F\u002Forcid.org\u002F0000-0001-8682-5748",{"EN":4125},"Arun J. Sanyal",{"url":26,"publisher":4127,"properties":4157},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":4128,"slug":663,"properties":4129,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":4135,"manageAffiliations":4136,"indexDatabases":4137,"url":753,"thumbnailPath":26,"statistic":4152,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"country":4130,"issn":4131,"introduce":4132,"eissn":4133,"title":4134},{"VOID":666},{"VOID":668},{"EN":670},{"VOID":672},{"EN":674},[],[],[4138,4145],{"id":735,"indexDatabase":4139,"url":750,"indexYears":26,"academicFieldIds":4144,"indexDatabaseRanking":26},{"id":737,"createTime":738,"updateTime":739,"relativeEntities":4140,"label":4141,"description":4142,"key":746,"publicationTags":4143,"standard":26},[],{"EN":742,"VI":742},{"VI":744,"EN":745},[748,749],[752],{"id":715,"indexDatabase":4146,"url":728,"indexYears":729,"academicFieldIds":4151,"indexDatabaseRanking":733},{"id":717,"createTime":718,"updateTime":719,"relativeEntities":4147,"label":4148,"description":4149,"key":725,"publicationTags":4150,"standard":26},[],{"EN":722,"VI":722},{"EN":722,"VI":724},[727],[731,732],{"impactFactor":36,"impactFactorByYear":4153,"i10Index":259,"i10IndexLast5Year":356,"totalPublication":259,"totalPublicationByYear":4154,"totalCitation":769,"totalCitationByYear":4155,"totalCitationPerPublication":783,"totalCitationPerPublicationByYear":4156,"hindexLast5Year":283,"hindex":283},{"2012":756,"2013":757,"2014":758,"2015":759,"2016":760,"2017":761,"2018":762,"2019":763,"2020":764,"2021":765,"2022":766,"2023":767},{"2009":59,"2010":59,"2011":162,"2012":114,"2013":111,"2014":59,"2015":162,"2016":111,"2017":158,"2018":111,"2019":111,"2020":114,"2021":162,"2022":114},{"2009":144,"2010":771,"2011":772,"2012":146,"2013":773,"2014":774,"2015":775,"2016":776,"2017":777,"2018":778,"2019":779,"2020":780,"2021":781,"2022":782},{"2009":785,"2010":786,"2011":787,"2012":788,"2013":789,"2014":790,"2015":791,"2016":792,"2017":793,"2018":794,"2019":795,"2020":796,"2021":797,"2022":798},{"volume":4158,"pages":4160,"issue":4162},{"VOID":4159},"10",{"VOID":4161},"686-690",{"VOID":1115},1475,{"total":4163,"publishYear":26,"statisticByYear":4165},{"2014":284,"2015":347,"2016":4166,"2017":4167,"2018":350,"2019":4168,"2020":4168,"2021":4169,"2022":121,"2023":127,"2024":652},120,155,168,184,"2013-11-01",2013,[4173,4177,4181,4185,4189,4193,4197,4201,4205,4207,4210,4214,4216,4218,4222,4226,4230,4232,4234,4236,4240,4242,4246,4250,4254,4258,4262,4265,4268,4272,4276,4280,4284,4287,4290,4294,4298,4302,4306,4310,4314,4318,4322,4326,4330,4334,4338,4342,4346,4350,4354,4358],{"id":26,"text":4174,"url":26,"identifiers":4175},"Chalasani, N. et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55, 2005–2023 (2012).",{"doi":4176},"10.1002\u002Fhep.25762",{"id":26,"text":4178,"url":26,"identifiers":4179},"Adams, L. A. et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129, 113–121 (2005).",{"doi":4180},"10.1053\u002Fj.gastro.2005.04.014",{"id":26,"text":4182,"url":26,"identifiers":4183},"Matteoni, C. A. et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116, 1413–1419 (1999).",{"doi":4184},"10.1016\u002FS0016-5085(99)70506-8",{"id":26,"text":4186,"url":26,"identifiers":4187},"Clark, J. M., Brancati, F. L. & Diehl, A. M. The prevalence and etiology of elevated aminotransferase levels in the United States. Am. J. Gastroenterol. 98, 960–967 (2003).",{"doi":4188},"10.1111\u002Fj.1572-0241.2003.07486.x",{"id":26,"text":4190,"url":26,"identifiers":4191},"Welsh, J. A., Karpen, S. & Vos, M. B. Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988–1994 to 2007–2010. J. Pediatr. 162, 496–500 (2013).",{"doi":4192},"10.1016\u002Fj.jpeds.2012.08.043",{"id":26,"text":4194,"url":26,"identifiers":4195},"Eguchi, Y. et al. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J. Gastroenterol. 47, 586–595 (2012).",{"doi":4196},"10.1007\u002Fs00535-012-0533-z",{"id":26,"text":4198,"url":26,"identifiers":4199},"Williams, C. D. et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140, 124–131 (2011).",{"doi":4200},"10.1053\u002Fj.gastro.2010.09.038",{"id":26,"text":4202,"url":26,"identifiers":4203},"Loomba, R. et al. Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology 56, 943–951 (2012).",{"doi":4204},"10.1002\u002Fhep.25772",{"id":26,"text":1693,"url":26,"identifiers":4206},{"doi":1695},{"id":26,"text":4208,"url":26,"identifiers":4209},"Centers for Disease Control and Prevention Overweight and Obesity [online] , (2012).",{},{"id":26,"text":4211,"url":26,"identifiers":4212},"Babusik, P., Bilal, M. & Duris, I. Nonalcoholic fatty liver disease of two ethnic groups in Kuwait: comparison of prevalence and risk factors. Med. Princ. Pract. 21, 56–62 (2012).",{"doi":4213},"10.1159\u002F000331591",{"id":26,"text":1792,"url":26,"identifiers":4215},{"doi":1794},{"id":26,"text":1788,"url":26,"identifiers":4217},{"doi":1790},{"id":26,"text":4219,"url":26,"identifiers":4220},"Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C. & Marchesini, G. A position statement on NAFLD\u002FNASH based on the EASL 2009 special conference. J. Hepatol. 53, 372–384 (2010).",{"doi":4221},"10.1016\u002Fj.jhep.2010.04.008",{"id":26,"text":4223,"url":26,"identifiers":4224},"Fan, J. G. et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18, 163–166). J. Dig. Dis. 12, 38–44 (2011).",{"doi":4225},"10.1111\u002Fj.1751-2980.2010.00476.x",{"id":26,"text":4227,"url":26,"identifiers":4228},"Farrell, G. C., Wong, V. W. & Chitturi, S. NAFLD in Asia—as common and important as in the West. Nat. Rev. Gastroenterol. Hepatol. 10, 307–318 (2013).",{"doi":4229},"10.1038\u002Fnrgastro.2013.34",{"id":26,"text":1894,"url":26,"identifiers":4231},{"doi":1896},{"id":26,"text":1901,"url":26,"identifiers":4233},{"doi":1903},{"id":26,"text":1898,"url":26,"identifiers":4235},{},{"id":26,"text":4237,"url":26,"identifiers":4238},"Amarapurkar, D. N. et al. How common is non-alcoholic fatty liver disease in the Asia–Pacific region and are there local differences? J. Gastroenterol. Hepatol. 22, 788–793 (2007).",{"doi":4239},"10.1111\u002Fj.1440-1746.2007.05042.x",{"id":26,"text":1920,"url":26,"identifiers":4241},{"doi":1922},{"id":26,"text":4243,"url":26,"identifiers":4244},"Mendez-Sanchez, N. Non alcoholic fatty liver disease. Ann. Hepatol. 8 (Suppl. 1), S3 (2009).",{"doi":4245},"10.1016\u002FS1665-2681(19)31819-8",{"id":26,"text":4247,"url":26,"identifiers":4248},"Chitturi, S. et al. Non-alcoholic fatty liver disease in the Asia–Pacific region: definitions and overview of proposed guidelines. J. Gastroenterol. Hepatol. 22, 778–787 (2007).",{"doi":4249},"10.1111\u002Fj.1440-1746.2007.05001.x",{"id":26,"text":4251,"url":26,"identifiers":4252},"Farrell, G. C., Chitturi, S., Lau, G. K., Sollano, J. D. & Asia–Pacific Working Party on NAFLD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia–Pacific region: executive summary. J. Gastroenterol. Hepatol. 22, 775–777 (2007).",{"doi":4253},"10.1111\u002Fj.1440-1746.2007.05002.x",{"id":26,"text":4255,"url":26,"identifiers":4256},"Larrain, S. & Rinella, M. E. A myriad of pathways to NASH. Clin. Liver Dis. 16, 525–548 (2012).",{"doi":4257},"10.1016\u002Fj.cld.2012.05.009",{"id":26,"text":4259,"url":26,"identifiers":4260},"Pratt, D. S., Knox, T. A. & Erban, J. Tamoxifen-induced steatohepatitis. Ann. Intern. Med. 123, 236 (1995).",{"doi":4261},"10.7326\u002F0003-4819-123-3-199508010-00018",{"id":26,"text":4263,"url":26,"identifiers":4264},"McLaren, D. S., Bitar, J. G. & Nassar, V. H. Protein–calorie malnutrition and the liver. Prog. Liver Dis. 4, 527–536 (1972).",{},{"id":26,"text":4266,"url":26,"identifiers":4267},"Misra, A. et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J. Assoc. Physicians India 57, 163–170 (2009).",{},{"id":26,"text":4269,"url":26,"identifiers":4270},"Doycheva, I., Patel, N., Peterson, M. & Loomba, R. Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes. J. Diabetes Complications 27, 293–300 (2013).",{"doi":4271},"10.1016\u002Fj.jdiacomp.2012.10.008",{"id":26,"text":4273,"url":26,"identifiers":4274},"Loomba, R. et al. Genetic covariance between γ-glutamyl transpeptidase and fatty liver risk factors: role of β2-adrenergic receptor genetic variation in twins. Gastroenterology 139, 836–845 (2010).",{"doi":4275},"10.1053\u002Fj.gastro.2010.06.009",{"id":26,"text":4277,"url":26,"identifiers":4278},"Petersen, K. F. et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc. Natl Acad. Sci. USA 103, 18273–18277 (2006).",{"doi":4279},"10.1073\u002Fpnas.0608537103",{"id":26,"text":4281,"url":26,"identifiers":4282},"Fan, J. G. et al. Effects of nonalcoholic fatty liver disease on the development of metabolic disorders. J. Gastroenterol. Hepatol. 22, 1086–1091 (2007).",{"doi":4283},"10.1111\u002Fj.1440-1746.2006.04781.x",{"id":26,"text":4285,"url":26,"identifiers":4286},"Prashanth, M. et al. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. J. Assoc. Physicians India 57, 205–210 (2009).",{},{"id":26,"text":4288,"url":26,"identifiers":4289},"Fan, J. G. & Peng, Y. D. Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies. Hepatobiliary Pancreat. Dis. Int. 6, 572–578 (2007).",{},{"id":26,"text":4291,"url":26,"identifiers":4292},"Romeo, S. et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40, 1461–1465 (2008).",{"doi":4293},"10.1038\u002Fng.257",{"id":26,"text":4295,"url":26,"identifiers":4296},"Rotman, Y. et al. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology 52, 894–903 (2010).",{"doi":4297},"10.1002\u002Fhep.23759",{"id":26,"text":4299,"url":26,"identifiers":4300},"Chalasani, N. et al. Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease. Gastroenterology 139, 1567–1576 (2010).",{"doi":4301},"10.1053\u002Fj.gastro.2010.07.057",{"id":26,"text":4303,"url":26,"identifiers":4304},"Speliotes, E. K. et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 7, e1001324 (2011).",{"doi":4305},"10.1371\u002Fjournal.pgen.1001324",{"id":26,"text":4307,"url":26,"identifiers":4308},"Miele, L. et al. The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease. Gastroenterology 135, 282–291 (2008).",{"doi":4309},"10.1053\u002Fj.gastro.2008.04.004",{"id":26,"text":4311,"url":26,"identifiers":4312},"Bechmann, L. P. et al. Glucokinase links Kruppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease. Hepatology 55, 1083–1093 (2012).",{"doi":4313},"10.1002\u002Fhep.24793",{"id":26,"text":4315,"url":26,"identifiers":4316},"Anstee, Q. M. & Day, C. P. The genetics of NAFLD. Nat. Rev. Gastroenterol. Hepatol. http:\u002F\u002Fdx.doi.org\u002F10.1038\u002Fnrgastro.2013.183 .",{"doi":4317},"10.1038\u002Fnrgastro.2013.183",{"id":26,"text":4319,"url":26,"identifiers":4320},"Petersen, K. F. et al. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N. Engl. J. Med. 362, 1082–1089 (2010).",{"doi":4321},"10.1056\u002FNEJMoa0907295",{"id":26,"text":4323,"url":26,"identifiers":4324},"Ekstedt, M. et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44, 865–873 (2006).",{"doi":4325},"10.1002\u002Fhep.21327",{"id":26,"text":4327,"url":26,"identifiers":4328},"Rafiq, N. et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin. Gastroenterol. Hepatol. 7, 234–238 (2009).",{"doi":4329},"10.1016\u002Fj.cgh.2008.11.005",{"id":26,"text":4331,"url":26,"identifiers":4332},"Noureddin, M. et al. Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients. Hepatology http:\u002F\u002Fdx.doi.org\u002F10.1002\u002Fhep.26465 .",{"doi":4333},"10.1002\u002Fhep.26465",{"id":26,"text":4335,"url":26,"identifiers":4336},"Sanyal, A. J. et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 43, 682–689 (2006).",{"doi":4337},"10.1002\u002Fhep.21103",{"id":26,"text":4339,"url":26,"identifiers":4340},"Ascha, M. S. et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 51, 1972–1978 (2010).",{"doi":4341},"10.1002\u002Fhep.23527",{"id":26,"text":4343,"url":26,"identifiers":4344},"White, D. L., Kanwal, F. & El-Serag, H. B. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin. Gastroenterol. Hepatol. 10, 1342–1359 (2012).",{"doi":4345},"10.1016\u002Fj.cgh.2012.10.001",{"id":26,"text":4347,"url":26,"identifiers":4348},"Sanyal, A., Poklepovic, A., Moyneur, E. & Barghout, V. Population-based risk factors and resource utilization for HCC: US perspective. Curr. Med. Res. Opin. 26, 2183–2191 (2010).",{"doi":4349},"10.1185\u002F03007995.2010.506375",{"id":26,"text":4351,"url":26,"identifiers":4352},"Charlton, M. R. et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 141, 1249–1253 (2011).",{"doi":4353},"10.1053\u002Fj.gastro.2011.06.061",{"id":26,"text":4355,"url":26,"identifiers":4356},"Finucane, M. M. et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 377, 557–567 (2011).",{"doi":4357},"10.1016\u002FS0140-6736(10)62037-5",{"id":26,"text":4359,"url":26,"identifiers":4360},"WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363, 157–163 (2004).",{"doi":4361},"10.1016\u002FS0140-6736(03)15268-3",{"id":4363,"createTime":4364,"updateTime":4364,"relativeEntities":4365,"slug":4366,"properties":4367,"entityType":821,"verifyStatus":25,"verifyTime":4364,"verifyNote":822,"syncStatus":28,"languages":4380,"translateLanguages":26,"viewCount":36,"primaryUrl":4381,"fullTextUrl":26,"authors":4382,"publicationType":1081,"publisherRelationship":4404,"citationCount":4441,"citationInfo":4442,"publishDate":4448,"publishYear":4449,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":4450,"isForceReanalyzing":1446},"99a8be6e-1f01-4ae0-9cf1-cb604caf796e","2024-10-08T04:55:02.068+00:00",[],"Epidemiology-and-risk-factors-for-IBD",{"mag":4368,"keywords":4370,"openalex":4371,"abstract":4373,"title":4374,"pm":4376,"doi":4378},{"VOID":4369},"2009710456",{},{"VOID":4372},"W2009710456",{},{"EN":4375},"Epidemiology and risk factors for IBD",{"VOID":4377},"25732745",{"VOID":4379},"10.1038\u002Fnrgastro.2015.34",[102],"https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fnrgastro.2015.34",[4383],{"id":4384,"sortIndex":36,"researcher":26,"roles":4385,"affiliations":4386,"properties":4397},"c411f51c-319a-459d-acd3-d8fb1095d985",[],[4387],{"id":4388,"sortIndex":36,"affiliation":4389,"properties":26},"627b2fce-e0ac-4ede-b096-0f5ffe26b0c5",{"id":4390,"createTime":4391,"updateTime":4391,"relativeEntities":4392,"slug":4393,"properties":4394,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"b07558ce-bab2-4393-ab0f-674c8d61a1c8","2024-10-08T04:55:02.088+00:00",[],"Massachusetts-General-Hospital-Crohn-s-and-Colitis-Centre-165-Cambridge-Street-9th-Floor-Boston-MA-02114-USA-",{"title":4395},{"EN":4396},"Massachusetts General Hospital Crohn's and Colitis Centre, 165 Cambridge Street, 9th Floor, Boston, MA 02114, USA.",{"openalex":4398,"orcid":4400,"title":4402},{"VOID":4399},"A5073977144",{"VOID":4401},"https:\u002F\u002Forcid.org\u002F0000-0002-9436-1821",{"EN":4403},"Ashwin N. Ananthakrishnan",{"url":26,"publisher":4405,"properties":4435},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":4406,"slug":663,"properties":4407,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":4413,"manageAffiliations":4414,"indexDatabases":4415,"url":753,"thumbnailPath":26,"statistic":4430,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"country":4408,"issn":4409,"introduce":4410,"eissn":4411,"title":4412},{"VOID":666},{"VOID":668},{"EN":670},{"VOID":672},{"EN":674},[],[],[4416,4423],{"id":735,"indexDatabase":4417,"url":750,"indexYears":26,"academicFieldIds":4422,"indexDatabaseRanking":26},{"id":737,"createTime":738,"updateTime":739,"relativeEntities":4418,"label":4419,"description":4420,"key":746,"publicationTags":4421,"standard":26},[],{"EN":742,"VI":742},{"VI":744,"EN":745},[748,749],[752],{"id":715,"indexDatabase":4424,"url":728,"indexYears":729,"academicFieldIds":4429,"indexDatabaseRanking":733},{"id":717,"createTime":718,"updateTime":719,"relativeEntities":4425,"label":4426,"description":4427,"key":725,"publicationTags":4428,"standard":26},[],{"EN":722,"VI":722},{"EN":722,"VI":724},[727],[731,732],{"impactFactor":36,"impactFactorByYear":4431,"i10Index":259,"i10IndexLast5Year":356,"totalPublication":259,"totalPublicationByYear":4432,"totalCitation":769,"totalCitationByYear":4433,"totalCitationPerPublication":783,"totalCitationPerPublicationByYear":4434,"hindexLast5Year":283,"hindex":283},{"2012":756,"2013":757,"2014":758,"2015":759,"2016":760,"2017":761,"2018":762,"2019":763,"2020":764,"2021":765,"2022":766,"2023":767},{"2009":59,"2010":59,"2011":162,"2012":114,"2013":111,"2014":59,"2015":162,"2016":111,"2017":158,"2018":111,"2019":111,"2020":114,"2021":162,"2022":114},{"2009":144,"2010":771,"2011":772,"2012":146,"2013":773,"2014":774,"2015":775,"2016":776,"2017":777,"2018":778,"2019":779,"2020":780,"2021":781,"2022":782},{"2009":785,"2010":786,"2011":787,"2012":788,"2013":789,"2014":790,"2015":791,"2016":792,"2017":793,"2018":794,"2019":795,"2020":796,"2021":797,"2022":798},{"volume":4436,"pages":4437,"issue":4439},{"VOID":3150},{"VOID":4438},"205-217",{"VOID":4440},"4",1388,{"total":4441,"publishYear":26,"statisticByYear":4443},{"2015":241,"2016":348,"2017":627,"2018":277,"2019":628,"2020":4444,"2021":4445,"2022":4446,"2023":4447,"2024":360},153,192,188,196,"2015-04-01",2015,[4451,4455,4459,4463,4467,4471,4475,4479,4483,4487,4491,4495,4499,4503,4507,4511,4515,4519,4523,4527,4531,4534,4538,4542,4545,4549,4553,4557,4561,4564,4568,4572,4576,4580,4584,4588,4592,4596,4600,4604,4608,4611,4615,4619,4623,4627,4631,4635,4639,4642,4646,4650,4654,4658,4660,4664,4668,4670,4674,4678,4681,4685,4689,4693,4697,4701,4705,4709,4713,4717,4721,4725,4729,4733,4737,4741,4745,4749,4753,4757,4761,4765,4769,4773,4777,4781,4785,4789,4793,4797,4801,4805,4809,4813,4817,4820,4824,4828,4832,4836,4840,4844,4848,4852,4856,4860,4864,4868,4872,4876,4880,4884,4888,4892,4896,4900,4904,4908,4912,4916,4920,4924,4928,4932,4936,4940,4944,4948,4952,4956,4960,4964,4968,4972,4976,4980,4984,4988,4991,4995,4999,5003,5007,5011,5015,5019,5023,5026,5030,5034,5038,5042,5046,5050,5054,5058,5062,5066,5070,5074,5078,5082,5086,5090,5094,5098,5102,5106,5110,5114,5118,5122,5126,5130,5133,5137,5141,5145,5149,5153,5157,5161,5165,5169,5173,5177,5181,5185,5189,5193,5197,5201,5205,5209,5213,5217,5220,5223,5226,5230,5234,5238,5242,5246,5250,5254,5258],{"id":26,"text":4452,"url":26,"identifiers":4453},"Cosnes, J.  et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140, 1785–1794 (2011).",{"doi":4454},"10.1053\u002Fj.gastro.2011.01.055",{"id":26,"text":4456,"url":26,"identifiers":4457},"Loftus, E. V. Jr Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126, 1504–1517 (2004).",{"doi":4458},"10.1053\u002Fj.gastro.2004.01.063",{"id":26,"text":4460,"url":26,"identifiers":4461},"Abraham, C. & Cho, J. H. Inflammatory bowel disease. N. Engl. J. Med. 361, 2066–2078 (2009).",{"doi":4462},"10.1056\u002FNEJMra0804647",{"id":26,"text":4464,"url":26,"identifiers":4465},"Molodecky, N. A.  et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142, 46–54.e42 (2012).",{"doi":4466},"10.1053\u002Fj.gastro.2011.10.001",{"id":26,"text":4468,"url":26,"identifiers":4469},"Hugot, J. P.  et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599–603 (2001).",{"doi":4470},"10.1038\u002F35079107",{"id":26,"text":4472,"url":26,"identifiers":4473},"Ogura, Y.  et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603–606 (2001).",{"doi":4474},"10.1038\u002F35079114",{"id":26,"text":4476,"url":26,"identifiers":4477},"Jostins, L.  et al. Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119–124 (2012).",{"doi":4478},"10.1038\u002Fnature11582",{"id":26,"text":4480,"url":26,"identifiers":4481},"Loftus, E. V. Jr.  et al. Ulcerative colitis in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gut 46, 336–343 (2000).",{"doi":4482},"10.1136\u002Fgut.46.3.336",{"id":26,"text":4484,"url":26,"identifiers":4485},"Loftus, E. V. Jr.  et al. Crohn's disease in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gastroenterology 114, 1161–1168 (1998).",{"doi":4486},"10.1016\u002FS0016-5085(98)70421-4",{"id":26,"text":4488,"url":26,"identifiers":4489},"Loftus, C. G.  et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000. Inflamm. Bowel Dis. 13, 254–261 (2007).",{"doi":4490},"10.1002\u002Fibd.20029",{"id":26,"text":4492,"url":26,"identifiers":4493},"Nerich, V.  et al. Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm. Bowel Dis. 12, 218–226 (2006).",{"doi":4494},"10.1097\u002F01.MIB.0000206540.38834.8c",{"id":26,"text":4496,"url":26,"identifiers":4497},"Khalili, H.  et al. Geographical variation and incidence of inflammatory bowel disease among US women. Gut 61, 1686–1692 (2012).",{"doi":4498},"10.1136\u002Fgutjnl-2011-301574",{"id":26,"text":4500,"url":26,"identifiers":4501},"Gearry, R. B.  et al. High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study. Inflamm. Bowel Dis. 12, 936–943 (2006).",{"doi":4502},"10.1097\u002F01.mib.0000231572.88806.b9",{"id":26,"text":4504,"url":26,"identifiers":4505},"Bernstein, C. N.  et al. Assessing inflammatory bowel disease-associated antibodies in Caucasian and First Nations cohorts. Can. J. Gastroenterol. 25, 269–273 (2011).",{"doi":4506},"10.1155\u002F2011\u002F712350",{"id":26,"text":4508,"url":26,"identifiers":4509},"Odes, H. S.  et al. Inflammatory bowel disease in the Bedouin Arabs of southern Israel: rarity of diagnosis and clinical features. Gut 32, 1024–1026 (1991).",{"doi":4510},"10.1136\u002Fgut.32.9.1024",{"id":26,"text":4512,"url":26,"identifiers":4513},"Bernstein, C. N.  et al. A population-based case control study of potential risk factors for IBD. Am. J. Gastroenterol. 101, 993–1002 (2006).",{"doi":4514},"10.1111\u002Fj.1572-0241.2006.00381.x",{"id":26,"text":4516,"url":26,"identifiers":4517},"Mahid, S. S.  et al. Inflammatory bowel disease and African Americans: a systematic review. Inflamm. Bowel Dis. 14, 960–967 (2008).",{"doi":4518},"10.1002\u002Fibd.20389",{"id":26,"text":4520,"url":26,"identifiers":4521},"Reddy, S. I. & Burakoff, R. Inflammatory bowel disease in African Americans. Inflamm. Bowel Dis. 9, 380–385 (2003).",{"doi":4522},"10.1097\u002F00054725-200311000-00006",{"id":26,"text":4524,"url":26,"identifiers":4525},"Thia, K. T.  et al. An update on the epidemiology of inflammatory bowel disease in Asia. Am. J. Gastroenterol. 103, 3167–3182 (2008).",{"doi":4526},"10.1111\u002Fj.1572-0241.2008.02158.x",{"id":26,"text":4528,"url":26,"identifiers":4529},"Ng, S. C.  et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia–Pacific Crohn's and colitis epidemiology study. Gastroenterology 145, 158–165.e2 (2013).",{"doi":4530},"10.1053\u002Fj.gastro.2013.04.007",{"id":26,"text":4532,"url":26,"identifiers":4533},"Archampong, T. N. & Nkrumah, K. N. Inflammatory bowel disease in Accra: what new trends. West Afr. J. Med. 32, 40–44 (2013).",{},{"id":26,"text":4535,"url":26,"identifiers":4536},"Ukwenya, A. Y.  et al. Inflammatory bowel disease in Nigerians: still a rare diagnosis? Ann. Afr. Med. 10, 175–179 (2011).",{"doi":4537},"10.4103\u002F1596-3519.82067",{"id":26,"text":4539,"url":26,"identifiers":4540},"Al-Mofarreh, M. A. & Al-Mofleh, I. A. Emerging inflammatory bowel disease in Saudi outpatients: a report of 693 cases. Saudi J. Gastroenterol. 19, 16–22 (2013).",{"doi":4541},"10.4103\u002F1319-3767.105915",{"id":26,"text":4543,"url":26,"identifiers":4544},"Sood, A. & Midha, V. Epidemiology of inflammatory bowel disease in Asia. Indian J. Gastroenterol. 26, 285–289 (2007).",{},{"id":26,"text":4546,"url":26,"identifiers":4547},"Probert, C. S.  et al. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut 33, 687–693 (1992).",{"doi":4548},"10.1136\u002Fgut.33.5.687",{"id":26,"text":4550,"url":26,"identifiers":4551},"Probert, C. S.  et al. Prevalence and family risk of ulcerative colitis and Crohn's disease: an epidemiological study among Europeans and south Asians in Leicestershire. Gut 34, 1547–1551 (1993).",{"doi":4552},"10.1136\u002Fgut.34.11.1547",{"id":26,"text":4554,"url":26,"identifiers":4555},"Li, X.  et al. Risk of inflammatory bowel disease in first- and second-generation immigrants in Sweden: a nationwide follow-up study. Inflamm. Bowel Dis. 17, 1784–1791 (2011).",{"doi":4556},"10.1002\u002Fibd.21535",{"id":26,"text":4558,"url":26,"identifiers":4559},"Pinsk, V.  et al. Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am. J. Gastroenterol. 102, 1077–1083 (2007).",{"doi":4560},"10.1111\u002Fj.1572-0241.2007.01124.x",{"id":26,"text":4562,"url":26,"identifiers":4563},"Benchimol, E. I.  et al. O-004 Inflammatory Bowel Disease in Immigrants to Canada and their Children: a Population-Based Cohort Study. Inflamm. Bowel Dis. 20 (Suppl. 1) S3–S4 (2014).",{},{"id":26,"text":4565,"url":26,"identifiers":4566},"Damas, O. M.  et al. Phenotypic manifestations of inflammatory bowel disease differ between Hispanics and non-Hispanic whites: results of a large cohort study. Am. J. Gastroenterol. 108, 231–239 (2013).",{"doi":4567},"10.1038\u002Fajg.2012.393",{"id":26,"text":4569,"url":26,"identifiers":4570},"Halme, L.  et al. Family and twin studies in inflammatory bowel disease. World J. Gastroenterol. 12, 3668–3672 (2006).",{"doi":4571},"10.3748\u002Fwjg.v12.i23.3668",{"id":26,"text":4573,"url":26,"identifiers":4574},"Khor, B., Gardet, A. & Xavier, R. J. Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307–317 (2011).",{"doi":4575},"10.1038\u002Fnature10209",{"id":26,"text":4577,"url":26,"identifiers":4578},"Liu, J. Z. & Anderson, C. A. Genetic studies of Crohn's disease: past, present and future. Best Pract. Res. Clin. Gastroenterol. 28, 373–386 (2014).",{"doi":4579},"10.1016\u002Fj.bpg.2014.04.009",{"id":26,"text":4581,"url":26,"identifiers":4582},"Orholm, M.  et al. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand. J. Gastroenterol. 35, 1075–1081 (2000).",{"doi":4583},"10.1080\u002F003655200451207",{"id":26,"text":4585,"url":26,"identifiers":4586},"Russell, R. K. & Satsangi, J. IBD: a family affair. Best Pract. Res. Clin. Gastroenterol. 18, 525–539 (2004).",{"doi":4587},"10.1016\u002Fj.bpg.2003.12.006",{"id":26,"text":4589,"url":26,"identifiers":4590},"Thompson, N. P.  et al. Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ 312, 95–96 (1996).",{"doi":4591},"10.1136\u002Fbmj.312.7023.95",{"id":26,"text":4593,"url":26,"identifiers":4594},"Tysk, C.  et al. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29, 990–996 (1988).",{"doi":4595},"10.1136\u002Fgut.29.7.990",{"id":26,"text":4597,"url":26,"identifiers":4598},"Yang, H.  et al. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut 34, 517–524 (1993).",{"doi":4599},"10.1136\u002Fgut.34.4.517",{"id":26,"text":4601,"url":26,"identifiers":4602},"Halfvarson, J.  et al. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 124, 1767–1773 (2003).",{"doi":4603},"10.1016\u002FS0016-5085(03)00385-8",{"id":26,"text":4605,"url":26,"identifiers":4606},"Hugot, J. P.  et al. Mapping a susceptibility locus for Crohn's disease on chromosome 16. Nature 29, 821–823 (1996).",{"doi":4607},"10.1038\u002F379821a0",{"id":26,"text":4609,"url":26,"identifiers":4610},"Jostins, L.  et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119–124 (2012).",{"doi":4478},{"id":26,"text":4612,"url":26,"identifiers":4613},"VanDussen, K. L.  et al. Genetic variants synthesize to produce paneth cell phenotypes that define subtypes of Crohn's disease. Gastroenterology 146, 200–209 (2014).",{"doi":4614},"10.1053\u002Fj.gastro.2013.09.048",{"id":26,"text":4616,"url":26,"identifiers":4617},"Van Limbergen, J., Radford-Smith, G. & Satsangi, J. Advances in IBD genetics. Nat. Rev. Gastroenterol. Hepatol. 11, 372–385 (2014).",{"doi":4618},"10.1038\u002Fnrgastro.2014.27",{"id":26,"text":4620,"url":26,"identifiers":4621},"Glocker, E. O.  et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361, 2033–2045 (2009).",{"doi":4622},"10.1056\u002FNEJMoa0907206",{"id":26,"text":4624,"url":26,"identifiers":4625},"Gevers, D.  et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15, 382–392 (2014).",{"doi":4626},"10.1016\u002Fj.chom.2014.02.005",{"id":26,"text":4628,"url":26,"identifiers":4629},"Kostic, A. D., Xavier, R. J. & Gevers, D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 146, 1489–1499 (2014).",{"doi":4630},"10.1053\u002Fj.gastro.2014.02.009",{"id":26,"text":4632,"url":26,"identifiers":4633},"Morgan, X. C.  et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13, R79 (2012).",{"doi":4634},"10.1186\u002Fgb-2012-13-9-r79",{"id":26,"text":4636,"url":26,"identifiers":4637},"Nagalingam, N. A. & Lynch, S. V. Role of the microbiota in inflammatory bowel diseases. Inflamm. Bowel Dis. 18, 968–984 (2012).",{"doi":4638},"10.1002\u002Fibd.21866",{"id":26,"text":4640,"url":26,"identifiers":4641},"Manichanh, C.  et al. The gut microbiota in IBD. Nat. Rev. Gastroenterol. Hepatol. 9, 599–608 (2012).",{"doi":1256},{"id":26,"text":4643,"url":26,"identifiers":4644},"Castiglione, F.  et al. Risk factors for inflammatory bowel diseases according to the “hygiene hypothesis”: a case-control, multi-centre, prospective study in Southern Italy. J. Crohns Colitis 6, 324–329 (2012).",{"doi":4645},"10.1016\u002Fj.crohns.2011.09.003",{"id":26,"text":4647,"url":26,"identifiers":4648},"Ng, S. C.  et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia–Pacific. Gut \n                    http:\u002F\u002Fdx.doi.org\u002F10.1136\u002Fgutjnl-2014-307410\n                    \n                  .",{"doi":4649},"10.1136\u002Fgutjnl-2014-307410",{"id":26,"text":4651,"url":26,"identifiers":4652},"Timm, S.  et al. Place of upbringing in early childhood as related to inflammatory bowel diseases in adulthood: a population-based cohort study in Northern Europe. Eur. J. Epidemiol. 29, 429–437 (2014).",{"doi":4653},"10.1007\u002Fs10654-014-9922-3",{"id":26,"text":4655,"url":26,"identifiers":4656},"Willing, B. P.  et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139, 1844–1854.e1 (2010).",{"doi":4657},"10.1053\u002Fj.gastro.2010.08.049",{"id":26,"text":1250,"url":26,"identifiers":4659},{"doi":1252},{"id":26,"text":4661,"url":26,"identifiers":4662},"Darfeuille-Michaud, A.  et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127, 412–421 (2004).",{"doi":4663},"10.1053\u002Fj.gastro.2004.04.061",{"id":26,"text":4665,"url":26,"identifiers":4666},"Martin, R.  et al. The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models. Inflamm. Bowel Dis. 20, 417–430 (2014).",{"doi":4667},"10.1097\u002F01.MIB.0000440815.76627.64",{"id":26,"text":1290,"url":26,"identifiers":4669},{"doi":1292},{"id":26,"text":4671,"url":26,"identifiers":4672},"Sokol, H.  et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 15, 1183–1189 (2009).",{"doi":4673},"10.1002\u002Fibd.20903",{"id":26,"text":4675,"url":26,"identifiers":4676},"Wu, G. D.  et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334, 105–108 (2011).",{"doi":4677},"10.1126\u002Fscience.1208344",{"id":26,"text":4679,"url":26,"identifiers":4680},"David, L. A.  et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559–563 (2014).",{"doi":2453},{"id":26,"text":4682,"url":26,"identifiers":4683},"Norman, J. M.  et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 160, 447–460 (2015).",{"doi":4684},"10.1016\u002Fj.cell.2015.01.002",{"id":26,"text":4686,"url":26,"identifiers":4687},"Iliev, I. D.  et al. Interaction between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 8, 1314–1347 (2012).",{"doi":4688},"10.1126\u002Fscience.1221789",{"id":26,"text":4690,"url":26,"identifiers":4691},"Harries, A. D., Baird, A. & Rhodes, J. Non-smoking: a feature of ulcerative colitis. Br. Med. J. (Clin. Res. Ed.) 284, 706 (1982).",{"doi":4692},"10.1136\u002Fbmj.284.6317.706",{"id":26,"text":4694,"url":26,"identifiers":4695},"Mahid, S. S.  et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin. Proc. 81, 1462–1471 (2006).",{"doi":4696},"10.4065\u002F81.11.1462",{"id":26,"text":4698,"url":26,"identifiers":4699},"Higuchi, L. M.  et al. A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am. J. Gastroenterol. 107, 1399–1406 (2012).",{"doi":4700},"10.1038\u002Fajg.2012.196",{"id":26,"text":4702,"url":26,"identifiers":4703},"Mahid, S. S.  et al. Active and passive smoking in childhood is related to the development of inflammatory bowel disease. Inflamm. Bowel Dis. 13, 431–438 (2007).",{"doi":4704},"10.1002\u002Fibd.20070",{"id":26,"text":4706,"url":26,"identifiers":4707},"Odes, H. S.  et al. Effects of current cigarette smoking on clinical course of Crohn's disease and ulcerative colitis. Dig. Dis. Sci. 46, 1717–1721 (2001).",{"doi":4708},"10.1023\u002FA:1010609722315",{"id":26,"text":4710,"url":26,"identifiers":4711},"Cosnes, J.  et al. Gender differences in the response of colitis to smoking. Clin. Gastroenterol. Hepatol. 2, 41–48 (2004).",{"doi":4712},"10.1016\u002FS1542-3565(03)00290-8",{"id":26,"text":4714,"url":26,"identifiers":4715},"Cosnes, J. What is the link between the use of tobacco and IBD? Inflamm. Bowel Dis. 14 (Suppl. 2) S14–S15 (2008).",{"doi":4716},"10.1097\u002F00054725-200810001-00007",{"id":26,"text":4718,"url":26,"identifiers":4719},"Cosnes, J.  et al. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 110, 424–431 (1996).",{"doi":4720},"10.1053\u002Fgast.1996.v110.pm8566589",{"id":26,"text":4722,"url":26,"identifiers":4723},"Cosnes, J.  et al. Effects of current and former cigarette smoking on the clinical course of Crohn's disease. Aliment. Pharmacol. Ther. 13, 1403–1411 (1999).",{"doi":4724},"10.1046\u002Fj.1365-2036.1999.00630.x",{"id":26,"text":4726,"url":26,"identifiers":4727},"Lakatos, P. L., Szamosi, T. & Lakatos, L. Smoking in inflammatory bowel diseases: good, bad or ugly? World J. Gastroenterol. 13, 6134–6139 (2007).",{"doi":4728},"10.3748\u002Fwjg.v13.i46.6134",{"id":26,"text":4730,"url":26,"identifiers":4731},"Cosnes, J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract. Res. Clin. Gastroenterol. 18, 481–496 (2004).",{"doi":4732},"10.1016\u002Fj.bpg.2003.12.003",{"id":26,"text":4734,"url":26,"identifiers":4735},"Birrenbach, T. & Bocker, U. Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm. Bowel Dis. 10, 848–859 (2004).",{"doi":4736},"10.1097\u002F00054725-200411000-00019",{"id":26,"text":4738,"url":26,"identifiers":4739},"Persson, P. G., Hellers, G. & Ahlbom, A. Use of oral moist snuff and inflammatory bowel disease. Int. J. Epidemiol. 22, 1101–1103 (1993).",{"doi":4740},"10.1093\u002Fije\u002F22.6.1101",{"id":26,"text":4742,"url":26,"identifiers":4743},"Hatoum, O. A., Heidemann, J. & Binion, D. G. The intestinal microvasculature as a therapeutic target in inflammatory bowel disease. Ann. NY Acad. Sci. 1072, 78–97 (2006).",{"doi":4744},"10.1196\u002Fannals.1326.003",{"id":26,"text":4746,"url":26,"identifiers":4747},"McGilligan, V. E.  et al. Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis. Inflamm. Bowel Dis. 13, 108–115 (2007).",{"doi":4748},"10.1002\u002Fibd.20020",{"id":26,"text":4750,"url":26,"identifiers":4751},"Bergeron, V.  et al. Current smoking differentially affects blood mononuclear cells from patients with Crohn's disease and ulcerative colitis: relevance to its adverse role in the disease. Inflamm. Bowel Dis. 18, 1101–1111 (2012).",{"doi":4752},"10.1002\u002Fibd.21889",{"id":26,"text":4754,"url":26,"identifiers":4755},"Ananthakrishnan, A. N.  et al. Genetic polymorphisms in metabolizing enzymes modifying the association between smoking and inflammatory bowel diseases. Inflamm. Bowel Dis. 20, 783–789 (2014).",{"doi":4756},"10.1097\u002FMIB.0000000000000014",{"id":26,"text":4758,"url":26,"identifiers":4759},"Biedermann, L.  et al. Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH. Inflamm. Bowel Dis. 20, 1496–1501 (2014).",{"doi":4760},"10.1097\u002FMIB.0000000000000129",{"id":26,"text":4762,"url":26,"identifiers":4763},"Munyaka, P. M., Khafipour, E. & Ghia, J. E. External influence of early childhood establishment of gut microbiota and subsequent health implications. Front. Pediatr. 2, 109 (2014).",{"doi":4764},"10.3389\u002Ffped.2014.00109",{"id":26,"text":4766,"url":26,"identifiers":4767},"Parkes, G. C., Whelan, K. & Lindsay, J. O. Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect. J. Crohns Colitis 8, 717–725 (2014).",{"doi":4768},"10.1016\u002Fj.crohns.2014.02.002",{"id":26,"text":4770,"url":26,"identifiers":4771},"Andersson, R. E.  et al. Appendectomy and protection against ulcerative colitis. N. Engl. J. Med. 344, 808–814 (2001).",{"doi":4772},"10.1056\u002FNEJM200103153441104",{"id":26,"text":4774,"url":26,"identifiers":4775},"Andersson, R. E.  et al. Appendectomy is followed by increased risk of Crohn's disease. Gastroenterology 124, 40–46 (2003).",{"doi":4776},"10.1053\u002Fgast.2003.50021",{"id":26,"text":4778,"url":26,"identifiers":4779},"Kaplan, G. G.  et al. The risk of developing Crohn's disease after an appendectomy: a meta-analysis. Am. J. Gastroenterol. 103, 2925–2931 (2008).",{"doi":4780},"10.1111\u002Fj.1572-0241.2008.02118.x",{"id":26,"text":4782,"url":26,"identifiers":4783},"Cosnes, J.  et al. Prior appendectomy and the phenotype and course of Crohn's disease. World J. Gastroenterol. 12, 1235–1242 (2006).",{"doi":4784},"10.3748\u002Fwjg.v12.i8.1235",{"id":26,"text":4786,"url":26,"identifiers":4787},"Gardenbroek, T. J.  et al. The effect of appendectomy on the course of ulcerative colitis: a systematic review. Colorectal Dis. 14, 545–553 (2012).",{"doi":4788},"10.1111\u002Fj.1463-1318.2011.02600.x",{"id":26,"text":4790,"url":26,"identifiers":4791},"Radford-Smith, G. L. What is the importance of appendectomy in the natural history of IBD? Inflamm. Bowel Dis. 14 (Suppl. 2), S72–S74 (2008).",{"doi":4792},"10.1002\u002Fibd.20623",{"id":26,"text":4794,"url":26,"identifiers":4795},"Radford-Smith, G. L.  et al. Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut 51, 808–813 (2002).",{"doi":4796},"10.1136\u002Fgut.51.6.808",{"id":26,"text":4798,"url":26,"identifiers":4799},"Strachan, D. P. Hay fever, hygiene, and household size. BMJ 299, 1259–1260 (1989).",{"doi":4800},"10.1136\u002Fbmj.299.6710.1259",{"id":26,"text":4802,"url":26,"identifiers":4803},"Radon, K.  et al. Contact with farm animals in early life and juvenile inflammatory bowel disease: a case–control study. Pediatrics 120, 354–361 (2007).",{"doi":4804},"10.1542\u002Fpeds.2006-3624",{"id":26,"text":4806,"url":26,"identifiers":4807},"Van Kruiningen, H. J.  et al. Environmental factors in familial Crohn's disease in Belgium. Inflamm. Bowel Dis. 11, 360–365 (2005).",{"doi":4808},"10.1097\u002F01.MIB.0000158536.31557.90",{"id":26,"text":4810,"url":26,"identifiers":4811},"Barclay, A. R.  et al. Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease. J. Pediatr. 155, 421–426 (2009).",{"doi":4812},"10.1016\u002Fj.jpeds.2009.03.017",{"id":26,"text":4814,"url":26,"identifiers":4815},"Bager, P.  et al. Cesarean section and offspring's risk of inflammatory bowel disease: a national cohort study. Inflamm. Bowel Dis. 18, 857–862 (2012).",{"doi":4816},"10.1002\u002Fibd.21805",{"id":26,"text":4818,"url":26,"identifiers":4819},"Sood, A.  et al. Low hygiene and exposure to infections may be associated with increased risk for ulcerative colitis in a North Indian population. Ann. Gastroenterol. 27, 219–223 (2014).",{},{"id":26,"text":4821,"url":26,"identifiers":4822},"Bernstein, C. N.  et al. Population-based case control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease and ulcerative colitis. J. Clin. Microbiol. 42, 1129–1135 (2004).",{"doi":4823},"10.1128\u002FJCM.42.3.1129-1135.2004",{"id":26,"text":4825,"url":26,"identifiers":4826},"Chacon, O., Bermudez, L. E. & Barletta, R. G. Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis. Annu. Rev. Microbiol. 58, 329–363 (2004).",{"doi":4827},"10.1146\u002Fannurev.micro.58.030603.123726",{"id":26,"text":4829,"url":26,"identifiers":4830},"Feller, M.  et al. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect. Dis. 7, 607–613 (2007).",{"doi":4831},"10.1016\u002FS1473-3099(07)70211-6",{"id":26,"text":4833,"url":26,"identifiers":4834},"Selby, W.  et al. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Gastroenterology 132, 2313–2319 (2007).",{"doi":4835},"10.1053\u002Fj.gastro.2007.03.031",{"id":26,"text":4837,"url":26,"identifiers":4838},"Gradel, K. O.  et al. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology 137, 495–501 (2009).",{"doi":4839},"10.1053\u002Fj.gastro.2009.04.001",{"id":26,"text":4841,"url":26,"identifiers":4842},"Porter, C. K.  et al. Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology 135, 781–786 (2008).",{"doi":4843},"10.1053\u002Fj.gastro.2008.05.081",{"id":26,"text":4845,"url":26,"identifiers":4846},"Garcia Rodriguez, L. A., Ruigomez, A. & Panes, J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 130, 1588–1594 (2006).",{"doi":4847},"10.1053\u002Fj.gastro.2006.02.004",{"id":26,"text":4849,"url":26,"identifiers":4850},"Jess, T.  et al. Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease. Gut 60, 318–324 (2011).",{"doi":4851},"10.1136\u002Fgut.2010.223396",{"id":26,"text":4853,"url":26,"identifiers":4854},"Thompson, N. P.  et al. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet 345, 1071–1074 (1995).",{"doi":4855},"10.1016\u002FS0140-6736(95)90816-1",{"id":26,"text":4857,"url":26,"identifiers":4858},"Bernstein, C. N., Rawsthorne, P. & Blanchard, J. F. Population-based case–control study of measles, mumps, and rubella and inflammatory bowel disease. Inflamm. Bowel Dis. 13, 759–762 (2007).",{"doi":4859},"10.1002\u002Fibd.20089",{"id":26,"text":4861,"url":26,"identifiers":4862},"Davis, R. L.  et al. Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case–control study from the Vaccine Safety Datalink project. Arch. Pediatr. Adolesc. Med. 155, 354–359 (2001).",{"doi":4863},"10.1001\u002Farchpedi.155.3.354",{"id":26,"text":4865,"url":26,"identifiers":4866},"Cadwell, K.  et al. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 141, 1135–1145 (2010).",{"doi":4867},"10.1016\u002Fj.cell.2010.05.009",{"id":26,"text":4869,"url":26,"identifiers":4870},"Ananthakrishnan, A. N., Issa, M. & Binion, D. G. Clostridium difficile and inflammatory bowel disease. Gastroenterol. Clin. North Am. 38, 711–728 (2009).",{"doi":4871},"10.1016\u002Fj.gtc.2009.07.003",{"id":26,"text":4873,"url":26,"identifiers":4874},"Singh, S., Graff, L. A. & Bernstein, C. N. Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD? Am. J. Gastroenterol. 104, 1298–1313 (2009).",{"doi":4875},"10.1038\u002Fajg.2009.15",{"id":26,"text":4877,"url":26,"identifiers":4878},"Penders, J.  et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118, 511–521 (2006).",{"doi":4879},"10.1542\u002Fpeds.2005-2824",{"id":26,"text":4881,"url":26,"identifiers":4882},"Shaw, S. Y., Blanchard, J. F. & Bernstein, C. N. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am. J. Gastroenterol. 105, 2687–2692 (2010).",{"doi":4883},"10.1038\u002Fajg.2010.398",{"id":26,"text":4885,"url":26,"identifiers":4886},"Virta, L.  et al. Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease—a nationwide, register-based finnish case–control study. Am. J. Epidemiol. 175, 775–784 (2012).",{"doi":4887},"10.1093\u002Faje\u002Fkwr400",{"id":26,"text":4889,"url":26,"identifiers":4890},"Shaw, S. Y., Blanchard, J. F. & Bernstein, C. N. Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis. Am. J. Gastroenterol. 106, 2133–2142 (2011).",{"doi":4891},"10.1038\u002Fajg.2011.304",{"id":26,"text":4893,"url":26,"identifiers":4894},"Kronman, M. P.  et al. Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics 130, e794–e803 (2012).",{"doi":4895},"10.1542\u002Fpeds.2011-3886",{"id":26,"text":4897,"url":26,"identifiers":4898},"Chan, S. S.  et al. Aspirin in the aetiology of Crohn's disease and ulcerative colitis: a European prospective cohort study. Aliment. Pharmacol. Ther. 34, 649–655 (2011).",{"doi":4899},"10.1111\u002Fj.1365-2036.2011.04784.x",{"id":26,"text":4901,"url":26,"identifiers":4902},"Ananthakrishnan, A. N.  et al. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study. Ann. Intern. Med. 156, 350–359 (2012).",{"doi":4903},"10.7326\u002F0003-4819-156-5-201203060-00007",{"id":26,"text":4905,"url":26,"identifiers":4906},"Cornish, J. A.  et al. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am. J. Gastroenterol. 103, 2394–2400 (2008).",{"doi":4907},"10.1111\u002Fj.1572-0241.2008.02064.x",{"id":26,"text":4909,"url":26,"identifiers":4910},"Khalili, H.  et al. Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. Gut 62, 1153–1159 (2013).",{"doi":4911},"10.1136\u002Fgutjnl-2012-302362",{"id":26,"text":4913,"url":26,"identifiers":4914},"Khalili, H.  et al. Hormone therapy increases risk of ulcerative colitis but not Crohn's disease. Gastroenterology 143, 1199–1206 (2012).",{"doi":4915},"10.1053\u002Fj.gastro.2012.07.096",{"id":26,"text":4917,"url":26,"identifiers":4918},"Chapman-Kiddell, C. A., Davies, P. S., Gillen, L. & Radford-Smith, G. L. Role of diet in the development of inflammatory bowel disease. Inflamm. Bowel Dis. 16, 137–151 (2010).",{"doi":4919},"10.1002\u002Fibd.20968",{"id":26,"text":4921,"url":26,"identifiers":4922},"Hou, J. K., Abraham, B. & El-Serag, H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am. J. Gastroenterol. 106, 563–573 (2011).",{"doi":4923},"10.1038\u002Fajg.2011.44",{"id":26,"text":4925,"url":26,"identifiers":4926},"Amre, D. K.  et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am. J. Gastroenterol. 102, 2016–2025 (2007).",{"doi":4927},"10.1111\u002Fj.1572-0241.2007.01411.x",{"id":26,"text":4929,"url":26,"identifiers":4930},"Ananthakrishnan, A. N.  et al. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology 145, 970–977 (2013).",{"doi":4931},"10.1053\u002Fj.gastro.2013.07.050",{"id":26,"text":4933,"url":26,"identifiers":4934},"Galvez, J., Rodriguez-Cabezas, M. E. & Zarzuelo, A. Effects of dietary fiber on inflammatory bowel disease. Mol. Nutr. Food Res. 49, 601–608 (2005).",{"doi":4935},"10.1002\u002Fmnfr.200500013",{"id":26,"text":4937,"url":26,"identifiers":4938},"Roberts, C. L.  et al. Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers. Gut 59, 1331–1339 (2010).",{"doi":4939},"10.1136\u002Fgut.2009.195370",{"id":26,"text":4941,"url":26,"identifiers":4942},"Ananthakrishnan, A. N.  et al. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut 63, 776–784 (2014).",{"doi":4943},"10.1136\u002Fgutjnl-2013-305304",{"id":26,"text":4945,"url":26,"identifiers":4946},"de Silva, P. S.  et al. An association between dietary arachidonic acid, measured in adipose tissue, and ulcerative colitis. Gastroenterology 139, 1912–1917 (2010).",{"doi":4947},"10.1053\u002Fj.gastro.2010.07.065",{"id":26,"text":4949,"url":26,"identifiers":4950},"D'Souza, S.  et al. Dietary patterns and risk for Crohn's disease in children. Inflamm. Bowel Dis. 14, 367–373 (2008).",{"doi":4951},"10.1002\u002Fibd.20516",{"id":26,"text":4953,"url":26,"identifiers":4954},"Geerling, B. J.  et al. Diet as a risk factor for the development of ulcerative colitis. Am. J. Gastroenterol. 95, 1008–1013 (2000).",{"doi":4955},"10.1111\u002Fj.1572-0241.2000.01942.x",{"id":26,"text":4957,"url":26,"identifiers":4958},"Hart, A. R.  et al. Diet in the aetiology of ulcerative colitis: a European prospective cohort study. Digestion 77, 57–64 (2008).",{"doi":4959},"10.1159\u002F000121412",{"id":26,"text":4961,"url":26,"identifiers":4962},"John, S.  et al. Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study. Eur. J. Gastroenterol. Hepatol. 22, 602–606 (2010).",{"doi":4963},"10.1097\u002FMEG.0b013e3283352d05",{"id":26,"text":4965,"url":26,"identifiers":4966},"Devkota, S.  et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10−\u002F− mice. Nature 487, 104–108 (2012).",{"doi":4967},"10.1038\u002Fnature11225",{"id":26,"text":4969,"url":26,"identifiers":4970},"Cabre, E. & Domenech, E. Impact of environmental and dietary factors on the course of inflammatory bowel disease. World J. Gastroenterol. 18, 3814–3822 (2012).",{"doi":4971},"10.3748\u002Fwjg.v18.i29.3814",{"id":26,"text":4973,"url":26,"identifiers":4974},"Costea, I.  et al. Interactions between the dietary polyunsaturated fatty acid ratio and genetic factors determine susceptibility to pediatric Crohn's disease. Gastroenterology 146, 929–931 (2014).",{"doi":4975},"10.1053\u002Fj.gastro.2013.12.034",{"id":26,"text":4977,"url":26,"identifiers":4978},"Jantchou, P.  et al. Animal protein intake and risk of inflammatory bowel disease: the E3N prospective study. Am. J. Gastroenterol. 105, 2195–201 (2010).",{"doi":4979},"10.1038\u002Fajg.2010.192",{"id":26,"text":4981,"url":26,"identifiers":4982},"Chan, S. S.  et al. Carbohydrate intake in the etiology of Crohn's disease and ulcerative colitis. Inflamm. Bowel Dis. 20, 2013–2021 (2014).",{"doi":4983},"10.1097\u002FMIB.0000000000000168",{"id":26,"text":4985,"url":26,"identifiers":4986},"Zallot, C.  et al. Dietary beliefs and behavior among inflammatory bowel disease patients. Inflamm. Bowel Dis. 19, 66–72 (2013).",{"doi":4987},"10.1002\u002Fibd.22965",{"id":26,"text":4989,"url":26,"identifiers":4990},"Cantorna, M. T. & Mahon, B. D. D-hormone and the immune system. J. Rheumatol. Suppl. 76, 11–20 (2005).",{},{"id":26,"text":4992,"url":26,"identifiers":4993},"Cantorna, M. T. & Mahon, B. D. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp. Biol. Med. (Maywood) 229, 1136–1142 (2004).",{"doi":4994},"10.1177\u002F153537020422901108",{"id":26,"text":4996,"url":26,"identifiers":4997},"Cantorna, M. T.  et al. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am. J. Clin. Nutr. 80, 1717S–1720S (2004).",{"doi":4998},"10.1093\u002Fajcn\u002F80.6.1717S",{"id":26,"text":5000,"url":26,"identifiers":5001},"Cantorna, M. T.  et al. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J. Nutr. 130, 2648–2652 (2000).",{"doi":5002},"10.1093\u002Fjn\u002F130.11.2648",{"id":26,"text":5004,"url":26,"identifiers":5005},"Froicu, M. & Cantorna, M. T. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol. 8, 5 (2007).",{"doi":5006},"10.1186\u002F1471-2172-8-5",{"id":26,"text":5008,"url":26,"identifiers":5009},"Froicu, M.  et al. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol. Endocrinol. 17, 2386–2392 (2003).",{"doi":5010},"10.1210\u002Fme.2003-0281",{"id":26,"text":5012,"url":26,"identifiers":5013},"Froicu, M., Zhu, Y. & Cantorna, M. T. Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice. Immunology 117, 310–318 (2006).",{"doi":5014},"10.1111\u002Fj.1365-2567.2005.02290.x",{"id":26,"text":5016,"url":26,"identifiers":5017},"Mouli, V. P. & Ananthakrishnan, A. N. Review article: vitamin D and inflammatory bowel diseases. Aliment. Pharmacol. Ther. 39, 125–136 (2014).",{"doi":5018},"10.1111\u002Fapt.12553",{"id":26,"text":5020,"url":26,"identifiers":5021},"Ananthakrishnan, A. N.  et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 142, 482–489 (2012).",{"doi":5022},"10.1053\u002Fj.gastro.2011.11.040",{"id":26,"text":5024,"url":26,"identifiers":5025},"Ananthakrishnan, A. N.  et al. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease. Inflamm. Bowel Dis. 19, 1921–1927 (2013).",{},{"id":26,"text":5027,"url":26,"identifiers":5028},"Cerasi, M., Ammendola S. & Battistoni, A. Competition for zinc binding in the host-pathogen interaction. Front. Cell. Infect. Microbiol. 3, 108 (2013).",{"doi":5029},"10.3389\u002Ffcimb.2013.00108",{"id":26,"text":5031,"url":26,"identifiers":5032},"Haase, H. & Rink, L. Zinc signals and immune function. Biofactors 40, 27–40 (2014).",{"doi":5033},"10.1002\u002Fbiof.1114",{"id":26,"text":5035,"url":26,"identifiers":5036},"Lahiri, A. & Abraham, C. Activation of pattern recognition receptors up-regulates metallothioneins, thereby increasing intracellular accumulation of zinc, autophagy, and bacterial clearance by macrophages. Gastroenterology 147, 835–846 (2014).",{"doi":5037},"10.1053\u002Fj.gastro.2014.06.024",{"id":26,"text":5039,"url":26,"identifiers":5040},"El-Tawil, A. M. Zinc supplementation tightens leaky gut in Crohn's disease. Inflamm. Bowel Dis. 18, E399 (2012).",{"doi":5041},"10.1002\u002Fibd.21926",{"id":26,"text":5043,"url":26,"identifiers":5044},"Chua, A. C.  et al. Dietary iron enhances colonic inflammation and IL-6\u002FIL-11–Stat3 signaling promoting colonic tumor development in mice. PLoS ONE 8, e78850 (2013).",{"doi":5045},"10.1371\u002Fjournal.pone.0078850",{"id":26,"text":5047,"url":26,"identifiers":5048},"Carrier, J.  et al. Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment. Pharmacol. Ther. 15, 1989–1999 (2001).",{"doi":5049},"10.1046\u002Fj.1365-2036.2001.01113.x",{"id":26,"text":5051,"url":26,"identifiers":5052},"Aamodt, G.  et al. The association between water supply and inflammatory bowel disease based on a 1990–1993 cohort study in southeastern Norway. Am. J. Epidemiol. 168, 1065–1072 (2008).",{"doi":5053},"10.1093\u002Faje\u002Fkwn218",{"id":26,"text":5055,"url":26,"identifiers":5056},"Bernstein, C. N.  et al. A prospective population-based study of triggers of symptomatic flares in IBD. Am. J. Gastroenterol. 105, 1994–2002 (2010).",{"doi":5057},"10.1038\u002Fajg.2010.140",{"id":26,"text":5059,"url":26,"identifiers":5060},"Bonaz, B. L. & Bernstein, C. N. Brain–gut interactions in inflammatory bowel disease. Gastroenterology 144, 36–49 (2013).",{"doi":5061},"10.1053\u002Fj.gastro.2012.10.003",{"id":26,"text":5063,"url":26,"identifiers":5064},"Bailey, M. T.  et al. Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav. Immun. 25, 397–407 (2011).",{"doi":5065},"10.1016\u002Fj.bbi.2010.10.023",{"id":26,"text":5067,"url":26,"identifiers":5068},"Ghia, J. E.  et al. Reactivation of inflammatory bowel disease in a mouse model of depression. Gastroenterology 136, 2280–2288.e1–e4 (2009).",{"doi":5069},"10.1053\u002Fj.gastro.2009.02.069",{"id":26,"text":5071,"url":26,"identifiers":5072},"Ananthakrishnan, A. N.  et al. Association between depressive symptoms and incidence of Crohn's disease and ulcerative colitis: results from the Nurses' Health Study. Clin. Gastroenterol. Hepatol. 11, 57–62 (2013).",{"doi":5073},"10.1016\u002Fj.cgh.2012.08.032",{"id":26,"text":5075,"url":26,"identifiers":5076},"Bitton, A.  et al. Predicting relapse in Crohn's disease: a biopsychosocial model. Gut 57, 1386–1392 (2008).",{"doi":5077},"10.1136\u002Fgut.2007.134817",{"id":26,"text":5079,"url":26,"identifiers":5080},"Goodhand, J. & Rampton, D. Psychological stress and coping in IBD. Gut 57, 1345–1347 (2008).",{"doi":5081},"10.1136\u002Fgut.2008.154229",{"id":26,"text":5083,"url":26,"identifiers":5084},"Goodhand, J. R.  et al. Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors. Inflamm. Bowel Dis. 18, 2301–2309 (2012).",{"doi":5085},"10.1002\u002Fibd.22916",{"id":26,"text":5087,"url":26,"identifiers":5088},"Goodhand, J. R., Wahed, M. & Rampton, D. S. Management of stress in inflammatory bowel disease: a therapeutic option? Expert Rev. Gastroenterol. Hepatol. 3, 661–679 (2009).",{"doi":5089},"10.1586\u002Fegh.09.55",{"id":26,"text":5091,"url":26,"identifiers":5092},"Lerebours, E.  et al. Stressful life events as a risk factor for inflammatory bowel disease onset: a population-based case-control study. Am. J. Gastroenterol. 102, 122–131 (2007).",{"doi":5093},"10.1111\u002Fj.1572-0241.2006.00931.x",{"id":26,"text":5095,"url":26,"identifiers":5096},"Levenstein, S.  et al. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am. J. Gastroenterol. 95, 1213–1220 (2000).",{"doi":5097},"10.1111\u002Fj.1572-0241.2000.02012.x",{"id":26,"text":5099,"url":26,"identifiers":5100},"Li, J.  et al. Psychological stress and inflammatory bowel disease: a follow-up study in parents who lost a child in Denmark. Am. J. Gastroenterol. 99, 1129–1133 (2004).",{"doi":5101},"10.1111\u002Fj.1572-0241.2004.04155.x",{"id":26,"text":5103,"url":26,"identifiers":5104},"Maunder, R. G. Evidence that stress contributes to inflammatory bowel disease: evaluation, synthesis, and future directions. Inflamm. Bowel Dis. 11, 600–608 (2005).",{"doi":5105},"10.1097\u002F01.MIB.0000161919.42878.a0",{"id":26,"text":5107,"url":26,"identifiers":5108},"Mawdsley, J. E. & Rampton, D. S. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut 54, 1481–1491 (2005).",{"doi":5109},"10.1136\u002Fgut.2005.064261",{"id":26,"text":5111,"url":26,"identifiers":5112},"Rampton, D. Does stress influence inflammatory bowel disease? The clinical data. Dig. Dis. 27 (Suppl. 1), 76–79 (2009).",{"doi":5113},"10.1159\u002F000268124",{"id":26,"text":5115,"url":26,"identifiers":5116},"Sonnenberg, A. Occupational distribution of inflammatory bowel disease among German employees. Gut 31, 1037–1040 (1990).",{"doi":5117},"10.1136\u002Fgut.31.9.1037",{"id":26,"text":5119,"url":26,"identifiers":5120},"Cook, M. D.  et al. Forced treadmill exercise training exacerbates inflammation and causes mortality while voluntary wheel training is protective in a mouse model of colitis. Brain Behav. Immun. 33, 46–56 (2013).",{"doi":5121},"10.1016\u002Fj.bbi.2013.05.005",{"id":26,"text":5123,"url":26,"identifiers":5124},"Khalili, H.  et al. Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts. BMJ 347, f6633 (2013).",{"doi":5125},"10.1136\u002Fbmj.f6633",{"id":26,"text":5127,"url":26,"identifiers":5128},"Ananthakrishnan, A. N.  et al. Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis. Clin. Gastroenterol. Hepatol. 11, 965–971 (2013).",{"doi":5129},"10.1016\u002Fj.cgh.2013.01.021",{"id":26,"text":5131,"url":26,"identifiers":5132},"Kinnucan, J. A., Rubin, D. T. & Ali, T. Sleep and inflammatory bowel disease: exploring the relationship between sleep disturbances and inflammation. Gastroenterol. Hepatol. (N. Y.) 9, 718–727 (2013).",{},{"id":26,"text":5134,"url":26,"identifiers":5135},"Swanson, G. R., Burgess, H. J. & Keshavarzian, A. Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare? Expert Rev. Clin. Immunol. 7, 29–36 (2011).",{"doi":5136},"10.1586\u002Feci.10.83",{"id":26,"text":5138,"url":26,"identifiers":5139},"Ananthakrishnan, A. N.  et al. Sleep duration affects risk for ulcerative colitis: a prospective cohort study. Clin. Gastroenterol. Hepatol. 12, 1879–1886 (2014).",{"doi":5140},"10.1016\u002Fj.cgh.2014.04.021",{"id":26,"text":5142,"url":26,"identifiers":5143},"Ali, T.  et al. Assessment of the relationship between quality of sleep and disease activity in inflammatory bowel disease patients. Inflamm. Bowel Dis. 19, 2440–2443 (2013).",{"doi":5144},"10.1097\u002FMIB.0b013e3182a0ea54",{"id":26,"text":5146,"url":26,"identifiers":5147},"Cosnes, J.  et al. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology 120, 1093–1099 (2001).",{"doi":5148},"10.1053\u002Fgast.2001.23231",{"id":26,"text":5150,"url":26,"identifiers":5151},"Lunney, P. C. & Leong, R. W. Review article: Ulcerative colitis, smoking and nicotine therapy. Aliment. Pharmacol. Ther. 36, 997–1008 (2012).",{"doi":5152},"10.1111\u002Fapt.12086",{"id":26,"text":5154,"url":26,"identifiers":5155},"Calabrese, E.  et al. Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis. J. Crohns Colitis 6, 756–762 (2012).",{"doi":5156},"10.1016\u002Fj.crohns.2011.12.010",{"id":26,"text":5158,"url":26,"identifiers":5159},"Noh, C. H.  et al. Remission of ulcerative colitis after appendectomy: a case report [Korean]. Korean J. Gastroenterol. 56, 201–204 (2010).",{"doi":5160},"10.4166\u002Fkjg.2010.56.3.201",{"id":26,"text":5162,"url":26,"identifiers":5163},"Okazaki, K.  et al. A patient with improvement of ulcerative colitis after appendectomy. Gastroenterology 119, 502–506 (2000).",{"doi":5164},"10.1053\u002Fgast.2000.9368",{"id":26,"text":5166,"url":26,"identifiers":5167},"Tighe, M. P., Cummings, J. R. & Afzal, N. A. Nutrition and inflammatory bowel disease: primary or adjuvant therapy. Curr. Opin. Clin. Nutr. Metab. Care 14, 491–496 (2011).",{"doi":5168},"10.1097\u002FMCO.0b013e328349eb4d",{"id":26,"text":5170,"url":26,"identifiers":5171},"D'Argenio, V.  et al. An altered gut microbiome profile in a child affected by Crohn's disease normalized after nutritional therapy. Am. J. Gastroenterol. 108, 851–852 (2013).",{"doi":5172},"10.1038\u002Fajg.2013.46",{"id":26,"text":5174,"url":26,"identifiers":5175},"Cohen, S. A.  et al. Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease. J. Pediatr. Gastroenterol. Nutr. 59, 516–521 (2014).",{"doi":5176},"10.1097\u002FMPG.0000000000000449",{"id":26,"text":5178,"url":26,"identifiers":5179},"Herfarth, H. H.  et al. Prevalence of a gluten-free diet and improvement of clinical symptoms in patients with inflammatory bowel diseases. Inflamm. Bowel Dis. 20, 1194–1197 (2014).",{"doi":5180},"10.1097\u002FMIB.0000000000000077",{"id":26,"text":5182,"url":26,"identifiers":5183},"Jorgensen, S. P.  et al. Clinical trial: vitamin D3 treatment in Crohn's disease—-a randomized double-blind placebo-controlled study. Aliment. Pharmacol. Ther. 32, 377–383 (2010).",{"doi":5184},"10.1111\u002Fj.1365-2036.2010.04355.x",{"id":26,"text":5186,"url":26,"identifiers":5187},"Lev-Tzion, R.  et al. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD006320 \n                    http:\u002F\u002Fdx.doi.org\u002F10.1002\u002F14651858.CD006320.pub4\n                    \n                  .",{"doi":5188},"10.1002\u002F14651858.CD006320.pub4",{"id":26,"text":5190,"url":26,"identifiers":5191},"Uchiyama, K.  et al. N-3 polyunsaturated fatty acid diet therapy for patients with inflammatory bowel disease. Inflamm. Bowel Dis. 16, 1696–1707 (2010).",{"doi":5192},"10.1002\u002Fibd.21251",{"id":26,"text":5194,"url":26,"identifiers":5195},"Wahed, M.  et al. Does psychological counseling alter the natural history of inflammatory bowel disease? Inflamm. Bowel Dis. 16, 664–669 (2010).",{"doi":5196},"10.1002\u002Fibd.21098",{"id":26,"text":5198,"url":26,"identifiers":5199},"Timmer, A.  et al. Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD006913 \n                    http:\u002F\u002Fdx.doi.org\u002F10.1002\u002F14651858.CD006913.pub2\n                    \n                  .",{"doi":5200},"10.1002\u002F14651858.CD006913.pub2",{"id":26,"text":5202,"url":26,"identifiers":5203},"Goodhand, J. R.  et al. Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study. Inflamm. Bowel Dis. 18, 1232–1239 (2011).",{"doi":5204},"10.1002\u002Fibd.21846",{"id":26,"text":5206,"url":26,"identifiers":5207},"Wild, C. P. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol. Biomarkers Prev. 14, 1847–1850 (2005).",{"doi":5208},"10.1158\u002F1055-9965.EPI-05-0456",{"id":26,"text":5210,"url":26,"identifiers":5211},"Kanaly, R. A.  et al. Development of the adductome approach to detect DNA damage in humans. Antioxid. Redox Signal. 8, 993–1001 (2006).",{"doi":5212},"10.1089\u002Fars.2006.8.993",{"id":26,"text":5214,"url":26,"identifiers":5215},"Bogdanos, D. P.  et al. Infectome: a platform to trace infectious triggers of autoimmunity. Autoimmun. Rev. 12, 726–740 (2013).",{"doi":5216},"10.1016\u002Fj.autrev.2012.12.005",{"id":26,"text":5218,"url":26,"identifiers":5219},"Crohn's and Colitis Canada Inflammatory Bowel Disease GEM Project. The GEM project \n                    [online]\n                    \n                  , (2015).",{},{"id":26,"text":5221,"url":26,"identifiers":5222},"Connecticut Children's Medical Center. PROTECT \n                    [online]\n                    \n                  , (2015).",{},{"id":26,"text":5224,"url":26,"identifiers":5225},"PROKIIDS data centre. PRO-KIIDS Data Centre \n                    [online]\n                    \n                  , (2015).",{},{"id":26,"text":5227,"url":26,"identifiers":5228},"Lomer, M. C.  et al. Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. Eur. J. Gastroenterol. Hepatol. 13, 101–106 (2001).",{"doi":5229},"10.1097\u002F00042737-200102000-00003",{"id":26,"text":5231,"url":26,"identifiers":5232},"Lomer, M. C.  et al. Lack of efficacy of a reduced microparticle diet in a multi-centred trial of patients with active Crohn's disease. Eur. J. Gastroenterol. Hepatol. 17, 377–384 (2005).",{"doi":5233},"10.1097\u002F00042737-200503000-00019",{"id":26,"text":5235,"url":26,"identifiers":5236},"Turner, D., Steinhart, A. H. & Griffiths, A. M. Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews, Issue 3. Art. No.: CD006443 \n                    http:\u002F\u002Fdx.doi.org\u002F10.1002\u002F14651858.CD006443.pub2\n                    \n                  .",{"doi":5237},"10.1002\u002F14651858.CD006443.pub2",{"id":26,"text":5239,"url":26,"identifiers":5240},"Wright, R. & Truelove, S. C. A controlled therapeutic trial of various diets in ulcerative colitis. Br. Med. J. 2, 138–141 (1965).",{"doi":5241},"10.1136\u002Fbmj.2.5454.138",{"id":26,"text":5243,"url":26,"identifiers":5244},"Ritchie, J. K.  et al. Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. Br. Med. J. (Clin. Res. Ed.) 295, 517–520 (1987).",{"doi":5245},"10.1136\u002Fbmj.295.6597.517",{"id":26,"text":5247,"url":26,"identifiers":5248},"Bartel, G.  et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflamm. Bowel Dis. 14, 374–382 (2008).",{"doi":5249},"10.1002\u002Fibd.20295",{"id":26,"text":5251,"url":26,"identifiers":5252},"Chiba, M.  et al. Lifestyle-related disease in Crohn's disease: relapse prevention by a semi-vegetarian diet. World J. Gastroenterol. 16, 2484–2495 (2010).",{"doi":5253},"10.3748\u002Fwjg.v16.i20.2484",{"id":26,"text":5255,"url":26,"identifiers":5256},"Zachos, M., Tondeur, M. & Griffiths, A. M. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD000542 \n                    http:\u002F\u002Fdx.doi.org\u002F10.1002\u002F14651858.CD000542.pub2\n                    \n                  .",{"doi":5257},"10.1002\u002F14651858.CD000542.pub2",{"id":26,"text":5259,"url":26,"identifiers":5260},"Boye, B.  et al. INSPIRE study: does stress management improve the course of inflammatory bowel disease and disease-specific quality of life in distressed patients with ulcerative colitis or Crohn's disease? A randomized controlled trial. Inflamm. Bowel Dis. 17, 1863–1873 (2011).",{"doi":5261},"10.1002\u002Fibd.21575",{"id":5263,"createTime":5264,"updateTime":5264,"relativeEntities":5265,"slug":5266,"properties":5267,"entityType":821,"verifyStatus":25,"verifyTime":5280,"verifyNote":822,"syncStatus":28,"languages":5281,"translateLanguages":26,"viewCount":36,"primaryUrl":5282,"fullTextUrl":26,"authors":5283,"publicationType":1081,"publisherRelationship":5305,"citationCount":5343,"citationInfo":5344,"publishDate":5352,"publishYear":5353,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":5354,"isForceReanalyzing":1446},"ae9297f4-da2e-4fc3-b45f-e723a6601a6d","2025-01-31T06:52:48.093+00:00",[],"The-enteric-nervous-system-and-neurogastroenterology",{"mag":5268,"keywords":5270,"openalex":5271,"abstract":5273,"title":5274,"pm":5276,"doi":5278},{"VOID":5269},"1981367331",{},{"VOID":5272},"W1981367331",{},{"EN":5275},"The enteric nervous system and neurogastroenterology",{"VOID":5277},"22392290",{"VOID":5279},"10.1038\u002Fnrgastro.2012.32","2025-01-31T06:52:48.092+00:00",[102],"https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fnrgastro.2012.32",[5284],{"id":5285,"sortIndex":36,"researcher":26,"roles":5286,"affiliations":5287,"properties":5298},"337bc53f-eac3-4c8f-96ac-6ca6bdfb8120",[],[5288],{"id":5289,"sortIndex":36,"affiliation":5290,"properties":26},"cd8c1697-aa92-4154-9499-6ea4b63be5d2",{"id":5291,"createTime":5292,"updateTime":5292,"relativeEntities":5293,"slug":5294,"properties":5295,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"f7fb34c1-8338-4dc6-912b-bc9191224487","2025-01-31T06:52:48.110+00:00",[],"Department-of-Anatomy-Neuroscience-University-of-Melbourne-Grattan-Street-Parkville-Vic-3010-Australia-",{"title":5296},{"EN":5297},"Department of Anatomy & Neuroscience, University of Melbourne, Grattan Street, Parkville, Vic 3010, Australia.",{"openalex":5299,"orcid":5301,"title":5303},{"VOID":5300},"A5060226120",{"VOID":5302},"https:\u002F\u002Forcid.org\u002F0000-0002-0219-3438",{"EN":5304},"John B. Furness",{"url":26,"publisher":5306,"properties":5336},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":5307,"slug":663,"properties":5308,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":5314,"manageAffiliations":5315,"indexDatabases":5316,"url":753,"thumbnailPath":26,"statistic":5331,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"country":5309,"issn":5310,"introduce":5311,"eissn":5312,"title":5313},{"VOID":666},{"VOID":668},{"EN":670},{"VOID":672},{"EN":674},[],[],[5317,5324],{"id":735,"indexDatabase":5318,"url":750,"indexYears":26,"academicFieldIds":5323,"indexDatabaseRanking":26},{"id":737,"createTime":738,"updateTime":739,"relativeEntities":5319,"label":5320,"description":5321,"key":746,"publicationTags":5322,"standard":26},[],{"EN":742,"VI":742},{"VI":744,"EN":745},[748,749],[752],{"id":715,"indexDatabase":5325,"url":728,"indexYears":729,"academicFieldIds":5330,"indexDatabaseRanking":733},{"id":717,"createTime":718,"updateTime":719,"relativeEntities":5326,"label":5327,"description":5328,"key":725,"publicationTags":5329,"standard":26},[],{"EN":722,"VI":722},{"EN":722,"VI":724},[727],[731,732],{"impactFactor":36,"impactFactorByYear":5332,"i10Index":259,"i10IndexLast5Year":356,"totalPublication":259,"totalPublicationByYear":5333,"totalCitation":769,"totalCitationByYear":5334,"totalCitationPerPublication":783,"totalCitationPerPublicationByYear":5335,"hindexLast5Year":283,"hindex":283},{"2012":756,"2013":757,"2014":758,"2015":759,"2016":760,"2017":761,"2018":762,"2019":763,"2020":764,"2021":765,"2022":766,"2023":767},{"2009":59,"2010":59,"2011":162,"2012":114,"2013":111,"2014":59,"2015":162,"2016":111,"2017":158,"2018":111,"2019":111,"2020":114,"2021":162,"2022":114},{"2009":144,"2010":771,"2011":772,"2012":146,"2013":773,"2014":774,"2015":775,"2016":776,"2017":777,"2018":778,"2019":779,"2020":780,"2021":781,"2022":782},{"2009":785,"2010":786,"2011":787,"2012":788,"2013":789,"2014":790,"2015":791,"2016":792,"2017":793,"2018":794,"2019":795,"2020":796,"2021":797,"2022":798},{"volume":5337,"pages":5339,"issue":5341},{"VOID":5338},"9",{"VOID":5340},"286-294",{"VOID":5342},"5",1327,{"total":5343,"publishYear":26,"statisticByYear":5345},{"2012":51,"2013":358,"2014":283,"2015":117,"2016":5346,"2017":536,"2018":117,"2019":5347,"2020":5348,"2021":5349,"2022":518,"2023":5350,"2024":5351},90,99,143,159,160,125,"2012-05-01",2012,[5355,5359,5362,5365,5369,5373,5377,5381,5385,5389,5393,5397,5401,5405,5408,5412,5416,5420,5424,5428,5431,5435,5439,5442,5446,5450,5453,5457,5461,5465,5469,5472,5476,5480,5483,5487,5491,5495,5499,5503,5507,5511,5515,5519,5523,5527,5531,5535,5539,5542,5546,5549,5552,5555,5559,5563,5567,5571,5575,5579,5583,5587,5591,5595,5599,5603,5607,5611,5615,5619,5623,5627,5631,5635,5639,5643,5647,5651,5655,5659,5663,5666,5670,5674,5678,5682,5686,5690,5694,5697,5701,5705,5709,5713,5717,5721,5725,5728,5732,5736,5740,5744,5748,5752,5756,5760,5764,5768,5772],{"id":26,"text":5356,"url":26,"identifiers":5357},"Bayliss, W. M. & Starling, E. H. The movements and innervation of the small intestine. J. Physiol. 24, 99–143 (1899).",{"doi":5358},"10.1113\u002Fjphysiol.1899.sp000752",{"id":26,"text":5360,"url":26,"identifiers":5361},"Furness, J. B. The Enteric Nervous System (Blackwell, Oxford, 2006).",{},{"id":26,"text":5363,"url":26,"identifiers":5364},"Brehmer, A. Structure of enteric neurons. Adv. Anat. 186, 1–94 (2006).",{},{"id":26,"text":5366,"url":26,"identifiers":5367},"Brehmer, A., Rupprecht, H. & Neuhuber, W. Two submucosal nerve plexus in human intestines. Histochem. Cell Biol. 133, 149–161 (2010).",{"doi":5368},"10.1007\u002Fs00418-009-0657-2",{"id":26,"text":5370,"url":26,"identifiers":5371},"Toumi, F.  et al. Human submucosal neurones regulate intestinal epithelial cell proliferation: evidence from a novel co-culture model. Neurogastroenterol. Motil. 15, 239–242 (2003).",{"doi":5372},"10.1046\u002Fj.1365-2982.2003.00409.x",{"id":26,"text":5374,"url":26,"identifiers":5375},"Savidge, T. C.  et al. Enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione. Gastroenterology 132, 1344–1358 (2007).",{"doi":5376},"10.1053\u002Fj.gastro.2007.01.051",{"id":26,"text":5378,"url":26,"identifiers":5379},"Swenson, O. Hirschsprung's disease: a review. Pediatrics 109, 914–918 (2002).",{"doi":5380},"10.1542\u002Fpeds.109.5.914",{"id":26,"text":5382,"url":26,"identifiers":5383},"Matsuda, N. M., Miller, S. M. & Evora, P. R. B. The chronic gastrointestinal manifestations of Chagas disease. Clinics 64, 1219–1224 (2009).",{"doi":5384},"10.1590\u002FS1807-59322009001200013",{"id":26,"text":5386,"url":26,"identifiers":5387},"De Giorgio, R.  et al. Inflammatory neuropathies of the enteric nervous system. Gastroenterology 126, 1872–1883 (2004).",{"doi":5388},"10.1053\u002Fj.gastro.2004.02.024",{"id":26,"text":5390,"url":26,"identifiers":5391},"Knowles, C. H.  et al. The London classification of gastrointestinal neuromuscular pathology: Report on behalf of the Gastro 2009 International Working Group. Gut 59, 882–887 (2010).",{"doi":5392},"10.1136\u002Fgut.2009.200444",{"id":26,"text":5394,"url":26,"identifiers":5395},"Di Nardo, G.  et al. Review article: molecular, pathological and therapeutic features of human enteric neuropathies. Aliment. Pharmacol. Ther. 28, 25–45 (2008).",{"doi":5396},"10.1111\u002Fj.1365-2036.2008.03707.x",{"id":26,"text":5398,"url":26,"identifiers":5399},"Lundgren, O. Enteric nerves and diarrhoea. Pharmacol. Toxicol. 90, 109–120 (2002).",{"doi":5400},"10.1034\u002Fj.1600-0773.2002.900301.x",{"id":26,"text":5402,"url":26,"identifiers":5403},"Podewils, L. J., Mintz, E. D., Nataro, J. P. & Parashar, U. D. Acute, infectious diarrhea among children in developing countries. Semin. Pediatr. Infect. Dis. 15, 155–168 (2004).",{"doi":5404},"10.1053\u002Fj.spid.2004.05.008",{"id":26,"text":5406,"url":26,"identifiers":5407},"Hasler, W. L. in Gastroenterology (ed. Yamada, T.) 195–219 (Lippincott Williams & Wilkins, Philadelphia, 2003).",{},{"id":26,"text":5409,"url":26,"identifiers":5410},"Schubert, M. L. & Peura, D. A. Control of gastric acid secretion in health and disease. Gastroenterology 134, 1842–1860 (2008).",{"doi":5411},"10.1053\u002Fj.gastro.2008.05.021",{"id":26,"text":5413,"url":26,"identifiers":5414},"de Groat, W. C.  et al. Organization of the sacral parasympathetic reflex pathways to the urinary bladder and large intestine. J. Auton. Nerv. Syst. 3, 135–160 (1981).",{"doi":5415},"10.1016\u002F0165-1838(81)90059-X",{"id":26,"text":5417,"url":26,"identifiers":5418},"Jean, A. Brain stem control of swallowing: neuronal network and cellular mechanisms. Physiol. Rev. 81, 929–969 (2001).",{"doi":5419},"10.1152\u002Fphysrev.2001.81.2.929",{"id":26,"text":5421,"url":26,"identifiers":5422},"Bieger, D. & Hopkins, D. A. Viscerotopic representation of the upper alimentary tract in the medulla oblongata in the rat: the nucleus ambiguus. J. Comp. Neurol. 262, 546–562 (1987).",{"doi":5423},"10.1002\u002Fcne.902620408",{"id":26,"text":5425,"url":26,"identifiers":5426},"Cannon, W. B. Oesophageal peristalsis after bilateral vagotomy. Am. J. Physiol. 19, 436–444 (1907).",{"doi":5427},"10.1152\u002Fajplegacy.1907.19.3.436",{"id":26,"text":5429,"url":26,"identifiers":5430},"Wörl, J., Mayer, B. & Neuhuber, W. L. Spatial relationships of enteric nerve fibers to vagal motor terminals and the sarcolemma in motor endplates of the rat esophagus: a confocal laser scanning and electron-microscopic study. Cell Tissue Res. 287, 113–118 (1997).",{},{"id":26,"text":5432,"url":26,"identifiers":5433},"Izumi, N., Matsuyama, H., Ko, M., Shimizu, Y. & Takewaki, T. Role of intrinsic nitrergic neurones on vagally mediated striated muscle contractions in the hamster oesophagus. J. Physiol. 551, 287–294 (2003).",{"doi":5434},"10.1113\u002Fjphysiol.2003.044669",{"id":26,"text":5436,"url":26,"identifiers":5437},"Spechler, S. J., Fitzgerald, R. C., Prasad, G. A. & Wang, K. G. History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterology 138, 854–869 (2010).",{"doi":5438},"10.1053\u002Fj.gastro.2010.01.002",{"id":26,"text":5440,"url":26,"identifiers":5441},"Reynolds, R. P. E., El-Sharkawy, T. Y. & Diamant, N. E. Lower esophageal sphincter function in the cat: role of central innervation assessed by transient vagal blockade. Am. J. Physiol. 246, G666–G674 (1984).",{},{"id":26,"text":5443,"url":26,"identifiers":5444},"Rivera, L. R., Poole, D. P., Thacker, M. & Furness, J. B. The involvement of nitric oxide synthase neurons in enteric neuropathies. Neurogastroenterol. Motil. 23, 980–988 (2011).",{"doi":5445},"10.1111\u002Fj.1365-2982.2011.01780.x",{"id":26,"text":5447,"url":26,"identifiers":5448},"Diamant, N. E. & Akin, A. Effect of gastric contraction of the lower esophageal sphincter. Gastroenterology 63, 38–44 (1972).",{"doi":5449},"10.1016\u002FS0016-5085(19)33346-3",{"id":26,"text":5451,"url":26,"identifiers":5452},"Franzi, S. J., Martin, C. J., Cox, M. R. & Dent, J. Response of canine lower esophageal sphincter to gastric distension. Am. J. Physiol. 259, G380–G385 (1990).",{},{"id":26,"text":5454,"url":26,"identifiers":5455},"Dent, J. From 1906 to 2006—a century of major evolution of understanding of gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 24, 1269–1281 (2006).",{"doi":5456},"10.1111\u002Fj.1365-2036.2006.03122.x",{"id":26,"text":5458,"url":26,"identifiers":5459},"Sanders, K. M., Koh, S. D. & Ward, S. M. Interstitial cells of Cajal as pacemakers in the gastrointestinal tract. Annu. Rev. Physiol. 68, 307–343 (2006).",{"doi":5460},"10.1146\u002Fannurev.physiol.68.040504.094718",{"id":26,"text":5462,"url":26,"identifiers":5463},"Cannon, W. B. Peristalsis, segmentation and the myenteric reflex. Am. J. Physiol. 30, 114–128 (1912).",{"doi":5464},"10.1152\u002Fajplegacy.1912.30.1.114",{"id":26,"text":5466,"url":26,"identifiers":5467},"Kelly, K. A., Code, C. F. & Elveback, L. R. Patterns of canine gastric electrical activity. Am. J. Physiol. 217, 461–470 (1969).",{"doi":5468},"10.1152\u002Fajplegacy.1969.217.2.461",{"id":26,"text":5470,"url":26,"identifiers":5471},"Hasler, W. L. in Gastroenterology (ed. Yamada, T.) 220–247 (Lippincott Williams & Wilkins, Philadelphia, USA, 2003).",{},{"id":26,"text":5473,"url":26,"identifiers":5474},"Furness, J. B., Jones, C., Nurgali, K. & Clerc, N. Intrinsic primary afferent neurons and nerve circuits within the intestine. Prog. Neurobiol. 72, 143–164 (2004).",{"doi":5475},"10.1016\u002Fj.pneurobio.2003.12.004",{"id":26,"text":5477,"url":26,"identifiers":5478},"Kirchgessner, A. L., Tamir, H. & Gershon, M. D. Identification and stimulation by serotonin of intrinsic sensory neurons of the submucosal plexus of the guinea pig gut: activity-induced expression of Fos immunoreactivity. J. Neurosci. 12, 235–248 (1992).",{"doi":5479},"10.1523\u002FJNEUROSCI.12-01-00235.1992",{"id":26,"text":5481,"url":26,"identifiers":5482},"Bertrand, P. P., Kunze, W. A. A., Bornstein, J. C., Furness, J. B. & Smith, M. L. Analysis of the responses of myenteric neurons in the small intestine to chemical stimulation of the mucosa. Am. J. Physiol. 273, G422–G435 (1997).",{},{"id":26,"text":5484,"url":26,"identifiers":5485},"Kunze, W. A. A., Furness, J. B., Bertrand, P. P. & Bornstein, J. C. Intracellular recording from myenteric neurons of the guinea-pig ileum that respond to stretch. J. Physiol. 506, 827–842 (1998).",{"doi":5486},"10.1111\u002Fj.1469-7793.1998.827bv.x",{"id":26,"text":5488,"url":26,"identifiers":5489},"Furness, J. B., Kunze, W. A. A., Bertrand, P. P., Clerc, N. & Bornstein, J. C. Intrinsic primary afferent neurons of the intestine. Prog. Neurobiol. 54, 1–18 (1998).",{"doi":5490},"10.1016\u002FS0301-0082(97)00051-8",{"id":26,"text":5492,"url":26,"identifiers":5493},"Spencer, N. J. & Smith, T. K. Mechanosensory S-neurons rather than AH-neurons appear to generate a rhythmic motor pattern in guinea-pig distal colon. J. Physiol. 558, 577–596 (2004).",{"doi":5494},"10.1113\u002Fjphysiol.2004.063586",{"id":26,"text":5496,"url":26,"identifiers":5497},"Spencer, N. J., Dickson, E. J., Hennig, G. W. & Smith, T. K. Sensory elements within the circular muscle are essential for mechanotransduction of ongoing peristaltic reflex activity in guinea-pig distal colon. J. Physiol. 576, 519–531 (2006).",{"doi":5498},"10.1113\u002Fjphysiol.2006.109561",{"id":26,"text":5500,"url":26,"identifiers":5501},"Mazzuoli, G. & Schemann, M. Multifunctional rapidly adapting mechanosensitive enteric neurons (RAMEN) in the myenteric plexus of the guinea pig ileum. J. Physiol. 587, 4681–4693 (2009).",{"doi":5502},"10.1113\u002Fjphysiol.2009.177105",{"id":26,"text":5504,"url":26,"identifiers":5505},"Hendriks, R., Bornstein, J. C. & Furness, J. B. An electrophysiological study of the projections of putative sensory neurons within the myenteric plexus of the guinea-pig ileum. Neurosci. Lett. 110, 286–290 (1990).",{"doi":5506},"10.1016\u002F0304-3940(90)90861-3",{"id":26,"text":5508,"url":26,"identifiers":5509},"Lawson S. N. in Peripheral Neuropathy (eds Dyck, P. J. & Thomas, P. K.) 163–202 (Elsevier, Philadelphia, PA, 2005).",{"doi":5510},"10.1016\u002FB978-0-7216-9491-7.50011-9",{"id":26,"text":5512,"url":26,"identifiers":5513},"Kunze, W. A. A. & Furness, J. B. The enteric nervous system and regulation of intestinal motility. Annu. Rev. Physiol. 61, 117–142 (1999).",{"doi":5514},"10.1146\u002Fannurev.physiol.61.1.117",{"id":26,"text":5516,"url":26,"identifiers":5517},"Weidmann, S., Schrödl, F., Neuhuber, W. & Brehmer, A. Quantitative estimation of putative primary afferent neurons in the myenteric plexus of human small intestine. Histochem. Cell Biol. 128, 399–407 (2007).",{"doi":5518},"10.1007\u002Fs00418-007-0335-1",{"id":26,"text":5520,"url":26,"identifiers":5521},"Chiocchetti, R.  et al. Characterisation of neurons expressing calbindin immunoreactivity in the ileum of the unweaned and mature sheep. Cell Tissue Res. 318, 289–303 (2004).",{"doi":5522},"10.1007\u002Fs00441-004-0906-6",{"id":26,"text":5524,"url":26,"identifiers":5525},"Gwynne, R. M., Thomas, E. A., Goh, S. M., Sjövall, H. & Bornstein, J. C. Segmentation induced by intraluminal fatty acid in isolated guinea-pig duodenum and jejunum. J. Physiol. 556, 557–569 (2004).",{"doi":5526},"10.1113\u002Fjphysiol.2003.057182",{"id":26,"text":5528,"url":26,"identifiers":5529},"Thomas, E. A. & Bornstein, J. C. Inhibitory cotransmission or after-hyperpolarizing potentials can regulate firing in recurrent networks with excitatory metabotropic transmission. Neuroscience 120, 333–352 (2003).",{"doi":5530},"10.1016\u002FS0306-4522(03)00039-3",{"id":26,"text":5532,"url":26,"identifiers":5533},"Ferens, D., Baell, J., Lessene, G., Smith, J. E. & Furness, J. B. Effects of modulators of Ca2+-activated, intermediate-conductance potassium channels on motility of the rat small intestine, in vivo. Neurogastroenterol. Motil. 19, 383–389 (2007).",{"doi":5534},"10.1111\u002Fj.1365-2982.2007.00898.x",{"id":26,"text":5536,"url":26,"identifiers":5537},"Wingate, D. L. Backwards and forwards with the migrating complex. Dig. Dis. Sci. 26, 641–666 (1981).",{"doi":5538},"10.1007\u002FBF01367678",{"id":26,"text":5540,"url":26,"identifiers":5541},"Sarna, S., Stoddard, C., Belbeck, L. & McWade, D. Intrinsic nervous control of migrating myoelectric complexes. Am. J. Physiol. 241, G16–G23 (1981).",{},{"id":26,"text":5543,"url":26,"identifiers":5544},"El Sharkawy, T. Y., Markus, H. & Diamant, N. E. Neural control of the intestinal migrating myoelectric complex. A pharmacological analysis. Can. J. Physiol. Pharmacol. 60, 794–804 (1982).",{"doi":5545},"10.1139\u002Fy82-111",{"id":26,"text":5547,"url":26,"identifiers":5548},"Ehrlein, H. J. Retroperistaltism and duodenogastric reflux in dogs. Scand. J. Gastroenterol. 16 (Suppl.), 29–32 (1981).",{},{"id":26,"text":5550,"url":26,"identifiers":5551},"Lang, I. M., Sarna, S. K. & Shaker, R. Gastrointestinal motor and myoelectric correlates of motion sickness. Am. J. Physiol. 277, G642–G652 (1999).",{},{"id":26,"text":5553,"url":26,"identifiers":5554},"Vallance, B. A., Blennerhassett, P. A. & Collins, S. M. Increased intestinal muscle contractility and worm expulsion in nematode-infected mice. Am. J. Physiol. 272, G321–G327 (1997).",{},{"id":26,"text":5556,"url":26,"identifiers":5557},"Field, M. Intestinal ion transport and the pathophysiology of diarrhea. J. Clin. Invest. 111, 931–943 (2003).",{"doi":5558},"10.1172\u002FJCI200318326",{"id":26,"text":5560,"url":26,"identifiers":5561},"Mellander, A., Järbur, K. & Sjövall, H. Pressure and frequency dependent linkage between motility and epithelial secretion in human proximal small intestine. Gut 46, 376–384 (2000).",{"doi":5562},"10.1136\u002Fgut.46.3.376",{"id":26,"text":5564,"url":26,"identifiers":5565},"Lynch, A. C. & Frizelle, F. A. Colorectal motility and defecation after spinal cord injury in humans. Prog. Brain Res. 152, 335–343 (2006).",{"doi":5566},"10.1016\u002FS0079-6123(05)52022-3",{"id":26,"text":5568,"url":26,"identifiers":5569},"Shimizu, Y.  et al. Evidence that stimulation of ghrelin receptors in the spinal cord initiates propulsive activity in the colon of the rat. J. Physiol. 576, 329–338 (2006).",{"doi":5570},"10.1113\u002Fjphysiol.2006.116160",{"id":26,"text":5572,"url":26,"identifiers":5573},"Lynch, A. C., Antony, A., Dobbs, B. R. & Frizelle, F. A. Bowel dysfunction following spinal cord injury. Spinal Cord 39, 193–203 (2001).",{"doi":5574},"10.1038\u002Fsj.sc.3101119",{"id":26,"text":5576,"url":26,"identifiers":5577},"Ferens, D. M.  et al. Stimulation of defecation in spinal cord-injured rats by a centrally acting ghrelin receptor agonist. Spinal Cord 49, 1036–1041 (2011).",{"doi":5578},"10.1038\u002Fsc.2011.60",{"id":26,"text":5580,"url":26,"identifiers":5581},"Wright, E. M. & Loo, D. D. F. Coupling between Na+, sugar, and water transport across the intestine. Ann. NY Acad. Sci. 915, 54–66 (2000).",{"doi":5582},"10.1111\u002Fj.1749-6632.2000.tb05223.x",{"id":26,"text":5584,"url":26,"identifiers":5585},"Sjövall, H.  et al. Intestinal fluid and electrolyte transport in man during reduced circulating blood volume. Gut 27, 913–918 (1986).",{"doi":5586},"10.1136\u002Fgut.27.8.913",{"id":26,"text":5588,"url":26,"identifiers":5589},"Young, R. L. Sensing via intestinal sweet taste pathways. Front. Neurosci. 5, 1–13 (2011).",{"doi":5590},"10.3389\u002Ffnins.2011.00023",{"id":26,"text":5592,"url":26,"identifiers":5593},"Shirazi-Beechey, S. P., Moran, A. W., Batchelor, D. J., Daly, K. & Al-Rammahi, M. Influences of food constituents on gut health glucose sensing and signalling; regulation of intestinal glucose transport. Proc. Nutr. Soc. 70, 185–193 (2011).",{"doi":5594},"10.1017\u002FS0029665111000103",{"id":26,"text":5596,"url":26,"identifiers":5597},"Sigalet, D. L.  et al. Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2. Am. J. Physiol. 293, G211–G221 (2007).",{"doi":5598},"10.1152\u002Fajpcell.00615.2006",{"id":26,"text":5600,"url":26,"identifiers":5601},"Cox, H. M. Peptide YY: a neuroendocrine neighbor of note. Peptides 28, 345–351 (2007).",{"doi":5602},"10.1016\u002Fj.peptides.2006.07.023",{"id":26,"text":5604,"url":26,"identifiers":5605},"Estall J. L. & Drucker D. J. Glucagon-like peptide-2. Annu. Rev. Nutr. 26, 391–411 (2006).",{"doi":5606},"10.1146\u002Fannurev.nutr.26.061505.111223",{"id":26,"text":5608,"url":26,"identifiers":5609},"Gwynne, R. M., Ellis, M., Sjövall, H. & Bornstein, J. C. Cholera toxin induces sustained hyperexcitability in submucosal secretomotor neurons in guinea pig jejunum. Gastroenterology 136, 299–308 (2009).",{"doi":5610},"10.1053\u002Fj.gastro.2008.09.071",{"id":26,"text":5612,"url":26,"identifiers":5613},"Malagelada, J.-R., Rees, W. D. W., Mazzotta, L. J. & Go, V. L. W. Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: effect of metoclopramide and bethanechol. Gastroenterology 78, 286–293 (1980).",{"doi":5614},"10.1016\u002F0016-5085(80)90578-8",{"id":26,"text":5616,"url":26,"identifiers":5617},"Camilleri, M. Alvimopan, a selective peripherally acting μ-opioid antagonist. Neurogastroenterol. Motil. 17, 157–165 (2005).",{"doi":5618},"10.1111\u002Fj.1365-2982.2005.00640.x",{"id":26,"text":5620,"url":26,"identifiers":5621},"Sanger, G. J. & Hicks, G. A. Drugs targeting functional bowel disorders: insights from animal studies. Curr. Opin. Pharmacol. 2, 678–683 (2002).",{"doi":5622},"10.1016\u002FS1471-4892(02)00228-X",{"id":26,"text":5624,"url":26,"identifiers":5625},"Camilleri, M.  et al. Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders. Gastroenterology 130, 1421–1434 (2006).",{"doi":5626},"10.1053\u002Fj.gastro.2005.08.062",{"id":26,"text":5628,"url":26,"identifiers":5629},"De Giorgio, R., Barbara, G., Furness, J. B. & Tonini, M. Novel therapeutic targets for enteric nervous system disorders. Trends Pharmacol. Sci. 28, 473–481 (2007).",{"doi":5630},"10.1016\u002Fj.tips.2007.08.003",{"id":26,"text":5632,"url":26,"identifiers":5633},"Sanger, G. J. & Alpers, D. H. Development of drugs for gastrointestinal motor disorders: translating science to clinical need. Neurogastroenterol. Motil. 20, 177–184 (2008).",{"doi":5634},"10.1111\u002Fj.1365-2982.2008.01084.x",{"id":26,"text":5636,"url":26,"identifiers":5637},"Rehfeld, J. F. A centenary of gastrointestinal endocrinology. Horm. Metab. Res. 36, 735–741 (2004).",{"doi":5638},"10.1055\u002Fs-2004-826154",{"id":26,"text":5640,"url":26,"identifiers":5641},"Raybould, H. E. Mechanisms of CCK signaling from gut to brain. Curr. Opin. Pharmacol. 7, 570–574 (2007).",{"doi":5642},"10.1016\u002Fj.coph.2007.09.006",{"id":26,"text":5644,"url":26,"identifiers":5645},"Brookes, S. J. H., Steele, P. A. & Costa, M. Identification and immunohistochemistry of cholinergic and non-cholinergic circular muscle motor neurons in the guinea-pig small intestine. Neuroscience 42, 863–878 (1991).",{"doi":5646},"10.1016\u002F0306-4522(91)90050-X",{"id":26,"text":5648,"url":26,"identifiers":5649},"Holzer, P. & Holzer Petsche, U. Tachykinins in the gut. Part 1. Expression, release and motor function. Pharmacol. Ther. 73, 173–217 (1997).",{"doi":5650},"10.1016\u002FS0163-7258(96)00195-7",{"id":26,"text":5652,"url":26,"identifiers":5653},"Grider, J. R. Neurotransmitters mediating the intestinal peristaltic reflex in the mouse. J. Pharmacol. Exp. Ther. 307, 460–467 (2003).",{"doi":5654},"10.1124\u002Fjpet.103.053512",{"id":26,"text":5656,"url":26,"identifiers":5657},"Fahrenkrug, J.  et al. Nervous release of vasoactive intestinal polypeptide in the gastrointestinal tract of cats: possible physiological implications. J. Physiol. 284, 291–305 (1978).",{"doi":5658},"10.1113\u002Fjphysiol.1978.sp012541",{"id":26,"text":5660,"url":26,"identifiers":5661},"Costa, M.  et al. Projections and chemical coding of neurons with immunoreactivity for nitric oxide synthase in the guinea-pig small intestine. Neurosci. Lett. 148, 121–125 (1992).",{"doi":5662},"10.1016\u002F0304-3940(92)90819-S",{"id":26,"text":5664,"url":26,"identifiers":5665},"Sanders, K. M. & Ward, S. M. Nitric oxide as a mediator of nonadrenergic noncholinergic neurotransmission. Am. J. Physiol. 262, G379–G392 (1992).",{},{"id":26,"text":5667,"url":26,"identifiers":5668},"Xue, L.  et al. Carbon monoxide and nitric oxide as coneurotransmitters in the enteric nervous system: evidence from genomic deletion of biosynthetic enzymes. Proc. Natl Acad. Sci. USA 97, 1851–1855 (2000).",{"doi":5669},"10.1073\u002Fpnas.97.4.1851",{"id":26,"text":5671,"url":26,"identifiers":5672},"Brookes, S. J. H., Steele, P. A. & Costa, M. Calretinin immunoreactivity in cholinergic motor neurones, interneurones and vasomotor neurones in the guinea-pig small intestine. Cell Tissue Res. 263, 471–481 (1991).",{"doi":5673},"10.1007\u002FBF00327280",{"id":26,"text":5675,"url":26,"identifiers":5676},"Young, H. M., Furness, J. B. & Povey, J. M. Analysis of connections between nitric oxide synthase neurons in the myenteric plexus of the guinea-pig small intestine. J. Neurocytol. 24, 257–263 (1995).",{"doi":5677},"10.1007\u002FBF01186538",{"id":26,"text":5679,"url":26,"identifiers":5680},"Brookes, S. J. H. Classes of enteric nerve cells in the guinea-pig small intestine. Anat. Rec. 262, 58–70 (2001).",{"doi":5681},"10.1002\u002F1097-0185(20010101)262:1\u003C58::AID-AR1011>3.0.CO;2-V",{"id":26,"text":5683,"url":26,"identifiers":5684},"Furness, J. B. & Costa, M. Neurons with 5-hydroxytryptamine-like immunoreactivity in the enteric nervous system: their projections in the guinea-pig small intestine. Neuroscience 7, 341–349 (1982).",{"doi":5685},"10.1016\u002F0306-4522(82)90271-8",{"id":26,"text":5687,"url":26,"identifiers":5688},"Monro, R. L., Bertrand, P. P. & Bornstein, J. C. ATP and 5-HT are the principal neurotransmitters in the descending excitatory reflex pathway of the guinea-pig ileum. Neurogastroenterol. Motil. 14, 255–264 (2002).",{"doi":5689},"10.1046\u002Fj.1365-2982.2002.00325.x",{"id":26,"text":5691,"url":26,"identifiers":5692},"Gwynne, R. M. & Bornstein, J. C. Synaptic transmission at functionally identified synapses in the enteric nervous system: roles for both ionotropic and metabotropic receptors. Curr. Neuropharmacol. 5, 1–17 (2007).",{"doi":5693},"10.2174\u002F157015907780077141",{"id":26,"text":5695,"url":26,"identifiers":5696},"Portbury, A. L.  et al. Cholinergic, somatostatin-immunoreactive interneurons in the guinea pig intestine: morphology, ultrastructure, connections and projections. J. Anat. 187, 303–321 (1995).",{},{"id":26,"text":5698,"url":26,"identifiers":5699},"Li, Z. S. & Furness, J. B. Immunohistochemical localization of cholinergic markers in putative intrinsic primary afferent neurons of the guinea-pig small intestine. Cell Tissue Res. 294, 35–43 (1998).",{"doi":5700},"10.1007\u002Fs004410051154",{"id":26,"text":5702,"url":26,"identifiers":5703},"Johnson, P. J. & Bornstein, J. C. Neurokinin-1 and -3 receptor blockade inhibits slow excitatory synaptic transmission in myenteric neurons and reveals slow inhibitory input. Neuroscience 126, 137–147 (2004).",{"doi":5704},"10.1016\u002Fj.neuroscience.2004.03.021",{"id":26,"text":5706,"url":26,"identifiers":5707},"Surprenant, A. Slow excitatory synaptic potentials recorded from neurones of guinea-pig submucous plexus. J. Physiol. 351, 343–361 (1984).",{"doi":5708},"10.1113\u002Fjphysiol.1984.sp015249",{"id":26,"text":5710,"url":26,"identifiers":5711},"Monro, R. L., Bertrand, P. P. & Bornstein, J. C. ATP participates in three excitatory postsynaptic potentials in the submucous plexus of the guinea pig ileum. J. Physiol. 556, 571–584 (2004).",{"doi":5712},"10.1113\u002Fjphysiol.2004.060848",{"id":26,"text":5714,"url":26,"identifiers":5715},"Cassuto, J., Fahrenkrug, J., Jodal, M., Tuttle, R. & Lundgren, O. The release of vasoactive intestinal polypeptide from the cat small intestine exposed to cholera toxin. Gut 22, 958–963 (1981).",{"doi":5716},"10.1136\u002Fgut.22.11.958",{"id":26,"text":5718,"url":26,"identifiers":5719},"Banks, M. R., Farthing, M. J. G., Robberecht, P. & Burleigh, D. E. Antisecretory actions of a novel vasoactive intestinal polypeptide (VIP) antagonist in human and rat small intestine. Br. J. Pharmacol. 144, 994–1001 (2005).",{"doi":5720},"10.1038\u002Fsj.bjp.0706128",{"id":26,"text":5722,"url":26,"identifiers":5723},"Keast, J. R., Furness, J. B. & Costa, M. Investigations of nerve populations influencing ion transport that can be stimulated electrically, by serotonin and by a nicotinic agonist. Naunyn-Schmiedeberg's Arch. Pharmacol. 331, 260–266 (1985).",{"doi":5724},"10.1007\u002FBF00634247",{"id":26,"text":5726,"url":26,"identifiers":5727},"Holst, J. J.  et al. GRP nerves in pig antrum: role of GRP in vagal control of gastrin secretion. Am. J. Physiol. 253, G643–G649 (1987).",{},{"id":26,"text":5729,"url":26,"identifiers":5730},"Weigert, N.  et al. Role of vagal fibers and bombesin\u002Fgastrin-releasing peptide-neurons in distension-induced gastrin release in rats. Regul. Pept. 69, 33–40 (1997).",{"doi":5731},"10.1016\u002FS0167-0115(97)02127-7",{"id":26,"text":5733,"url":26,"identifiers":5734},"Nilsson, G., Simon, J., Yalow, R. S. & Berson, S. A. Plasma gastrin and gastric acid responses to sham feeding and feeding in dogs. Gastroenterology 63, 51–59 (1972).",{"doi":5735},"10.1016\u002FS0016-5085(19)33348-7",{"id":26,"text":5737,"url":26,"identifiers":5738},"Feldman, M., Richardson, C. T., Taylor, I. L. & Walsh, J. H. Effect of atropine on vagal release of gastrin and pancreatic polypeptide. J. Clin. Invest. 63, 294–298 (1979).",{"doi":5739},"10.1172\u002FJCI109302",{"id":26,"text":5741,"url":26,"identifiers":5742},"Finkleman, B. On the nature of inhibition in the intestine. J. Physiol. 70, 145–157 (1930).",{"doi":5743},"10.1113\u002Fjphysiol.1930.sp002683",{"id":26,"text":5745,"url":26,"identifiers":5746},"Macrae, L. M., Furness, J. B. & Costa, M. Distribution of subgroups of noradrenaline neurons in the coeliac ganglion of the guinea-pig. Cell Tissue Res. 244, 173–180 (1986).",{"doi":5747},"10.1007\u002FBF00218395",{"id":26,"text":5749,"url":26,"identifiers":5750},"Costa, M. & Furness, J. B. Somatostatin is present in a subpopulation of noradrenergic nerve fibres supplying the intestine. Neuroscience 13, 911–919 (1984).",{"doi":5751},"10.1016\u002F0306-4522(84)90105-2",{"id":26,"text":5753,"url":26,"identifiers":5754},"Dresel, P. & Wallentin, L. Effects of sympathetic vasoconstrictor fibres, noradrenaline and vasopresin on the intestinal vascular resistance during constant blood flow or blood pressure. Acta Physiol. Scand. 66, 427–436 (1966).",{"doi":5755},"10.1111\u002Fj.1748-1716.1966.tb03220.x",{"id":26,"text":5757,"url":26,"identifiers":5758},"Furness, J. B. The adrenergic innervation of the vessels supplying and draining the gastrointestinal tract. Z. Zellforsch. Mikrosk. Anat. 113, 67–82 (1971).",{"doi":5759},"10.1007\u002FBF00331202",{"id":26,"text":5761,"url":26,"identifiers":5762},"Furness, J. B.  et al. Distribution, pathways and reactions to drug treatment of nerves with neuropeptide Y- and pancreatic polypeptide-like immunoreactivity in the guinea-pig digestive tract. Cell Tissue Res. 234, 71–92 (1983).",{"doi":5763},"10.1007\u002FBF00217403",{"id":26,"text":5765,"url":26,"identifiers":5766},"Crowcroft, P. J., Holman, M. E. & Szurszewski, J. H. Excitatory input from the distal colon to the inferior mesenteric ganglion in the guinea-pig. J. Physiol. 219, 443–461 (1971).",{"doi":5767},"10.1113\u002Fjphysiol.1971.sp009671",{"id":26,"text":5769,"url":26,"identifiers":5770},"Dalsgaard, C. J.  et al. Origin of peptide-containing fibers in the inferior mesenteric ganglion of the guinea-pig: immunohistochemical studies with antisera to substance P, enkephalin, vasoactive intestinal polypeptide, cholecystokinin and bombesin. Neuroscience 9, 191–211 (1983).",{"doi":5771},"10.1016\u002F0306-4522(83)90056-8",{"id":26,"text":5773,"url":26,"identifiers":5774},"Love, J. A. & Szurszewski, J. H. The electrophysiological effects of vasoactive intestinal peptide in the guinea-pig inferior mesenteric ganglion. J. Physiol. 394, 67–84 (1987).",{"doi":5775},"10.1113\u002Fjphysiol.1987.sp016860",{"id":5777,"createTime":5778,"updateTime":5778,"relativeEntities":5779,"slug":5780,"properties":5781,"entityType":821,"verifyStatus":25,"verifyTime":5778,"verifyNote":822,"syncStatus":28,"languages":5796,"translateLanguages":26,"viewCount":36,"primaryUrl":5797,"fullTextUrl":26,"authors":5798,"publicationType":1081,"publisherRelationship":5854,"citationCount":5891,"citationInfo":5892,"publishDate":5897,"publishYear":1674,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":5898,"isForceReanalyzing":1446},"2e724edf-fb8a-4701-a43b-f33adcc68a85","2024-12-04T03:45:49.665+00:00",[],"Bile-acid-microbiota-crosstalk-in-gastrointestinal-inflammation-and-carcinogenesis",{"mag":5782,"keywords":5784,"pmc":5785,"openalex":5787,"abstract":5789,"title":5790,"pm":5792,"doi":5794},{"VOID":5783},"2761145411",{},{"VOID":5786},"5899973",{"VOID":5788},"W2761145411",{},{"EN":5791},"Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis",{"VOID":5793},"29018272",{"VOID":5795},"10.1038\u002Fnrgastro.2017.119",[102],"https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fnrgastro.2017.119",[5799,5820,5837],{"id":5800,"sortIndex":115,"researcher":26,"roles":5801,"affiliations":5802,"properties":5813},"4e17efc1-f93e-4016-8ac9-7d601ce261c8",[],[5803],{"id":5804,"sortIndex":36,"affiliation":5805,"properties":26},"53749ecd-36f0-4fef-a644-470d13e68cb8",{"id":5806,"createTime":5807,"updateTime":5807,"relativeEntities":5808,"slug":5809,"properties":5810,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"7bf313bf-c58d-4be2-85aa-2b96b978f028","2024-12-04T03:45:49.680+00:00",[],"Department-of-Endocrinology-Metabolism-Center-for-Translational-Medicine-and-Shanghai-Key-Laboratory-of-Diabetes-Mellitus-Shanghai-Jiao-Tong-University-Affiliated-Sixth-People-s-Hospital-Shanghai-200233-China",{"title":5811},{"EN":5812},"Department of Endocrinology & Metabolism, Center for Translational Medicine and Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200233, China",{"openalex":5814,"orcid":5816,"title":5818},{"VOID":5815},"A5051833306",{"VOID":5817},"https:\u002F\u002Forcid.org\u002F0000-0002-0951-4150",{"EN":5819},"Guoxiang Xie",{"id":5821,"sortIndex":114,"researcher":26,"roles":5822,"affiliations":5823,"properties":5830},"29cefb12-919e-4170-9560-16fbdb42de43",[],[5824],{"id":5825,"sortIndex":36,"affiliation":5826,"properties":26},"113c1ae4-3c49-4b45-846e-6157b004188d",{"id":5806,"createTime":5807,"updateTime":5807,"relativeEntities":5827,"slug":5809,"properties":5828,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":5829},{"EN":5812},{"openalex":5831,"orcid":5833,"title":5835},{"VOID":5832},"A5007251193",{"VOID":5834},"https:\u002F\u002Forcid.org\u002F0000-0002-6244-2168",{"EN":5836},"Weiping Jia",{"id":5838,"sortIndex":36,"researcher":26,"roles":5839,"affiliations":5840,"properties":5847},"8cf3e5bb-4168-489a-8405-ff32ee0a0036",[],[5841],{"id":5842,"sortIndex":36,"affiliation":5843,"properties":26},"961311c5-1864-4034-86d9-4c30aa4b67e5",{"id":5806,"createTime":5807,"updateTime":5807,"relativeEntities":5844,"slug":5809,"properties":5845,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":5846},{"EN":5812},{"openalex":5848,"orcid":5850,"title":5852},{"VOID":5849},"A5100404644",{"VOID":5851},"https:\u002F\u002Forcid.org\u002F0000-0002-3739-8994",{"EN":5853},"Jia Wang",{"url":26,"publisher":5855,"properties":5885},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":5856,"slug":663,"properties":5857,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":5863,"manageAffiliations":5864,"indexDatabases":5865,"url":753,"thumbnailPath":26,"statistic":5880,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"country":5858,"issn":5859,"introduce":5860,"eissn":5861,"title":5862},{"VOID":666},{"VOID":668},{"EN":670},{"VOID":672},{"EN":674},[],[],[5866,5873],{"id":735,"indexDatabase":5867,"url":750,"indexYears":26,"academicFieldIds":5872,"indexDatabaseRanking":26},{"id":737,"createTime":738,"updateTime":739,"relativeEntities":5868,"label":5869,"description":5870,"key":746,"publicationTags":5871,"standard":26},[],{"EN":742,"VI":742},{"VI":744,"EN":745},[748,749],[752],{"id":715,"indexDatabase":5874,"url":728,"indexYears":729,"academicFieldIds":5879,"indexDatabaseRanking":733},{"id":717,"createTime":718,"updateTime":719,"relativeEntities":5875,"label":5876,"description":5877,"key":725,"publicationTags":5878,"standard":26},[],{"EN":722,"VI":722},{"EN":722,"VI":724},[727],[731,732],{"impactFactor":36,"impactFactorByYear":5881,"i10Index":259,"i10IndexLast5Year":356,"totalPublication":259,"totalPublicationByYear":5882,"totalCitation":769,"totalCitationByYear":5883,"totalCitationPerPublication":783,"totalCitationPerPublicationByYear":5884,"hindexLast5Year":283,"hindex":283},{"2012":756,"2013":757,"2014":758,"2015":759,"2016":760,"2017":761,"2018":762,"2019":763,"2020":764,"2021":765,"2022":766,"2023":767},{"2009":59,"2010":59,"2011":162,"2012":114,"2013":111,"2014":59,"2015":162,"2016":111,"2017":158,"2018":111,"2019":111,"2020":114,"2021":162,"2022":114},{"2009":144,"2010":771,"2011":772,"2012":146,"2013":773,"2014":774,"2015":775,"2016":776,"2017":777,"2018":778,"2019":779,"2020":780,"2021":781,"2022":782},{"2009":785,"2010":786,"2011":787,"2012":788,"2013":789,"2014":790,"2015":791,"2016":792,"2017":793,"2018":794,"2019":795,"2020":796,"2021":797,"2022":798},{"volume":5886,"pages":5887,"issue":5889},{"VOID":1658},{"VOID":5888},"111-128",{"VOID":5890},"2",1321,{"total":5891,"publishYear":26,"statisticByYear":5893},{"2018":287,"2019":623,"2020":243,"2021":150,"2022":5894,"2023":5895,"2024":5896},308,292,245,"2018-02-01",[5899,5903,5907,5911,5914,5918,5922,5926,5930,5934,5938,5942,5946,5950,5954,5957,5961,5965,5969,5973,5977,5981,5985,5989,5992,5996,6000,6004,6008,6012,6016,6019,6023,6027,6031,6035,6039,6043,6047,6051,6055,6059,6063,6066,6070,6074,6078,6082,6086,6090,6094,6098,6102,6106,6110,6114,6118,6122,6126,6129,6133,6137,6141,6145,6149,6153,6157,6161,6165,6169,6173,6177,6181,6185,6189,6193,6197,6201,6205,6209,6213,6217,6221,6225,6229,6233,6237,6241,6245,6249,6253,6257,6261,6265,6269,6273,6277,6281,6284,6288,6292,6296,6300,6304,6308,6312,6316,6320,6324,6328,6332,6336,6340,6344,6348,6352,6356,6360,6364,6368,6372,6376,6379,6383,6387,6391,6395,6399,6402,6406,6410,6414,6418,6422,6426,6430,6434,6438,6442,6446,6450,6454,6458,6462,6466,6470,6474,6477,6481,6485,6489,6493,6497,6501,6505,6509,6513,6517,6521,6523,6527,6531,6535,6539,6543,6547,6551,6555,6559,6563,6567,6571,6575,6579,6583,6586,6590,6594,6597,6601,6604,6608,6612,6616,6620,6623,6626,6630,6634,6638,6642,6646,6650,6654,6658,6662,6666,6670,6674,6678,6682,6686,6690,6694,6698,6702,6706,6710,6714,6718,6721,6725,6728,6731,6734,6737,6740,6743,6746,6749,6752,6755,6758,6761,6764],{"id":26,"text":5900,"url":26,"identifiers":5901},"Mucci, L. A., Wedren, S., Tamimi, R. M., Trichopoulos, D. & Adami, H. O. The role of gene-environment interaction in the aetiology of human cancer: examples from cancers of the large bowel, lung and breast. J. Intern. Med. 249, 477–493 (2001).",{"doi":5902},"10.1046\u002Fj.1365-2796.2001.00839.x",{"id":26,"text":5904,"url":26,"identifiers":5905},"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2017. CA Cancer J. Clin. 67, 7–30 (2017).",{"doi":5906},"10.3322\u002Fcaac.21387",{"id":26,"text":5908,"url":26,"identifiers":5909},"Siegel, R. L. et al. Colorectal cancer statistics, 2017. CA Cancer J. Clini. 67, 177–193 (2017).",{"doi":5910},"10.3322\u002Fcaac.21395",{"id":26,"text":5912,"url":26,"identifiers":5913},"International Agency for Research on Cancer. Liver cancer. GLOBOCAN 2012: Estimated Incidence Mortality and Prevalence Worldwide in 2012 http:\u002F\u002Fglobocan.iarc.fr\u002FPages\u002Ffact_sheets_cancer.aspx (2017).",{},{"id":26,"text":5915,"url":26,"identifiers":5916},"Jemal, A. et al. Global cancer statistics. CA Cancer J. Clin. 61, 69–90 (2011).",{"doi":5917},"10.3322\u002Fcaac.20107",{"id":26,"text":5919,"url":26,"identifiers":5920},"Jia, W., Li, H., Zhao, L. & Nicholson, J. K. Gut microbiota: a potential new territory for drug targeting. Nat. Rev. Drug Discov. 7, 123–129 (2008).",{"doi":5921},"10.1038\u002Fnrd2505",{"id":26,"text":5923,"url":26,"identifiers":5924},"Nicholson, J. K. et al. Host-gut microbiota metabolic interactions. Science 336, 1262–1267 (2012).",{"doi":5925},"10.1126\u002Fscience.1223813",{"id":26,"text":5927,"url":26,"identifiers":5928},"Monte, M. J., Marin, J. J. G., Antelo, A. & Vazquez-Tato, J. Bile acids: chemistry, physiology, and pathophysiology. World J. Gastroenterol. 15, 804–816 (2009).",{"doi":5929},"10.3748\u002Fwjg.15.804",{"id":26,"text":5931,"url":26,"identifiers":5932},"Swann, J. R. et al. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc. Natl Acad. Sci. USA 108 (Suppl. 1), 4523–4530 (2011).",{"doi":5933},"10.1073\u002Fpnas.1006734107",{"id":26,"text":5935,"url":26,"identifiers":5936},"Dumas, M. E. et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc. Natl Acad. Sci. USA 103, 12511–12516 (2006).",{"doi":5937},"10.1073\u002Fpnas.0601056103",{"id":26,"text":5939,"url":26,"identifiers":5940},"Holmes, E. et al. Therapeutic modulation of microbiota-host metabolic interactions. Sci. Transl Med. 4, 137rv136 (2012).",{"doi":5941},"10.1126\u002Fscitranslmed.3004244",{"id":26,"text":5943,"url":26,"identifiers":5944},"Musso, G., Gambino, R. & Cassader, M. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu. Rev. Med. 62, 361–380 (2011).",{"doi":5945},"10.1146\u002Fannurev-med-012510-175505",{"id":26,"text":5947,"url":26,"identifiers":5948},"Corrêa-Oliveira, R., Fachi, J. L., Vieira, A., Sato, F. T. & Vinolo, M. A. R. Regulation of immune cell function by short-chain fatty acids. Clin. Transl Immunology 5, e73 (2016).",{"doi":5949},"10.1038\u002Fcti.2016.17",{"id":26,"text":5951,"url":26,"identifiers":5952},"Iida, N. et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342, 967–970 (2013).",{"doi":5953},"10.1126\u002Fscience.1240527",{"id":26,"text":5955,"url":26,"identifiers":5956},"Zheng, X. et al. Melamine-induced renal toxicity is mediated by the gut microbiota. Sci. Transl Med. 5, 172ra122 (2013).",{},{"id":26,"text":5958,"url":26,"identifiers":5959},"Ahn, J. et al. Human gut microbiome and risk for colorectal cancer. J. Natl Cancer Inst. 105, 1907–1911 (2013).",{"doi":5960},"10.1093\u002Fjnci\u002Fdjt300",{"id":26,"text":5962,"url":26,"identifiers":5963},"Yoshimoto, S. et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499, 97–101 (2013).",{"doi":5964},"10.1038\u002Fnature12347",{"id":26,"text":5966,"url":26,"identifiers":5967},"Sheh, A. & Fox, J. G. The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis. Gut Microbes 4, 505–531 (2013).",{"doi":5968},"10.4161\u002Fgmic.26205",{"id":26,"text":5970,"url":26,"identifiers":5971},"Moss, S. F. The clinical evidence linking Helicobacter pylori to gastric cancer. Cell. Mol. Gastroenterol. Hepatol. 3, 183–191 (2017).",{"doi":5972},"10.1016\u002Fj.jcmgh.2016.12.001",{"id":26,"text":5974,"url":26,"identifiers":5975},"Carboni, M. et al. Chronic atrophic gastritis and risk of N-nitroso compounds carcinogenesis. Langenbecks Arch. Chir. 373, 82–90 (1988).",{"doi":5976},"10.1007\u002FBF01262769",{"id":26,"text":5978,"url":26,"identifiers":5979},"Caygill, C. P., Hill, M. J., Braddick, M. & Sharp, J. C. Cancer mortality in chronic typhoid and paratyphoid carriers. Lancet 343, 83–84 (1994).",{"doi":5980},"10.1016\u002FS0140-6736(94)90816-8",{"id":26,"text":5982,"url":26,"identifiers":5983},"Prieto, A. I., Ramos-Morales, F. & Casadesús, J. Bile-induced DNA damage in Salmonella enterica. Genetics 168, 1787–1794 (2004).",{"doi":5984},"10.1534\u002Fgenetics.104.031062",{"id":26,"text":5986,"url":26,"identifiers":5987},"Boleij, A. et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin. Infect. Dis. 60, 208–215 (2015).",{"doi":5988},"10.1093\u002Fcid\u002Fciu787",{"id":26,"text":5990,"url":26,"identifiers":5991},"McCoy, A. N. et al. Fusobacterium is associated with colorectal adenomas. PLoS ONE 8, 15 (2013).",{},{"id":26,"text":5993,"url":26,"identifiers":5994},"Schwabe, R. F. & Jobin, C. The microbiome and cancer. Nat. Rev. Cancer 13, 800–812 (2013).",{"doi":5995},"10.1038\u002Fnrc3610",{"id":26,"text":5997,"url":26,"identifiers":5998},"Chen, G. Y., Shaw, M. H., Redondo, G. & Nunez, G. The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis. Cancer Res. 68, 10060–10067 (2008).",{"doi":5999},"10.1158\u002F0008-5472.CAN-08-2061",{"id":26,"text":6001,"url":26,"identifiers":6002},"Quante, M. et al. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell 21, 36–51 (2012).",{"doi":6003},"10.1016\u002Fj.ccr.2011.12.004",{"id":26,"text":6005,"url":26,"identifiers":6006},"Bernstein, C. et al. Carcinogenicity of deoxycholate, a secondary bile acid. Arch. Toxicol. 85, 863–871 (2011).",{"doi":6007},"10.1007\u002Fs00204-011-0648-7",{"id":26,"text":6009,"url":26,"identifiers":6010},"Lozano, E. et al. Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development. Mol. Cancer Res. 12, 91–100 (2014).",{"doi":6011},"10.1158\u002F1541-7786.MCR-13-0503",{"id":26,"text":6013,"url":26,"identifiers":6014},"Forman, B. M. et al. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81, 687–693 (1995).",{"doi":6015},"10.1016\u002F0092-8674(95)90530-8",{"id":26,"text":6017,"url":26,"identifiers":6018},"Seol, W., Choi, H. S. & Moore, D. D. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol. Endocrinol. 9, 72–85 (1995).",{},{"id":26,"text":6020,"url":26,"identifiers":6021},"Hylemon, P. B. et al. Bile acids as regulatory molecules. J. Lipid Res. 50, 1509–1520 (2009).",{"doi":6022},"10.1194\u002Fjlr.R900007-JLR200",{"id":26,"text":6024,"url":26,"identifiers":6025},"Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J. & Schoonjans, K. Targeting bile-acid signalling for metabolic diseases. Nat. Rev. Drug Discov. 7, 678–693 (2008).",{"doi":6026},"10.1038\u002Fnrd2619",{"id":26,"text":6028,"url":26,"identifiers":6029},"Zollner, G., Wagner, M. & Trauner, M. Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity. Pharmacol. Ther. 126, 228–243 (2010).",{"doi":6030},"10.1016\u002Fj.pharmthera.2010.03.005",{"id":26,"text":6032,"url":26,"identifiers":6033},"Mora, J. R., Iwata, M. & von Andrian, U. H. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat. Rev. Immunol. 8, 685–698 (2008).",{"doi":6034},"10.1038\u002Fnri2378",{"id":26,"text":6036,"url":26,"identifiers":6037},"Allen, K., Jaeschke, H. & Copple, B. L. Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. Am. J. Pathol. 178, 175–186 (2011).",{"doi":6038},"10.1016\u002Fj.ajpath.2010.11.026",{"id":26,"text":6040,"url":26,"identifiers":6041},"Dawson, P. A., Lan, T. & Rao, A. Bile acid transporters. J. Lipid Res. 50, 2340–2357 (2009).",{"doi":6042},"10.1194\u002Fjlr.R900012-JLR200",{"id":26,"text":6044,"url":26,"identifiers":6045},"Ridlon, J. M., Kang, D. J. & Hylemon, P. B. Bile salt biotransformations by human intestinal bacteria. J. Lipid. Res. 47, 241–259 (2006).",{"doi":6046},"10.1194\u002Fjlr.R500013-JLR200",{"id":26,"text":6048,"url":26,"identifiers":6049},"Axelson, M. et al. Bile acid synthesis in cultured human hepatocytes: support for an alternative biosynthetic pathway to cholic acid. Hepatology 31, 1305–1312 (2000).",{"doi":6050},"10.1053\u002Fjhep.2000.7877",{"id":26,"text":6052,"url":26,"identifiers":6053},"Trauner, M. & Boyer, J. L. Bile salt transporters: molecular characterization, function, and regulation. Physiol. Rev. 83, 633–671 (2003).",{"doi":6054},"10.1152\u002Fphysrev.00027.2002",{"id":26,"text":6056,"url":26,"identifiers":6057},"Meier, P. J. & Stieger, B. Bile salt transporters. Annu. Rev. Physiol. 64, 635–661 (2002).",{"doi":6058},"10.1146\u002Fannurev.physiol.64.082201.100300",{"id":26,"text":6060,"url":26,"identifiers":6061},"Zollner, G., Marschall, H. U., Wagner, M. & Trauner, M. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol. Pharm. 3, 231–251 (2006).",{"doi":6062},"10.1021\u002Fmp060010s",{"id":26,"text":6064,"url":26,"identifiers":6065},"Lemoy, M.-J. M. F., Westworth, D. R., Ardeshir, A. & Tarara, R. P. Reference intervals for preprandial and postprandial serum bile acid in adult rhesus macaques (Macaca mulatta). J. Am. Assoc. Lab. Anim. Sci. 52, 444–447 (2013).",{},{"id":26,"text":6067,"url":26,"identifiers":6068},"Holm, R., Mullertz, A. & Mu, H. Bile salts and their importance for drug absorption. Int. J. Pharm. 453, 44–55 (2013).",{"doi":6069},"10.1016\u002Fj.ijpharm.2013.04.003",{"id":26,"text":6071,"url":26,"identifiers":6072},"Geyer, J., Wilke, T. & Petzinger, E. The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships. Naunyn Schmiedebergs Arch. Pharmacol. 372, 413–431 (2006).",{"doi":6073},"10.1007\u002Fs00210-006-0043-8",{"id":26,"text":6075,"url":26,"identifiers":6076},"Dawson, P. A. Role of the intestinal bile acid transporters in bile acid and drug disposition. Handb. Exp. Pharmacol. http:\u002F\u002Fdx.doi.org\u002F10.1007\u002F978-3-642-14541-4_4 (2011).",{"doi":6077},"10.1007\u002F978-3-642-14541-4_4",{"id":26,"text":6079,"url":26,"identifiers":6080},"Gadaleta, R. M., Cariello, M., Sabba, C. & Moschetta, A. Tissue-specific actions of FXR in metabolism and cancer. Biochim. Biophys. Acta 1851, 30–39 (2015).",{"doi":6081},"10.1016\u002Fj.bbalip.2014.08.005",{"id":26,"text":6083,"url":26,"identifiers":6084},"Matsubara, T., Li, F. & Gonzalez, F. J. FXR signaling in the enterohepatic system. Mol. Cell. Endocrinol. 368, 17–29 (2013).",{"doi":6085},"10.1016\u002Fj.mce.2012.05.004",{"id":26,"text":6087,"url":26,"identifiers":6088},"Kullak-Ublick, G. A., Stieger, B. & Meier, P. J. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 126, 322–342 (2004).",{"doi":6089},"10.1053\u002Fj.gastro.2003.06.005",{"id":26,"text":6091,"url":26,"identifiers":6092},"Hata, S. et al. Substrate specificities of rat oatp1 and ntcp: implications for hepatic organic anion uptake. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G829–G839 (2003).",{"doi":6093},"10.1152\u002Fajpgi.00352.2002",{"id":26,"text":6095,"url":26,"identifiers":6096},"Chiang, J. Y. Bile acids: regulation of synthesis. J. Lipid Res. 50, 1955–1966 (2009).",{"doi":6097},"10.1194\u002Fjlr.R900010-JLR200",{"id":26,"text":6099,"url":26,"identifiers":6100},"Stanimirov, B., Stankov, K. & Mikov, M. Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseases. Hepatobiliary Pancreat. Dis. Int. 14, 18–33 (2015).",{"doi":6101},"10.1016\u002FS1499-3872(14)60307-6",{"id":26,"text":6103,"url":26,"identifiers":6104},"Botham, K. M. & Boyd, G. S. The metabolism of chenodeoxycholic acid to beta-muricholic acid in rat liver. Eur. J. Biochem. 134, 191–196 (1983).",{"doi":6105},"10.1111\u002Fj.1432-1033.1983.tb07550.x",{"id":26,"text":6107,"url":26,"identifiers":6108},"Bergstrom, S., Danielsson, H. & Goransson, A. On the bile acid meataboism in the pig. Acta Chem. Scand. 13, 776–783 (1959).",{"doi":6109},"10.3891\u002Facta.chem.scand.13-0776",{"id":26,"text":6111,"url":26,"identifiers":6112},"Martin, F. P. et al. A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol. Syst. Biol. 3, 112 (2007).",{"doi":6113},"10.1038\u002Fmsb4100153",{"id":26,"text":6115,"url":26,"identifiers":6116},"Gao, J. et al. Association between serum bile acid profiles and gestational diabetes mellitus: a targeted metabolomics study. Clin. Chim. Acta 459, 63–72 (2016).",{"doi":6117},"10.1016\u002Fj.cca.2016.05.026",{"id":26,"text":6119,"url":26,"identifiers":6120},"García-Cañaveras, J. C., Donato, M. T., Castell, J. V. & Lahoz, A. Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method. J. Lipid Res. 53, 2231–2241 (2012).",{"doi":6121},"10.1194\u002Fjlr.D028803",{"id":26,"text":6123,"url":26,"identifiers":6124},"Sayin, S. I. et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17, 225–235 (2013).",{"doi":6125},"10.1016\u002Fj.cmet.2013.01.003",{"id":26,"text":6127,"url":26,"identifiers":6128},"Stanimirov, B., Stankov, K. & Mikov, M. Pleiotropic functions of bile acids mediated by the farnesoid X receptor. Acta Gastroenterol. Belg. 75, 389–398 (2012).",{},{"id":26,"text":6130,"url":26,"identifiers":6131},"Gérard, P. Metabolism of cholesterol and bile acids by the gut microbiota. Pathogens 3, 14–24 (2014).",{"doi":6132},"10.3390\u002Fpathogens3010014",{"id":26,"text":6134,"url":26,"identifiers":6135},"Parks, D. J. et al. Bile acids: natural ligands for an orphan nuclear receptor. Science 284, 1365–1368 (1999).",{"doi":6136},"10.1126\u002Fscience.284.5418.1365",{"id":26,"text":6138,"url":26,"identifiers":6139},"Makishima, M. et al. Identification of a nuclear receptor for bile acids. Science 284, 1362–1365 (1999).",{"doi":6140},"10.1126\u002Fscience.284.5418.1362",{"id":26,"text":6142,"url":26,"identifiers":6143},"Vaquero, J., Monte, M. J., Dominguez, M., Muntane, J. & Marin, J. J. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition. Biochem. Pharmacol. 86, 926–939 (2013).",{"doi":6144},"10.1016\u002Fj.bcp.2013.07.022",{"id":26,"text":6146,"url":26,"identifiers":6147},"Song, P., Rockwell, C. E., Cui, J. Y. & Klaassen, C. D. Individual bile acids have differential effects on bile acid signaling in mice. Toxicol. Appl. Pharmacol. 283, 57–64 (2015).",{"doi":6148},"10.1016\u002Fj.taap.2014.12.005",{"id":26,"text":6150,"url":26,"identifiers":6151},"Kanda, T. et al. Regulation of expression of human intestinal bile acid-binding protein in Caco-2 cells. Biochem. J. 330, 261–265 (1998).",{"doi":6152},"10.1042\u002Fbj3300261",{"id":26,"text":6154,"url":26,"identifiers":6155},"Beuers, U., Trauner, M., Jansen, P. & Poupon, R. New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond. J. Hepatol. 62, S25–S37 (2015).",{"doi":6156},"10.1016\u002Fj.jhep.2015.02.023",{"id":26,"text":6158,"url":26,"identifiers":6159},"Duboc, H., Taché, Y. & Hofmann, A. F. The bile acid TGR5 membrane receptor: from basic research to clinical application. Dig. Liver Dis. 46, 302–312 (2014).",{"doi":6160},"10.1016\u002Fj.dld.2013.10.021",{"id":26,"text":6162,"url":26,"identifiers":6163},"Maruyama, T. et al. Identification of membrane-type receptor for bile acids (M-BAR). Biochem. Biophys. Res. Commun. 298, 714–719 (2002).",{"doi":6164},"10.1016\u002FS0006-291X(02)02550-0",{"id":26,"text":6166,"url":26,"identifiers":6167},"Kawamata, Y. et al. A G protein-coupled receptor responsive to bile acids. J. Biol. Chem. 278, 9435–9440 (2003).",{"doi":6168},"10.1074\u002Fjbc.M209706200",{"id":26,"text":6170,"url":26,"identifiers":6171},"Stanley, L. A., Horsburgh, B. C., Ross, J., Scheer, N. & Wolf, C. R. PXR and CAR: nuclear receptors which play a pivotal role in drug disposition and chemical toxicity. Drug Metab. Rev. 38, 515–597 (2006).",{"doi":6172},"10.1080\u002F03602530600786232",{"id":26,"text":6174,"url":26,"identifiers":6175},"Yoneno, K. et al. TGR5 signalling inhibits the production of pro-inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease. Immunology 139, 19–29 (2013).",{"doi":6176},"10.1111\u002Fimm.12045",{"id":26,"text":6178,"url":26,"identifiers":6179},"Kliewer, S. A. & Willson, T. M. Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor. J. Lipid Res. 43, 359–364 (2002).",{"doi":6180},"10.1016\u002FS0022-2275(20)30141-3",{"id":26,"text":6182,"url":26,"identifiers":6183},"Wagner, M. et al. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice. Hepatology 42, 420–430 (2005).",{"doi":6184},"10.1002\u002Fhep.20784",{"id":26,"text":6186,"url":26,"identifiers":6187},"Zhou, J., Liu, M., Zhai, Y. & Xie, W. The antiapoptotic role of pregnane X receptor in human colon cancer cells. Mol. Endocrinol. 22, 868–880 (2008).",{"doi":6188},"10.1210\u002Fme.2007-0197",{"id":26,"text":6190,"url":26,"identifiers":6191},"Uppal, H. et al. Combined loss of orphan receptors PXR and CAR heightens sensitivity to toxic bile acids in mice. Hepatology 41, 168–176 (2005).",{"doi":6192},"10.1002\u002Fhep.20512",{"id":26,"text":6194,"url":26,"identifiers":6195},"Stedman, C. A. et al. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. Proc. Natl Acad. Sci. USA 102, 2063–2068 (2005).",{"doi":6196},"10.1073\u002Fpnas.0409794102",{"id":26,"text":6198,"url":26,"identifiers":6199},"Wang, H. et al. Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice. J. Clin. Invest. 121, 3220–3232 (2011).",{"doi":6200},"10.1172\u002FJCI41514",{"id":26,"text":6202,"url":26,"identifiers":6203},"He, J., Nishida, S., Xu, M., Makishima, M. & Xie, W. PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts. Gastroenterology 140, 2095–2106 (2011).",{"doi":6204},"10.1053\u002Fj.gastro.2011.02.055",{"id":26,"text":6206,"url":26,"identifiers":6207},"Chatterjee, B., Echchgadda, I. & Song, C. S. Vitamin D receptor regulation of the steroid\u002Fbile acid sulfotransferase SULT2A1. Methods Enzymol. 400, 165–191 (2005).",{"doi":6208},"10.1016\u002FS0076-6879(05)00010-8",{"id":26,"text":6210,"url":26,"identifiers":6211},"Chen, X. et al. Transactivation of rat apical sodium-dependent bile acid transporter and increased bile acid transport by 1alpha, 25-dihydroxyvitamin D3 via the vitamin D receptor. Mol. Pharmacol. 69, 1913–1923 (2006).",{"doi":6212},"10.1124\u002Fmol.105.020792",{"id":26,"text":6214,"url":26,"identifiers":6215},"Schmidt, D. R. et al. Regulation of bile acid synthesis by fat-soluble vitamins A and D. J. Biol. Chem. 285, 14486–14494 (2010).",{"doi":6216},"10.1074\u002Fjbc.M110.116004",{"id":26,"text":6218,"url":26,"identifiers":6219},"Ding, N. et al. A vitamin D receptor\u002FSMAD genomic circuit gates hepatic fibrotic response. Cell 153, 601–613 (2013).",{"doi":6220},"10.1016\u002Fj.cell.2013.03.028",{"id":26,"text":6222,"url":26,"identifiers":6223},"Massague, J. TGFbeta in Cancer. Cell 134, 215–230 (2008).",{"doi":6224},"10.1016\u002Fj.cell.2008.07.001",{"id":26,"text":6226,"url":26,"identifiers":6227},"Gadaleta, R. M. et al. Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-kappaB signaling in the intestine. Biochim. Biophys. Acta 1812, 851–858 (2011).",{"doi":6228},"10.1016\u002Fj.bbadis.2011.04.005",{"id":26,"text":6230,"url":26,"identifiers":6231},"Lefebvre, P., Cariou, B., Lien, F., Kuipers, F. & Staels, B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol. Rev. 89, 147–191 (2009).",{"doi":6232},"10.1152\u002Fphysrev.00010.2008",{"id":26,"text":6234,"url":26,"identifiers":6235},"Chiang, J. Y. Bile acid metabolism and signaling. Compr. Physiol. 3, 1191–1212 (2013).",{"doi":6236},"10.1002\u002Fcphy.c120023",{"id":26,"text":6238,"url":26,"identifiers":6239},"Chen, T. L. et al. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol. Cell. Proteomics 10, M110.004945 (2011).",{"doi":6240},"10.1074\u002Fmcp.M110.004945",{"id":26,"text":6242,"url":26,"identifiers":6243},"Wang, X. N. et al. Urinary metabolite variation is associated with pathological progression of the post-hepatitis B cirrhosis patients. J. Proteome Res. 11, 3838–3847 (2012).",{"doi":6244},"10.1021\u002Fpr300337s",{"id":26,"text":6246,"url":26,"identifiers":6247},"Ananthanarayanan, M., Balasubramanian, N., Makishima, M., Mangelsdorf, D. J. & Suchy, F. J. Human bile salt export pump promoter is transactivated by the farnesoid X receptor\u002Fbile acid receptor. J. Biol. Chem. 276, 28857–28865 (2001).",{"doi":6248},"10.1074\u002Fjbc.M011610200",{"id":26,"text":6250,"url":26,"identifiers":6251},"Landrier, J. F., Eloranta, J. J., Vavricka, S. R. & Kullak-Ublick, G. A. The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G476–G485 (2006).",{"doi":6252},"10.1152\u002Fajpgi.00430.2005",{"id":26,"text":6254,"url":26,"identifiers":6255},"Boyer, J. L. et al. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G1124–G1130 (2006).",{"doi":6256},"10.1152\u002Fajpgi.00539.2005",{"id":26,"text":6258,"url":26,"identifiers":6259},"Zhao, L. et al. High throughput and quantitative measurement of microbial metabolome by gas chromatography\u002Fmass spectrometry using automated alkyl chloroformate derivatization. Anal. Chem. 89, 5565–5577 (2017).",{"doi":6260},"10.1021\u002Facs.analchem.7b00660",{"id":26,"text":6262,"url":26,"identifiers":6263},"Sinal, C. J. et al. Targeted disruption of the nuclear receptor FXR\u002FBAR impairs bile acid and lipid homeostasis. Cell 102, 731–744 (2000).",{"doi":6264},"10.1016\u002FS0092-8674(00)00062-3",{"id":26,"text":6266,"url":26,"identifiers":6267},"Yang, F. et al. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. Cancer Res. 67, 863–867 (2007).",{"doi":6268},"10.1158\u002F0008-5472.CAN-06-1078",{"id":26,"text":6270,"url":26,"identifiers":6271},"Cuperus, F. J., Claudel, T., Gautherot, J., Halilbasic, E. & Trauner, M. The role of canalicular ABC transporters in cholestasis. Drug Metab. Dispos. 42, 546–560 (2014).",{"doi":6272},"10.1124\u002Fdmd.113.056358",{"id":26,"text":6274,"url":26,"identifiers":6275},"Halilbasic, E., Claudel, T. & Trauner, M. Bile acid transporters and regulatory nuclear receptors in the liver and beyond. J. Hepatol. 58, 155–168 (2013).",{"doi":6276},"10.1016\u002Fj.jhep.2012.08.002",{"id":26,"text":6278,"url":26,"identifiers":6279},"Zollner, G. et al. Hepatobiliary transporter expression in human hepatocellular carcinoma. Liver Int. 25, 367–379 (2005).",{"doi":6280},"10.1111\u002Fj.1478-3231.2005.01033.x",{"id":26,"text":6282,"url":26,"identifiers":6283},"Anwer, M. S. Intracellular signaling by bile acids. J. Biosci. (Rajshari) 20, 1–23 (2014).",{},{"id":26,"text":6285,"url":26,"identifiers":6286},"Pikarsky, E. et al. NF-[kappa]B functions as a tumour promoter in inflammation-associated cancer. Nature 431, 461–466 (2004).",{"doi":6287},"10.1038\u002Fnature02924",{"id":26,"text":6289,"url":26,"identifiers":6290},"Luedde, T. & Schwabe, R. F. NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 8, 108–118 (2011).",{"doi":6291},"10.1038\u002Fnrgastro.2010.213",{"id":26,"text":6293,"url":26,"identifiers":6294},"Jung, I. H. et al. Predominant activation of JAK\u002FSTAT3 pathway by interleukin-6 is implicated in hepatocarcinogenesis. Neoplasia 17, 586–597 (2015).",{"doi":6295},"10.1016\u002Fj.neo.2015.07.005",{"id":26,"text":6297,"url":26,"identifiers":6298},"Nag, S., Qin, J., Srivenugopal, K. S., Wang, M. & Zhang, R. The MDM2-p53 pathway revisited. J. Biomed. Res. 27, 254–271 (2013).",{"doi":6299},"10.7555\u002FJBR.27.20130030",{"id":26,"text":6301,"url":26,"identifiers":6302},"Bernstein, H., Bernstein, C., Payne, C. M., Dvorakova, K. & Garewal, H. Bile acids as carcinogens in human gastrointestinal cancers. Mutat. Res. 589, 47–65 (2005).",{"doi":6303},"10.1016\u002Fj.mrrev.2004.08.001",{"id":26,"text":6305,"url":26,"identifiers":6306},"Bernstein, H., Bernstein, C., Payne, C. M. & Dvorak, K. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J. Gastroenterol. 15, 3329–3340 (2009).",{"doi":6307},"10.3748\u002Fwjg.15.3329",{"id":26,"text":6309,"url":26,"identifiers":6310},"Ouyang, X., Ghani, A. & Mehal, W. Z. Inflammasome biology in fibrogenesis. Biochim. Biophys. Acta 1832, 979–988 (2013).",{"doi":6311},"10.1016\u002Fj.bbadis.2013.03.020",{"id":26,"text":6313,"url":26,"identifiers":6314},"Degirolamo, C. et al. Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation. Hepatology 61, 161–170 (2015).",{"doi":6315},"10.1002\u002Fhep.27274",{"id":26,"text":6317,"url":26,"identifiers":6318},"Kong, B. et al. Mice with hepatocyte-specific FXR deficiency are resistant to spontaneous but susceptible to cholic acid-induced hepatocarcinogenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 310, G295–G302 (2016).",{"doi":6319},"10.1152\u002Fajpgi.00134.2015",{"id":26,"text":6321,"url":26,"identifiers":6322},"Knisely, A. S. et al. Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency. Hepatology 44, 478–486 (2006).",{"doi":6323},"10.1002\u002Fhep.21287",{"id":26,"text":6325,"url":26,"identifiers":6326},"Iannelli, F. et al. Massive gene amplification drives paediatric hepatocellular carcinoma caused by bile salt export pump deficiency. Nat. Commun. 5, 3850 (2014).",{"doi":6327},"10.1038\u002Fncomms4850",{"id":26,"text":6329,"url":26,"identifiers":6330},"Amaral, J. D., Viana, R. J., Ramalho, R. M., Steer, C. J. & Rodrigues, C. M. Bile acids: regulation of apoptosis by ursodeoxycholic acid. J. Lipid Res. 50, 1721–1734 (2009).",{"doi":6331},"10.1194\u002Fjlr.R900011-JLR200",{"id":26,"text":6333,"url":26,"identifiers":6334},"Woolbright, B. L. & Jaeschke, H. Novel insight into mechanisms of cholestatic liver injury. World J. Gastroenterol. 18, 4985–4993 (2012).",{"doi":6335},"10.3748\u002Fwjg.v18.i36.4985",{"id":26,"text":6337,"url":26,"identifiers":6338},"Pean, N., Doignon, I. & Tordjmann, T. Bile acids and liver carcinogenesis: TGR5 as a novel piece in the puzzle? Clin. Res. Hepatol. Gastroenterol. 37, 226–229 (2013).",{"doi":6339},"10.1016\u002Fj.clinre.2012.12.005",{"id":26,"text":6341,"url":26,"identifiers":6342},"Gadaleta, R. M. et al. Bile acids and their nuclear receptor FXR: relevance for hepatobiliary and gastrointestinal disease. Biochim. Biophys. Acta 7, 683–692 (2010).",{"doi":6343},"10.1016\u002Fj.bbalip.2010.04.006",{"id":26,"text":6345,"url":26,"identifiers":6346},"Zhang, Y. & Wang, L. Nuclear receptor small heterodimer partner in apoptosis signaling and liver cancer. Cancers 3, 198–212 (2011).",{"doi":6347},"10.3390\u002Fcancers3010198",{"id":26,"text":6349,"url":26,"identifiers":6350},"Li, G. et al. Small heterodimer partner overexpression partially protects against liver tumor development in farnesoid X receptor knockout mice. Toxicol. Appl. Pharmacol. 272, 299–305 (2013).",{"doi":6351},"10.1016\u002Fj.taap.2013.06.016",{"id":26,"text":6353,"url":26,"identifiers":6354},"Wolfe, A. et al. Increased activation of the Wnt\u002Fbeta-catenin pathway in spontaneous hepatocellular carcinoma observed in farnesoid X receptor knockout mice. J. Pharmacol. Exp. Ther. 338, 12–21 (2011).",{"doi":6355},"10.1124\u002Fjpet.111.179390",{"id":26,"text":6357,"url":26,"identifiers":6358},"Anakk, S. et al. Bile acids activate YAP to promote liver carcinogenesis. Cell Rep. 5, 1060–1069 (2013).",{"doi":6359},"10.1016\u002Fj.celrep.2013.10.030",{"id":26,"text":6361,"url":26,"identifiers":6362},"Cook, J. W., Kennaway, E. L. & Kennaway, N. M. Production of tumours in mice by deoxycholic acid. Nature 145, 627–627 (1940).",{"doi":6363},"10.1038\u002F145627a0",{"id":26,"text":6365,"url":26,"identifiers":6366},"Xie, G. et al. Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis. Int. J. Cancer 139, 1764–1775 (2016).",{"doi":6367},"10.1002\u002Fijc.30219",{"id":26,"text":6369,"url":26,"identifiers":6370},"Xie, G. et al. Distinctly altered gut microbiota in the progression of liver disease. Oncotarget 7, 19355–19366 (2016).",{"doi":6371},"10.18632\u002Foncotarget.8466",{"id":26,"text":6373,"url":26,"identifiers":6374},"Frank, D. N. et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl Acad. Sci. USA 104, 13780–13785 (2007).",{"doi":6375},"10.1073\u002Fpnas.0706625104",{"id":26,"text":6377,"url":26,"identifiers":6378},"Sokol, H. et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 15, 1183–1189 (2009).",{"doi":4673},{"id":26,"text":6380,"url":26,"identifiers":6381},"Swidsinski, A., Loening-Baucke, V., Vaneechoutte, M. & Doerffel, Y. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm. Bowel Dis. 14, 147–161 (2008).",{"doi":6382},"10.1002\u002Fibd.20330",{"id":26,"text":6384,"url":26,"identifiers":6385},"Dawson, P. A. & Karpen, S. J. Intestinal transport and metabolism of bile acids. J. Lipid Res. 56, 1085–1099 (2015).",{"doi":6386},"10.1194\u002Fjlr.R054114",{"id":26,"text":6388,"url":26,"identifiers":6389},"Degirolamo, C., Rainaldi, S., Bovenga, F., Murzilli, S. & Moschetta, A. Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice. Cell Rep. 7, 12–18 (2014).",{"doi":6390},"10.1016\u002Fj.celrep.2014.02.032",{"id":26,"text":6392,"url":26,"identifiers":6393},"Nagengast, F. M., Grubben, M. J. & van Munster, I. P. Role of bile acids in colorectal carcinogenesis. Eur. J. Cancer 31A, 1067–1070 (1995).",{"doi":6394},"10.1016\u002F0959-8049(95)00216-6",{"id":26,"text":6396,"url":26,"identifiers":6397},"Hofmann, A. F., Cravetto, C., Molino, G., Belforte, G. & Bona, B. Simulation of the metabolism and enterohepatic circulation of endogenous deoxycholic acid in humans using a physiologic pharmacokinetic model for bile acid metabolism. Gastroenterology 93, 693–709 (1987).",{"doi":6398},"10.1016\u002F0016-5085(87)90430-6",{"id":26,"text":6400,"url":26,"identifiers":6401},"Huang, Y. & Chen, Z. Inflammatory bowel disease related innate immunity and adaptive immunity. Am. J. Transl Res. 8, 2490–2497 (2016).",{},{"id":26,"text":6403,"url":26,"identifiers":6404},"Wang, Y. D., Chen, W. D., Yu, D., Forman, B. M. & Huang, W. The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-kappaB) in mice. Hepatology 54, 1421–1432 (2011).",{"doi":6405},"10.1002\u002Fhep.24525",{"id":26,"text":6407,"url":26,"identifiers":6408},"Jensen, D. D. et al. The bile acid receptor TGR5 does not interact with beta-arrestins or traffic to endosomes but transmits sustained signals from plasma membrane rafts. J. Biol. Chem. 288, 22942–22960 (2013).",{"doi":6409},"10.1074\u002Fjbc.M113.455774",{"id":26,"text":6411,"url":26,"identifiers":6412},"Cao, W. et al. Expression of bile acid receptor TGR5 in gastric adenocarcinoma. Am. J. Physiol. Gastrointest. Liver Physiol. 304, G322–G327 (2013).",{"doi":6413},"10.1152\u002Fajpgi.00263.2012",{"id":26,"text":6415,"url":26,"identifiers":6416},"Komohara, Y., Fujiwara, Y., Ohnishi, K. & Takeya, M. Tumor-associated macrophages: potential therapeutic targets for anti-cancer therapy. Adv. Drug Deliv. Rev. 99, 180–185 (2016).",{"doi":6417},"10.1016\u002Fj.addr.2015.11.009",{"id":26,"text":6419,"url":26,"identifiers":6420},"Algars, A. et al. Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients. Int. J. Cancer 131, 864–873 (2012).",{"doi":6421},"10.1002\u002Fijc.26457",{"id":26,"text":6423,"url":26,"identifiers":6424},"Cook, J. & Hagemann, T. Tumour-associated macrophages and cancer. Curr. Opin. Pharmacol. 13, 595–601 (2013).",{"doi":6425},"10.1016\u002Fj.coph.2013.05.017",{"id":26,"text":6427,"url":26,"identifiers":6428},"McMahan, R. H. et al. Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease. J. Bio. Chem. 288, 11761–11770 (2013).",{"doi":6429},"10.1074\u002Fjbc.M112.446575",{"id":26,"text":6431,"url":26,"identifiers":6432},"Zhang, Y., Sime, W., Juhas, M. & Sjolander, A. Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration. Eur. J. Cancer 49, 3320–3334 (2013).",{"doi":6433},"10.1016\u002Fj.ejca.2013.06.005",{"id":26,"text":6435,"url":26,"identifiers":6436},"Calmus, Y. & Poupon, R. Shaping macrophages function and innate immunity by bile acids: mechanisms and implication in cholestatic liver diseases. Clin. Res. Hepatol. Gastroenterol. 38, 550–556 (2014).",{"doi":6437},"10.1016\u002Fj.clinre.2014.07.007",{"id":26,"text":6439,"url":26,"identifiers":6440},"Haselow, K. et al. Bile acids PKA-dependently induce a switch of the IL-10\u002FIL-12 ratio and reduce proinflammatory capability of human macrophages. J. Leukoc. Biol. 94, 1253–1264 (2013).",{"doi":6441},"10.1189\u002Fjlb.0812396",{"id":26,"text":6443,"url":26,"identifiers":6444},"Kamada, N., Seo, S. U., Chen, G. Y. & Nunez, G. Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 13, 321–335 (2013).",{"doi":6445},"10.1038\u002Fnri3430",{"id":26,"text":6447,"url":26,"identifiers":6448},"Littman, D. R. & Rudensky, A. Y. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140, 845–858 (2010).",{"doi":6449},"10.1016\u002Fj.cell.2010.02.021",{"id":26,"text":6451,"url":26,"identifiers":6452},"Shapiro, H., Thaiss, C. A., Levy, M. & Elinav, E. The cross talk between microbiota and the immune system: metabolites take center stage. Curr. Opin. Immunol. 30, 54–62 (2014).",{"doi":6453},"10.1016\u002Fj.coi.2014.07.003",{"id":26,"text":6455,"url":26,"identifiers":6456},"Stenman, L. K., Holma, R., Eggert, A. & Korpela, R. A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids. Am. J. Physiol. Gastrointest. Liver Physiol. 304, 29 (2013).",{"doi":6457},"10.1152\u002Fajpgi.00267.2012",{"id":26,"text":6459,"url":26,"identifiers":6460},"Brestoff, J. R. & Artis, D. Commensal bacteria at the interface of host metabolism and the immune system. Nat. Immunol. 14, 676–684 (2013).",{"doi":6461},"10.1038\u002Fni.2640",{"id":26,"text":6463,"url":26,"identifiers":6464},"Duboc, H. et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut 62, 531–539 (2013).",{"doi":6465},"10.1136\u002Fgutjnl-2012-302578",{"id":26,"text":6467,"url":26,"identifiers":6468},"Attili, A. F., Angelico, M., Cantafora, A., Alvaro, D. & Capocaccia, L. Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids. Med. Hypotheses 19, 57–69 (1986).",{"doi":6469},"10.1016\u002F0306-9877(86)90137-4",{"id":26,"text":6471,"url":26,"identifiers":6472},"Radominska, A. et al. Human liver steroid sulphotransferase sulphates bile acids. Biochem. J. 272, 597–604 (1990).",{"doi":6473},"10.1042\u002Fbj2720597",{"id":26,"text":6475,"url":26,"identifiers":6476},"Gerard, P. Metabolism of cholesterol and bile acids by the gut microbiota. Pathogens 3, 14–24 (2013).",{"doi":6132},{"id":26,"text":6478,"url":26,"identifiers":6479},"Van den Abbeele, P. et al. Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. ISME J. 7, 949–961 (2013).",{"doi":6480},"10.1038\u002Fismej.2012.158",{"id":26,"text":6482,"url":26,"identifiers":6483},"Wang, T. et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 6, 320–329 (2012).",{"doi":6484},"10.1038\u002Fismej.2011.109",{"id":26,"text":6486,"url":26,"identifiers":6487},"Goncalves, P., Araujo, J. R., Pinho, M. J. & Martel, F. In vitro studies on the inhibition of colon cancer by butyrate and polyphenolic compounds. Nutr. Cancer 63, 282–294 (2011).",{"doi":6488},"10.1080\u002F01635581.2011.523166",{"id":26,"text":6490,"url":26,"identifiers":6491},"Hague, A., Elder, D. J., Hicks, D. J. & Paraskeva, C. Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int. J. Cancer 60, 400–406 (1995).",{"doi":6492},"10.1002\u002Fijc.2910600322",{"id":26,"text":6494,"url":26,"identifiers":6495},"Bingham, S. A. et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 361, 1496–1501 (2003).",{"doi":6496},"10.1016\u002FS0140-6736(03)13174-1",{"id":26,"text":6498,"url":26,"identifiers":6499},"Clausen, M. R., Bonnen, H. & Mortensen, P. B. Colonic fermentation of dietary fibre to short chain fatty acids in patients with adenomatous polyps and colonic cancer. Gut 32, 923–928 (1991).",{"doi":6500},"10.1136\u002Fgut.32.8.923",{"id":26,"text":6502,"url":26,"identifiers":6503},"Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883–899 (2010).",{"doi":6504},"10.1016\u002Fj.cell.2010.01.025",{"id":26,"text":6506,"url":26,"identifiers":6507},"Wang, Y. D. et al. Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response. Hepatology 48, 1632–1643 (2008).",{"doi":6508},"10.1002\u002Fhep.22519",{"id":26,"text":6510,"url":26,"identifiers":6511},"Fiorucci, S. et al. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis. J. Pharmacol. Exp. Ther. 313, 604–612 (2005).",{"doi":6512},"10.1124\u002Fjpet.104.079665",{"id":26,"text":6514,"url":26,"identifiers":6515},"Vavassori, P., Mencarelli, A., Renga, B., Distrutti, E. & Fiorucci, S. The bile acid receptor FXR is a modulator of intestinal innate immunity. J. Immunol. 183, 6251–6261 (2009).",{"doi":6516},"10.4049\u002Fjimmunol.0803978",{"id":26,"text":6518,"url":26,"identifiers":6519},"Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759–767 (1990).",{"doi":6520},"10.1016\u002F0092-8674(90)90186-I",{"id":26,"text":3338,"url":26,"identifiers":6522},{},{"id":26,"text":6524,"url":26,"identifiers":6525},"Sears, C. L. & Garrett, W. S. Microbes, microbiota, and colon cancer. Cell Host Microbe 15, 317–328 (2014).",{"doi":6526},"10.1016\u002Fj.chom.2014.02.007",{"id":26,"text":6528,"url":26,"identifiers":6529},"De Gottardi, A. et al. The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer. Dig. Dis. Sci. 49, 982–989 (2004).",{"doi":6530},"10.1023\u002FB:DDAS.0000034558.78747.98",{"id":26,"text":6532,"url":26,"identifiers":6533},"Modica, S., Murzilli, S., Salvatore, L., Schmidt, D. R. & Moschetta, A. Nuclear bile acid receptor FXR protects against intestinal tumorigenesis. Cancer Res. 68, 9589–9594 (2008).",{"doi":6534},"10.1158\u002F0008-5472.CAN-08-1791",{"id":26,"text":6536,"url":26,"identifiers":6537},"Torres, J. et al. Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia. Inflamm. Bowel Dis. 19, 275–282 (2013).",{"doi":6538},"10.1097\u002FMIB.0b013e318286ff2e",{"id":26,"text":6540,"url":26,"identifiers":6541},"Bailey, A. M. et al. FXR silencing in human colon cancer by DNA methylation and KRAS signaling. Am. J. Physiol. Gastrointest. Liver Physiol. 306, G48–G58 (2014).",{"doi":6542},"10.1152\u002Fajpgi.00234.2013",{"id":26,"text":6544,"url":26,"identifiers":6545},"Lax, S. et al. Expression of the nuclear bile acid receptor\u002Ffarnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis. Int. J. Cancer 130, 2232–2239 (2012).",{"doi":6546},"10.1002\u002Fijc.26293",{"id":26,"text":6548,"url":26,"identifiers":6549},"Maran, R. R. et al. Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development. J. Pharm. Exp. Ther. 328, 469–477 (2009).",{"doi":6550},"10.1124\u002Fjpet.108.145409",{"id":26,"text":6552,"url":26,"identifiers":6553},"Ajouz, H., Mukherji, D. & Shamseddine, A. Secondary bile acids: an underrecognized cause of colon cancer. World J. Surg. Oncol. 12, 164–164 (2014).",{"doi":6554},"10.1186\u002F1477-7819-12-164",{"id":26,"text":6556,"url":26,"identifiers":6557},"Payne, C. M., Bernstein, C., Dvorak, K. & Bernstein, H. Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis. Clin. Exp. Gastroenterol. 1, 19–47 (2008).",{"doi":6558},"10.2147\u002FCEG.S4343",{"id":26,"text":6560,"url":26,"identifiers":6561},"Washo-Stultz, D. et al. Role of mitochondrial complexes I and II, reactive oxygen species and arachidonic acid metabolism in deoxycholate-induced apoptosis. Cancer Lett. 177, 129–144 (2002).",{"doi":6562},"10.1016\u002FS0304-3835(01)00786-8",{"id":26,"text":6564,"url":26,"identifiers":6565},"Ridlon, J. M. & Bajaj, J. S. The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics. Acta Pharm. Sin. B 5, 99–105 (2015).",{"doi":6566},"10.1016\u002Fj.apsb.2015.01.006",{"id":26,"text":6568,"url":26,"identifiers":6569},"Labbe, A., Ganopolsky, J. G., Martoni, C. J., Prakash, S. & Jones, M. L. Bacterial bile metabolising gene abundance in Crohn's, ulcerative colitis and type 2 diabetes metagenomes. PLoS ONE 9, e115175 (2014).",{"doi":6570},"10.1371\u002Fjournal.pone.0115175",{"id":26,"text":6572,"url":26,"identifiers":6573},"Barrasa, J. I., Olmo, N., Lizarbe, M. A. & Turnay, J. Bile acids in the colon, from healthy to cytotoxic molecules. Toxicol. In Vitro 27, 964–977 (2013).",{"doi":6574},"10.1016\u002Fj.tiv.2012.12.020",{"id":26,"text":6576,"url":26,"identifiers":6577},"Axelrad, J. E., Lichtiger, S. & Yajnik, V. Inflammatory bowel disease and cancer: the role of inflammation, immunosuppression, and cancer treatment. World J. Gastroenterol. 22, 4794–4801 (2016).",{"doi":6578},"10.3748\u002Fwjg.v22.i20.4794",{"id":26,"text":6580,"url":26,"identifiers":6581},"Hold, G. L. et al. Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? World J. Gastroenterol. 20, 1192–1210 (2014).",{"doi":6582},"10.3748\u002Fwjg.v20.i5.1192",{"id":26,"text":6584,"url":26,"identifiers":6585},"Mattar, M. C., Lough, D., Pishvaian, M. J. & Charabaty, A. Current management of inflammatory bowel disease and colorectal cancer. Gastrointest. Cancer Res. 4, 53–61 (2011).",{},{"id":26,"text":6587,"url":26,"identifiers":6588},"Morelli, L. & Capurso, L. FAO\u002FWHO guidelines on probiotics: 10 years later. J. Clin. Gastroenterol. 46, S1–S2 (2012).",{"doi":6589},"10.1097\u002FMCG.0b013e318269fdd5",{"id":26,"text":6591,"url":26,"identifiers":6592},"Louis, P., Hold, G. L. & Flint, H. J. The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 12, 661–672 (2014).",{"doi":6593},"10.1038\u002Fnrmicro3344",{"id":26,"text":6595,"url":26,"identifiers":6596},"Ghouri, Y. A. et al. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. Clin. Exp. Gastroenterol. 7, 473–487 (2014).",{},{"id":26,"text":6598,"url":26,"identifiers":6599},"Scaldaferri, F. et al. Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. Biomed. Res. Int. 2013, 435268 (2013).",{"doi":6600},"10.1155\u002F2013\u002F435268",{"id":26,"text":6602,"url":26,"identifiers":6603},"Mallon, P., McKay, D., Kirk, S. & Gardiner, K. Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst. Rev. 4, CD005573 (2007).",{},{"id":26,"text":6605,"url":26,"identifiers":6606},"Boyer, J. L. Nuclear receptor ligands: rational and effective therapy for chronic cholestatic liver disease? Gastroenterology 129, 735–740 (2005).",{"doi":6607},"10.1016\u002Fj.gastro.2005.06.053",{"id":26,"text":6609,"url":26,"identifiers":6610},"Zollner, G. & Trauner, M. Nuclear receptors as therapeutic targets in cholestatic liver diseases. Br. J. Pharmacol. 156, 7–27 (2009).",{"doi":6611},"10.1111\u002Fj.1476-5381.2008.00030.x",{"id":26,"text":6613,"url":26,"identifiers":6614},"Hohenester, S. et al. A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes. Hepatology 55, 173–183 (2012).",{"doi":6615},"10.1002\u002Fhep.24691",{"id":26,"text":6617,"url":26,"identifiers":6618},"Fickert, P. et al. 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 130, 465–481 (2006).",{"doi":6619},"10.1053\u002Fj.gastro.2005.10.018",{"id":26,"text":6621,"url":26,"identifiers":6622},"Ali, A. H., Carey, E. J. & Lindor, K. D. Recent advances in the development of farnesoid X receptor agonists. Ann. Transl Med. 3, 5 (2015).",{},{"id":26,"text":6624,"url":26,"identifiers":6625},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fclinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT02516605 (2017).",{},{"id":26,"text":6627,"url":26,"identifiers":6628},"Nevens, F. et al. A placebo-controlled trial of obeticholic acid in primary biliary cholangitis. N. Engl. J. Med. 375, 631–643 (2016).",{"doi":6629},"10.1056\u002FNEJMoa1509840",{"id":26,"text":6631,"url":26,"identifiers":6632},"De Magalhaes Filho, C. D., Downes, M. & Evans, R. Bile acid analog intercepts liver fibrosis. Cell 166, 789 (2016)",{"doi":6633},"10.1016\u002Fj.cell.2016.08.001",{"id":26,"text":6635,"url":26,"identifiers":6636},"Perino, A. & Schoonjans, K. TGR5 and immunometabolism: insights from physiology and pharmacology. Trends Pharmacol. Sci. 36, 847–857 (2015).",{"doi":6637},"10.1016\u002Fj.tips.2015.08.002",{"id":26,"text":6639,"url":26,"identifiers":6640},"Festa, C. et al. Exploitation of cholane scaffold for the discovery of potent and selective farnesoid x receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands. J. Med. Chem. 57, 8477–8495 (2014).",{"doi":6641},"10.1021\u002Fjm501273r",{"id":26,"text":6643,"url":26,"identifiers":6644},"Pellicciari, R. et al. Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23- and 6,23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein coupled receptor TGR5. J. Med. Chem. 50, 4265–4268 (2007).",{"doi":6645},"10.1021\u002Fjm070633p",{"id":26,"text":6647,"url":26,"identifiers":6648},"Pellicciari, R. et al. Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity. J. Med. Chem. 52, 7958–7961 (2009).",{"doi":6649},"10.1021\u002Fjm901390p",{"id":26,"text":6651,"url":26,"identifiers":6652},"Kobayashi, M. et al. Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin. Diabetes 56, 239–247 (2007).",{"doi":6653},"10.2337\u002Fdb06-0353",{"id":26,"text":6655,"url":26,"identifiers":6656},"Rao, A. et al. Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice. Sci. Transl Med. 8, 357ra122 (2016).",{"doi":6657},"10.1126\u002Fscitranslmed.aaf4823",{"id":26,"text":6659,"url":26,"identifiers":6660},"Baghdasaryan, A. et al. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis. J. Hepatol. 64, 674–681 (2016).",{"doi":6661},"10.1016\u002Fj.jhep.2015.10.024",{"id":26,"text":6663,"url":26,"identifiers":6664},"Nicaise, C. et al. Control of acute, chronic, and constitutive hyperammonemia by wild-type and genetically engineered Lactobacillus plantarum in rodents. Hepatology 48, 1184–1192 (2008).",{"doi":6665},"10.1002\u002Fhep.22445",{"id":26,"text":6667,"url":26,"identifiers":6668},"Jones, M. L., Chen, H., Ouyang, W., Metz, T. & Prakash, S. Microencapsulated genetically engineered Lactobacillus plantarum 80 (pCBH1) for bile acid deconjugation and its implication in lowering cholesterol. J. Biomed. Biotechnol. 2004, 61–69 (2004).",{"doi":6669},"10.1155\u002FS1110724304307011",{"id":26,"text":6671,"url":26,"identifiers":6672},"Xie, G. et al. Sex-dependent effects on gut microbiota regulate hepatic carcinogenic outcomes. Sci. Rep. 7, 45232 (2017).",{"doi":6673},"10.1038\u002Fsrep45232",{"id":26,"text":6675,"url":26,"identifiers":6676},"Zheng, M. M., Wang, R. F., Li, C. X. & Xu, J. H. Two-step enzymatic synthesis of ursodeoxycholic acid with a new 7β-hydroxysteroid dehydrogenase from Ruminococcus torques. Process Biochem. 50, 598–604 (2015).",{"doi":6677},"10.1016\u002Fj.procbio.2014.12.026",{"id":26,"text":6679,"url":26,"identifiers":6680},"Palmer, R. H. Bile acid sulfates. II. Formation, metabolism, and excretion of lithocholic acid sulfates in the rat. J. Lipid Res. 12, 680–687 (1971).",{"doi":6681},"10.1016\u002FS0022-2275(20)39455-4",{"id":26,"text":6683,"url":26,"identifiers":6684},"Lee, J. et al. Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology 121, 1473–1484 (2001).",{"doi":6685},"10.1053\u002Fgast.2001.29608",{"id":26,"text":6687,"url":26,"identifiers":6688},"Nijmeijer, R. M. et al. Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease. PLoS ONE 6, e23745 (2011).",{"doi":6689},"10.1371\u002Fjournal.pone.0023745",{"id":26,"text":6691,"url":26,"identifiers":6692},"Li, T. & Chiang, J. Y. Bile acid signaling in metabolic disease and drug therapy. Pharmacol. Rev. 66, 948–983 (2014).",{"doi":6693},"10.1124\u002Fpr.113.008201",{"id":26,"text":6695,"url":26,"identifiers":6696},"Holt, J. A. et al. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev. 17, 1581–1591 (2003).",{"doi":6697},"10.1101\u002Fgad.1083503",{"id":26,"text":6699,"url":26,"identifiers":6700},"Inagaki, T. et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2, 217–225 (2005).",{"doi":6701},"10.1016\u002Fj.cmet.2005.09.001",{"id":26,"text":6703,"url":26,"identifiers":6704},"Mellor, H. R. Targeted inhibition of the FGF19-FGFR4 pathway in hepatocellular carcinoma; translational safety considerations. Liver Int. 34, e1–9 (2014).",{"doi":6705},"10.1111\u002Fliv.12462",{"id":26,"text":6707,"url":26,"identifiers":6708},"Halilbasic, E., Baghdasaryan, A. & Trauner, M. Nuclear receptors as drug targets in cholestatic liver diseases. Clin. Liver Dis. 17, 161–189 (2013).",{"doi":6709},"10.1016\u002Fj.cld.2012.12.001",{"id":26,"text":6711,"url":26,"identifiers":6712},"Prenzel, N. et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402, 884–888 (1999).",{"doi":6713},"10.1038\u002F47260",{"id":26,"text":6715,"url":26,"identifiers":6716},"Pelengaris, S., Khan, M. & Evan, G. c-MYC: more than just a matter of life and death. Nat. Rev. Cancer 2, 764–776 (2002).",{"doi":6717},"10.1038\u002Fnrc904",{"id":26,"text":6719,"url":26,"identifiers":6720},"Lee, H. Y., Crawley, S., Hokari, R., Kwon, S. & Kim, Y. S. Bile acid regulates MUC2 transcription in colon cancer cells via positive EGFR\u002FPKC\u002FRas\u002FERK\u002FCREB, PI3K\u002FAkt\u002FIkappaB\u002FNF-kappaB and p38\u002FMSK1\u002FCREB pathways and negative JNK\u002Fc-Jun\u002FAP-1 pathway. Int. J. Oncol. 36, 941–953 (2010).",{},{"id":26,"text":6722,"url":26,"identifiers":6723},"Pai, R., Tarnawski, A. S. & Tran, T. Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness. Mol. Biol. Cell 15, 2156–2163 (2004).",{"doi":6724},"10.1091\u002Fmbc.e03-12-0894",{"id":26,"text":6726,"url":26,"identifiers":6727},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fclinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT02308111 (2017).",{},{"id":26,"text":6729,"url":26,"identifiers":6730},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fclinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT01999101 (2016).",{},{"id":26,"text":6732,"url":26,"identifiers":6733},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fclinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT02177136 (2016).",{},{"id":26,"text":6735,"url":26,"identifiers":6736},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fclinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT02548351 (2017).",{},{"id":26,"text":6738,"url":26,"identifiers":6739},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fclinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT02039219 (2017).",{},{"id":26,"text":6741,"url":26,"identifiers":6742},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fclinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT01265498 (2015).",{},{"id":26,"text":6744,"url":26,"identifiers":6745},"Intercept Pharmaceuticals. Intercept Pharmaceuticals initiates phase 1 study of INT-767, a dual FXR and TGR5 agonist. InterceptPharma. http:\u002F\u002Fir.interceptpharma.com\u002Freleasedetail.cfm?releaseid=944736 (2015).",{},{"id":26,"text":6747,"url":26,"identifiers":6748},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fclinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT01877577 (2014).",{},{"id":26,"text":6750,"url":26,"identifiers":6751},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fclinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT03162432 (2017).",{},{"id":26,"text":6753,"url":26,"identifiers":6754},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fclinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT01755507 (2016).",{},{"id":26,"text":6756,"url":26,"identifiers":6757},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fclinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT02021110 (2016).",{},{"id":26,"text":6759,"url":26,"identifiers":6760},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fclinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT03004118 (2016).",{},{"id":26,"text":6762,"url":26,"identifiers":6763},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fclinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT01857284 (2013).",{},{"id":26,"text":6765,"url":26,"identifiers":6766},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fclinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT00808743 (2013).",{},{"id":6768,"createTime":6769,"updateTime":6769,"relativeEntities":6770,"slug":6771,"properties":6772,"entityType":821,"verifyStatus":25,"verifyTime":6769,"verifyNote":822,"syncStatus":28,"languages":6787,"translateLanguages":26,"viewCount":36,"primaryUrl":6788,"fullTextUrl":26,"authors":6789,"publicationType":1081,"publisherRelationship":6917,"citationCount":6954,"citationInfo":6955,"publishDate":6960,"publishYear":3159,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":6961,"isForceReanalyzing":1446},"78cc2d20-5a7c-49e4-a949-37edb7123fd2","2025-01-07T06:18:22.239+00:00",[],"Immunotherapy-in-colorectal-cancer-rationale-challenges-and-potential",{"mag":6773,"keywords":6775,"pmc":6776,"openalex":6778,"abstract":6780,"title":6781,"pm":6783,"doi":6785},{"VOID":6774},"2920863623",{},{"VOID":6777},"7295073",{"VOID":6779},"W2920863623",{},{"EN":6782},"Immunotherapy in colorectal cancer: rationale, challenges and potential",{"VOID":6784},"30886395",{"VOID":6786},"10.1038\u002Fs41575-019-0126-x",[102],"https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fs41575-019-0126-x",[6790,6811,6828,6849,6866,6883,6900],{"id":6791,"sortIndex":59,"researcher":26,"roles":6792,"affiliations":6793,"properties":6804},"56d5d82b-3d17-42d2-b0e1-1fe985b42620",[],[6794],{"id":6795,"sortIndex":36,"affiliation":6796,"properties":26},"4c01fae3-f243-4e69-9efb-5156e07a7a8f",{"id":6797,"createTime":6798,"updateTime":6798,"relativeEntities":6799,"slug":6800,"properties":6801,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"17533d24-a57a-4c21-985c-da7ed74adc66","2025-01-07T06:18:22.252+00:00",[],"Department-of-Medicine-Memorial-Sloan-Kettering-Cancer-Center-York-Avenue-New-York-NY-USA",{"title":6802},{"EN":6803},"Department of Medicine, Memorial Sloan Kettering Cancer Center, York Avenue, New York, NY, USA",{"openalex":6805,"orcid":6807,"title":6809},{"VOID":6806},"A5047340192",{"VOID":6808},"https:\u002F\u002Forcid.org\u002F0000-0002-5291-0191",{"EN":6810},"Robin B. Mendelsohn",{"id":6812,"sortIndex":115,"researcher":26,"roles":6813,"affiliations":6814,"properties":6821},"5f23f7c9-13c5-4b91-88f7-90271c8ed1dc",[],[6815],{"id":6816,"sortIndex":36,"affiliation":6817,"properties":26},"55bb03e3-aa04-47f1-a81a-0d594953c88b",{"id":6797,"createTime":6798,"updateTime":6798,"relativeEntities":6818,"slug":6800,"properties":6819,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":6820},{"EN":6803},{"openalex":6822,"orcid":6824,"title":6826},{"VOID":6823},"A5074087271",{"VOID":6825},"https:\u002F\u002Forcid.org\u002F0000-0002-6985-2864",{"EN":6827},"Zsofia K. Stadler",{"id":6829,"sortIndex":111,"researcher":26,"roles":6830,"affiliations":6831,"properties":6842},"5389cc38-fe28-45ec-acc7-2ce6221f209f",[],[6832],{"id":6833,"sortIndex":36,"affiliation":6834,"properties":26},"2fb19bdb-80c9-48b8-8a2b-3c073823cd00",{"id":6835,"createTime":6836,"updateTime":6836,"relativeEntities":6837,"slug":6838,"properties":6839,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"adffceca-0d9d-47a1-80ce-6a1b20d5e6cc","2025-01-07T06:18:22.293+00:00",[],"Department-of-Pathology-Memorial-Sloan-Kettering-Cancer-Center-York-Avenue-New-York-NY-USA",{"title":6840},{"EN":6841},"Department of Pathology, Memorial Sloan Kettering Cancer Center, York Avenue, New York, NY, USA",{"openalex":6843,"orcid":6845,"title":6847},{"VOID":6844},"A5082001484",{"VOID":6846},"https:\u002F\u002Forcid.org\u002F0000-0002-4351-2511",{"EN":6848},"Jinru Shia",{"id":6850,"sortIndex":36,"researcher":26,"roles":6851,"affiliations":6852,"properties":6859},"2583885f-937e-4792-80b9-8043c8221cca",[],[6853],{"id":6854,"sortIndex":36,"affiliation":6855,"properties":26},"52bf001e-4bb1-45f1-8051-e7bc9613a7a4",{"id":6797,"createTime":6798,"updateTime":6798,"relativeEntities":6856,"slug":6800,"properties":6857,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":6858},{"EN":6803},{"openalex":6860,"orcid":6862,"title":6864},{"VOID":6861},"A5014354294",{"VOID":6863},"https:\u002F\u002Forcid.org\u002F0000-0002-4948-1082",{"EN":6865},"Karuna Ganesh",{"id":6867,"sortIndex":114,"researcher":26,"roles":6868,"affiliations":6869,"properties":6876},"11b83a1b-a1d5-4587-82b4-855e5e643443",[],[6870],{"id":6871,"sortIndex":36,"affiliation":6872,"properties":26},"5e92e659-4524-4141-b818-9ba52af2f0a4",{"id":6797,"createTime":6798,"updateTime":6798,"relativeEntities":6873,"slug":6800,"properties":6874,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":6875},{"EN":6803},{"openalex":6877,"orcid":6879,"title":6881},{"VOID":6878},"A5031539570",{"VOID":6880},"https:\u002F\u002Forcid.org\u002F0000-0002-5054-8192",{"EN":6882},"Andrea Cercek",{"id":6884,"sortIndex":135,"researcher":26,"roles":6885,"affiliations":6886,"properties":6893},"54e0e817-b600-436f-947d-fbc23c18e6bf",[],[6887],{"id":6888,"sortIndex":36,"affiliation":6889,"properties":26},"aa7d079d-3abc-41b9-8370-fb566510d7aa",{"id":6797,"createTime":6798,"updateTime":6798,"relativeEntities":6890,"slug":6800,"properties":6891,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":6892},{"EN":6803},{"openalex":6894,"orcid":6896,"title":6898},{"VOID":6895},"A5050789569",{"VOID":6897},"https:\u002F\u002Forcid.org\u002F0000-0002-7079-8914",{"EN":6899},"Luis A. Díaz",{"id":6901,"sortIndex":162,"researcher":26,"roles":6902,"affiliations":6903,"properties":6910},"9d757d68-c307-433e-9c70-f1cf81f3cc81",[],[6904],{"id":6905,"sortIndex":36,"affiliation":6906,"properties":26},"bad4182a-2408-40c3-8225-46cc38157069",{"id":6797,"createTime":6798,"updateTime":6798,"relativeEntities":6907,"slug":6800,"properties":6908,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":6909},{"EN":6803},{"openalex":6911,"orcid":6913,"title":6915},{"VOID":6912},"A5062202820",{"VOID":6914},"https:\u002F\u002Forcid.org\u002F0000-0002-3047-2303",{"EN":6916},"Neil H. Segal",{"url":26,"publisher":6918,"properties":6948},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":6919,"slug":663,"properties":6920,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":6926,"manageAffiliations":6927,"indexDatabases":6928,"url":753,"thumbnailPath":26,"statistic":6943,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"country":6921,"issn":6922,"introduce":6923,"eissn":6924,"title":6925},{"VOID":666},{"VOID":668},{"EN":670},{"VOID":672},{"EN":674},[],[],[6929,6936],{"id":735,"indexDatabase":6930,"url":750,"indexYears":26,"academicFieldIds":6935,"indexDatabaseRanking":26},{"id":737,"createTime":738,"updateTime":739,"relativeEntities":6931,"label":6932,"description":6933,"key":746,"publicationTags":6934,"standard":26},[],{"EN":742,"VI":742},{"VI":744,"EN":745},[748,749],[752],{"id":715,"indexDatabase":6937,"url":728,"indexYears":729,"academicFieldIds":6942,"indexDatabaseRanking":733},{"id":717,"createTime":718,"updateTime":719,"relativeEntities":6938,"label":6939,"description":6940,"key":725,"publicationTags":6941,"standard":26},[],{"EN":722,"VI":722},{"EN":722,"VI":724},[727],[731,732],{"impactFactor":36,"impactFactorByYear":6944,"i10Index":259,"i10IndexLast5Year":356,"totalPublication":259,"totalPublicationByYear":6945,"totalCitation":769,"totalCitationByYear":6946,"totalCitationPerPublication":783,"totalCitationPerPublicationByYear":6947,"hindexLast5Year":283,"hindex":283},{"2012":756,"2013":757,"2014":758,"2015":759,"2016":760,"2017":761,"2018":762,"2019":763,"2020":764,"2021":765,"2022":766,"2023":767},{"2009":59,"2010":59,"2011":162,"2012":114,"2013":111,"2014":59,"2015":162,"2016":111,"2017":158,"2018":111,"2019":111,"2020":114,"2021":162,"2022":114},{"2009":144,"2010":771,"2011":772,"2012":146,"2013":773,"2014":774,"2015":775,"2016":776,"2017":777,"2018":778,"2019":779,"2020":780,"2021":781,"2022":782},{"2009":785,"2010":786,"2011":787,"2012":788,"2013":789,"2014":790,"2015":791,"2016":792,"2017":793,"2018":794,"2019":795,"2020":796,"2021":797,"2022":798},{"volume":6949,"pages":6950,"issue":6952},{"VOID":3146},{"VOID":6951},"361-375",{"VOID":6953},"6",1294,{"total":6954,"publishYear":26,"statisticByYear":6956},{"2019":242,"2020":248,"2021":6957,"2022":394,"2023":6958,"2024":6959},231,330,279,"2019-06-01",[6962,6966,6970,6974,6978,6982,6986,6990,6994,6998,7002,7006,7010,7014,7018,7022,7026,7030,7034,7038,7042,7046,7050,7054,7058,7062,7066,7069,7072,7076,7080,7084,7088,7092,7096,7100,7104,7108,7112,7116,7119,7123,7127,7130,7134,7138,7142,7146,7150,7154,7158,7162,7165,7169,7173,7177,7180,7183,7186,7190,7194,7198,7202,7205,7208,7211,7214,7217,7220,7223,7227,7231,7235,7239,7243,7247,7251,7254,7258,7262,7266,7270,7274,7278,7282,7286,7290,7294,7297,7301,7305,7309,7313,7317,7320,7323,7326,7330,7334,7338,7342,7346,7350,7354,7358,7361,7364,7368,7371,7375,7379,7383,7387,7390,7394,7398,7402,7406,7410,7414,7418,7422,7426,7430,7434,7438,7442,7446,7450,7454,7458,7462,7466,7470,7474,7478,7482,7486,7490,7493,7497,7501,7505,7509,7513,7517,7520,7523,7526,7530,7534,7538],{"id":26,"text":6963,"url":26,"identifiers":6964},"Garborg, K. et al. Current status of screening for colorectal cancer. Ann. Oncol. 24, 1963–1972 (2013).",{"doi":6965},"10.1093\u002Fannonc\u002Fmdt157",{"id":26,"text":6967,"url":26,"identifiers":6968},"Siegel, R., Desantis, C. & Jemal, A. Colorectal cancer statistics, 2014. CA Cancer J. Clin. 64, 104–117 (2014).",{"doi":6969},"10.3322\u002Fcaac.21220",{"id":26,"text":6971,"url":26,"identifiers":6972},"Edwards, B. K. et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116, 544–573 (2010).",{"doi":6973},"10.1002\u002Fcncr.24760",{"id":26,"text":6975,"url":26,"identifiers":6976},"Sargent, D. et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J. Clin. Oncol. 27, 872–877 (2009).",{"doi":6977},"10.1200\u002FJCO.2008.19.5362",{"id":26,"text":6979,"url":26,"identifiers":6980},"Samstein, R. M. et al. Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat. Genet. 51, 202–206 (2019).",{"doi":6981},"10.1038\u002Fs41588-018-0312-8",{"id":26,"text":6983,"url":26,"identifiers":6984},"Chan, T. A. et al. Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic. Ann. Oncol. 30, 44–56 (2019).",{"doi":6985},"10.1093\u002Fannonc\u002Fmdy495",{"id":26,"text":6987,"url":26,"identifiers":6988},"Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960–1964 (2006).",{"doi":6989},"10.1126\u002Fscience.1129139",{"id":26,"text":6991,"url":26,"identifiers":6992},"Le, D. T. et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357, 409–413 (2017).",{"doi":6993},"10.1126\u002Fscience.aan6733",{"id":26,"text":6995,"url":26,"identifiers":6996},"Pages, F. et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N. Engl. J. Med. 353, 2654–2666 (2005).",{"doi":6997},"10.1056\u002FNEJMoa051424",{"id":26,"text":6999,"url":26,"identifiers":7000},"Galon, J., Fridman, W. H. & Pages, F. The adaptive immunologic microenvironment in colorectal cancer: a novel perspective. Cancer Res. 67, 1883–1886 (2007).",{"doi":7001},"10.1158\u002F0008-5472.CAN-06-4806",{"id":26,"text":7003,"url":26,"identifiers":7004},"Khalil, D. N., Smith, E. L., Brentjens, R. J. & Wolchok, J. D. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy. Nat. Rev. Clin. Oncol. 13, 273–290 (2016).",{"doi":7005},"10.1038\u002Fnrclinonc.2016.25",{"id":26,"text":7007,"url":26,"identifiers":7008},"Schreiber, R. D., Old, L. J. & Smyth, M. J. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 331, 1565–1570 (2011).",{"doi":7009},"10.1126\u002Fscience.1203486",{"id":26,"text":7011,"url":26,"identifiers":7012},"Sharma, P. & Allison, J. P. The future of immune checkpoint therapy. Science 348, 56–61 (2015).",{"doi":7013},"10.1126\u002Fscience.aaa8172",{"id":26,"text":7015,"url":26,"identifiers":7016},"Townsend, S. E. & Allison, J. P. Tumor rejection after direct costimulation of CD8+T cells by B7-transfected melanoma cells. Science 259, 368–370 (1993).",{"doi":7017},"10.1126\u002Fscience.7678351",{"id":26,"text":7019,"url":26,"identifiers":7020},"Wei, S. C., Duffy, C. R. & Allison, J. P. Fundamental mechanisms of immune checkpoint blockade therapy. Cancer Discov. 8, 1069–1086 (2018).",{"doi":7021},"10.1158\u002F2159-8290.CD-18-0367",{"id":26,"text":7023,"url":26,"identifiers":7024},"Hodi, F. S. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711–723 (2010).",{"doi":7025},"10.1056\u002FNEJMoa1003466",{"id":26,"text":7027,"url":26,"identifiers":7028},"Robert, C. et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N. Engl. J. Med. 364, 2517–2526 (2011).",{"doi":7029},"10.1056\u002FNEJMoa1104621",{"id":26,"text":7031,"url":26,"identifiers":7032},"Robert, C. et al. Nivolumab in previously untreated melanoma without BRAF mutation. N. Engl. J. Med. 372, 320–330 (2015).",{"doi":7033},"10.1056\u002FNEJMoa1412082",{"id":26,"text":7035,"url":26,"identifiers":7036},"Robert, C. et al. Pembrolizumab versus ipilimumab in advanced melanoma. N. Engl. J. Med. 372, 2521–2532 (2015).",{"doi":7037},"10.1056\u002FNEJMoa1503093",{"id":26,"text":7039,"url":26,"identifiers":7040},"Schadendorf, D. et al. Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma. J. Clin. Oncol. 33, 1889–1894 (2015).",{"doi":7041},"10.1200\u002FJCO.2014.56.2736",{"id":26,"text":7043,"url":26,"identifiers":7044},"Larkin, J. et al. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N. Engl. J. Med. 373, 23–34 (2015).",{"doi":7045},"10.1056\u002FNEJMoa1504030",{"id":26,"text":7047,"url":26,"identifiers":7048},"Garon, E. B. et al. Pembrolizumab for the treatment of non-small-cell lung cancer. N. Engl. J. Med. 372, 2018–2028 (2015).",{"doi":7049},"10.1056\u002FNEJMoa1501824",{"id":26,"text":7051,"url":26,"identifiers":7052},"Brahmer, J. et al. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N. Engl. J. Med. 373, 123–135 (2015).",{"doi":7053},"10.1056\u002FNEJMoa1504627",{"id":26,"text":7055,"url":26,"identifiers":7056},"Borghaei, H. et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N. Engl. J. Med. 373, 1627–1639 (2015).",{"doi":7057},"10.1056\u002FNEJMoa1507643",{"id":26,"text":7059,"url":26,"identifiers":7060},"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415–421 (2013).",{"doi":7061},"10.1038\u002Fnature12477",{"id":26,"text":7063,"url":26,"identifiers":7064},"Rizvi, N. A. et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 348, 124–128 (2015).",{"doi":7065},"10.1126\u002Fscience.aaa1348",{"id":26,"text":7067,"url":26,"identifiers":7068},"Schumacher, T. N. & Schreiber, R. D. Neoantigens in cancer immunotherapy. Science 348, 69–74 (2015).",{"doi":3430},{"id":26,"text":7070,"url":26,"identifiers":7071},"The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330–337 (2012).",{"doi":3418},{"id":26,"text":7073,"url":26,"identifiers":7074},"Salipante, S. J., Scroggins, S. M., Hampel, H. L., Turner, E. H. & Pritchard, C. C. Microsatellite instability detection by next generation sequencing. Clin. Chem. 60, 1192–1199 (2014).",{"doi":7075},"10.1373\u002Fclinchem.2014.223677",{"id":26,"text":7077,"url":26,"identifiers":7078},"Niu, B. et al. MSIsensor: microsatellite instability detection using paired tumor-normal sequence data. Bioinformatics 30, 1015–1016 (2014).",{"doi":7079},"10.1093\u002Fbioinformatics\u002Fbtt755",{"id":26,"text":7081,"url":26,"identifiers":7082},"Middha, S. et al. Reliable pan-cancer microsatellite instability assessment by using targeted next-generation sequencing data. JCO Precis. Oncol. 1, 1–17 (2017).",{"doi":7083},"10.1200\u002FPO.17.00084",{"id":26,"text":7085,"url":26,"identifiers":7086},"Hause, R. J., Pritchard, C. C., Shendure, J. & Salipante, S. J. Classification and characterization of microsatellite instability across 18 cancer types. Nat. Med. 22, 1342–1350 (2016).",{"doi":7087},"10.1038\u002Fnm.4191",{"id":26,"text":7089,"url":26,"identifiers":7090},"Giardiello, F. M. et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastroenterology 147, 502–526 (2014).",{"doi":7091},"10.1053\u002Fj.gastro.2014.04.001",{"id":26,"text":7093,"url":26,"identifiers":7094},"Alexander, J. et al. Histopathological identification of colon cancer with microsatellite instability. Am. J. Pathol. 158, 527–535 (2001).",{"doi":7095},"10.1016\u002FS0002-9440(10)63994-6",{"id":26,"text":7097,"url":26,"identifiers":7098},"Dolcetti, R. et al. High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am. J. Pathol. 154, 1805–1813 (1999).",{"doi":7099},"10.1016\u002FS0002-9440(10)65436-3",{"id":26,"text":7101,"url":26,"identifiers":7102},"Smyrk, T. C., Watson, P., Kaul, K. & Lynch, H. T. Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer 91, 2417–2422 (2001).",{"doi":7103},"10.1002\u002F1097-0142(20010615)91:12\u003C2417::AID-CNCR1276>3.0.CO;2-U",{"id":26,"text":7105,"url":26,"identifiers":7106},"Young, J. et al. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am. J. Pathol. 159, 2107–2116 (2001).",{"doi":7107},"10.1016\u002FS0002-9440(10)63062-3",{"id":26,"text":7109,"url":26,"identifiers":7110},"Gajewski, T. F., Schreiber, H. & Fu, Y. X. Innate and adaptive immune cells in the tumor microenvironment. Nat. Immunol. 14, 1014–1022 (2013).",{"doi":7111},"10.1038\u002Fni.2703",{"id":26,"text":7113,"url":26,"identifiers":7114},"Llosa, N. J. et al. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov. 5, 43–51 (2015).",{"doi":7115},"10.1158\u002F2159-8290.CD-14-0863",{"id":26,"text":7117,"url":26,"identifiers":7118},"Graham, D. M. & Appelman, H. D. Crohn’s-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator. Mod. Pathol. 3, 332–335 (1990).",{},{"id":26,"text":7120,"url":26,"identifiers":7121},"Jass, J. R. et al. Morphology of sporadic colorectal cancer with DNA replication errors. Gut 42, 673–679 (1998).",{"doi":7122},"10.1136\u002Fgut.42.5.673",{"id":26,"text":7124,"url":26,"identifiers":7125},"Nagorsen, D. et al. Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T cell response against tumor-associated antigens and survival. J. Transl Med. 5, 62 (2007).",{"doi":7126},"10.1186\u002F1479-5876-5-62",{"id":26,"text":7128,"url":26,"identifiers":7129},"Boland, C. R. et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58, 5248–5257 (1998).",{},{"id":26,"text":7131,"url":26,"identifiers":7132},"Popat, S., Hubner, R. & Houlston, R. S. Systematic review of microsatellite instability and colorectal cancer prognosis. J. Clin. Oncol. 23, 609–618 (2005).",{"doi":7133},"10.1200\u002FJCO.2005.01.086",{"id":26,"text":7135,"url":26,"identifiers":7136},"Venderbosch, S. et al. Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies. Clin. Cancer Res. 20, 5322–5330 (2014).",{"doi":7137},"10.1158\u002F1078-0432.CCR-14-0332",{"id":26,"text":7139,"url":26,"identifiers":7140},"Chung, K. Y. et al. Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer. J. Clin. Oncol. 28, 3485–3490 (2010).",{"doi":7141},"10.1200\u002FJCO.2010.28.3994",{"id":26,"text":7143,"url":26,"identifiers":7144},"Brahmer, J. R. et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N. Engl. J. Med. 366, 2455–2465 (2012).",{"doi":7145},"10.1056\u002FNEJMoa1200694",{"id":26,"text":7147,"url":26,"identifiers":7148},"Topalian, S. L. et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366, 2443–2454 (2012).",{"doi":7149},"10.1056\u002FNEJMoa1200690",{"id":26,"text":7151,"url":26,"identifiers":7152},"Brahmer, J. R. et al. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J. Clin. Oncol. 28, 3167–3175 (2010).",{"doi":7153},"10.1200\u002FJCO.2009.26.7609",{"id":26,"text":7155,"url":26,"identifiers":7156},"Lipson, E. J. et al. Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody. Clin. Cancer Res. 19, 462–468 (2013).",{"doi":7157},"10.1158\u002F1078-0432.CCR-12-2625",{"id":26,"text":7159,"url":26,"identifiers":7160},"Le, D. T. et al. PD-1 blockade in tumors with mismatch-repair deficiency. N. Engl. J. Med. 372, 2509–2520 (2015).",{"doi":7161},"10.1056\u002FNEJMoa1500596",{"id":26,"text":7163,"url":26,"identifiers":7164},"Le, D. T. et al. Programmed death-1 blockade in mismatch repair deficient colorectal cancer. J. Clin. Oncol. 34, 103 (2016).",{},{"id":26,"text":7166,"url":26,"identifiers":7167},"Overman, M. J. et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol. 18, 1182–1191 (2017).",{"doi":7168},"10.1016\u002FS1470-2045(17)30422-9",{"id":26,"text":7170,"url":26,"identifiers":7171},"Overman, M. J. et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient\u002Fmicrosatellite instability-high metastatic colorectal cancer. J. Clin. Oncol. 36, 773–779 (2018).",{"doi":7172},"10.1200\u002FJCO.2017.76.9901",{"id":26,"text":7174,"url":26,"identifiers":7175},"Andre, T. L. et al. Nivolumab+ipilimumab combination in patients with DNA mismatch repair-deficient\u002Fmicrosatellite instability-high (dMMR\u002FMSI-H) metastatic colorectal cancer (mCRC): first report of the full cohort from CheckMate-142. J. Clin. Oncol. 36 (Suppl.), 553 (2018).",{"doi":7176},"10.1200\u002FJCO.2018.36.4_suppl.553",{"id":26,"text":7178,"url":26,"identifiers":7179},"Lenz, H.-J. J. et al. Durable clinical benefit with nivolumab (NIVO) plus low-dose ipilimumab (IPI) as first-line therapy in microsatellite instability-high\u002Fmismatch repair deficient (MSI-H\u002FdMMR) metastatic colorectal cancer (mCRC). Ann. Oncol. 29 (Suppl.), LBA18_PR (2018).",{},{"id":26,"text":7181,"url":26,"identifiers":7182},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fwww.clinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT02997228 (2019).",{},{"id":26,"text":7184,"url":26,"identifiers":7185},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fwww.clinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT02563002 (2018).",{},{"id":26,"text":7187,"url":26,"identifiers":7188},"Liu, L. et al. The BRAF and MEK inhibitors dabrafenib and trametinib: effects on immune function and in combination with immunomodulatory antibodies targeting PD-1, PD-L1, and CTLA-4. Clin. Cancer Res. 21, 1639–1651 (2015).",{"doi":7189},"10.1158\u002F1078-0432.CCR-14-2339",{"id":26,"text":7191,"url":26,"identifiers":7192},"Ebert, P. J. R. et al. MAP kinase inhibition promotes T cell and anti-tumor activity in combination with PD-L1 checkpoint blockade. Immunity 44, 609–621 (2016).",{"doi":7193},"10.1016\u002Fj.immuni.2016.01.024",{"id":26,"text":7195,"url":26,"identifiers":7196},"Bendell, J. C. et al. Clinical activity and safety of cobimetinib (cobi) and atezolizumab in colorectal cancer (CRC). J. Clin. Oncol. 34 (Suppl.), 3502 (2016).",{"doi":7197},"10.1200\u002FJCO.2016.34.15_suppl.3502",{"id":26,"text":7199,"url":26,"identifiers":7200},"Bendell, J. C. B. et al. A phase 1b study of safety and clinical activity of atezolizumab (A) and cobimetinib (C) in patients (pts) with metastatic colorectal cancer (mCRC). J. Clin. Oncol. 36, 560 (2018).",{"doi":7201},"10.1200\u002FJCO.2018.36.4_suppl.560",{"id":26,"text":7203,"url":26,"identifiers":7204},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fwww.clinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT02788279 (2019).",{},{"id":26,"text":7206,"url":26,"identifiers":7207},"Bendell, J. et al. Efficacy and safety results from IMblaze370, a randomised Phase III study comparing atezolizumab+cobimetinib and atezolizumab monotherapy versus regorafenib in chemotherapy-refractory metastatic colorectal cancer. Ann. Oncol. 29, LBA–004 (2018).",{},{"id":26,"text":7209,"url":26,"identifiers":7210},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fwww.clinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT02060188 (2018).",{},{"id":26,"text":7212,"url":26,"identifiers":7213},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fwww.clinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT02876224 (2019).",{},{"id":26,"text":7215,"url":26,"identifiers":7216},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fwww.clinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT02324257 (2019).",{},{"id":26,"text":7218,"url":26,"identifiers":7219},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fwww.clinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT02650713 (2019).",{},{"id":26,"text":7221,"url":26,"identifiers":7222},"Segal, N. H. S. et al. Phase-I studies of the novel carcinoembryonic antigen T cell bispecific (CEA-CD3 TCB) antibody as a single agent and in combination with atezolizumab. Ann. Oncol. 28 (Suppl. 5), 122–141 (2017).",{},{"id":26,"text":7224,"url":26,"identifiers":7225},"Pfirschke, C. et al. Immunogenic chemotherapy sensitizes tumors to checkpoint blockade therapy. Immunity 44, 343–354 (2016).",{"doi":7226},"10.1016\u002Fj.immuni.2015.11.024",{"id":26,"text":7228,"url":26,"identifiers":7229},"Hodi, F. S. et al. Bevacizumab plus ipilimumab in patients with metastatic melanoma. Cancer Immunol. Res. 2, 632–642 (2014).",{"doi":7230},"10.1158\u002F2326-6066.CIR-14-0053",{"id":26,"text":7232,"url":26,"identifiers":7233},"Hochster, H. S. B. et al. Efficacy and safety of atezolizumab (atezo) and bevacizumab (bev) in a phase Ib study of microsatellite instability (MSI)-high metastatic colorectal cancer (mCRC). J. Clin. Oncol. 35 (Suppl.), 673 (2017).",{"doi":7234},"10.1200\u002FJCO.2017.35.4_suppl.673",{"id":26,"text":7236,"url":26,"identifiers":7237},"Bendell, J. C. et al. Safety and efficacy of MPDL3280A (anti-PDL1) in combination with bevacizumab (bev) and\u002For FOLFOX in patients (pts) with metastatic colorectal cancer (mCRC). J. Clin. Oncol. 33, 704 (2015).",{"doi":7238},"10.1200\u002Fjco.2015.33.3_suppl.704",{"id":26,"text":7240,"url":26,"identifiers":7241},"Wallin, J. et al. Clinical activity and immune correlates from a phase Ib study evaluating atezolizumab (anti-PDL1) in combination with FOLFOX and bevacizumab (anti-VEGF) in metastatic colorectal carcinoma. Cancer Res. 76, 2651 (2016).",{"doi":7242},"10.1158\u002F1538-7445.AM2016-2651",{"id":26,"text":7244,"url":26,"identifiers":7245},"Park, S. S. et al. PD-1 restrains radiotherapy-induced abscopal effect. Cancer Immunol. Res. 3, 610–619 (2015).",{"doi":7246},"10.1158\u002F2326-6066.CIR-14-0138",{"id":26,"text":7248,"url":26,"identifiers":7249},"Twyman-Saint Victor, C. et al. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nature 520, 373–377 (2015).",{"doi":7250},"10.1038\u002Fnature14292",{"id":26,"text":7252,"url":26,"identifiers":7253},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fwww.clinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT03122509 (2018).",{},{"id":26,"text":7255,"url":26,"identifiers":7256},"Snyder, A. et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. N. Engl. J. Med. 371, 2189–2199 (2014).",{"doi":7257},"10.1056\u002FNEJMoa1406498",{"id":26,"text":7259,"url":26,"identifiers":7260},"Van Allen, E. M. et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science 350, 207–211 (2015).",{"doi":7261},"10.1126\u002Fscience.aad0095",{"id":26,"text":7263,"url":26,"identifiers":7264},"Tumeh, P. C. et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515, 568–571 (2014).",{"doi":7265},"10.1038\u002Fnature13954",{"id":26,"text":7267,"url":26,"identifiers":7268},"Kreiter, S. et al. Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature 520, 692–696 (2015).",{"doi":7269},"10.1038\u002Fnature14426",{"id":26,"text":7271,"url":26,"identifiers":7272},"Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G. & Hacohen, N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 160, 48–61 (2015).",{"doi":7273},"10.1016\u002Fj.cell.2014.12.033",{"id":26,"text":7275,"url":26,"identifiers":7276},"Li, B. et al. Landscape of tumor-infiltrating T cell repertoire of human cancers. Nat. Genet. 48, 725–732 (2016).",{"doi":7277},"10.1038\u002Fng.3581",{"id":26,"text":7279,"url":26,"identifiers":7280},"McGranahan, N. et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science 351, 1463–1469 (2016).",{"doi":7281},"10.1126\u002Fscience.aaf1490",{"id":26,"text":7283,"url":26,"identifiers":7284},"Anagnostou, V. et al. Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer. Cancer Discov. 7, 264–276 (2017).",{"doi":7285},"10.1158\u002F2159-8290.CD-16-0828",{"id":26,"text":7287,"url":26,"identifiers":7288},"Mlecnik, B. et al. Integrative analyses of colorectal cancer show immunoscore is a stronger predictor of patient survival than microsatellite instability. Immunity 44, 698–711 (2016).",{"doi":7289},"10.1016\u002Fj.immuni.2016.02.025",{"id":26,"text":7291,"url":26,"identifiers":7292},"Pages, F. et al. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet 391, 2128–2139 (2018).",{"doi":7293},"10.1016\u002FS0140-6736(18)30789-X",{"id":26,"text":7295,"url":26,"identifiers":7296},"Guinney, J. et al. The consensus molecular subtypes of colorectal cancer. Nat. Med. 21, 1350–1356 (2015).",{"doi":3454},{"id":26,"text":7298,"url":26,"identifiers":7299},"Yaeger, R. et al. Clinical sequencing defines the genomic landscape of metastatic colorectal cancer. Cancer Cell 33, 125–136 (2018).",{"doi":7300},"10.1016\u002Fj.ccell.2017.12.004",{"id":26,"text":7302,"url":26,"identifiers":7303},"Palles, C. et al. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat. Genet. 45, 136–144 (2013).",{"doi":7304},"10.1038\u002Fng.2503",{"id":26,"text":7306,"url":26,"identifiers":7307},"Elsayed, F. A. et al. Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer. Eur. J. Hum. Genet. 23, 1080–1084 (2015).",{"doi":7308},"10.1038\u002Fejhg.2014.242",{"id":26,"text":7310,"url":26,"identifiers":7311},"Jansen, A. M. et al. Combined mismatch repair and POLE\u002FPOLD1 defects explain unresolved suspected Lynch syndrome cancers. Eur. J. Hum. Genet. 24, 1089–1092 (2016).",{"doi":7312},"10.1038\u002Fejhg.2015.252",{"id":26,"text":7314,"url":26,"identifiers":7315},"Domingo, E. et al. Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study. Lancet Gastroenterol. Hepatol. 1, 207–216 (2016).",{"doi":7316},"10.1016\u002FS2468-1253(16)30014-0",{"id":26,"text":7318,"url":26,"identifiers":7319},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fwww.clinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT02912572 (2018).",{},{"id":26,"text":7321,"url":26,"identifiers":7322},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fwww.clinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT02899793 (2018).",{},{"id":26,"text":7324,"url":26,"identifiers":7325},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fwww.clinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT02658279 (2019).",{},{"id":26,"text":7327,"url":26,"identifiers":7328},"Hersom, M. & Jorgensen, J. T. Companion and complementary diagnostics-focus on PD-L1 expression assays for PD-1\u002FPD-L1 checkpoint inhibitors in NSCLC. Ther. Drug Monit. 40, 9–16 (2017).",{"doi":7329},"10.1097\u002FFTD.0000000000000460",{"id":26,"text":7331,"url":26,"identifiers":7332},"André, T. et al. Analysis of tumor PD-L1 expression and biomarkers in relation to clinical activity in patients (pts) with deficient DNA mismatch repair (dMMR)\u002Fhigh microsatellite instability (MSI-H) metastatic colorectal cancer (mCRC) treated with nivolumab (NIVO) + ipilimumab (IPI): CheckMate 142. Ann. Oncol. 28, 484PD (2017).",{"doi":7333},"10.1093\u002Fannonc\u002Fmdx393.011",{"id":26,"text":7335,"url":26,"identifiers":7336},"Zaretsky, J. M. et al. Mutations associated with acquired resistance to PD-1 blockade in melanoma. N. Engl. J. Med. 375, 819–829 (2016).",{"doi":7337},"10.1056\u002FNEJMoa1604958",{"id":26,"text":7339,"url":26,"identifiers":7340},"Koelzer, V. H., Baker, K., Kassahn, D., Baumhoer, D. & Zlobec, I. Prognostic impact of beta-2-microglobulin expression in colorectal cancers stratified by mismatch repair status. J. Clin. Pathol. 65, 996–1002 (2012).",{"doi":7341},"10.1136\u002Fjclinpath-2012-200742",{"id":26,"text":7343,"url":26,"identifiers":7344},"Shin, D. S. et al. Primary resistance to PD-1 blockade mediated by JAK1\u002F2 mutations. Cancer Discov. 7, 188–201 (2017).",{"doi":7345},"10.1158\u002F2159-8290.CD-16-1223",{"id":26,"text":7347,"url":26,"identifiers":7348},"Bindea, G. et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39, 782–795 (2013).",{"doi":7349},"10.1016\u002Fj.immuni.2013.10.003",{"id":26,"text":7351,"url":26,"identifiers":7352},"Chifman, J., Pullikuth, A., Chou, J. W., Bedognetti, D. & Miller, L. D. Conservation of immune gene signatures in solid tumors and prognostic implications. BMC Cancer 16, 911 (2016).",{"doi":7353},"10.1186\u002Fs12885-016-2948-z",{"id":26,"text":7355,"url":26,"identifiers":7356},"Sinicrope, F. A. O. et al. Randomized trial of FOLFOX alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient DNA mismatch repair or microsatellite instability (ATOMIC, Alliance A021502). J. Clin. Oncol. 35, TPS3630 (2017).",{"doi":7357},"10.1200\u002FJCO.2017.35.15_suppl.TPS3630",{"id":26,"text":7359,"url":26,"identifiers":7360},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fwww.clinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT02912559 (2019).",{},{"id":26,"text":7362,"url":26,"identifiers":7363},"Grootscholten, C. et al. Neoadjuvant ipilimumab plus nivolumab in early stage colon cancer. Ann. Oncol. 29, LBA37_PR (2018).",{},{"id":26,"text":7365,"url":26,"identifiers":7366},"Watson, P. et al. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int. J. Cancer 123, 444–449 (2008).",{"doi":7367},"10.1002\u002Fijc.23508",{"id":26,"text":7369,"url":26,"identifiers":7370},"Syngal, S. et al. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am. J. Gastroenterol. 110, 223–262; quiz 263 (2015).",{"doi":4013},{"id":26,"text":7372,"url":26,"identifiers":7373},"Schwitalle, Y. et al. Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers. Gastroenterology 134, 988–997 (2008).",{"doi":7374},"10.1053\u002Fj.gastro.2008.01.015",{"id":26,"text":7376,"url":26,"identifiers":7377},"Kloor, M. & von Knebel Doeberitz, M. The immune biology of microsatellite-unstable cancer. Trends Cancer 2, 121–133 (2016).",{"doi":7378},"10.1016\u002Fj.trecan.2016.02.004",{"id":26,"text":7380,"url":26,"identifiers":7381},"Reuschenbach, M. et al. Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome. Fam. Cancer 9, 173–179 (2010).",{"doi":7382},"10.1007\u002Fs10689-009-9307-z",{"id":26,"text":7384,"url":26,"identifiers":7385},"Doeberitz, M. v. K. et al. Frameshift peptide neoantigens as vaccine targets in microsatellite-unstable cancers. Cancer Immunol. Res. 4, A006 (2016).",{"doi":7386},"10.1158\u002F2326-6066.IMM2016-A006",{"id":26,"text":7388,"url":26,"identifiers":7389},"Woo, S. R. et al. Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T cell function to promote tumoral immune escape. Cancer Res. 72, 917–927 (2012).",{},{"id":26,"text":7391,"url":26,"identifiers":7392},"Grosso, J. F. et al. LAG-3 regulates CD8+T cell accumulation and effector function in murine self- and tumor-tolerance systems. J. Clin. Invest. 117, 3383–3392 (2007).",{"doi":7393},"10.1172\u002FJCI31184",{"id":26,"text":7395,"url":26,"identifiers":7396},"Ngiow, S. F. et al. Anti-TIM3 antibody promotes T cell IFN-gamma-mediated antitumor immunity and suppresses established tumors. Cancer Res. 71, 3540–3551 (2011).",{"doi":7397},"10.1158\u002F0008-5472.CAN-11-0096",{"id":26,"text":7399,"url":26,"identifiers":7400},"Sakuishi, K. et al. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J. Exp. Med. 207, 2187–2194 (2010).",{"doi":7401},"10.1084\u002Fjem.20100643",{"id":26,"text":7403,"url":26,"identifiers":7404},"Anderson, A. C., Joller, N. & Kuchroo, V. K. Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation. Immunity 44, 989–1004 (2016).",{"doi":7405},"10.1016\u002Fj.immuni.2016.05.001",{"id":26,"text":7407,"url":26,"identifiers":7408},"Ward-Kavanagh, L. K., Lin, W. W., Sedy, J. R. & Ware, C. F. The TNF receptor superfamily in co-stimulating and co-inhibitory responses. Immunity 44, 1005–1019 (2016).",{"doi":7409},"10.1016\u002Fj.immuni.2016.04.019",{"id":26,"text":7411,"url":26,"identifiers":7412},"Croft, M., Benedict, C. A. & Ware, C. F. Clinical targeting of the TNF and TNFR superfamilies. Nat. Rev. Drug Discov. 12, 147–168 (2013).",{"doi":7413},"10.1038\u002Fnrd3930",{"id":26,"text":7415,"url":26,"identifiers":7416},"Brenner, D., Blaser, H. & Mak, T. W. Regulation of tumour necrosis factor signalling: live or let die. Nat. Rev. Immunol. 15, 362–374 (2015).",{"doi":7417},"10.1038\u002Fnri3834",{"id":26,"text":7419,"url":26,"identifiers":7420},"Rosenberg, S. A. & Restifo, N. P. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348, 62–68 (2015).",{"doi":7421},"10.1126\u002Fscience.aaa4967",{"id":26,"text":7423,"url":26,"identifiers":7424},"Miliotou, A. N. & Papadopoulou, L. C. CAR T cell therapy: a new era in cancer immunotherapy. Curr. Pharm. Biotechnol. 19, 5–18 (2018).",{"doi":7425},"10.2174\u002F1389201019666180418095526",{"id":26,"text":7427,"url":26,"identifiers":7428},"Yeku, O. O. & Brentjens, R. J. Armored CAR T cells: utilizing cytokines and pro-inflammatory ligands to enhance CAR T cell anti-tumour efficacy. Biochem. Soc. Trans. 44, 412–418 (2016).",{"doi":7429},"10.1042\u002FBST20150291",{"id":26,"text":7431,"url":26,"identifiers":7432},"Shum, T., Kruse, R. L. & Rooney, C. M. Strategies for enhancing adoptive T cell immunotherapy against solid tumors using engineered cytokine signaling and other modalities. Expert Opin. Biol. Ther. 18, 653–664 (2018).",{"doi":7433},"10.1080\u002F14712598.2018.1473368",{"id":26,"text":7435,"url":26,"identifiers":7436},"Parkhurst, M. R. et al. T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis. Mol. Ther. 19, 620–626 (2011).",{"doi":7437},"10.1038\u002Fmt.2010.272",{"id":26,"text":7439,"url":26,"identifiers":7440},"Katz, S. C. et al. Phase I hepatic immunotherapy for metastases study of intra-arterial chimeric antigen receptor-modified T cell therapy for CEA+liver metastases. Clin. Cancer Res. 21, 3149–3159 (2015).",{"doi":7441},"10.1158\u002F1078-0432.CCR-14-1421",{"id":26,"text":7443,"url":26,"identifiers":7444},"Zhang, C. et al. Phase I escalating-dose trial of CAR-T therapy targeting CEA(+) metastatic colorectal cancers. Mol. Ther. 25, 1248–1258 (2017).",{"doi":7445},"10.1016\u002Fj.ymthe.2017.03.010",{"id":26,"text":7447,"url":26,"identifiers":7448},"Tran, E. et al. T-cell transfer therapy targeting mutant KRAS in cancer. N. Engl. J. Med. 375, 2255–2262 (2016).",{"doi":7449},"10.1056\u002FNEJMoa1609279",{"id":26,"text":7451,"url":26,"identifiers":7452},"Maude, S. L. et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N. Engl. J. Med. 371, 1507–1517 (2014).",{"doi":7453},"10.1056\u002FNEJMoa1407222",{"id":26,"text":7455,"url":26,"identifiers":7456},"Kochenderfer, J. N. et al. Chemotherapy-refractory diffuse large B cell lymphoma and indolent B cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor. J. Clin. Oncol. 33, 540–549 (2015).",{"doi":7457},"10.1200\u002FJCO.2014.56.2025",{"id":26,"text":7459,"url":26,"identifiers":7460},"Johnson, L. A. & June, C. H. Driving gene-engineered T cell immunotherapy of cancer. Cell Res. 27, 38–58 (2017).",{"doi":7461},"10.1038\u002Fcr.2016.154",{"id":26,"text":7463,"url":26,"identifiers":7464},"Newick, K., O’Brien, S., Moon, E. & Albelda, S. M. CAR T cell therapy for solid tumors. Annu. Rev. Med. 68, 139–152 (2017).",{"doi":7465},"10.1146\u002Fannurev-med-062315-120245",{"id":26,"text":7467,"url":26,"identifiers":7468},"Hoover, H. C. Jr. et al. Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial. J. Clin. Oncol. 11, 390–399 (1993).",{"doi":7469},"10.1200\u002FJCO.1993.11.3.390",{"id":26,"text":7471,"url":26,"identifiers":7472},"Harris, J. E. et al. Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283. J. Clin. Oncol. 18, 148–157 (2000).",{"doi":7473},"10.1200\u002FJCO.2000.18.1.148",{"id":26,"text":7475,"url":26,"identifiers":7476},"Mantovani, A., Marchesi, F., Malesci, A., Laghi, L. & Allavena, P. Tumour-associated macrophages as treatment targets in oncology. Nat. Rev. Clin. Oncol. 14, 399–416 (2017).",{"doi":7477},"10.1038\u002Fnrclinonc.2016.217",{"id":26,"text":7479,"url":26,"identifiers":7480},"Lin, H. et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320, 807–811 (2008).",{"doi":7481},"10.1126\u002Fscience.1154370",{"id":26,"text":7483,"url":26,"identifiers":7484},"Otero, K. et al. Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin. Nat. Immunol. 10, 734–743 (2009).",{"doi":7485},"10.1038\u002Fni.1744",{"id":26,"text":7487,"url":26,"identifiers":7488},"Ngambenjawong, C., Gustafson, H. H. & Pun, S. H. Progress in tumor-associated macrophage (TAM)-targeted therapeutics. Adv. Drug Deliv. Rev. 114, 206–221 (2017).",{"doi":7489},"10.1016\u002Fj.addr.2017.04.010",{"id":26,"text":7491,"url":26,"identifiers":7492},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fwww.clinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT02777710 (2019).",{},{"id":26,"text":7494,"url":26,"identifiers":7495},"Pollard, J. W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4, 71–78 (2004).",{"doi":7496},"10.1038\u002Fnrc1256",{"id":26,"text":7498,"url":26,"identifiers":7499},"Gordon, S. R. et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature 545, 495–499 (2017).",{"doi":7500},"10.1038\u002Fnature22396",{"id":26,"text":7502,"url":26,"identifiers":7503},"Arlauckas, S. P. et al. In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy. Sci. Transl Med. 9, eaal3604 (2017).",{"doi":7504},"10.1126\u002Fscitranslmed.aal3604",{"id":26,"text":7506,"url":26,"identifiers":7507},"Ablasser, A. et al. cGAS produces a 2′;-5′;-linked cyclic dinucleotide second messenger that activates STING. Nature 498, 380–384 (2013).",{"doi":7508},"10.1038\u002Fnature12306",{"id":26,"text":7510,"url":26,"identifiers":7511},"Woo, S. R. et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity 41, 830–842 (2014).",{"doi":7512},"10.1016\u002Fj.immuni.2014.10.017",{"id":26,"text":7514,"url":26,"identifiers":7515},"Corrales, L. et al. Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity. Cell Rep. 11, 1018–1030 (2015).",{"doi":7516},"10.1016\u002Fj.celrep.2015.04.031",{"id":26,"text":7518,"url":26,"identifiers":7519},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fwww.clinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT02675439 (2018).",{},{"id":26,"text":7521,"url":26,"identifiers":7522},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fwww.clinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT03010176 (2019).",{},{"id":26,"text":7524,"url":26,"identifiers":7525},"US National Library of Medicine. ClinicalTrials.gov https:\u002F\u002Fwww.clinicaltrials.gov\u002Fct2\u002Fshow\u002FNCT03172936 (2018).",{},{"id":26,"text":7527,"url":26,"identifiers":7528},"Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J. & Schreiber, R. D. Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3, 991–998 (2002).",{"doi":7529},"10.1038\u002Fni1102-991",{"id":26,"text":7531,"url":26,"identifiers":7532},"Freeman-Keller, M. et al. Nivolumab in resected and unresectable metastatic melanoma: characteristics of immune-related adverse events and association with outcomes. Clin. Cancer Res. 22, 886–894 (2016).",{"doi":7533},"10.1158\u002F1078-0432.CCR-15-1136",{"id":26,"text":7535,"url":26,"identifiers":7536},"Lo, J. A., Fisher, D. E. & Flaherty, K. T. Prognostic significance of cutaneous adverse events associated with pembrolizumab therapy. JAMA Oncol. 1, 1340–1341 (2015).",{"doi":7537},"10.1001\u002Fjamaoncol.2015.2274",{"id":26,"text":7539,"url":26,"identifiers":7540},"Boland, P. M. & Ma, W. W. Immunotherapy for colorectal cancer. Cancers 9, 50 (2017).",{"doi":7541},"10.3390\u002Fcancers9050050",{"id":7543,"createTime":7544,"updateTime":7544,"relativeEntities":7545,"slug":7546,"properties":7547,"entityType":821,"verifyStatus":25,"verifyTime":7544,"verifyNote":822,"syncStatus":28,"languages":7560,"translateLanguages":26,"viewCount":36,"primaryUrl":7561,"fullTextUrl":26,"authors":7562,"publicationType":1081,"publisherRelationship":7654,"citationCount":7690,"citationInfo":7691,"publishDate":7697,"publishYear":3159,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":7698,"isForceReanalyzing":1446},"0698a7ff-8cdb-4fe1-9481-a080e616c333","2024-09-20T00:48:27.344+00:00",[],"Probiotics-and-prebiotics-in-intestinal-health-and-disease-from-biology-to-the-clinic",{"mag":7548,"keywords":7550,"openalex":7551,"abstract":7553,"title":7554,"pm":7556,"doi":7558},{"VOID":7549},"2956175090",{},{"VOID":7552},"W2956175090",{},{"EN":7555},"Probiotics and prebiotics in intestinal health and disease: from biology to the clinic",{"VOID":7557},"31296969",{"VOID":7559},"10.1038\u002Fs41575-019-0173-3",[102],"https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fs41575-019-0173-3",[7563,7585,7604,7618,7636],{"id":7564,"sortIndex":111,"researcher":26,"roles":7565,"affiliations":7566,"properties":7578},"4a5a8cb9-ca73-446c-8434-6244b10a48fa",[],[7567],{"id":7568,"sortIndex":36,"affiliation":7569,"properties":26},"9e35afc7-a821-4ac5-8cea-890dd3d04a1e",{"id":7570,"createTime":7571,"updateTime":7572,"relativeEntities":7573,"slug":7574,"properties":7575,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"4a67a2dc-b315-4ec8-8381-ac3f266eccf3","2023-11-30T21:56:45.469+00:00","2024-10-12T02:23:58.232+00:00",[],"Department-of-Food-and-Nutritional-Sciences-University-of-Reading-Reading-UK",{"title":7576},{"VI":7577},"Department of Food and Nutritional Sciences, University of Reading, Reading, UK",{"openalex":7579,"orcid":7581,"title":7583},{"VOID":7580},"A5044428286",{"VOID":7582},"https:\u002F\u002Forcid.org\u002F0000-0003-1775-5226",{"EN":7584},"Robert A. Rastall",{"id":7586,"sortIndex":115,"researcher":26,"roles":7587,"affiliations":7588,"properties":7600},"4af808e4-c87e-4a60-a42a-84cf50de295a",[],[7589],{"id":7590,"sortIndex":36,"affiliation":7591,"properties":26},"26df29d0-465f-438a-a613-6d5594969d57",{"id":7592,"createTime":7593,"updateTime":7594,"relativeEntities":7595,"slug":7596,"properties":7597,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"6dc70e2e-e32a-42e0-a30c-a879055ef866","2024-04-11T13:42:19.963+00:00","2024-09-20T00:48:27.369+00:00",[],"Department-of-Family-Medicine-Georgetown-University-Medical-Center-Washington-DC-USA",{"title":7598},{"EN":7599},"Department of Family Medicine, Georgetown University Medical Center, Washington, DC, USA",{"openalex":7601,"orcid":7602,"title":7603},{"VOID":992},{"VOID":994},{"EN":996},{"id":7605,"sortIndex":59,"researcher":26,"roles":7606,"affiliations":7607,"properties":7614},"a0812f98-0a3f-4174-9fd9-7252b060d6f6",[],[7608],{"id":7609,"sortIndex":36,"affiliation":7610,"properties":26},"d1d7d546-8fda-4547-ba61-2d0e189b3230",{"id":7570,"createTime":7571,"updateTime":7572,"relativeEntities":7611,"slug":7574,"properties":7612,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":7613},{"VI":7577},{"openalex":7615,"orcid":7616,"title":7617},{"VOID":843},{"VOID":845},{"EN":847},{"id":7619,"sortIndex":36,"researcher":26,"roles":7620,"affiliations":7621,"properties":7632},"2f40b591-a9b3-40bc-98ac-247918b2d966",[],[7622],{"id":7623,"sortIndex":36,"affiliation":7624,"properties":26},"4a2219f3-d439-4c18-9479-4963c43dfd0d",{"id":7625,"createTime":7626,"updateTime":7626,"relativeEntities":7627,"slug":7628,"properties":7629,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"c85cc167-29e1-4ed9-ac21-c2617be20f1c","2024-09-20T00:48:27.359+00:00",[],"International-Scientific-Association-for-Probiotics-and-Prebiotics-Centennial-CO-USA",{"title":7630},{"EN":7631},"International Scientific Association for Probiotics and Prebiotics, Centennial, CO, USA",{"openalex":7633,"orcid":7634,"title":7635},{"VOID":971},{"VOID":973},{"EN":975},{"id":7637,"sortIndex":114,"researcher":26,"roles":7638,"affiliations":7639,"properties":7650},"28aac1ab-10cc-4f96-b180-931a693a0fe6",[],[7640],{"id":7641,"sortIndex":36,"affiliation":7642,"properties":26},"d94fa810-d778-4ea0-9049-4fd0af112ae8",{"id":7643,"createTime":7644,"updateTime":7644,"relativeEntities":7645,"slug":7646,"properties":7647,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"4f3faa7b-6038-4029-88e9-376f5ddfab8d","2024-09-20T00:48:27.379+00:00",[],"Lawson-Research-Institute-and-Western-University-London-Ontario-Canada",{"title":7648},{"EN":7649},"Lawson Research Institute, and Western University, London, Ontario, Canada",{"openalex":7651,"orcid":7652,"title":7653},{"VOID":1034},{"VOID":1036},{"EN":1038},{"url":26,"publisher":7655,"properties":7685},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":7656,"slug":663,"properties":7657,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":7663,"manageAffiliations":7664,"indexDatabases":7665,"url":753,"thumbnailPath":26,"statistic":7680,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"country":7658,"issn":7659,"introduce":7660,"eissn":7661,"title":7662},{"VOID":666},{"VOID":668},{"EN":670},{"VOID":672},{"EN":674},[],[],[7666,7673],{"id":735,"indexDatabase":7667,"url":750,"indexYears":26,"academicFieldIds":7672,"indexDatabaseRanking":26},{"id":737,"createTime":738,"updateTime":739,"relativeEntities":7668,"label":7669,"description":7670,"key":746,"publicationTags":7671,"standard":26},[],{"EN":742,"VI":742},{"VI":744,"EN":745},[748,749],[752],{"id":715,"indexDatabase":7674,"url":728,"indexYears":729,"academicFieldIds":7679,"indexDatabaseRanking":733},{"id":717,"createTime":718,"updateTime":719,"relativeEntities":7675,"label":7676,"description":7677,"key":725,"publicationTags":7678,"standard":26},[],{"EN":722,"VI":722},{"EN":722,"VI":724},[727],[731,732],{"impactFactor":36,"impactFactorByYear":7681,"i10Index":259,"i10IndexLast5Year":356,"totalPublication":259,"totalPublicationByYear":7682,"totalCitation":769,"totalCitationByYear":7683,"totalCitationPerPublication":783,"totalCitationPerPublicationByYear":7684,"hindexLast5Year":283,"hindex":283},{"2012":756,"2013":757,"2014":758,"2015":759,"2016":760,"2017":761,"2018":762,"2019":763,"2020":764,"2021":765,"2022":766,"2023":767},{"2009":59,"2010":59,"2011":162,"2012":114,"2013":111,"2014":59,"2015":162,"2016":111,"2017":158,"2018":111,"2019":111,"2020":114,"2021":162,"2022":114},{"2009":144,"2010":771,"2011":772,"2012":146,"2013":773,"2014":774,"2015":775,"2016":776,"2017":777,"2018":778,"2019":779,"2020":780,"2021":781,"2022":782},{"2009":785,"2010":786,"2011":787,"2012":788,"2013":789,"2014":790,"2015":791,"2016":792,"2017":793,"2018":794,"2019":795,"2020":796,"2021":797,"2022":798},{"volume":7686,"pages":7687,"issue":7689},{"VOID":3146},{"VOID":7688},"605-616",{"VOID":4159},1214,{"total":7690,"publishYear":26,"statisticByYear":7692},{"2017":115,"2019":103,"2020":7693,"2021":7694,"2022":160,"2023":7695,"2024":7696},136,230,289,229,"2019-10-01",[7699,7702,7705,7709,7713,7715,7718,7722,7725,7729,7733,7737,7741,7745,7749,7753,7757,7760,7764,7767,7770,7774,7778,7782,7786,7790,7794,7798,7802,7806,7809,7813,7817,7821,7825,7829,7833,7837,7840,7844,7848,7852,7856,7858,7862,7866,7870,7874,7878,7882,7886,7889,7893,7897,7901,7905,7909,7912,7916,7919,7923,7927,7931,7935,7939,7943,7946,7950,7954,7958,7960,7964,7968,7972,7976,7980,7984,7988,7992,7996,8000,8004,8008,8011,8015,8018,8021,8024,8027,8031,8035,8039,8043,8047,8051,8055,8059,8063,8065,8067,8069,8073,8076,8080,8084,8088,8092,8096,8100,8104,8108,8112,8116,8119,8123,8127,8131,8135,8139,8141,8144,8148,8152,8154,8156,8160,8164,8168,8172,8176,8180,8184,8188,8192,8195,8199,8203,8206,8210,8214,8218,8222,8226,8230,8233,8237,8241,8245,8248,8252,8256,8260,8264,8268,8272,8276,8280,8283,8287,8290,8293,8297,8301,8305,8308,8312,8316,8319,8323,8327,8330,8334,8338,8342,8344,8348,8352,8355,8358,8362,8366,8370,8374,8378,8382,8386,8389,8393,8397,8401,8405,8409,8413,8417,8421,8424,8428,8432,8436,8440,8444],{"id":26,"text":7700,"url":26,"identifiers":7701},"Food and Agriculture Organization of the United Nations & World Health Organization. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. FAO http:\u002F\u002Fwww.fao.org\u002F3\u002Fa-a0512e.pdf (2001).",{},{"id":26,"text":7703,"url":26,"identifiers":7704},"Hill, C. et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11, 506–514 (2014). This Consensus Statement examines the definition, evolution, uses, types and health attributes of probiotics.",{"doi":820},{"id":26,"text":7706,"url":26,"identifiers":7707},"Rook, G., Backhed, F., Levin, B. R., McFall-Ngai, M. J. & McLean, A. R. Evolution, human-microbe interactions, and life history plasticity. Lancet 390, 521–530 (2017). This article discusses how some microorganisms have co-evolved with humans and have crucial roles in host physiology and metabolism, whereas others are intrusive.",{"doi":7708},"10.1016\u002FS0140-6736(17)30566-4",{"id":26,"text":7710,"url":26,"identifiers":7711},"Reid, G. et al. Expanding the reach of probiotics through social enterprises. Benef. Microbes 9, 707–715 (2018).",{"doi":7712},"10.3920\u002FBM2018.0015",{"id":26,"text":2459,"url":26,"identifiers":7714},{"doi":2461},{"id":26,"text":7716,"url":26,"identifiers":7717},"Gibson, G. R. et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat. Rev. Gastroenterol. Hepatol. 14, 491–502 (2017). This Consensus Statement examines the definition, evolution, uses, types and health attributes of prebiotics.",{"doi":2156},{"id":26,"text":7719,"url":26,"identifiers":7720},"Collins, S. L. et al. Promising prebiotic candidate established by evaluation of lactitol, lactulose, raffinose, and oligofructose for maintenance of a Lactobacillus-dominated vaginal microbiota. Appl. Environ. Microbiol. 84, e02200-17 (2018).",{"doi":7721},"10.1128\u002FAEM.02200-17",{"id":26,"text":7723,"url":26,"identifiers":7724},"Rodriguez, J. M. et al. The composition of the gut microbiota throughout life, with an emphasis on early life. Microb. Ecol. Health Dis. 26, 26050 (2015).",{},{"id":26,"text":7726,"url":26,"identifiers":7727},"Donaldson, G. P., Lee, S. M. & Mazmanian, S. K. Gut biogeography of the bacterial microbiota. Nat. Rev. Microbiol. 14, 20–32 (2016).",{"doi":7728},"10.1038\u002Fnrmicro3552",{"id":26,"text":7730,"url":26,"identifiers":7731},"Rowland, I. et al. Gut microbiota functions: metabolism of nutrients and other food components. Eur. J. Nutr. 57, 1–24 (2018).",{"doi":7732},"10.1007\u002Fs00394-017-1445-8",{"id":26,"text":7734,"url":26,"identifiers":7735},"Thursby, E. & Juge, N. Introduction to the human gut microbiota. Biochem. J. 474, 1823–1836 (2017). This article provides current understanding of the development and composition of the human gut microbiota, and its effects on gut integrity and host health.",{"doi":7736},"10.1042\u002FBCJ20160510",{"id":26,"text":7738,"url":26,"identifiers":7739},"Fava, F. et al. The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome ‘at-risk’ population. Int. J. Obes. (Lond.) 37, 216–223 (2013).",{"doi":7740},"10.1038\u002Fijo.2012.33",{"id":26,"text":7742,"url":26,"identifiers":7743},"Dicks, L. M. T., Geldenhuys, J., Mikkelsen, L. S., Brandsborg, E. & Marcotte, H. Our gut microbiota: a long walk to homeostasis. Benef. Microbes 9, 3–20 (2018).",{"doi":7744},"10.3920\u002FBM2017.0066",{"id":26,"text":7746,"url":26,"identifiers":7747},"Dethlefsen, L. & Relman, D. A. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl Acad. Sci. U. S. A. 108 (Suppl. 1), 4554–4561 (2011).",{"doi":7748},"10.1073\u002Fpnas.1000087107",{"id":26,"text":7750,"url":26,"identifiers":7751},"Gagliardi, A. et al. Rebuilding the gut microbiota ecosystem. Int. J. Environ. Res. Public Health 15, E1679 (2018).",{"doi":7752},"10.3390\u002Fijerph15081679",{"id":26,"text":7754,"url":26,"identifiers":7755},"Hatton, G. B., Madla, C. M., Rabbie, S. C. & Basit, A. W. All disease begins in the gut: influence of gastrointestinal disorders and surgery on oral drug performance. Int. J. Pharm. 548, 408–422 (2018).",{"doi":7756},"10.1016\u002Fj.ijpharm.2018.06.054",{"id":26,"text":7758,"url":26,"identifiers":7759},"John, G. K. et al. Dietary alteration of the gut microbiome and its impact on weight and fat mass: a systematic review and meta-analysis. Genes (Basel) 9, (E167 (2018).",{},{"id":26,"text":7761,"url":26,"identifiers":7762},"Yoshida, N., Yamashita, T. & Hirata, K. I. Gut microbiome and cardiovascular diseases. Diseases 6, E56 (2018).",{"doi":7763},"10.3390\u002Fdiseases6030056",{"id":26,"text":7765,"url":26,"identifiers":7766},"Hansen, L. B. S. et al. A low-gluten diet induces changes in the intestinal microbiome of healthy Danish adults. Nat. Commun. 9, 4630 (2018).",{},{"id":26,"text":7768,"url":26,"identifiers":7769},"Parker, R. B. Probiotics, the other half of the antibiotic story. Anim. Nutr. Health 29, 4–8 (1974).",{},{"id":26,"text":7771,"url":26,"identifiers":7772},"Havenaar, R. & Huis In’t Veld, J. M. J. in Lactic Acid Bacteria in Health and Disease Vol. 1 (ed. Wood, B. J. B.) 151–170 (Elsevier Applied Science Publishers, 1992).",{"doi":7773},"10.1007\u002F978-1-4615-3522-5_6",{"id":26,"text":7775,"url":26,"identifiers":7776},"Ng, S. C. et al. Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis. Inflamm. Bowel Dis. 16, 1286–1298 (2010).",{"doi":7777},"10.1002\u002Fibd.21222",{"id":26,"text":7779,"url":26,"identifiers":7780},"Mujagic, Z. et al. The effects of Lactobacillus plantarum on small intestinal barrier function and mucosal gene transcription; a randomized double-blind placebo controlled trial. Sci. Rep. 7, 40128 (2017).",{"doi":7781},"10.1038\u002Fsrep40128",{"id":26,"text":7783,"url":26,"identifiers":7784},"Del Piano, M. et al. The use of probiotics in healthy volunteers with evacuation disorders and hard stools: a double-blind, randomized, placebo-controlled study. J. Clin. Gastroenterol. 44 (Suppl. 1), S30–S34 (2010).",{"doi":7785},"10.1097\u002FMCG.0b013e3181ee31c3",{"id":26,"text":7787,"url":26,"identifiers":7788},"Reid, G., Gadir, A. A. & Dhir, R. Probiotics: reiterating what they are and what they are not. Front. Microbiol. 10, 424 (2019).",{"doi":7789},"10.3389\u002Ffmicb.2019.00424",{"id":26,"text":7791,"url":26,"identifiers":7792},"Cabre, E. & Gassull, M. A. Probiotics for preventing relapse or recurrence in Crohn’s disease involving the ileum: are there reasons for failure? J. Crohns Colitis 1, 47–52 (2007).",{"doi":7793},"10.1016\u002Fj.crohns.2007.06.003",{"id":26,"text":7795,"url":26,"identifiers":7796},"Kelly, J. R. et al. Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects. Brain Behav. Immun. 61, 50–59 (2017).",{"doi":7797},"10.1016\u002Fj.bbi.2016.11.018",{"id":26,"text":7799,"url":26,"identifiers":7800},"Panigrahi, P. et al. A randomized synbiotic trial to prevent sepsis among infants in rural India. Nature 548, 407–412 (2017).",{"doi":7801},"10.1038\u002Fnature23480",{"id":26,"text":7803,"url":26,"identifiers":7804},"Costeloe, K. et al. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet 387, 649–660 (2016).",{"doi":7805},"10.1016\u002FS0140-6736(15)01027-2",{"id":26,"text":7807,"url":26,"identifiers":7808},"Sorbara, M. T. & Pamer, E. G. Interbacterial mechanisms of colonization resistance and the strategies pathogens use to overcome them. Mucosal Immunol. 34, 1608 (2018).",{},{"id":26,"text":7810,"url":26,"identifiers":7811},"Chiu, L. et al. Protective microbiota: from localized to long-reaching co-immunity. Front. Immunol. 8, 1678 (2017).",{"doi":7812},"10.3389\u002Ffimmu.2017.01678",{"id":26,"text":7814,"url":26,"identifiers":7815},"Maldonado-Gomez, M. X. et al. Stable engraftment of Bifidobacterium longum AH1206 in the human gut depends on individualized features of the resident microbiome. Cell Host Microbe 20, 515–526 (2016).",{"doi":7816},"10.1016\u002Fj.chom.2016.09.001",{"id":26,"text":7818,"url":26,"identifiers":7819},"Murphy, R. et al. Eczema-protective probiotic alters infant gut microbiome functional capacity but not composition: sub-sample analysis from a RCT. Benef. Microbes 10, 5–17 (2019).",{"doi":7820},"10.3920\u002FBM2017.0191",{"id":26,"text":7822,"url":26,"identifiers":7823},"Korpela, K. et al. Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants. Microbiome 6, 182 (2018).",{"doi":7824},"10.1186\u002Fs40168-018-0567-4",{"id":26,"text":7826,"url":26,"identifiers":7827},"Clarke, G. et al. Gut reactions: breaking down xenobiotic-microbiome interactions. Pharmacol. Rev. 71, 198–224 (2019).",{"doi":7828},"10.1124\u002Fpr.118.015768",{"id":26,"text":7830,"url":26,"identifiers":7831},"Klaenhammer, T. R., Kleerebezem, M., Kopp, M. V. & Rescigno, M. The impact of probiotics and prebiotics on the immune system. Nat. Rev. Immunol. 12, 728–734 (2012). Here, four experts discuss probiotics, prebiotics and immunity, then provide their thoughts on the future application as a disease therapy.",{"doi":7832},"10.1038\u002Fnri3312",{"id":26,"text":7834,"url":26,"identifiers":7835},"Przemska-Kosicka, A. et al. Effect of a synbiotic on the response to seasonal influenza vaccination is strongly influenced by degree of immunosenescence. Immun. Ageing 13, 6 (2016).",{"doi":7836},"10.1186\u002Fs12979-016-0061-4",{"id":26,"text":7838,"url":26,"identifiers":7839},"Vitetta, L., Saltzman, E. T., Thomsen, M., Nikov, T. & Hall, S. Adjuvant probiotics and the intestinal microbiome: enhancing vaccines and immunotherapy outcomes. Vaccines (Basel) 5, (E50 (2017).",{},{"id":26,"text":7841,"url":26,"identifiers":7842},"Childs, C. E. et al. Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study. Br. J. Nutr. 111, 1945–1956 (2014).",{"doi":7843},"10.1017\u002FS0007114513004261",{"id":26,"text":7845,"url":26,"identifiers":7846},"Flint, H. J., Duncan, S. H., Scott, K. P. & Louis, P. Links between diet, gut microbiota composition and gut metabolism. Proc. Nutr. Soc. 74, 13–22 (2015).",{"doi":7847},"10.1017\u002FS0029665114001463",{"id":26,"text":7849,"url":26,"identifiers":7850},"Aoudia, N. et al. Biofilms of Lactobacillus plantarum and Lactobacillus fermentum: effect on stress responses, antagonistic effects on pathogen growth and immunomodulatory properties. Food Microbiol. 53, 51–59 (2016).",{"doi":7851},"10.1016\u002Fj.fm.2015.04.009",{"id":26,"text":7853,"url":26,"identifiers":7854},"Rios-Covian, D. et al. Intestinal short chain fatty acids and their link with diet and human health. Front. Microbiol. 7, 185 (2016).",{"doi":7855},"10.3389\u002Ffmicb.2016.00185",{"id":26,"text":2552,"url":26,"identifiers":7857},{"doi":2554},{"id":26,"text":7859,"url":26,"identifiers":7860},"Sanna, S. et al. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat. Genet. 51, 600–605 (2019).",{"doi":7861},"10.1038\u002Fs41588-019-0350-x",{"id":26,"text":7863,"url":26,"identifiers":7864},"Stefan, N., Fritsche, A., Schick, F. & Haring, H. U. Phenotypes of prediabetes and stratification of cardiometabolic risk. Lancet Diabetes Endocrinol. 4, 789–798 (2016).",{"doi":7865},"10.1016\u002FS2213-8587(16)00082-6",{"id":26,"text":7867,"url":26,"identifiers":7868},"van Baarlen, P., Wells, J. M. & Kleerebezem, M. Regulation of intestinal homeostasis and immunity with probiotic lactobacilli. Trends Immunol. 34, 208–215 (2013).",{"doi":7869},"10.1016\u002Fj.it.2013.01.005",{"id":26,"text":7871,"url":26,"identifiers":7872},"Hegarty, J. W., Guinane, C. M., Ross, R. P., Hill, C. & Cotter, P. D. Bacteriocin production: a relatively unharnessed probiotic trait? F1000Res. 5, 2587 (2016).",{"doi":7873},"10.12688\u002Ff1000research.9615.1",{"id":26,"text":7875,"url":26,"identifiers":7876},"Mokoena, M. P. Lactic acid bacteria and their bacteriocins: classification, biosynthesis and applications against uropathogens: a mini-review. Molecules 22, E1255 (2017).",{"doi":7877},"10.3390\u002Fmolecules22081255",{"id":26,"text":7879,"url":26,"identifiers":7880},"Bali, V., Panesar, P. S., Bera, M. B. & Kennedy, J. F. Bacteriocins: recent trends and potential applications. Crit. Rev. Food Sci. Nutr. 56, 817–834 (2016).",{"doi":7881},"10.1080\u002F10408398.2012.729231",{"id":26,"text":7883,"url":26,"identifiers":7884},"Riviere, A., Selak, M., Lantin, D., Leroy, F. & De Vuyst, L. Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front. Microbiol. 7, 979 (2016).",{"doi":7885},"10.3389\u002Ffmicb.2016.00979",{"id":26,"text":7887,"url":26,"identifiers":7888},"Abdulkadir, B. et al. Routine use of probiotics in preterm infants: longitudinal impact on the microbiome and metabolome. Neonatology 109, (239–247 (2016).",{},{"id":26,"text":7890,"url":26,"identifiers":7891},"Fang, H. R., Zhang, G. Q., Cheng, J. Y. & Li, Z. Y. Efficacy of Lactobacillus-supplemented triple therapy for Helicobacter pylori infection in children: a meta-analysis of randomized controlled trials. Eur. J. Pediatr. 178, 7–16 (2019).",{"doi":7892},"10.1007\u002Fs00431-018-3282-z",{"id":26,"text":7894,"url":26,"identifiers":7895},"Sanders, M. E., Benson, A., Lebeer, S., Merenstein, D. J. & Klaenhammer, T. R. Shared mechanisms among probiotic taxa: implications for general probiotic claims. Curr. Opin. Biotechnol. 49, 207–216 (2018).",{"doi":7896},"10.1016\u002Fj.copbio.2017.09.007",{"id":26,"text":7898,"url":26,"identifiers":7899},"Petrova, M. I. et al. Comparative genomic and phenotypic analysis of the vaginal probiotic Lactobacillus rhamnosus GR-1. Front. Microbiol. 9, 1278 (2018).",{"doi":7900},"10.3389\u002Ffmicb.2018.01278",{"id":26,"text":7902,"url":26,"identifiers":7903},"La Fata, G., Weber, P. & Mohajeri, M. H. Probiotics and the gut immune system: indirect regulation. Probiot. Antimicrob. Proteins 10, 11–21 (2018).",{"doi":7904},"10.1007\u002Fs12602-017-9322-6",{"id":26,"text":7906,"url":26,"identifiers":7907},"Han, X. et al. Lactobacillus rhamnosus GG prevents epithelial barrier dysfunction induced by interferon-gamma and fecal supernatants from irritable bowel syndrome patients in human intestinal enteroids and colonoids. Gut Microbes 10, 59–76 (2019).",{"doi":7908},"10.1080\u002F19490976.2018.1479625",{"id":26,"text":7910,"url":26,"identifiers":7911},"Mack, D. R., Michail, S., Wei, S., McDougall, L. & Hollingsworth, M. A. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 276, G941–G950 (1999).",{},{"id":26,"text":7913,"url":26,"identifiers":7914},"Yan, F. et al. A Lactobacillus rhamnosus GG-derived soluble protein, p40, stimulates ligand release from intestinal epithelial cells to transactivate epidermal growth factor receptor. J. Biol. Chem. 288, 30742–30751 (2013).",{"doi":7915},"10.1074\u002Fjbc.M113.492397",{"id":26,"text":7917,"url":26,"identifiers":7918},"Stadlbauer, V. et al. Lactobacillus casei Shirota supplementation does not restore gut microbiota composition and gut barrier in metabolic syndrome: a randomized pilot study. PLOS ONE 10, e0141399 (2015).",{},{"id":26,"text":7920,"url":26,"identifiers":7921},"Kim, N., Yun, M., Oh, Y. J. & Choi, H. J. Mind-altering with the gut: modulation of the gut-brain axis with probiotics. J. Microbiol. 56, 172–182 (2018).",{"doi":7922},"10.1007\u002Fs12275-018-8032-4",{"id":26,"text":7924,"url":26,"identifiers":7925},"Janik, R. et al. Magnetic resonance spectroscopy reveals oral Lactobacillus promotion of increases in brain GABA, N-acetyl aspartate and glutamate. Neuroimage 125, 988–995 (2016).",{"doi":7926},"10.1016\u002Fj.neuroimage.2015.11.018",{"id":26,"text":7928,"url":26,"identifiers":7929},"Reid, G. Disentangling what we know about microbes and mental health. Front. Endocrinol. 10, 81 (2019).",{"doi":7930},"10.3389\u002Ffendo.2019.00081",{"id":26,"text":7932,"url":26,"identifiers":7933},"Liang, S. et al. Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress. Neuroscience 310, 561–577 (2015).",{"doi":7934},"10.1016\u002Fj.neuroscience.2015.09.033",{"id":26,"text":7936,"url":26,"identifiers":7937},"Kotz, C. M., Furne, J. K., Savaiano, D. A. & Levitt, M. D. Factors affecting the ability of a high beta-galactosidase yogurt to enhance lactose absorption. J. Dairy Sci. 77, 3538–3544 (1994).",{"doi":7938},"10.3168\u002Fjds.S0022-0302(94)77296-9",{"id":26,"text":7940,"url":26,"identifiers":7941},"Costabile, A. et al. An in vivo assessment of the cholesterol-lowering efficacy of Lactobacillus plantarum ECGC 13110402 in normal to mildly hypercholesterolaemic adults. PLOS ONE 12, e0187964 (2017).",{"doi":7942},"10.1371\u002Fjournal.pone.0187964",{"id":26,"text":7944,"url":26,"identifiers":7945},"European Food Safety Authority Panel on Dietetic Products. Scientific opinion on the substantiation of health claims related to live yoghurt cultures and improved lactose digestion (ID 1143, 2976) pursuant to article 13(1) of regulation (EC) No 1924\u002F2006. EFSA J. 8, 1763 (2010).",{},{"id":26,"text":7947,"url":26,"identifiers":7948},"Li, D., Wang, P., Wang, P., Hu, X. & Chen, F. The gut microbiota: a treasure for human health. Biotechnol. Adv. 34, 1210–1224 (2016).",{"doi":7949},"10.1016\u002Fj.biotechadv.2016.08.003",{"id":26,"text":7951,"url":26,"identifiers":7952},"Kasubuchi, M., Hasegawa, S., Hiramatsu, T., Ichimura, A. & Kimura, I. Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients 7, 2839–2849 (2015).",{"doi":7953},"10.3390\u002Fnu7042839",{"id":26,"text":7955,"url":26,"identifiers":7956},"Verbeke, K. A. et al. Towards microbial fermentation metabolites as markers for health benefits of prebiotics. Nutr. Res. Rev. 28, 42–66 (2015).",{"doi":7957},"10.1017\u002FS0954422415000037",{"id":26,"text":2451,"url":26,"identifiers":7959},{"doi":2453},{"id":26,"text":7961,"url":26,"identifiers":7962},"Fogliano, V. et al. In vitro bioaccessibility and gut biotransformation of polyphenols present in the water-insoluble cocoa fraction. Mol. Nutr. Food Res. 55 (Suppl. 1), S44–S55 (2011).",{"doi":7963},"10.1002\u002Fmnfr.201000360",{"id":26,"text":7965,"url":26,"identifiers":7966},"Falony, G. et al. In vitro kinetic analysis of fermentation of prebiotic inulin-type fructans by Bifidobacterium species reveals four different phenotypes. Appl. Environ. Microbiol. 75, 454–461 (2009).",{"doi":7967},"10.1128\u002FAEM.01488-08",{"id":26,"text":7969,"url":26,"identifiers":7970},"Riviere, A., Selak, M., Geirnaert, A., Van den Abbeele, P. & De Vuyst, L. Complementary mechanisms for degradation of inulin-type fructans and arabinoxylan oligosaccharides among bifidobacterial strains suggest bacterial cooperation. Appl. Environ. Microbiol. 84, e02893-17 (2018).",{"doi":7971},"10.1128\u002FAEM.02893-17",{"id":26,"text":7973,"url":26,"identifiers":7974},"Flint, H. J., Scott, K. P., Duncan, S. H., Louis, P. & Forano, E. Microbial degradation of complex carbohydrates in the gut. Gut Microbes 3, 289–306 (2012).",{"doi":7975},"10.4161\u002Fgmic.19897",{"id":26,"text":7977,"url":26,"identifiers":7978},"Hamaker, B. R. & Tuncil, Y. E. A perspective on the complexity of dietary fiber structures and their potential effect on the gut microbiota. J. Mol. Biol. 426, 3838–3850 (2014).",{"doi":7979},"10.1016\u002Fj.jmb.2014.07.028",{"id":26,"text":7981,"url":26,"identifiers":7982},"Ze, X., Le Mougen, F., Duncan, S. H., Louis, P. & Flint, H. J. Some are more equal than others: the role of “keystone” species in the degradation of recalcitrant substrates. Gut Microbes 4, 236–240 (2013).",{"doi":7983},"10.4161\u002Fgmic.23998",{"id":26,"text":7985,"url":26,"identifiers":7986},"Ze, X., Duncan, S. H., Louis, P. & Flint, H. J. Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J. 6, 1535–1543 (2012).",{"doi":7987},"10.1038\u002Fismej.2012.4",{"id":26,"text":7989,"url":26,"identifiers":7990},"Hosseini, E., Grootaert, C., Verstraete, W. & Van de Wiele, T. Propionate as a health-promoting microbial metabolite in the human gut. Nutr. Rev. 69, 245–258 (2011).",{"doi":7991},"10.1111\u002Fj.1753-4887.2011.00388.x",{"id":26,"text":7993,"url":26,"identifiers":7994},"Louis, P. & Flint, H. J. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol. Lett. 294, 1–8 (2009).",{"doi":7995},"10.1111\u002Fj.1574-6968.2009.01514.x",{"id":26,"text":7997,"url":26,"identifiers":7998},"Falony, G., Calmeyn, T., Leroy, F. & De Vuyst, L. Coculture fermentations of Bifidobacterium species and Bacteroides thetaiotaomicron reveal a mechanistic insight into the prebiotic effect of inulin-type fructans. Appl. Environ. Microbiol. 75, 2312–2319 (2009).",{"doi":7999},"10.1128\u002FAEM.02649-08",{"id":26,"text":8001,"url":26,"identifiers":8002},"Scott, K. P., Martin, J. C., Duncan, S. H. & Flint, H. J. Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro. FEMS Microbiol. Ecol. 87, 30–40 (2014).",{"doi":8003},"10.1111\u002F1574-6941.12186",{"id":26,"text":8005,"url":26,"identifiers":8006},"Flint, H. J., Duncan, S. H. & Louis, P. The impact of nutrition on intestinal bacterial communities. Curr. Opin. Microbiol. 38, 59–65 (2017).",{"doi":8007},"10.1016\u002Fj.mib.2017.04.005",{"id":26,"text":8009,"url":26,"identifiers":8010},"Chen, T. et al. Fiber-utilizing capacity varies in Prevotella- versus Bacteroides-dominated gut microbiota. Sci. Rep. 7, 2594 (2017).",{},{"id":26,"text":8012,"url":26,"identifiers":8013},"Wu, Q. et al. Fermentation properties of isomaltooligosaccharides are affected by human fecal enterotypes. Anaerobe 48, 206–214 (2017).",{"doi":8014},"10.1016\u002Fj.anaerobe.2017.08.016",{"id":26,"text":8016,"url":26,"identifiers":8017},"Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65 (2010).",{"doi":1248},{"id":26,"text":8019,"url":26,"identifiers":8020},"Frank, D. N. et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl Acad. Sci. U. S. A. 104, 13780–13785 (2007).",{"doi":6375},{"id":26,"text":8022,"url":26,"identifiers":8023},"Larsen, N. et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLOS ONE 5, e9085 (2010).",{},{"id":26,"text":8025,"url":26,"identifiers":8026},"Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55–60 (2012). This study provides a definition and description of the minimal gut metagenome and bacterial genome in terms of functions.",{"doi":1260},{"id":26,"text":8028,"url":26,"identifiers":8029},"Karlsson, F. H. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99–103 (2013).",{"doi":8030},"10.1038\u002Fnature12198",{"id":26,"text":8032,"url":26,"identifiers":8033},"Carroll, I. M., Chang, Y. H., Park, J., Sartor, R. B. & Ringel, Y. Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Gut Pathog. 2, 19 (2010).",{"doi":8034},"10.1186\u002F1757-4749-2-19",{"id":26,"text":8036,"url":26,"identifiers":8037},"Krogius-Kurikka, L. et al. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol. 9, 95 (2009).",{"doi":8038},"10.1186\u002F1471-230X-9-95",{"id":26,"text":8040,"url":26,"identifiers":8041},"Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1031 (2006).",{"doi":8042},"10.1038\u002Fnature05414",{"id":26,"text":8044,"url":26,"identifiers":8045},"Zhang, H. et al. Human gut microbiota in obesity and after gastric bypass. Proc. Natl Acad. Sci. U. S. A. 106, 2365–2370 (2009).",{"doi":8046},"10.1073\u002Fpnas.0812600106",{"id":26,"text":8048,"url":26,"identifiers":8049},"Ha, C. W., Lam, Y. Y. & Holmes, A. J. Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health. World J. Gastroenterol. 20, 16498–16517 (2014).",{"doi":8050},"10.3748\u002Fwjg.v20.i44.16498",{"id":26,"text":8052,"url":26,"identifiers":8053},"Moya, A. & Ferrer, M. Functional redundancy-induced stability of gut microbiota subjected to disturbance. Trends Microbiol. 24, 402–413 (2016).",{"doi":8054},"10.1016\u002Fj.tim.2016.02.002",{"id":26,"text":8056,"url":26,"identifiers":8057},"Fooks, L. J. & Gibson, G. R. In vitro investigations of the effect of probiotics and prebiotics on selected human intestinal pathogens. FEMS Microbiol. Ecol. 39, 67–75 (2002).",{"doi":8058},"10.1111\u002Fj.1574-6941.2002.tb00907.x",{"id":26,"text":8060,"url":26,"identifiers":8061},"Tzortzis, G., Baillon, M. L., Gibson, G. R. & Rastall, R. A. Modulation of anti-pathogenic activity in canine-derived Lactobacillus species by carbohydrate growth substrate. J. Appl. Microbiol. 96, 552–559 (2004).",{"doi":8062},"10.1111\u002Fj.1365-2672.2004.02172.x",{"id":26,"text":2911,"url":26,"identifiers":8064},{"doi":2913},{"id":26,"text":2663,"url":26,"identifiers":8066},{"doi":2665},{"id":26,"text":2706,"url":26,"identifiers":8068},{"doi":2708},{"id":26,"text":8070,"url":26,"identifiers":8071},"Ivakhnenko, O. S. & Nyankovskyy, S. L. Effect of the specific infant formula mixture of oligosaccharides on local immunity and development of allergic and infectious disease in young children: randomized study. Pediatr. Pol. 88, 398–404 (2013).",{"doi":8072},"10.1016\u002Fj.pepo.2013.07.002",{"id":26,"text":8074,"url":26,"identifiers":8075},"Arslanoglu, S. et al. Early neutral prebiotic oligosaccharide supplementation reduces the incidence of some allergic manifestations in the first 5 years of life. J. Biol. Regul. Homeost. Agents 26, 49–59 (2012).",{},{"id":26,"text":8077,"url":26,"identifiers":8078},"Diaz de Barboza, G. & Guizzardi, S. & Tolosa de Talamoni, N. Molecular aspects of intestinal calcium absorption. World J. Gastroenterol. 21, 7142–7154 (2015).",{"doi":8079},"10.3748\u002Fwjg.v21.i23.7142",{"id":26,"text":8081,"url":26,"identifiers":8082},"Goss, S. L., Lemons, K. A., Kerstetter, J. E. & Bogner, R. H. Determination of calcium salt solubility with changes in pH and P(CO(2)), simulating varying gastrointestinal environments. J. Pharm. Pharmacol. 59, 1485–1492 (2007).",{"doi":8083},"10.1211\u002Fjpp.59.11.0004",{"id":26,"text":8085,"url":26,"identifiers":8086},"Abrams, S. A., Griffin, I. J., Hawthorne, K. M. & Ellis, K. J. Effect of prebiotic supplementation and calcium intake on body mass index. J. Pediatr. 151, 293–298 (2007).",{"doi":8087},"10.1016\u002Fj.jpeds.2007.03.043",{"id":26,"text":8089,"url":26,"identifiers":8090},"Abrams, S. A., Griffin, I. J. & Hawthorne, K. M. Young adolescents who respond to an inulin-type fructan substantially increase total absorbed calcium and daily calcium accretion to the skeleton. J. Nutr. 137, 2524S–2526S (2007).",{"doi":8091},"10.1093\u002Fjn\u002F137.11.2524S",{"id":26,"text":8093,"url":26,"identifiers":8094},"Whisner, C. M. et al. Galacto-oligosaccharides increase calcium absorption and gut bifidobacteria in young girls: a double-blind cross-over trial. Br. J. Nutr. 110, 1292–1303 (2013).",{"doi":8095},"10.1017\u002FS000711451300055X",{"id":26,"text":8097,"url":26,"identifiers":8098},"Chonan, O., Matsumoto, K. & Watanuki, M. Effect of galactooligosaccharides on calcium absorption and preventing bone loss in ovariectomized rats. Biosci. Biotechnol. Biochem. 59, 236–239 (1995).",{"doi":8099},"10.1271\u002Fbbb.59.236",{"id":26,"text":8101,"url":26,"identifiers":8102},"Kanauchi, O., Andoh, A. & Mitsuyama, K. Effects of the modulation of microbiota on the gastrointestinal immune system and bowel function. J. Agric. Food Chem. 61, 9977–9983 (2013).",{"doi":8103},"10.1021\u002Fjf402441f",{"id":26,"text":8105,"url":26,"identifiers":8106},"Hurst, N. R., Kendig, D. M., Murthy, K. S. & Grider, J. R. The short chain fatty acids, butyrate and propionate, have differential effects on the motility of the guinea pig colon. Neurogastroenterol. Motil. 26, 1586–1596 (2014).",{"doi":8107},"10.1111\u002Fnmo.12425",{"id":26,"text":8109,"url":26,"identifiers":8110},"Lamsal, B. P. Production, health aspects and potential food uses of dairy prebiotic galactooligosaccharides. J. Sci. Food Agric. 92, 2020–2028 (2012).",{"doi":8111},"10.1002\u002Fjsfa.5712",{"id":26,"text":8113,"url":26,"identifiers":8114},"Hager, A.-S. et al. Influence of the soluble fibres inulin and oat β-glucan on quality of dough and bread. Eur. Food Res. Technol. 232, 405–413 (2011).",{"doi":8115},"10.1007\u002Fs00217-010-1409-1",{"id":26,"text":8117,"url":26,"identifiers":8118},"Collado Yurrita, L., San Mauro Martin, I., Ciudad-Cabanas, M. J., Calle-Puron, M. E. & Hernandez Cabria, M. Effectiveness of inulin intake on indicators of chronic constipation; a meta-analysis of controlled randomized clinical trials. Nutr. Hosp. 30, 244–252 (2014).",{},{"id":26,"text":8120,"url":26,"identifiers":8121},"Buddington, R. K., Kapadia, C., Neumer, F. & Theis, S. Oligofructose provides laxation for irregularity associated with low fiber intake. Nutrients 9, E1372 (2017).",{"doi":8122},"10.3390\u002Fnu9121372",{"id":26,"text":8124,"url":26,"identifiers":8125},"Krumbeck, J. A. et al. Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics. Microbiome 6, 121 (2018).",{"doi":8126},"10.1186\u002Fs40168-018-0494-4",{"id":26,"text":8128,"url":26,"identifiers":8129},"Cani, P. D. et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761–1772 (2007).",{"doi":8130},"10.2337\u002Fdb06-1491",{"id":26,"text":8132,"url":26,"identifiers":8133},"Cani, P. D. et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470–1481 (2008).",{"doi":8134},"10.2337\u002Fdb07-1403",{"id":26,"text":8136,"url":26,"identifiers":8137},"Cani, P. D. et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091–1103 (2009).",{"doi":8138},"10.1136\u002Fgut.2008.165886",{"id":26,"text":2769,"url":26,"identifiers":8140},{"doi":2771},{"id":26,"text":8142,"url":26,"identifiers":8143},"Beserra, B. T. et al. A systematic review and meta-analysis of the prebiotics and synbiotics effects on glycaemia, insulin concentrations and lipid parameters in adult patients with overweight or obesity. Clin. Nutr. 34, 845–858 (2015).",{"doi":2775},{"id":26,"text":8145,"url":26,"identifiers":8146},"Liu, F., Prabhakar, M., Ju, J., Long, H. & Zhou, H. W. Effect of inulin-type fructans on blood lipid profile and glucose level: a systematic review and meta-analysis of randomized controlled trials. Eur. J. Clin. Nutr. 71, 9–20 (2017).",{"doi":8147},"10.1038\u002Fejcn.2016.156",{"id":26,"text":8149,"url":26,"identifiers":8150},"Guo, Z. et al. Effects of inulin on the plasma lipid profile of normolipidemic and hyperlipidemic subjects: a meta-analysis of randomized controlled trials. Clin. Lipidol 7, 215–222 (2012).",{"doi":8151},"10.2217\u002Fclp.12.8",{"id":26,"text":2793,"url":26,"identifiers":8153},{"doi":2795},{"id":26,"text":2528,"url":26,"identifiers":8155},{"doi":2530},{"id":26,"text":8157,"url":26,"identifiers":8158},"Bhatia, S. et al. Galacto-oligosaccharides may directly enhance intestinal barrier function through the modulation of goblet cells. Mol. Nutr. Food Res. 59, 566–573 (2015).",{"doi":8159},"10.1002\u002Fmnfr.201400639",{"id":26,"text":8161,"url":26,"identifiers":8162},"Akbari, P. et al. Characterizing microbiota-independent effects of oligosaccharides on intestinal epithelial cells: insight into the role of structure and size: structure-activity relationships of non-digestible oligosaccharides. Eur. J. Nutr. 56, 1919–1930 (2017).",{"doi":8163},"10.1007\u002Fs00394-016-1234-9",{"id":26,"text":8165,"url":26,"identifiers":8166},"Neyrinck, A. M. et al. Intestinal sucrase as a novel target contributing to the regulation of glycemia by prebiotics. PLOS ONE 11, e0160488 (2016).",{"doi":8167},"10.1371\u002Fjournal.pone.0160488",{"id":26,"text":8169,"url":26,"identifiers":8170},"Stoddart, L. A., Smith, N. J. & Milligan, G. International Union of Pharmacology. LXXI. Free fatty acid receptors FFA1, -2, and -3: pharmacology and pathophysiological functions. Pharmacol. Rev. 60, 405–417 (2008).",{"doi":8171},"10.1124\u002Fpr.108.00802",{"id":26,"text":8173,"url":26,"identifiers":8174},"Bolognini, D. et al. Chemogenetics defines receptor-mediated functions of short chain free fatty acids. Nat. Chem. Biol. 15, 489–498 (2019).",{"doi":8175},"10.1038\u002Fs41589-019-0270-1",{"id":26,"text":8177,"url":26,"identifiers":8178},"Chambers, E. S., Morrison, D. J. & Frost, G. Control of appetite and energy intake by SCFA: what are the potential underlying mechanisms? Proc. Nutr. Soc. 74, 328–336 (2015).",{"doi":8179},"10.1017\u002FS0029665114001657",{"id":26,"text":8181,"url":26,"identifiers":8182},"Mithieux, G. Metabolic effects of portal vein sensing. Diabetes Obes. Metab. 16 (Suppl. 1), 56–60 (2014).",{"doi":8183},"10.1111\u002Fdom.12338",{"id":26,"text":8185,"url":26,"identifiers":8186},"Frost, G. et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat. Commun. 5, 3611 (2014).",{"doi":8187},"10.1038\u002Fncomms4611",{"id":26,"text":8189,"url":26,"identifiers":8190},"Jackson, S. A. et al. Improving end-user trust in the quality of commercial probiotic products. Front. Microbiol. 10, 739 (2019).",{"doi":8191},"10.3389\u002Ffmicb.2019.00739",{"id":26,"text":8193,"url":26,"identifiers":8194},"AlFaleh, K. & Anabrees, J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst. Rev. 4, CD005496 (2014).",{},{"id":26,"text":8196,"url":26,"identifiers":8197},"Vanderhoof, J. A. et al. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J. Pediatr. 135, 564–568 (1999).",{"doi":8198},"10.1016\u002FS0022-3476(99)70053-3",{"id":26,"text":8200,"url":26,"identifiers":8201},"Szajewska, H., Albrecht, P. & Topczewska-Cabanek, A. Randomized, double-blind, placebo-controlled trial: effect of Lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children. J. Pediatr. Gastroenterol. Nutr. 48, 431–436 (2009).",{"doi":8202},"10.1097\u002FMPG.0b013e318182e716",{"id":26,"text":8204,"url":26,"identifiers":8205},"Goldenberg, J. Z. et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst. Rev. 4, CD004827 (2015).",{},{"id":26,"text":8207,"url":26,"identifiers":8208},"Eskesen, D. et al. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial. Br. J. Nutr. 114, 1638–1646 (2015).",{"doi":8209},"10.1017\u002FS0007114515003347",{"id":26,"text":8211,"url":26,"identifiers":8212},"Yang, Y. X. et al. Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women. World J. Gastroenterol. 14, 6237–6243 (2008).",{"doi":8213},"10.3748\u002Fwjg.14.6237",{"id":26,"text":8215,"url":26,"identifiers":8216},"Sung, V. et al. Lactobacillus reuteri to treat infant colic: a meta-analysis. Pediatrics 141, e20171811 (2018).",{"doi":8217},"10.1542\u002Fpeds.2017-1811",{"id":26,"text":8219,"url":26,"identifiers":8220},"Mardini, H. E. & Grigorian, A. Y. Probiotic mix VSL#3 is effective adjunctive therapy for mild to moderately active ulcerative colitis: a meta-analysis. Inflamm. Bowel Dis. 20, 1562–1567 (2014).",{"doi":8221},"10.1097\u002FMIB.0000000000000084",{"id":26,"text":8223,"url":26,"identifiers":8224},"Whorwell, P. J. et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am. J. Gastroenterol. 101, 1581–1590 (2006).",{"doi":8225},"10.1111\u002Fj.1572-0241.2006.00734.x",{"id":26,"text":8227,"url":26,"identifiers":8228},"Szajewska, H. et al. Systematic review with meta-analysis: Lactobacillus rhamnosus GG for treating acute gastroenteritis in children - a 2019 update. Aliment. Pharmacol. Ther. 49, 1376–1384 (2019).",{"doi":8229},"10.1111\u002Fapt.15267",{"id":26,"text":8231,"url":26,"identifiers":8232},"Goldenberg, J. Z. et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst. Rev. 12, CD006095 (2017).",{},{"id":26,"text":8234,"url":26,"identifiers":8235},"King, S. et al. Does probiotic consumption reduce antibiotic utilization for common acute infections? A systematic review and meta-analysis. Eur. J. Public Health 29, 494–499 (2019).",{"doi":8236},"10.1093\u002Feurpub\u002Fcky185",{"id":26,"text":8238,"url":26,"identifiers":8239},"Cruchet, S. et al. The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts. Paediatr. Drugs 17, 199–216 (2015).",{"doi":8240},"10.1007\u002Fs40272-015-0124-6",{"id":26,"text":8242,"url":26,"identifiers":8243},"Cameron, D. et al. Probiotics for gastrointestinal disorders: proposed recommendations for children of the Asia-Pacific region. World J. Gastroenterol. 23, 7952–7964 (2017).",{"doi":8244},"10.3748\u002Fwjg.v23.i45.7952",{"id":26,"text":8246,"url":26,"identifiers":8247},"Hao, Q., Dong, B. R. & Wu, T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst. Rev. 9, CD006895 (2015).",{},{"id":26,"text":8249,"url":26,"identifiers":8250},"King, S., Glanville, J., Sanders, M. E., Fitzgerald, A. & Varley, D. Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: a systematic review and meta-analysis. Br. J. Nutr. 112, 41–54 (2014).",{"doi":8251},"10.1017\u002FS0007114514000075",{"id":26,"text":8253,"url":26,"identifiers":8254},"Yang, L. et al. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology 137, 588–597 (2009).",{"doi":8255},"10.1053\u002Fj.gastro.2009.04.046",{"id":26,"text":8257,"url":26,"identifiers":8258},"Szymanski, H. & Szajewska, H. Lack of efficacy of Lactobacillus reuteri DSM 17938 for the treatment of acute gastroenteritis: a randomized controlled trial. Pediatr. Infect. Dis. J. https:\u002F\u002Fdoi.org\u002F10.1097\u002FINF.0000000000002355 (2019).",{"doi":8259},"10.1097\u002FINF.0000000000002355",{"id":26,"text":8261,"url":26,"identifiers":8262},"van den Akker, C. H. P. et al. Probiotics for preterm infants: a strain-specific systematic review and network meta-analysis. J. Pediatr. Gastroenterol. Nutr. 67, 103–122 (2018).",{"doi":8263},"10.1097\u002FMPG.0000000000001897",{"id":26,"text":8265,"url":26,"identifiers":8266},"Arslanoglu, S., Moro, G. E. & Boehm, G. Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. J. Nutr. 137, 2420–2424 (2007).",{"doi":8267},"10.1093\u002Fjn\u002F137.11.2420",{"id":26,"text":8269,"url":26,"identifiers":8270},"Arslanoglu, S. et al. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J. Nutr. 138, 1091–1095 (2008).",{"doi":8271},"10.1093\u002Fjn\u002F138.6.1091",{"id":26,"text":8273,"url":26,"identifiers":8274},"Boehm, G. et al. Prebiotics in infant formulas. J. Clin. Gastroenterol. 38, S76–S79 (2004).",{"doi":8275},"10.1097\u002F01.mcg.0000128927.91414.93",{"id":26,"text":8277,"url":26,"identifiers":8278},"Shahramian, I. et al. The effects of prebiotic supplementation on weight gain, diarrhoea, constipation, fever and respiratory tract infections in the first year of life. J. Paediatr. Child Health 54, 875–880 (2018).",{"doi":8279},"10.1111\u002Fjpc.13906",{"id":26,"text":8281,"url":26,"identifiers":8282},"Drakoularakou, A., Tzortzis, G., Rastall, R. A. & Gibson, G. R. A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers’ diarrhoea. Eur. J. Clin. Nutr. 64, 146–152 (2010).",{"doi":2902},{"id":26,"text":8284,"url":26,"identifiers":8285},"Micka, A., Siepelmeyer, A., Holz, A., Theis, S. & Schon, C. Effect of consumption of chicory inulin on bowel function in healthy subjects with constipation: a randomized, double-blind, placebo-controlled trial. Int. J. Food Sci. Nutr. 68, 82–89 (2017).",{"doi":8286},"10.1080\u002F09637486.2016.1212819",{"id":26,"text":8288,"url":26,"identifiers":8289},"European Food Safety Authority Panel on Dietetic Products. Scientific opinion on the substantiation of a health claim related to “native chicory inulin” and maintenance of normal defecation by increasing stool frequency pursuant to article 13.5 of regulation (EC) No 1924\u002F2006. EFSA J. 13, 3951 (2015).",{"doi":3045},{"id":26,"text":8291,"url":26,"identifiers":8292},"Hume, M. P., Nicolucci, A. C. & Reimer, R. A. Prebiotic supplementation improves appetite control in children with overweight and obesity: a randomized controlled trial. Am. J. Clin. Nutr. 105, 790–799 (2017).",{"doi":2807},{"id":26,"text":8294,"url":26,"identifiers":8295},"Nicolucci, A. C. et al. Prebiotics reduce body fat and alter intestinal microbiota in children who are overweight or with obesity. Gastroenterology 153, 711–722 (2017).",{"doi":8296},"10.1053\u002Fj.gastro.2017.05.055",{"id":26,"text":8298,"url":26,"identifiers":8299},"Pol, K., de Graaf, C., Meyer, D. & Mars, M. The efficacy of daily snack replacement with oligofructose-enriched granola bars in overweight and obese adults: a 12-week randomised controlled trial. Br. J. Nutr. 119, 1076–1086 (2018).",{"doi":8300},"10.1017\u002FS0007114518000211",{"id":26,"text":8302,"url":26,"identifiers":8303},"Liber, A. & Szajewska, H. Effect of oligofructose supplementation on body weight in overweight and obese children: a randomised, double-blind, placebo-controlled trial. Br. J. Nutr. 112, 2068–2074 (2014).",{"doi":8304},"10.1017\u002FS0007114514003110",{"id":26,"text":8306,"url":26,"identifiers":8307},"European Food Safety Authority Panel on Dietetic Products. Scientific opinion on the substantiation of a health claim related to non-digestible carbohydrates and a reduction of post-prandial glycaemic responses pursuant to article 13(5) of regulation (EC) No 1924\u002F2006. EFSA J. 12, 3513 (2015).",{},{"id":26,"text":8309,"url":26,"identifiers":8310},"Lightowler, H., Thondre, S., Holz, A. & Theis, S. Replacement of glycaemic carbohydrates by inulin-type fructans from chicory (oligofructose, inulin) reduces the postprandial blood glucose and insulin response to foods: report of two double-blind, randomized, controlled trials. Eur. J. Nutr. 57, 1259–1268 (2018).",{"doi":8311},"10.1007\u002Fs00394-017-1409-z",{"id":26,"text":8313,"url":26,"identifiers":8314},"Olbjorn, C. et al. Fecal microbiota profiles in treatment-naive pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcome. Clin. Exp. Gastroenterol. 12, 37–49 (2019).",{"doi":8315},"10.2147\u002FCEG.S186235",{"id":26,"text":8317,"url":26,"identifiers":8318},"Backhed, F. et al. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 12, 611–622 (2012).",{"doi":1168},{"id":26,"text":8320,"url":26,"identifiers":8321},"Dey, M. Toward a personalized approach in prebiotics research. Nutrients 9, 92 (2017).",{"doi":8322},"10.3390\u002Fnu9020092",{"id":26,"text":8324,"url":26,"identifiers":8325},"Healey, G. et al. Habitual dietary fibre intake influences gut microbiota response to an inulin-type fructan prebiotic: a randomised, double-blind, placebo-controlled, cross-over, human intervention study. Br. J. Nutr. 119, 176–189 (2018).",{"doi":8326},"10.1017\u002FS0007114517003440",{"id":26,"text":8328,"url":26,"identifiers":8329},"Tandon, D. et al. A prospective randomized, double-blind, placebo-controlled, dose-response relationship study to investigate efficacy of fructo-oligosaccharides (FOS) on human gut microflora. Sci. Rep. 9, 5473 (2019).",{},{"id":26,"text":8331,"url":26,"identifiers":8332},"Bian, G. et al. The gut microbiota of healthy aged Chinese is similar to that of the healthy young. mSphere 2, e00327–17 (2017).",{"doi":8333},"10.1128\u002FmSphere.00327-17",{"id":26,"text":8335,"url":26,"identifiers":8336},"Gloor, G. B., Macklaim, J. M., Pawlowsky-Glahn, V. & Egozcue, J. J. Microbiome datasets are compositional: and this is not optional. Front. Microbiol. 8, 2224 (2017).",{"doi":8337},"10.3389\u002Ffmicb.2017.02224",{"id":26,"text":8339,"url":26,"identifiers":8340},"Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222–227 (2012). This study considers the gut microbiome in evaluating human development, nutritional needs, physiological variations and the effects of westernization.",{"doi":8341},"10.1038\u002Fnature11053",{"id":26,"text":2919,"url":26,"identifiers":8343},{"doi":2921},{"id":26,"text":8345,"url":26,"identifiers":8346},"Claesson, M. J. et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488, 178–184 (2012).",{"doi":8347},"10.1038\u002Fnature11319",{"id":26,"text":8349,"url":26,"identifiers":8350},"Clarke, S. F. et al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut 63, 1913–1920 (2014).",{"doi":8351},"10.1136\u002Fgutjnl-2013-306541",{"id":26,"text":8353,"url":26,"identifiers":8354},"Engen, P. A., Green, S. J., Voigt, R. M., Forsyth, C. B. & Keshavarzian, A. The gastrointestinal microbiome: alcohol effects on the composition of intestinal microbiota. Alcohol Res. 37, 223–236 (2015).",{},{"id":26,"text":8356,"url":26,"identifiers":8357},"Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119–124 (2012).",{"doi":4478},{"id":26,"text":8359,"url":26,"identifiers":8360},"Picoraro, J. A. & LeLeiko, N. S. Omes of inflammatory bowel disease: a primer for clinicians. J. Pediatr. Gastroenterol. Nutr. 66, 374–377 (2018).",{"doi":8361},"10.1097\u002FMPG.0000000000001844",{"id":26,"text":8363,"url":26,"identifiers":8364},"Weiser, M. et al. Molecular classification of Crohn’s disease reveals two clinically relevant subtypes. Gut 67, 36–42 (2018).",{"doi":8365},"10.1136\u002Fgutjnl-2016-312518",{"id":26,"text":8367,"url":26,"identifiers":8368},"Bourreille, A. et al. Saccharomyces boulardii does not prevent relapse of Crohn’s disease. Clin. Gastroenterol. Hepatol. 11, 982–987 (2013).",{"doi":8369},"10.1016\u002Fj.cgh.2013.02.021",{"id":26,"text":8371,"url":26,"identifiers":8372},"Van Gossum, A. et al. Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn’s disease after ileo-caecal resection. Inflamm. Bowel Dis. 13, 135–142 (2007).",{"doi":8373},"10.1002\u002Fibd.20063",{"id":26,"text":8375,"url":26,"identifiers":8376},"Tursi, A. et al. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am. J. Gastroenterol. 105, 2218–2227 (2010).",{"doi":8377},"10.1038\u002Fajg.2010.218",{"id":26,"text":8379,"url":26,"identifiers":8380},"O’Toole, P. W., Marchesi, J. R. & Hill, C. Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat. Microbiol. 2, 17057 (2017).",{"doi":8381},"10.1038\u002Fnmicrobiol.2017.57",{"id":26,"text":8383,"url":26,"identifiers":8384},"Ridaura, V. K. et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341, 1241214 (2013).",{"doi":8385},"10.1126\u002Fscience.1241214",{"id":26,"text":8387,"url":26,"identifiers":8388},"van Nood, E. et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368, 407–415 (2013).",{"doi":1324},{"id":26,"text":8390,"url":26,"identifiers":8391},"Lee, C. H. et al. Frozen versus fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial. JAMA 315, 142–149 (2016).",{"doi":8392},"10.1001\u002Fjama.2015.18098",{"id":26,"text":8394,"url":26,"identifiers":8395},"Kelly, C. R. et al. Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection: a randomized trial. Ann. Intern. Med. 165, 609–616 (2016).",{"doi":8396},"10.7326\u002FM16-0271",{"id":26,"text":8398,"url":26,"identifiers":8399},"Halkjaer, S. I. et al. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study. Gut 67, 2107–2115 (2018).",{"doi":8400},"10.1136\u002Fgutjnl-2018-316434",{"id":26,"text":8402,"url":26,"identifiers":8403},"Delaune, V. et al. Fecal microbiota transplantation: a promising strategy in preventing the progression of non-alcoholic steatohepatitis and improving the anti-cancer immune response. Expert Opin. Biol. Ther. 18, 1061–1071 (2018).",{"doi":8404},"10.1080\u002F14712598.2018.1518424",{"id":26,"text":8406,"url":26,"identifiers":8407},"Moayyedi, P. et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149, 102–109 (2015).",{"doi":8408},"10.1053\u002Fj.gastro.2015.04.001",{"id":26,"text":8410,"url":26,"identifiers":8411},"Gupta, S., Allen-Vercoe, E. & Petrof, E. O. Fecal microbiota transplantation: in perspective. Therap. Adv. Gastroenterol. 9, 229–239 (2016).",{"doi":8412},"10.1177\u002F1756283X15607414",{"id":26,"text":8414,"url":26,"identifiers":8415},"Reid, G. et al. How do probiotics and prebiotics function at distant sites? Benef. Microbes 8, 521–533 (2017). An ISAPP working group article that looks at how microbiome programming in early life influences the gut microbiota communication with distant sites, such as airways, heart and brain, and influences metabolism.",{"doi":8416},"10.3920\u002FBM2016.0222",{"id":26,"text":8418,"url":26,"identifiers":8419},"Hiippala, K. et al. The potential of gut commensals in reinforcing intestinal barrier function and alleviating inflammation. Nutrients 10, E988 (2018).",{"doi":8420},"10.3390\u002Fnu10080988",{"id":26,"text":8422,"url":26,"identifiers":8423},"Crusell, M. K. W. et al. Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum. Microbiome 6, 89 (2018).",{},{"id":26,"text":8425,"url":26,"identifiers":8426},"Cousin, F. J. et al. The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-based therapy in colorectal cancer. Oncotarget 7, 7161–7178 (2016).",{"doi":8427},"10.18632\u002Foncotarget.6881",{"id":26,"text":8429,"url":26,"identifiers":8430},"Zullo, B. A. & Ciafardini, G. Evaluation of physiological properties of yeast strains isolated from olive oil and their in vitro probiotic trait. Food Microbiol. 78, 179–187 (2019).",{"doi":8431},"10.1016\u002Fj.fm.2018.10.016",{"id":26,"text":8433,"url":26,"identifiers":8434},"Gonzalez-Rodriguez, I. et al. Catabolism of glucose and lactose in Bifidobacterium animalis subsp. lactis, studied by 13C nuclear magnetic resonance. Appl. Environ. Microbiol. 79, 7628–7638 (2013).",{"doi":8435},"10.1128\u002FAEM.02529-13",{"id":26,"text":8437,"url":26,"identifiers":8438},"Kostinek, M. et al. Characterisation and biochemical properties of predominant lactic acid bacteria from fermenting cassava for selection as starter cultures. Int. J. Food Microbiol. 114, 342–351 (2007).",{"doi":8439},"10.1016\u002Fj.ijfoodmicro.2006.09.029",{"id":26,"text":8441,"url":26,"identifiers":8442},"Hancock, T., Capon, A., Dooris, M. & Patrick, R. One planet regions: planetary health at the local level. Lancet Planet. Health 1, e92–e93 (2017).",{"doi":8443},"10.1016\u002FS2542-5196(17)30044-X",{"id":26,"text":8445,"url":26,"identifiers":8446},"Garchitorena, A. et al. Disease ecology, health and the environment: a framework to account for ecological and socio-economic drivers in the control of neglected tropical diseases. Philos. Trans. R. Soc. B. 372, 20160128 (2017).",{"doi":8447},"10.1098\u002Frstb.2016.0128"]